primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Blood pressure systolic increased,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Visual impairment,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Paranasal sinus discomfort,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Neuritis,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Pain in extremity,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Blood pressure increased,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Nasal discharge discolouration,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Visual field defect,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Weight decreased,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Gastroenteritis,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Periarthritis,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Bronchospasm,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Nerve injury,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Drug hypersensitivity,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Nasal congestion,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Muscle spasms,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Blindness,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Optic nerve disorder,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Blood cholesterol increased,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Sputum discoloured,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Asthma,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Myalgia,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Rales,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Sinusitis,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Wheezing,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Middle insomnia,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Cervical spinal stenosis,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Forced expiratory volume decreased,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Blood pressure increased,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Nervous system disorder,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Eye disorder,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Heart rate increased,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Nerve compression,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Musculoskeletal stiffness,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Lung disorder,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Fatigue,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1177931127,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Eye pain,,2022,Q1,27,F,20120306.0,20220325.0,20151125,20220330,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220330,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Blood glucose abnormal,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Headache,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Abdominal distension,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Fall,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Nephrolithiasis,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Breast mass,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Head injury,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Palpitations,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Hypercholesterolaemia,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Illness,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Hypertension,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Urinary tract infection,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,White blood cell count increased,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Nausea,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Sinusitis,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Coma,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Renal pain,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Abdominal pain upper,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Fatigue,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Blood pressure increased,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Hepatic pain,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Blood pressure systolic increased,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Pain in extremity,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Hepatic enzyme increased,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Diabetes mellitus,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Discoloured vomit,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
1524593420,15245934,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK (brand name: Ozempic),,,U,,,,,,,,,2022,Q1,Injection site pain,,2022,Q1,20,F,20180105.0,20220309.0,20180806,20220315,EXP,,PHHY2018CA002570,NOVARTIS,,53.0,YR,,F,Y,,,20220315,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Lower respiratory tract infection,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Flank pain,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Dyspnoea exertional,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Insomnia,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Upper respiratory tract infection,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Dyspnoea,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Rales,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Appetite disorder,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Nasal congestion,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Wheezing,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Malaise,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Rhinorrhoea,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Chest discomfort,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Stress,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Chest pain,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Cough,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Injury,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Weight decreased,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Productive cough,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Pyrexia,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Angina pectoris,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Respiration abnormal,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Nasopharyngitis,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Fall,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Depressed mood,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Asthma,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Influenza,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Depressive symptom,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Heart sounds,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
175684664,17568466,47,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q1,Prolonged expiration,,2022,Q1,4,F,,20220113.0,20200320,20220121,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220121,,MD,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Pyrexia,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Heart sounds,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Injury,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Chest discomfort,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Rhinorrhoea,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Depressive symptom,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Depressed mood,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Angina pectoris,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Nasal congestion,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Respiration abnormal,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Asthma,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Prolonged expiration,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Wheezing,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Fall,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Dyspnoea,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Cough,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Upper respiratory tract infection,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Lower respiratory tract infection,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Rales,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Flank pain,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Insomnia,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Dyspnoea exertional,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Appetite disorder,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Malaise,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Productive cough,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Influenza,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Stress,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Weight decreased,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Nasopharyngitis,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,38,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q1,Chest pain,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Pyrexia,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Heart sounds,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Injury,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Chest discomfort,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Rhinorrhoea,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Depressive symptom,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Depressed mood,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Angina pectoris,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Nasal congestion,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Respiration abnormal,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Asthma,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Prolonged expiration,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Wheezing,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Fall,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Dyspnoea,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Cough,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Upper respiratory tract infection,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Lower respiratory tract infection,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Rales,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Flank pain,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Insomnia,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Dyspnoea exertional,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Appetite disorder,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Malaise,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Productive cough,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Influenza,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Stress,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Weight decreased,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Nasopharyngitis,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
177196112,17719611,39,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q1,Chest pain,,2022,Q1,2,F,,20220110.0,20200428,20220118,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220118,,CN,CA,CA,2022,Q1,Adult
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Balance disorder,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood potassium increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Protein urine present,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Urine calcium/creatinine ratio increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood pressure fluctuation,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood pressure decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood sodium increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood urea increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Pulmonary mass,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood iron decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Dry skin,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blindness,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Lymphocyte count decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood creatinine increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Light chain analysis increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Haemoglobin decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Gait disturbance,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Nerve injury,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Muscle spasms,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Osteoporosis,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Memory impairment,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Urinary incontinence,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood pressure systolic increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood chloride decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Hypophagia,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood parathyroid hormone increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Nocturia,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Erythema,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,White blood cell count decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Skin discolouration,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood phosphorus increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Vitamin B12 decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Hypoglycaemia,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Neuropathy peripheral,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Red blood cell count decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Limb discomfort,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Muscular weakness,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Pruritus,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Anxiety,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Headache,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Sleep apnoea syndrome,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Haematocrit decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Insulin-like growth factor decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Fatigue,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Joint swelling,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Atrophic vulvovaginitis,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Alopecia,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Peripheral swelling,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Hyperglycaemia,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Hepatic steatosis,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Heart rate irregular,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Faeces discoloured,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Head injury,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Rash erythematous,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Urethral caruncle,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Cholelithiasis,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Lethargy,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Apraxia,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Confusional state,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Anaemia,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Paraesthesia,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Weight decreased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Sleep disorder,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood pressure increased,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
179366223,17936622,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Bite,,2022,Q1,3,F,,20220119.0,20200624,20220131,EXP,E2B_02935237,CA-Accord-185790,ACCORD,,75.0,YR,,F,Y,40.0,KG,20220131,,HP,CA,CA,2022,Q1,Elderly
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Productive cough,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Influenza,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Nasal congestion,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Chest discomfort,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Depressive symptom,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Cough,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Wheezing,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Dyspnoea,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Pyrexia,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Rales,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Nasopharyngitis,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Rhinorrhoea,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Fall,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Depressed mood,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Flank pain,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Weight decreased,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Stress,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Asthma,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Respiration abnormal,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Dyspnoea exertional,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Prolonged expiration,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Insomnia,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Heart sounds,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Upper respiratory tract infection,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Malaise,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Appetite disorder,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Lower respiratory tract infection,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Angina pectoris,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Chest pain,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
182657232,18265723,36,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,,2022,Q1,Injury,,2022,Q1,2,F,,20220110.0,20200915,20220113,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220113,,CN,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Respiration abnormal,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Nasopharyngitis,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Influenza,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Upper respiratory tract infection,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Lower respiratory tract infection,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Depressed mood,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Pyrexia,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Dyspnoea exertional,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Rhinorrhoea,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Fall,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Malaise,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Prolonged expiration,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Injury,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Heart sounds,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Chest pain,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Cough,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Weight decreased,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Depressive symptom,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Asthma,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Nasal congestion,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Productive cough,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Chest discomfort,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Flank pain,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Stress,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Angina pectoris,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Appetite disorder,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Wheezing,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Rales,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Dyspnoea,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
183019476,18301947,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q1,Insomnia,,2022,Q1,6,F,,20220114.0,20200923,20220125,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220125,,HP,CA,CA,2022,Q1,Adult
186846168,18684616,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Diabetic retinopathy,,2022,Q1,8,F,20200914.0,20220302.0,20201230,20220310,EXP,,US-NOVOPROD-764730,NOVO NORDISK,,62.0,YR,,F,Y,88.0,KG,20220310,,MD,US,US,2022,Q1,Adult
186846168,18684616,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Vitreous haemorrhage,,2022,Q1,8,F,20200914.0,20220302.0,20201230,20220310,EXP,,US-NOVOPROD-764730,NOVO NORDISK,,62.0,YR,,F,Y,88.0,KG,20220310,,MD,US,US,2022,Q1,Adult
186846168,18684616,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Diabetic retinopathy,,2022,Q1,8,F,20200914.0,20220302.0,20201230,20220310,EXP,,US-NOVOPROD-764730,NOVO NORDISK,,62.0,YR,,F,Y,88.0,KG,20220310,,MD,US,US,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Sleep apnoea syndrome,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Nasopharyngitis,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Hyperlipidaemia,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Productive cough,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Oropharyngeal pain,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Asthma,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Pharyngitis,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Nasal congestion,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Lower respiratory tract infection,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Urinary incontinence,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Hypertension,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Type 2 diabetes mellitus,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,20,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,0.25,MG,,QD,2022,Q1,Chronic kidney disease,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Sleep apnoea syndrome,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Nasopharyngitis,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Hyperlipidaemia,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Productive cough,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Oropharyngeal pain,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Asthma,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Pharyngitis,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Nasal congestion,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Lower respiratory tract infection,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Urinary incontinence,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Hypertension,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Type 2 diabetes mellitus,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
189705733,18970573,21,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution Subcutaneous,,,U,,,,,0.25,MG,Solution,QD,2022,Q1,Chronic kidney disease,,2022,Q1,3,F,,20220302.0,20210304,20220309,EXP,,CA-BAUSCH-BL-2021-006680,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Nasal ulcer,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Sinusitis,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Osteoarthritis,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Blood alkaline phosphatase increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Total cholesterol/HDL ratio increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Blood creatinine increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Urine abnormality,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Creatinine urine decreased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Myalgia,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Pyrexia,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Cough,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,C-reactive protein increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Red cell distribution width increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Urine albumin/creatinine ratio increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Body surface area increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Bursitis,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Urine leukocyte esterase positive,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,C-reactive protein,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Blood glucose increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Nasal ulcer,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Weight increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Sinusitis,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Osteoarthritis,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Blood alkaline phosphatase increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Total cholesterol/HDL ratio increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Blood creatinine increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Urine abnormality,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Creatinine urine decreased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Myalgia,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Pyrexia,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Cough,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,C-reactive protein increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Red cell distribution width increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Urine albumin/creatinine ratio increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Body surface area increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Bursitis,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Urine leukocyte esterase positive,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,C-reactive protein,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191341434,19134143,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,4,F,,20220201.0,20210414,20220214,EXP,,CA-PFIZER INC-2021372853,PFIZER,,58.0,YR,,F,Y,91.0,KG,20220214,,HP,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Diarrhoea,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Hormone level abnormal,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Nervousness,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Urinary tract infection,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Headache,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Vaginal infection,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Anxiety,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Constipation,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Fatigue,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Vulvovaginal dryness,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Food craving,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Feeling abnormal,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Heart rate increased,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.5,MG,Solution for injection/infusion,QD,2022,Q1,Feeling jittery,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Diarrhoea,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Hormone level abnormal,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Nervousness,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Urinary tract infection,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Headache,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Vaginal infection,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Anxiety,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Constipation,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Fatigue,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Vulvovaginal dryness,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Food craving,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Feeling abnormal,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Heart rate increased,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191691422,19169142,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,QD,2022,Q1,Feeling jittery,,2022,Q1,2,F,,20220110.0,20210422,20220118,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-098247",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,178.0,KG,20220118,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Insomnia,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Productive cough,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Flank pain,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Influenza,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Depressive symptom,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Dyspnoea,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Chest pain,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Respiration abnormal,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Malaise,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Rhinorrhoea,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Asthma,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Angina pectoris,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Pyrexia,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Chest discomfort,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Lower respiratory tract infection,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Fall,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Upper respiratory tract infection,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Stress,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Weight decreased,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Depressed mood,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Heart sounds,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Rales,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Dyspnoea exertional,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Wheezing,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Injury,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Nasopharyngitis,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Appetite disorder,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Prolonged expiration,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Cough,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,113,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,U,Unknown,,,1.25,MG,Solution for injection,/WK,2022,Q1,Nasal congestion,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Insomnia,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Productive cough,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Flank pain,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Influenza,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Depressive symptom,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Dyspnoea,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Chest pain,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Respiration abnormal,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Malaise,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Rhinorrhoea,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Asthma,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Angina pectoris,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Pyrexia,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Chest discomfort,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Lower respiratory tract infection,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Fall,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Upper respiratory tract infection,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Stress,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Weight decreased,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Depressed mood,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Heart sounds,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Rales,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Dyspnoea exertional,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Wheezing,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Injury,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Nasopharyngitis,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Appetite disorder,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Prolonged expiration,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Cough,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,114,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,Unknown,,,125.0,ML,Solution for injection,/WK,2022,Q1,Nasal congestion,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Insomnia,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Productive cough,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Flank pain,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Influenza,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Depressive symptom,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Dyspnoea,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Chest pain,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Respiration abnormal,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Malaise,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Rhinorrhoea,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Asthma,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Angina pectoris,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Pyrexia,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Chest discomfort,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Lower respiratory tract infection,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Fall,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Upper respiratory tract infection,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Stress,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Weight decreased,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Depressed mood,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Heart sounds,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Rales,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Dyspnoea exertional,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Wheezing,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Injury,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Nasopharyngitis,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Appetite disorder,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Prolonged expiration,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Cough,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
191958364,19195836,115,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q1,Nasal congestion,,2022,Q1,4,F,,20220118.0,20210429,20220128,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220127,,CN,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Prolonged expiration,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Chest pain,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Wheezing,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Dyspnoea,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Productive cough,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Asthma,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Nasopharyngitis,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Influenza,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Depressed mood,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Appetite disorder,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Malaise,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Insomnia,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Rales,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Stress,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Fall,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Lower respiratory tract infection,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Pyrexia,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Nasal congestion,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Heart sounds,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Dyspnoea exertional,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Cough,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Angina pectoris,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Rhinorrhoea,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Depressive symptom,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Chest discomfort,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Injury,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Weight decreased,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Upper respiratory tract infection,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Flank pain,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
193555912,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q1,Respiration abnormal,,2022,Q1,2,F,,20220123.0,20210601,20220204,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220204,,HP,CA,CA,2022,Q1,Adult
194033842,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Impaired quality of life,,2022,Q1,2,F,,20220110.0,20210611,20220121,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20220121,,HP,CA,CA,2022,Q1,Adult
194033842,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Pain,,2022,Q1,2,F,,20220110.0,20210611,20220121,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20220121,,HP,CA,CA,2022,Q1,Adult
194033842,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Emotional distress,,2022,Q1,2,F,,20220110.0,20210611,20220121,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20220121,,HP,CA,CA,2022,Q1,Adult
194033842,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,2,F,,20220110.0,20210611,20220121,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20220121,,HP,CA,CA,2022,Q1,Adult
194033842,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Joint injury,,2022,Q1,2,F,,20220110.0,20210611,20220121,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20220121,,HP,CA,CA,2022,Q1,Adult
194033842,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Somatic symptom disorder,,2022,Q1,2,F,,20220110.0,20210611,20220121,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20220121,,HP,CA,CA,2022,Q1,Adult
194033842,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Drug use disorder,,2022,Q1,2,F,,20220110.0,20210611,20220121,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20220121,,HP,CA,CA,2022,Q1,Adult
194033842,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,2,F,,20220110.0,20210611,20220121,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20220121,,HP,CA,CA,2022,Q1,Adult
194033842,19403384,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Intentional product use issue,,2022,Q1,2,F,,20220110.0,20210611,20220121,EXP,,CA-PFIZER INC-2021630295,PFIZER,,44.0,YR,,M,Y,,,20220121,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Influenza,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Nasopharyngitis,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Prolonged expiration,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Fall,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Heart sounds,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Wheezing,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Upper respiratory tract infection,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Nasal congestion,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Lower respiratory tract infection,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Cough,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Dyspnoea exertional,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Dyspnoea,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Insomnia,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Appetite disorder,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Stress,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Asthma,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Angina pectoris,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Pyrexia,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Injury,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Flank pain,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Respiration abnormal,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Chest pain,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Malaise,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Depressive symptom,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Productive cough,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Weight decreased,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Chest discomfort,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Rhinorrhoea,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Rales,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Depressed mood,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
194155413,19415541,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,U,,,,1.25,MG,,/WK,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,3,F,,20220119.0,20210615,20220202,EXP,,CA-AUROBINDO-AUR-APL-2021-023988,AUROBINDO,,61.0,YR,,F,Y,,,20220202,,HP,CA,CA,2022,Q1,Adult
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Drug ineffective,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Periorbital oedema,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Off label use,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Peripheral swelling,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Rash,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Periorbital swelling,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Renal pain,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Hypoaesthesia,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Incorrect dose administered,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Adverse event,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Pain in extremity,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Eye oedema,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Incontinence,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
1945953013,19459530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.25 mg,,,,,,,,0.25,MG,,,2022,Q1,Rash macular,,2022,Q1,13,F,20210701.0,20220104.0,20210624,20220210,PER,,US-DSJP-DSU-2021-118873,DAIICHI,,71.0,YR,,M,Y,,,20220210,,MD,US,US,2022,Q1,Elderly
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Pharyngitis,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Nasal congestion,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Chronic kidney disease,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Asthma,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Type 2 diabetes mellitus,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Productive cough,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Hyperlipidaemia,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Hypertension,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Urinary incontinence,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Oropharyngeal pain,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Nasopharyngitis,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Lower respiratory tract infection,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
194844246,19484424,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, 1 every 1 Days",,,U,,,,,0.25,MG,,QD,2022,Q1,Sleep apnoea syndrome,,2022,Q1,6,F,,20220309.0,20210701,20220311,EXP,,CA-ORGANON-2007CAN011632,ORGANON,,51.0,YR,,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
196635246,19663524,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 Milligram,,,,,,,,7.0,MG,Unknown,QD,2022,Q1,Gastrointestinal haemorrhage,,2022,Q1,6,F,20210721.0,20220210.0,20210805,20220221,EXP,,US-CELGENEUS-USA-20210800566,CELGENE,,74.0,YR,,M,Y,90.0,KG,20220221,,MD,US,US,2022,Q1,Elderly
196762442,19676244,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Unknown,,,,,,,,,,Tablet,,2022,Q1,Condition aggravated,,2022,Q1,2,F,,20211231.0,20210809,20220111,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-18710,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,69.0,KG,20220111,,HP,CA,CA,2022,Q1,Adult
196762442,19676244,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Unknown,,,,,,,,,,Tablet,,2022,Q1,Lymphoma,,2022,Q1,2,F,,20211231.0,20210809,20220111,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-18710,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,69.0,KG,20220111,,HP,CA,CA,2022,Q1,Adult
196762442,19676244,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Unknown,,,,,,,,,,Tablet,,2022,Q1,Arthralgia,,2022,Q1,2,F,,20211231.0,20210809,20220111,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-18710,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,69.0,KG,20220111,,HP,CA,CA,2022,Q1,Adult
196762442,19676244,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Unknown,,,,,,,,,,Tablet,,2022,Q1,Lymphadenopathy,,2022,Q1,2,F,,20211231.0,20210809,20220111,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-18710,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,69.0,KG,20220111,,HP,CA,CA,2022,Q1,Adult
196762442,19676244,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Unknown,,,,,,,,,,Tablet,,2022,Q1,Non-Hodgkin's lymphoma,,2022,Q1,2,F,,20211231.0,20210809,20220111,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-18710,SAMSUNG BIOEPIS,,62.0,YR,A,F,Y,69.0,KG,20220111,,HP,CA,CA,2022,Q1,Adult
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Peripheral swelling,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Carpal tunnel syndrome,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Psoriatic arthropathy,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Weight decreased,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Feeling hot,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Diabetes mellitus,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Cellulitis,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Off label use,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Arthritis,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Psoriasis,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Skin depigmentation,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
196851985,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Pain in extremity,,2022,Q1,5,F,20200927.0,20220125.0,20210811,20220201,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20220201,,CN,CA,CA,2022,Q1,Elderly
198340603,19834060,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20200601.0,20220225.0,20210915,20220304,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20220304,,HP,DE,DE,2022,Q1,Elderly
198340603,19834060,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Overdose,,2022,Q1,3,F,20200601.0,20220225.0,20210915,20220304,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20220304,,HP,DE,DE,2022,Q1,Elderly
198340603,19834060,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Vertigo,,2022,Q1,3,F,20200601.0,20220225.0,20210915,20220304,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20220304,,HP,DE,DE,2022,Q1,Elderly
198340603,19834060,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Vertigo,,2022,Q1,3,F,20200601.0,20220225.0,20210915,20220304,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20220304,,HP,DE,DE,2022,Q1,Elderly
198340603,19834060,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Hypertensive crisis,,2022,Q1,3,F,20200601.0,20220225.0,20210915,20220304,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20220304,,HP,DE,DE,2022,Q1,Elderly
198340603,19834060,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Deafness,,2022,Q1,3,F,20200601.0,20220225.0,20210915,20220304,EXP,,DE-GLAXOSMITHKLINE-DE2021EME193040,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20220304,,HP,DE,DE,2022,Q1,Elderly
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Malaise,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Influenza,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Disease recurrence,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Chest pain,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Productive cough,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Heart sounds,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Insomnia,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Angina pectoris,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Fall,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Rhinitis,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Cough,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Dyspnoea,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Stress,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Oral candidiasis,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Drug intolerance,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Injury,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Weight decreased,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Eosinophilic bronchitis,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Appetite disorder,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Condition aggravated,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Throat irritation,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Rhonchi,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Cushingoid,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Rhinorrhoea,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Depressed mood,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Oropharyngeal pain,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Decreased activity,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Lung infiltration,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Nasopharyngitis,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Full blood count abnormal,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Bronchitis,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Lower respiratory tract infection,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Wheezing,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Eosinophilia,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Rales,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Depressive symptom,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Eosinophilic pneumonia chronic,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Nasal polyps,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Flank pain,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Haemophilus infection,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Respiration abnormal,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Seasonal allergy,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Prolonged expiration,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Dyspnoea exertional,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Sputum discoloured,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Upper respiratory tract infection,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Pyrexia,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Asthma,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Chest discomfort,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Nasal septum deviation,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198416183,19841618,111,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, weekly",,,U,U,,,,,,,/WK,2022,Q1,Nasal congestion,,2022,Q1,3,F,,20220105.0,20210915,20220114,EXP,,CA-PURDUE-USA-2021-0283999,PURDUE,,61.0,YR,,F,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Constipation,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Nervousness,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Fatigue,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Urinary tract infection,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Vaginal infection,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Heart rate increased,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Diarrhoea,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Feeling abnormal,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Headache,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Feeling jittery,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Hormone level abnormal,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Food craving,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Anxiety,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,,2022,Q1,Vulvovaginal dryness,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Constipation,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Nervousness,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Fatigue,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Urinary tract infection,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Vaginal infection,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Heart rate increased,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Diarrhoea,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Feeling abnormal,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Headache,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Feeling jittery,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Hormone level abnormal,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Food craving,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Anxiety,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198834553,19883455,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.5,MG,,,2022,Q1,Vulvovaginal dryness,,2022,Q1,3,F,,20220126.0,20210926,20220203,EXP,,CA-BAUSCH-BL-2021-032485,BAUSCH AND LOMB,,43.0,YR,,F,Y,178.0,KG,20220203,,HP,CA,CA,2022,Q1,Adult
198881692,19888169,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Vertigo,,2022,Q1,2,F,20200601.0,20220307.0,20210927,20220310,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20220310,,HP,DE,DE,2022,Q1,Elderly
198881692,19888169,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Gait disturbance,,2022,Q1,2,F,20200601.0,20220307.0,20210927,20220310,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20220310,,HP,DE,DE,2022,Q1,Elderly
198881692,19888169,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Vertigo,,2022,Q1,2,F,20200601.0,20220307.0,20210927,20220310,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20220310,,HP,DE,DE,2022,Q1,Elderly
198881692,19888169,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Deafness,,2022,Q1,2,F,20200601.0,20220307.0,20210927,20220310,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20220310,,HP,DE,DE,2022,Q1,Elderly
198881692,19888169,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hypertensive crisis,,2022,Q1,2,F,20200601.0,20220307.0,20210927,20220310,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20220310,,HP,DE,DE,2022,Q1,Elderly
198881692,19888169,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Overdose,,2022,Q1,2,F,20200601.0,20220307.0,20210927,20220310,EXP,,NVSC2021DE215205,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20220310,,HP,DE,DE,2022,Q1,Elderly
198969353,19896935,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,3,F,20200601.0,20220305.0,20210930,20220318,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20220318,,MD,DE,DE,2022,Q1,Elderly
198969353,19896935,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hypertensive crisis,,2022,Q1,3,F,20200601.0,20220305.0,20210930,20220318,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20220318,,MD,DE,DE,2022,Q1,Elderly
198969353,19896935,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20200601.0,20220305.0,20210930,20220318,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20220318,,MD,DE,DE,2022,Q1,Elderly
198969353,19896935,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Overdose,,2022,Q1,3,F,20200601.0,20220305.0,20210930,20220318,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20220318,,MD,DE,DE,2022,Q1,Elderly
198969353,19896935,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Deafness,,2022,Q1,3,F,20200601.0,20220305.0,20210930,20220318,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20220318,,MD,DE,DE,2022,Q1,Elderly
198969353,19896935,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Vertigo,,2022,Q1,3,F,20200601.0,20220305.0,20210930,20220318,EXP,,DE-AUROBINDO-AUR-APL-2021-040286,AUROBINDO,,70.0,YR,,F,Y,82.0,KG,20220318,,MD,DE,DE,2022,Q1,Elderly
199382436,19938243,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",132.0,MG,Y,N,,,215256.0,1.0,MG,Solution for injection,/WK,2022,Q1,Cholelithiasis,,2022,Q1,6,F,20210928.0,20220211.0,20211011,20220222,EXP,,GB-NOVOPROD-853106,NOVO NORDISK,,16.0,YR,,F,Y,121.0,KG,20220222,,MD,GB,GB,2022,Q1,Youth
199382436,19938243,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",132.0,MG,Y,N,,,215256.0,1.0,MG,Solution for injection,/WK,2022,Q1,Hepatic function abnormal,,2022,Q1,6,F,20210928.0,20220211.0,20211011,20220222,EXP,,GB-NOVOPROD-853106,NOVO NORDISK,,16.0,YR,,F,Y,121.0,KG,20220222,,MD,GB,GB,2022,Q1,Youth
199382436,19938243,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4,mg,Once per week",132.0,MG,Y,N,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q1,Cholelithiasis,,2022,Q1,6,F,20210928.0,20220211.0,20211011,20220222,EXP,,GB-NOVOPROD-853106,NOVO NORDISK,,16.0,YR,,F,Y,121.0,KG,20220222,,MD,GB,GB,2022,Q1,Youth
199382436,19938243,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4,mg,Once per week",132.0,MG,Y,N,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q1,Hepatic function abnormal,,2022,Q1,6,F,20210928.0,20220211.0,20211011,20220222,EXP,,GB-NOVOPROD-853106,NOVO NORDISK,,16.0,YR,,F,Y,121.0,KG,20220222,,MD,GB,GB,2022,Q1,Youth
199382436,19938243,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.7 mg, Once per week",132.0,MG,Y,N,,,215256.0,1.7,MG,Solution for injection,/WK,2022,Q1,Cholelithiasis,,2022,Q1,6,F,20210928.0,20220211.0,20211011,20220222,EXP,,GB-NOVOPROD-853106,NOVO NORDISK,,16.0,YR,,F,Y,121.0,KG,20220222,,MD,GB,GB,2022,Q1,Youth
199382436,19938243,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1.7 mg, Once per week",132.0,MG,Y,N,,,215256.0,1.7,MG,Solution for injection,/WK,2022,Q1,Hepatic function abnormal,,2022,Q1,6,F,20210928.0,20220211.0,20211011,20220222,EXP,,GB-NOVOPROD-853106,NOVO NORDISK,,16.0,YR,,F,Y,121.0,KG,20220222,,MD,GB,GB,2022,Q1,Youth
200125466,20012546,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,Y,,,,215256.0,,,Solution for injection,,2022,Q1,Obstructive pancreatitis,,2022,Q1,6,F,20210818.0,20220124.0,20211029,20220202,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20220202,,MD,DE,DE,2022,Q1,Elderly
200125466,20012546,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,Y,,,,215256.0,,,Solution for injection,,2022,Q1,Bile duct stone,,2022,Q1,6,F,20210818.0,20220124.0,20211029,20220202,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20220202,,MD,DE,DE,2022,Q1,Elderly
200125466,20012546,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",23.28,MG,Y,,,,215256.0,0.24,MG,Solution for injection,/WK,2022,Q1,Obstructive pancreatitis,,2022,Q1,6,F,20210818.0,20220124.0,20211029,20220202,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20220202,,MD,DE,DE,2022,Q1,Elderly
200125466,20012546,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",23.28,MG,Y,,,,215256.0,0.24,MG,Solution for injection,/WK,2022,Q1,Bile duct stone,,2022,Q1,6,F,20210818.0,20220124.0,20211029,20220202,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20220202,,MD,DE,DE,2022,Q1,Elderly
200125466,20012546,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,Y,,,,215256.0,,,Solution for injection,,2022,Q1,Obstructive pancreatitis,,2022,Q1,6,F,20210818.0,20220124.0,20211029,20220202,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20220202,,MD,DE,DE,2022,Q1,Elderly
200125466,20012546,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,Y,,,,215256.0,,,Solution for injection,,2022,Q1,Bile duct stone,,2022,Q1,6,F,20210818.0,20220124.0,20211029,20220202,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20220202,,MD,DE,DE,2022,Q1,Elderly
200125466,20012546,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,Y,,,,215256.0,,,Solution for injection,,2022,Q1,Obstructive pancreatitis,,2022,Q1,6,F,20210818.0,20220124.0,20211029,20220202,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20220202,,MD,DE,DE,2022,Q1,Elderly
200125466,20012546,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,23.28,MG,Y,,,,215256.0,,,Solution for injection,,2022,Q1,Bile duct stone,,2022,Q1,6,F,20210818.0,20220124.0,20211029,20220202,EXP,,DE-NOVOPROD-856566,NOVO NORDISK,,73.0,YR,,M,Y,85.0,KG,20220202,,MD,DE,DE,2022,Q1,Elderly
201232822,20123282,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",28.8,MG,D,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q1,Abortion spontaneous,,2022,Q1,2,F,20211008.0,20220222.0,20211129,20220304,EXP,,US-NOVOPROD-863279,NOVO NORDISK,,26.0,YR,,F,Y,82.2,KG,20220304,,MD,US,US,2022,Q1,Young Adult
201232822,20123282,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",28.8,MG,D,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q1,Maternal exposure during pregnancy,,2022,Q1,2,F,20211008.0,20220222.0,20211129,20220304,EXP,,US-NOVOPROD-863279,NOVO NORDISK,,26.0,YR,,F,Y,82.2,KG,20220304,,MD,US,US,2022,Q1,Young Adult
201327912,20132791,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Nausea,,2022,Q1,2,F,20210415.0,20211229.0,20211130,20220104,EXP,,GB-MYLANLABS-2021M1088488,MYLAN,,65.0,YR,,M,Y,80.0,KG,20220104,,HP,GB,GB,2022,Q1,Elderly
201327912,20132791,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,2,F,20210415.0,20211229.0,20211130,20220104,EXP,,GB-MYLANLABS-2021M1088488,MYLAN,,65.0,YR,,M,Y,80.0,KG,20220104,,HP,GB,GB,2022,Q1,Elderly
201327912,20132791,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210415.0,20211229.0,20211130,20220104,EXP,,GB-MYLANLABS-2021M1088488,MYLAN,,65.0,YR,,M,Y,80.0,KG,20220104,,HP,GB,GB,2022,Q1,Elderly
201327912,20132791,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,2,F,20210415.0,20211229.0,20211130,20220104,EXP,,GB-MYLANLABS-2021M1088488,MYLAN,,65.0,YR,,M,Y,80.0,KG,20220104,,HP,GB,GB,2022,Q1,Elderly
201327912,20132791,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Gastrointestinal disorder,,2022,Q1,2,F,20210415.0,20211229.0,20211130,20220104,EXP,,GB-MYLANLABS-2021M1088488,MYLAN,,65.0,YR,,M,Y,80.0,KG,20220104,,HP,GB,GB,2022,Q1,Elderly
201389275,20138927,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Pleural effusion,,2022,Q1,5,F,20211126.0,20220330.0,20211202,20220331,EXP,,NVSC2021JP273267,NOVARTIS,,63.0,YR,,M,Y,75.5,KG,20220331,,MD,JP,JP,2022,Q1,Adult
201497722,20149772,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Gastrointestinal disorder,,2022,Q1,2,F,20210415.0,20211229.0,20211206,20220104,EXP,,GB-EMD Serono-E2B_90085943,EMD SERONO INC,,65.0,YR,E,M,Y,80.0,KG,20220104,,HP,GB,GB,2022,Q1,Elderly
201497722,20149772,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Nausea,,2022,Q1,2,F,20210415.0,20211229.0,20211206,20220104,EXP,,GB-EMD Serono-E2B_90085943,EMD SERONO INC,,65.0,YR,E,M,Y,80.0,KG,20220104,,HP,GB,GB,2022,Q1,Elderly
201497722,20149772,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,2,F,20210415.0,20211229.0,20211206,20220104,EXP,,GB-EMD Serono-E2B_90085943,EMD SERONO INC,,65.0,YR,E,M,Y,80.0,KG,20220104,,HP,GB,GB,2022,Q1,Elderly
201497722,20149772,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210415.0,20211229.0,20211206,20220104,EXP,,GB-EMD Serono-E2B_90085943,EMD SERONO INC,,65.0,YR,E,M,Y,80.0,KG,20220104,,HP,GB,GB,2022,Q1,Elderly
201497722,20149772,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,2,F,20210415.0,20211229.0,20211206,20220104,EXP,,GB-EMD Serono-E2B_90085943,EMD SERONO INC,,65.0,YR,E,M,Y,80.0,KG,20220104,,HP,GB,GB,2022,Q1,Elderly
201498132,20149813,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,1971.0,MG,D,,,,213051.0,,,Tablet,,2022,Q1,Hypovolaemia,,2022,Q1,2,F,20211104.0,20220110.0,20211206,20220120,EXP,,DE-NOVOPROD-870399,NOVO NORDISK,,71.0,YR,,F,Y,96.0,KG,20220120,,MD,DE,DE,2022,Q1,Elderly
201498132,20149813,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,1971.0,MG,D,,,,213051.0,,,Tablet,,2022,Q1,Constipation,,2022,Q1,2,F,20211104.0,20220110.0,20211206,20220120,EXP,,DE-NOVOPROD-870399,NOVO NORDISK,,71.0,YR,,F,Y,96.0,KG,20220120,,MD,DE,DE,2022,Q1,Elderly
201498132,20149813,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,1971.0,MG,D,,,,213051.0,,,Tablet,,2022,Q1,Gastritis,,2022,Q1,2,F,20211104.0,20220110.0,20211206,20220120,EXP,,DE-NOVOPROD-870399,NOVO NORDISK,,71.0,YR,,F,Y,96.0,KG,20220120,,MD,DE,DE,2022,Q1,Elderly
201498132,20149813,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, qd",1971.0,MG,D,,,,213051.0,3.0,MG,Tablet,QD,2022,Q1,Hypovolaemia,,2022,Q1,2,F,20211104.0,20220110.0,20211206,20220120,EXP,,DE-NOVOPROD-870399,NOVO NORDISK,,71.0,YR,,F,Y,96.0,KG,20220120,,MD,DE,DE,2022,Q1,Elderly
201498132,20149813,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, qd",1971.0,MG,D,,,,213051.0,3.0,MG,Tablet,QD,2022,Q1,Constipation,,2022,Q1,2,F,20211104.0,20220110.0,20211206,20220120,EXP,,DE-NOVOPROD-870399,NOVO NORDISK,,71.0,YR,,F,Y,96.0,KG,20220120,,MD,DE,DE,2022,Q1,Elderly
201498132,20149813,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, qd",1971.0,MG,D,,,,213051.0,3.0,MG,Tablet,QD,2022,Q1,Gastritis,,2022,Q1,2,F,20211104.0,20220110.0,20211206,20220120,EXP,,DE-NOVOPROD-870399,NOVO NORDISK,,71.0,YR,,F,Y,96.0,KG,20220120,,MD,DE,DE,2022,Q1,Elderly
201498132,20149813,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,1971.0,MG,D,,,,213051.0,,,Tablet,,2022,Q1,Hypovolaemia,,2022,Q1,2,F,20211104.0,20220110.0,20211206,20220120,EXP,,DE-NOVOPROD-870399,NOVO NORDISK,,71.0,YR,,F,Y,96.0,KG,20220120,,MD,DE,DE,2022,Q1,Elderly
201498132,20149813,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,1971.0,MG,D,,,,213051.0,,,Tablet,,2022,Q1,Constipation,,2022,Q1,2,F,20211104.0,20220110.0,20211206,20220120,EXP,,DE-NOVOPROD-870399,NOVO NORDISK,,71.0,YR,,F,Y,96.0,KG,20220120,,MD,DE,DE,2022,Q1,Elderly
201498132,20149813,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,1971.0,MG,D,,,,213051.0,,,Tablet,,2022,Q1,Gastritis,,2022,Q1,2,F,20211104.0,20220110.0,20211206,20220120,EXP,,DE-NOVOPROD-870399,NOVO NORDISK,,71.0,YR,,F,Y,96.0,KG,20220120,,MD,DE,DE,2022,Q1,Elderly
201536712,20153671,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,2,F,20210415.0,20211229.0,20211206,20220109,EXP,,GB-AUROBINDO-AUR-APL-2021-050005,AUROBINDO,,65.0,YR,,M,Y,80.0,KG,20220109,,HP,GB,GB,2022,Q1,Elderly
201536712,20153671,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,2,F,20210415.0,20211229.0,20211206,20220109,EXP,,GB-AUROBINDO-AUR-APL-2021-050005,AUROBINDO,,65.0,YR,,M,Y,80.0,KG,20220109,,HP,GB,GB,2022,Q1,Elderly
201536712,20153671,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210415.0,20211229.0,20211206,20220109,EXP,,GB-AUROBINDO-AUR-APL-2021-050005,AUROBINDO,,65.0,YR,,M,Y,80.0,KG,20220109,,HP,GB,GB,2022,Q1,Elderly
201536712,20153671,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Gastrointestinal disorder,,2022,Q1,2,F,20210415.0,20211229.0,20211206,20220109,EXP,,GB-AUROBINDO-AUR-APL-2021-050005,AUROBINDO,,65.0,YR,,M,Y,80.0,KG,20220109,,HP,GB,GB,2022,Q1,Elderly
201536712,20153671,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Nausea,,2022,Q1,2,F,20210415.0,20211229.0,20211206,20220109,EXP,,GB-AUROBINDO-AUR-APL-2021-050005,AUROBINDO,,65.0,YR,,M,Y,80.0,KG,20220109,,HP,GB,GB,2022,Q1,Elderly
201604812,20160481,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,UNKNOWN,,,0.25,MG,,,2022,Q1,Toxicity to various agents,,2022,Q1,2,F,,20220118.0,20211208,20220126,EXP,,US-drreddys-SPO/USA/21/0144486,DR REDDYS,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. Am J Gastroenterol. 2021;116:S1192-S1192. doi:10.14309/01.ajg.0000785036.55393.38",66.0,YR,E,M,Y,,,20220127,,MD,US,US,2022,Q1,Elderly
201604812,20160481,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,UNKNOWN,,,0.25,MG,,,2022,Q1,Hypoglycaemia,,2022,Q1,2,F,,20220118.0,20211208,20220126,EXP,,US-drreddys-SPO/USA/21/0144486,DR REDDYS,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. Am J Gastroenterol. 2021;116:S1192-S1192. doi:10.14309/01.ajg.0000785036.55393.38",66.0,YR,E,M,Y,,,20220127,,MD,US,US,2022,Q1,Elderly
201604812,20160481,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,UNKNOWN,,,0.25,MG,,,2022,Q1,Drug level increased,,2022,Q1,2,F,,20220118.0,20211208,20220126,EXP,,US-drreddys-SPO/USA/21/0144486,DR REDDYS,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. Am J Gastroenterol. 2021;116:S1192-S1192. doi:10.14309/01.ajg.0000785036.55393.38",66.0,YR,E,M,Y,,,20220127,,MD,US,US,2022,Q1,Elderly
201604812,20160481,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25 mg q weekly,,,Y,,UNKNOWN,,,0.25,MG,,,2022,Q1,Encephalopathy,,2022,Q1,2,F,,20220118.0,20211208,20220126,EXP,,US-drreddys-SPO/USA/21/0144486,DR REDDYS,"Marks J, Dara P, Edwards C. Novel chemotherapy combination leading to novel problems: A case report on sulfonylurea toxicity secondary to hepatic impairment. Am J Gastroenterol. 2021;116:S1192-S1192. doi:10.14309/01.ajg.0000785036.55393.38",66.0,YR,E,M,Y,,,20220127,,MD,US,US,2022,Q1,Elderly
201637343,20163734,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"14 mg, qd",5180.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis,,2022,Q1,3,F,20211122.0,20220215.0,20211209,20220225,EXP,,TR-NOVOPROD-871731,NOVO NORDISK,,69.0,YR,,F,Y,78.0,KG,20220225,,MD,TR,TR,2022,Q1,Elderly
201637343,20163734,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",5180.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis,,2022,Q1,3,F,20211122.0,20220215.0,20211209,20220225,EXP,,TR-NOVOPROD-871731,NOVO NORDISK,,69.0,YR,,F,Y,78.0,KG,20220225,,MD,TR,TR,2022,Q1,Elderly
201637343,20163734,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,5180.0,MG,Y,N,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis,,2022,Q1,3,F,20211122.0,20220215.0,20211209,20220225,EXP,,TR-NOVOPROD-871731,NOVO NORDISK,,69.0,YR,,F,Y,78.0,KG,20220225,,MD,TR,TR,2022,Q1,Elderly
201637343,20163734,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,5180.0,MG,Y,N,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis,,2022,Q1,3,F,20211122.0,20220215.0,20211209,20220225,EXP,,TR-NOVOPROD-871731,NOVO NORDISK,,69.0,YR,,F,Y,78.0,KG,20220225,,MD,TR,TR,2022,Q1,Elderly
201637343,20163734,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,5180.0,MG,Y,N,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis,,2022,Q1,3,F,20211122.0,20220215.0,20211209,20220225,EXP,,TR-NOVOPROD-871731,NOVO NORDISK,,69.0,YR,,F,Y,78.0,KG,20220225,,MD,TR,TR,2022,Q1,Elderly
201637343,20163734,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",5180.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis,,2022,Q1,3,F,20211122.0,20220215.0,20211209,20220225,EXP,,TR-NOVOPROD-871731,NOVO NORDISK,,69.0,YR,,F,Y,78.0,KG,20220225,,MD,TR,TR,2022,Q1,Elderly
201741303,20174130,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.17 mg, qw",1.53,MG,Y,,,,209637.0,0.17,MG,Solution for injection,/WK,2022,Q1,Loss of consciousness,,2022,Q1,3,F,20211123.0,20220211.0,20211213,20220222,EXP,,US-NOVOPROD-872485,NOVO NORDISK,,58.0,YR,,M,Y,95.0,KG,20220222,,MD,US,US,2022,Q1,Adult
201779292,20177929,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 ug weekly,,,,,,,,1.0,MG,,/WK,2022,Q1,Malaise,,2022,Q1,2,F,20211205.0,20220117.0,20211213,20220123,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143346",BOEHRINGER INGELHEIM,,49.0,YR,A,M,Y,,,20220124,,MD,CA,CA,2022,Q1,Adult
201779292,20177929,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 ug weekly,,,,,,,,1.0,MG,,/WK,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,2,F,20211205.0,20220117.0,20211213,20220123,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143346",BOEHRINGER INGELHEIM,,49.0,YR,A,M,Y,,,20220124,,MD,CA,CA,2022,Q1,Adult
201904092,20190409,2,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Intravenous (not otherwise specified),,,,,,,,,0.25,MG,Injection,,2022,Q1,Urine ketone body present,,2022,Q1,2,F,20210401.0,20220107.0,20211215,20220111,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143737",BOEHRINGER INGELHEIM,,47.0,YR,A,F,Y,,,20220111,,MD,JP,JP,2022,Q1,Adult
201904092,20190409,2,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Intravenous (not otherwise specified),,,,,,,,,0.25,MG,Injection,,2022,Q1,Weight decreased,,2022,Q1,2,F,20210401.0,20220107.0,20211215,20220111,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143737",BOEHRINGER INGELHEIM,,47.0,YR,A,F,Y,,,20220111,,MD,JP,JP,2022,Q1,Adult
201904092,20190409,3,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Intravenous (not otherwise specified),,,,,,,,,0.5,MG,Injection,,2022,Q1,Urine ketone body present,,2022,Q1,2,F,20210401.0,20220107.0,20211215,20220111,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143737",BOEHRINGER INGELHEIM,,47.0,YR,A,F,Y,,,20220111,,MD,JP,JP,2022,Q1,Adult
201904092,20190409,3,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Intravenous (not otherwise specified),,,,,,,,,0.5,MG,Injection,,2022,Q1,Weight decreased,,2022,Q1,2,F,20210401.0,20220107.0,20211215,20220111,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143737",BOEHRINGER INGELHEIM,,47.0,YR,A,F,Y,,,20220111,,MD,JP,JP,2022,Q1,Adult
201904092,20190409,4,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Intravenous (not otherwise specified),,,,,,,,,1.0,MG,Injection,,2022,Q1,Urine ketone body present,,2022,Q1,2,F,20210401.0,20220107.0,20211215,20220111,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143737",BOEHRINGER INGELHEIM,,47.0,YR,A,F,Y,,,20220111,,MD,JP,JP,2022,Q1,Adult
201904092,20190409,4,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Intravenous (not otherwise specified),,,,,,,,,1.0,MG,Injection,,2022,Q1,Weight decreased,,2022,Q1,2,F,20210401.0,20220107.0,20211215,20220111,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143737",BOEHRINGER INGELHEIM,,47.0,YR,A,F,Y,,,20220111,,MD,JP,JP,2022,Q1,Adult
201971982,20197198,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24,mg,Once per week",,,,,,,215256.0,0.24,MG,Solution for injection,/WK,2022,Q1,Gastric pH decreased,,2022,Q1,2,F,20211124.0,20220120.0,20211217,20220128,EXP,,DK-NOVOPROD-870957,NOVO NORDISK,,67.0,YR,,M,Y,117.0,KG,20220128,,MD,DK,DK,2022,Q1,Elderly
202255685,20225568,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis acute,,2022,Q1,5,F,20211024.0,20220223.0,20211224,20220304,EXP,,CA-NOVOPROD-876341,NOVO NORDISK,,78.0,YR,,M,Y,96.0,KG,20220304,,MD,CA,CA,2022,Q1,Elderly
202294133,20229413,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q1,Non-cardiac chest pain,,2022,Q1,3,F,20201214.0,20220107.0,20211225,20220112,EXP,,NVSC2021DK289506,NOVARTIS,,79.0,YR,,M,Y,89.0,KG,20220112,,MD,DK,DK,2022,Q1,Elderly
202294133,20229413,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q1,Non-cardiac chest pain,,2022,Q1,3,F,20201214.0,20220107.0,20211225,20220112,EXP,,NVSC2021DK289506,NOVARTIS,,79.0,YR,,M,Y,89.0,KG,20220112,,MD,DK,DK,2022,Q1,Elderly
202307253,20230725,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK, qd",,,Y,,,,213051.0,,,Tablet,QD,2022,Q1,Cholecystitis acute,,2022,Q1,3,F,20211206.0,20211229.0,20211227,20220110,EXP,,BG-NOVOPROD-876831,NOVO NORDISK,,74.0,YR,,M,Y,123.0,KG,20220110,,MD,BG,BG,2022,Q1,Elderly
202355972,20235597,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"7.0 mg, qd",81.0,MG,Y,N,,,213051.0,7.0,MG,Tablet,QD,2022,Q1,Vertigo positional,,2022,Q1,2,F,20211209.0,20220121.0,20211228,20220202,EXP,,FI-NOVOPROD-877748,NOVO NORDISK,,46.0,YR,,F,Y,102.0,KG,20220202,,MD,FI,FI,2022,Q1,Adult
202355972,20235597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3.0,mg,Once per day",81.0,MG,Y,N,,,213051.0,3.0,MG,Tablet,QD,2022,Q1,Vertigo positional,,2022,Q1,2,F,20211209.0,20220121.0,20211228,20220202,EXP,,FI-NOVOPROD-877748,NOVO NORDISK,,46.0,YR,,F,Y,102.0,KG,20220202,,MD,FI,FI,2022,Q1,Adult
202499492,20249949,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,,,2022,Q1,Non-cardiac chest pain,,2022,Q1,2,F,20201214.0,20220107.0,20211229,20220117,EXP,,DK-TEVA-2021-DK-1990884,TEVA,,79.0,YR,E,M,Y,89.0,KG,20220117,,HP,DK,DK,2022,Q1,Elderly
202732741,20273274,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,,,,,2022,Q1,Device expulsion,,2022,Q1,1,I,20210826.0,20211007.0,20220101,20220101,PER,,"US-COOPERSURGICAL, INC.-US-2021CPS003068",COOPERSURGICAL,,35.0,YR,,F,Y,104.31,KG,20220102,,HP,US,US,2022,Q1,Adult
202777121,20277712,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,U,,,,,,,,,2022,Q1,Reperfusion arrhythmia,,2022,Q1,1,I,20211219.0,20211221.0,20220103,20220103,EXP,,GB-AUROBINDO-AUR-APL-2021-053804,AUROBINDO,,35.0,YR,,F,Y,110.0,KG,20220103,,HP,GB,GB,2022,Q1,Adult
202802641,20280264,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, QW",4.8,MG,,,,,,2.0,MG,,/WK,2022,Q1,Lymphoedema,,2022,Q1,1,I,20200916.0,20210222.0,20220103,20220103,EXP,,NVSC2021IT043618,NOVARTIS,,64.0,YR,,M,Y,90.0,KG,20220103,,HP,IT,IT,2022,Q1,Adult
202827521,20282752,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,1,I,,20211220.0,20220103,20220103,EXP,,CZ-EMD Serono-9288523,EMD SERONO INC,Unknown. Semaglutide: a simple solution of a common barrier in the intensification of diabetes therapy. KAZUISTIKY V DIABETOLOGII. 2021;19(4):38-39.,69.0,YR,E,M,Y,114.0,KG,20220103,,MD,CZ,,2022,Q1,Elderly
202827521,20282752,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q1,Diabetic metabolic decompensation,,2022,Q1,1,I,,20211220.0,20220103,20220103,EXP,,CZ-EMD Serono-9288523,EMD SERONO INC,Unknown. Semaglutide: a simple solution of a common barrier in the intensification of diabetes therapy. KAZUISTIKY V DIABETOLOGII. 2021;19(4):38-39.,69.0,YR,E,M,Y,114.0,KG,20220103,,MD,CZ,,2022,Q1,Elderly
202896602,20289660,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Non-cardiac chest pain,,2022,Q1,2,F,20201214.0,20220127.0,20220104,20220129,EXP,,NVSC2022DK000563,NOVARTIS,,79.0,YR,,M,Y,89.0,KG,20220129,,MD,DK,DK,2022,Q1,Elderly
202896602,20289660,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Non-cardiac chest pain,,2022,Q1,2,F,20201214.0,20220127.0,20220104,20220129,EXP,,NVSC2022DK000563,NOVARTIS,,79.0,YR,,M,Y,89.0,KG,20220129,,MD,DK,DK,2022,Q1,Elderly
202905051,20290505,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Cholecystitis,,2022,Q1,1,I,20211118.0,,20220103,20220103,DIR,FDA-CDER-CTU-2022-412,,FDA-CTU,,79.0,YR,,M,N,,,20211201,N,PH,US,,2022,Q1,Elderly
202912761,20291276,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Negative thoughts,,2022,Q1,1,I,20211004.0,,20220103,20220103,DIR,597504,,FDA-CTU,,39.0,YR,,F,N,103.0,KG,20220103,N,PH,US,,2022,Q1,Adult
202912761,20291276,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Anxiety,,2022,Q1,1,I,20211004.0,,20220103,20220103,DIR,597504,,FDA-CTU,,39.0,YR,,F,N,103.0,KG,20220103,N,PH,US,,2022,Q1,Adult
202912761,20291276,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Depression,,2022,Q1,1,I,20211004.0,,20220103,20220103,DIR,597504,,FDA-CTU,,39.0,YR,,F,N,103.0,KG,20220103,N,PH,US,,2022,Q1,Adult
202978991,20297899,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Pneumonia,,2022,Q1,1,I,20201219.0,20220103.0,20220105,20220105,EXP,,NVSC2022DE000756,NOVARTIS,,66.0,YR,,M,Y,90.0,KG,20220105,,MD,DE,DE,2022,Q1,Elderly
202978991,20297899,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Illness,,2022,Q1,1,I,20201219.0,20220103.0,20220105,20220105,EXP,,NVSC2022DE000756,NOVARTIS,,66.0,YR,,M,Y,90.0,KG,20220105,,MD,DE,DE,2022,Q1,Elderly
202978991,20297899,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Pneumonia,,2022,Q1,1,I,20201219.0,20220103.0,20220105,20220105,EXP,,NVSC2022DE000756,NOVARTIS,,66.0,YR,,M,Y,90.0,KG,20220105,,MD,DE,DE,2022,Q1,Elderly
202978991,20297899,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Illness,,2022,Q1,1,I,20201219.0,20220103.0,20220105,20220105,EXP,,NVSC2022DE000756,NOVARTIS,,66.0,YR,,M,Y,90.0,KG,20220105,,MD,DE,DE,2022,Q1,Elderly
203029371,20302937,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,,,Unknown,,,,,,,2022,Q1,Reperfusion arrhythmia,,2022,Q1,1,I,20211219.0,20211222.0,20220106,20220106,EXP,GB-MHRA-TPP44631731C8333173YC1639874873888,GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2021-08335,ALKEM,,35.0,YR,,F,Y,110.0,KG,20220106,,HP,GB,GB,2022,Q1,Adult
203063554,20306355,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qwk",,,,,,,,,,,/WK,2022,Q1,Hepatic enzyme increased,,2022,Q1,4,F,20211203.0,20220121.0,20220106,20220128,EXP,,CA-UROVANT SCIENCES GMBH-202112-URV-000802,UROVANT SCIENCES,,62.0,YR,,M,Y,100.23,KG,20220128,,MD,CA,CA,2022,Q1,Adult
203063554,20306355,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qwk",,,,,,,,,,,/WK,2022,Q1,Jaundice cholestatic,,2022,Q1,4,F,20211203.0,20220121.0,20220106,20220128,EXP,,CA-UROVANT SCIENCES GMBH-202112-URV-000802,UROVANT SCIENCES,,62.0,YR,,M,Y,100.23,KG,20220128,,MD,CA,CA,2022,Q1,Adult
203103761,20310376,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"strength: 1 mg, Solution for injection, solution in pre-filled injection pen, 1 mg/v, dose: 1",,,,,,,,,,,,2022,Q1,Muscle twitching,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,SE-MPA-2021-094550,SE-Accord-249250,ACCORD,,76.0,YR,,M,Y,,,20220107,,MD,SE,SE,2022,Q1,Elderly
203103761,20310376,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"strength: 1 mg, Solution for injection, solution in pre-filled injection pen, 1 mg/v, dose: 1",,,,,,,,,,,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,SE-MPA-2021-094550,SE-Accord-249250,ACCORD,,76.0,YR,,M,Y,,,20220107,,MD,SE,SE,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,White blood cell count decreased,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Chills,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Haemorrhage intracranial,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Supraventricular tachycardia,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Angina pectoris,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Hypophosphataemia,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Hypoalbuminaemia,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Pyrexia,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood bicarbonate decreased,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Sepsis,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Syncope,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Troponin I increased,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Neutrophil count decreased,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Atrial flutter,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203117463,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Blood creatinine increased,,2022,Q1,3,F,20210815.0,20220302.0,20220108,20220314,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220314,,MD,US,,2022,Q1,Elderly
203131233,20313123,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Non-cardiac chest pain,,2022,Q1,3,F,20201214.0,20220126.0,20220109,20220203,EXP,,DK-ORGANON-O2201DNK000014,ORGANON,,79.0,YR,,M,Y,89.0,KG,20220203,,MD,DK,DK,2022,Q1,Elderly
203131233,20313123,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Non-cardiac chest pain,,2022,Q1,3,F,20201214.0,20220126.0,20220109,20220203,EXP,,DK-ORGANON-O2201DNK000014,ORGANON,,79.0,YR,,M,Y,89.0,KG,20220203,,MD,DK,DK,2022,Q1,Elderly
203165533,20316553,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Non-cardiac chest pain,,2022,Q1,3,F,20201214.0,20220228.0,20220110,20220304,EXP,,DK-MYLANLABS-2022M1000790,MYLAN,,79.0,YR,,M,Y,89.0,KG,20220304,,MD,DK,DK,2022,Q1,Elderly
203165533,20316553,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Non-cardiac chest pain,,2022,Q1,3,F,20201214.0,20220228.0,20220110,20220304,EXP,,DK-MYLANLABS-2022M1000790,MYLAN,,79.0,YR,,M,Y,89.0,KG,20220304,,MD,DK,DK,2022,Q1,Elderly
203171751,20317175,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK (1 IE, montags)",,,,,,,,,,Injection,,2022,Q1,Cold sweat,,2022,Q1,1,I,,20211230.0,20220110,20220110,EXP,,DE-MYLANLABS-2021M1098067,MYLAN,,72.0,YR,,M,Y,121.0,KG,20220110,,MD,DE,DE,2022,Q1,Elderly
203171751,20317175,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK (1 IE, montags)",,,,,,,,,,Injection,,2022,Q1,Hypotension,,2022,Q1,1,I,,20211230.0,20220110,20220110,EXP,,DE-MYLANLABS-2021M1098067,MYLAN,,72.0,YR,,M,Y,121.0,KG,20220110,,MD,DE,DE,2022,Q1,Elderly
203171751,20317175,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK (1 IE, montags)",,,,,,,,,,Injection,,2022,Q1,Malaise,,2022,Q1,1,I,,20211230.0,20220110,20220110,EXP,,DE-MYLANLABS-2021M1098067,MYLAN,,72.0,YR,,M,Y,121.0,KG,20220110,,MD,DE,DE,2022,Q1,Elderly
203171751,20317175,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK (1 IE, montags)",,,,,,,,,,Injection,,2022,Q1,Tachycardia,,2022,Q1,1,I,,20211230.0,20220110,20220110,EXP,,DE-MYLANLABS-2021M1098067,MYLAN,,72.0,YR,,M,Y,121.0,KG,20220110,,MD,DE,DE,2022,Q1,Elderly
203171751,20317175,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK (1 IE, montags)",,,,,,,,,,Injection,,2022,Q1,Dyspnoea exertional,,2022,Q1,1,I,,20211230.0,20220110,20220110,EXP,,DE-MYLANLABS-2021M1098067,MYLAN,,72.0,YR,,M,Y,121.0,KG,20220110,,MD,DE,DE,2022,Q1,Elderly
203171751,20317175,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK (1 IE, montags)",,,,,,,,,,Injection,,2022,Q1,Dizziness,,2022,Q1,1,I,,20211230.0,20220110,20220110,EXP,,DE-MYLANLABS-2021M1098067,MYLAN,,72.0,YR,,M,Y,121.0,KG,20220110,,MD,DE,DE,2022,Q1,Elderly
203200852,20320085,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24,mg,Once per week",0.72,MG,D,,,,215256.0,0.24,MG,Solution for injection,/WK,2022,Q1,Gastric ulcer haemorrhage,,2022,Q1,2,F,20220102.0,20220111.0,20220111,20220114,EXP,,CO-NOVOPROD-881667,NOVO NORDISK,,83.0,YR,,F,Y,77.0,KG,20220114,,MD,CO,CO,2022,Q1,Elderly
203223781,20322378,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Off label use,,2022,Q1,1,I,20210101.0,20211221.0,20220111,20220111,PER,,US-BEH-2021139905,CSL BEHRING,,65.0,YR,E,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203223781,20322378,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Bronchitis,,2022,Q1,1,I,20210101.0,20211221.0,20220111,20220111,PER,,US-BEH-2021139905,CSL BEHRING,,65.0,YR,E,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203223781,20322378,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,No adverse event,,2022,Q1,1,I,20210101.0,20211221.0,20220111,20220111,PER,,US-BEH-2021139905,CSL BEHRING,,65.0,YR,E,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203223781,20322378,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Bronchitis,,2022,Q1,1,I,20210101.0,20211221.0,20220111,20220111,PER,,US-BEH-2021139905,CSL BEHRING,,65.0,YR,E,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203449691,20344969,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2022,Q1,Haematuria,,2022,Q1,1,I,,20220112.0,20220118,20220118,EXP,,CA-ROCHE-3001040,ROCHE,,79.0,YR,,M,Y,,,20220118,,HP,CA,,2022,Q1,Elderly
203449691,20344969,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,,,2022,Q1,Blood pressure systolic increased,,2022,Q1,1,I,,20220112.0,20220118,20220118,EXP,,CA-ROCHE-3001040,ROCHE,,79.0,YR,,M,Y,,,20220118,,HP,CA,,2022,Q1,Elderly
203541462,20354146,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q1,Cholecystitis acute,,2022,Q1,2,F,20211201.0,20220210.0,20220120,20220218,EXP,,UA-NOVOPROD-883120,NOVO NORDISK,,61.0,YR,,M,Y,98.0,KG,20220218,,MD,UA,UA,2022,Q1,Adult
203541511,20354151,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",7518.0,MG,Y,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis acute,,2022,Q1,1,I,20220101.0,20220110.0,20220120,20220120,EXP,,UA-NOVOPROD-882519,NOVO NORDISK,,69.0,YR,,M,Y,101.0,KG,20220120,,MD,UA,UA,2022,Q1,Elderly
203541511,20354151,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,7518.0,MG,Y,,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis acute,,2022,Q1,1,I,20220101.0,20220110.0,20220120,20220120,EXP,,UA-NOVOPROD-882519,NOVO NORDISK,,69.0,YR,,M,Y,101.0,KG,20220120,,MD,UA,UA,2022,Q1,Elderly
203541511,20354151,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,7518.0,MG,Y,,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis acute,,2022,Q1,1,I,20220101.0,20220110.0,20220120,20220120,EXP,,UA-NOVOPROD-882519,NOVO NORDISK,,69.0,YR,,M,Y,101.0,KG,20220120,,MD,UA,UA,2022,Q1,Elderly
203556413,20355641,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, weekly",,,U,,,,,0.5,MG,,/WK,2022,Q1,Serotonin syndrome,,2022,Q1,3,F,,20220127.0,20220120,20220131,EXP,,NVSC2022PL008821,NOVARTIS,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. PRACTICE MEDICINE - PSYCHIATRY. 2021",29.0,YR,,F,Y,,,20220131,,HP,PL,PL,2022,Q1,Young Adult
203642701,20364270,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Tachycardia,,2022,Q1,1,I,20211115.0,,20220121,20220121,DIR,FDA-CDER-CTU-2022-5613,,FDA-CTU,,51.0,YR,,M,N,126.0,KG,20220118,N,PH,US,,2022,Q1,Adult
203642701,20364270,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Cholelithiasis,,2022,Q1,1,I,20211115.0,,20220121,20220121,DIR,FDA-CDER-CTU-2022-5613,,FDA-CTU,,51.0,YR,,M,N,126.0,KG,20220118,N,PH,US,,2022,Q1,Adult
203642701,20364270,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Infection,,2022,Q1,1,I,20211115.0,,20220121,20220121,DIR,FDA-CDER-CTU-2022-5613,,FDA-CTU,,51.0,YR,,M,N,126.0,KG,20220118,N,PH,US,,2022,Q1,Adult
203699361,20369936,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg 1x weekly subcutaneous,,,,,,,,,,,,2022,Q1,Atrial fibrillation,,2022,Q1,1,I,,20220116.0,20220124,20220124,EXP,,DE-AstraZeneca-2022A028055,ASTRAZENECA,,67.0,YR,,M,Y,112.0,KG,20220124,,MD,DE,,2022,Q1,Elderly
203699361,20369936,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg 1x weekly subcutaneous,,,,,,,,,,,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220116.0,20220124,20220124,EXP,,DE-AstraZeneca-2022A028055,ASTRAZENECA,,67.0,YR,,M,Y,112.0,KG,20220124,,MD,DE,,2022,Q1,Elderly
203699361,20369936,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.5 mg 1x weekly subcutaneous,,,,,,,,,,,,2022,Q1,Dyspnoea at rest,,2022,Q1,1,I,,20220116.0,20220124,20220124,EXP,,DE-AstraZeneca-2022A028055,ASTRAZENECA,,67.0,YR,,M,Y,112.0,KG,20220124,,MD,DE,,2022,Q1,Elderly
203731433,20373143,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",5460.0,MG,Y,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis acute,,2022,Q1,3,F,20211221.0,20220222.0,20220125,20220303,EXP,,US-NOVOPROD-883877,NOVO NORDISK,,74.0,YR,,M,Y,101.0,KG,20220303,,MD,US,US,2022,Q1,Elderly
203731433,20373143,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",5460.0,MG,Y,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholelithiasis,,2022,Q1,3,F,20211221.0,20220222.0,20220125,20220303,EXP,,US-NOVOPROD-883877,NOVO NORDISK,,74.0,YR,,M,Y,101.0,KG,20220303,,MD,US,US,2022,Q1,Elderly
203731433,20373143,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",5460.0,MG,Y,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Pancreatitis acute,,2022,Q1,3,F,20211221.0,20220222.0,20220125,20220303,EXP,,US-NOVOPROD-883877,NOVO NORDISK,,74.0,YR,,M,Y,101.0,KG,20220303,,MD,US,US,2022,Q1,Elderly
204031841,20403184,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2022,Q1,Hypoacusis,,2022,Q1,1,I,,20220119.0,20220131,20220131,EXP,CA- HEALTHCANVIG- E2B_04528744,CA-NOVOPROD-884882,NOVO NORDISK,,51.0,YR,,F,Y,,,20220131,,CN,CA,CA,2022,Q1,Adult
204031841,20403184,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2022,Q1,Diabetes mellitus,,2022,Q1,1,I,,20220119.0,20220131,20220131,EXP,CA- HEALTHCANVIG- E2B_04528744,CA-NOVOPROD-884882,NOVO NORDISK,,51.0,YR,,F,Y,,,20220131,,CN,CA,CA,2022,Q1,Adult
204031841,20403184,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220119.0,20220131,20220131,EXP,CA- HEALTHCANVIG- E2B_04528744,CA-NOVOPROD-884882,NOVO NORDISK,,51.0,YR,,F,Y,,,20220131,,CN,CA,CA,2022,Q1,Adult
204031841,20403184,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2022,Q1,Depression,,2022,Q1,1,I,,20220119.0,20220131,20220131,EXP,CA- HEALTHCANVIG- E2B_04528744,CA-NOVOPROD-884882,NOVO NORDISK,,51.0,YR,,F,Y,,,20220131,,CN,CA,CA,2022,Q1,Adult
204031841,20403184,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2022,Q1,Sleep disorder due to a general medical condition,,2022,Q1,1,I,,20220119.0,20220131,20220131,EXP,CA- HEALTHCANVIG- E2B_04528744,CA-NOVOPROD-884882,NOVO NORDISK,,51.0,YR,,F,Y,,,20220131,,CN,CA,CA,2022,Q1,Adult
204031841,20403184,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2022,Q1,Asthma,,2022,Q1,1,I,,20220119.0,20220131,20220131,EXP,CA- HEALTHCANVIG- E2B_04528744,CA-NOVOPROD-884882,NOVO NORDISK,,51.0,YR,,F,Y,,,20220131,,CN,CA,CA,2022,Q1,Adult
204031841,20403184,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,1,I,,20220119.0,20220131,20220131,EXP,CA- HEALTHCANVIG- E2B_04528744,CA-NOVOPROD-884882,NOVO NORDISK,,51.0,YR,,F,Y,,,20220131,,CN,CA,CA,2022,Q1,Adult
204031841,20403184,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,209637.0,,,,,2022,Q1,Wheezing,,2022,Q1,1,I,,20220119.0,20220131,20220131,EXP,CA- HEALTHCANVIG- E2B_04528744,CA-NOVOPROD-884882,NOVO NORDISK,,51.0,YR,,F,Y,,,20220131,,CN,CA,CA,2022,Q1,Adult
204098201,20409820,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IU, Mondays",,,,,,,,,,,,2022,Q1,Cold sweat,,2022,Q1,1,I,,20220119.0,20220201,20220201,EXP,DE-BFARM-21011927,DE-Accord-251898,ACCORD,,72.0,YR,E,M,Y,121.0,KG,20220201,,MD,DE,DE,2022,Q1,Elderly
204098201,20409820,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IU, Mondays",,,,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,1,I,,20220119.0,20220201,20220201,EXP,DE-BFARM-21011927,DE-Accord-251898,ACCORD,,72.0,YR,E,M,Y,121.0,KG,20220201,,MD,DE,DE,2022,Q1,Elderly
204098201,20409820,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IU, Mondays",,,,,,,,,,,,2022,Q1,Tachycardia,,2022,Q1,1,I,,20220119.0,20220201,20220201,EXP,DE-BFARM-21011927,DE-Accord-251898,ACCORD,,72.0,YR,E,M,Y,121.0,KG,20220201,,MD,DE,DE,2022,Q1,Elderly
204098201,20409820,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IU, Mondays",,,,,,,,,,,,2022,Q1,Dyspnoea exertional,,2022,Q1,1,I,,20220119.0,20220201,20220201,EXP,DE-BFARM-21011927,DE-Accord-251898,ACCORD,,72.0,YR,E,M,Y,121.0,KG,20220201,,MD,DE,DE,2022,Q1,Elderly
204098201,20409820,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IU, Mondays",,,,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,1,I,,20220119.0,20220201,20220201,EXP,DE-BFARM-21011927,DE-Accord-251898,ACCORD,,72.0,YR,E,M,Y,121.0,KG,20220201,,MD,DE,DE,2022,Q1,Elderly
204098201,20409820,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 IU, Mondays",,,,,,,,,,,,2022,Q1,Malaise,,2022,Q1,1,I,,20220119.0,20220201,20220201,EXP,DE-BFARM-21011927,DE-Accord-251898,ACCORD,,72.0,YR,E,M,Y,121.0,KG,20220201,,MD,DE,DE,2022,Q1,Elderly
204100841,20410084,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,,,,,1.0,MG,,QW,2022,Q1,Diarrhoea,,2022,Q1,1,I,20220121.0,,20220131,20220131,DIR,FDA-CDER-CTU-2022-8630,,FDA-CTU,,75.0,YR,,M,N,117.0,KG,20220128,N,PH,US,,2022,Q1,Elderly
204100841,20410084,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,,,,,1.0,MG,,QW,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20220121.0,,20220131,20220131,DIR,FDA-CDER-CTU-2022-8630,,FDA-CTU,,75.0,YR,,M,N,117.0,KG,20220128,N,PH,US,,2022,Q1,Elderly
204109611,20410961,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : .25MG;?Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2022,Q1,Rash,,2022,Q1,1,I,20211109.0,,20220131,20220131,DIR,FDA-CDER-CTU-2022-8703,,FDA-CTU,,73.0,YR,,M,N,,,20211112,N,PH,US,,2022,Q1,Elderly
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Headache,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Myopathy,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Drug interaction,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Muscle spasms,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Chills,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Renal failure,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Labelled drug-drug interaction medication error,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Serotonin syndrome,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Product prescribing error,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Drug titration error,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Off label use,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Urine flow decreased,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Contraindicated product administered,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Myalgia,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Myoglobinuria,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Body temperature increased,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Hyperhidrosis,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Rhabdomyolysis,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Product use in unapproved indication,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,12,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Contraindicated product prescribed,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Headache,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Myopathy,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Drug interaction,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Muscle spasms,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Chills,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Renal failure,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Labelled drug-drug interaction medication error,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Serotonin syndrome,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Product prescribing error,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Drug titration error,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Off label use,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Urine flow decreased,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Contraindicated product administered,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Myalgia,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Myoglobinuria,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Body temperature increased,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Hyperhidrosis,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Rhabdomyolysis,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Product use in unapproved indication,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204119875,20411987,13,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,U,,Unknown,,,0.5,MG,,/WK,2022,Q1,Contraindicated product prescribed,,2022,Q1,5,F,,20220321.0,20220201,20220329,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,,29.0,YR,,F,Y,,,20220329,,HP,PL,PL,2022,Q1,Young Adult
204124062,20412406,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",,,,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q1,Cholecystitis chronic,,2022,Q1,2,F,20211115.0,20220201.0,20220201,20220210,EXP,,US-NOVOPROD-868072,NOVO NORDISK,,63.0,YR,,M,Y,154.0,KG,20220210,,MD,US,US,2022,Q1,Adult
204130683,20413068,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 mg,,,,,,,,7.0,MG,Tablet,,2022,Q1,Dyspnoea,,2022,Q1,3,F,20211006.0,20220308.0,20220201,20220309,EXP,,NVSJ2022JP002194,NOVARTIS,,81.0,YR,,F,Y,,,20220310,,MD,JP,JP,2022,Q1,Elderly
204130683,20413068,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 mg,,,,,,,,7.0,MG,Tablet,,2022,Q1,Interstitial lung disease,,2022,Q1,3,F,20211006.0,20220308.0,20220201,20220309,EXP,,NVSJ2022JP002194,NOVARTIS,,81.0,YR,,F,Y,,,20220310,,MD,JP,JP,2022,Q1,Elderly
204187162,20418716,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,D,,,,,0.5,MG,,,2022,Q1,Myoglobinuria,,2022,Q1,2,F,,20220204.0,20220202,20220213,EXP,,PL-BAXTER-2022BAX001920,BAXTER,"WORON J, SIWEK M. PHARMACOLOGICAL TREATMENT OF OBESITY AND HEALTH- AND LIFE-THREATENING DRUG INTERACTIONS. PRACTICAL MEDICINE - PSYCHIATRY. 2021;83(6):49-51.",29.0,YR,,F,Y,,,20220213,,MD,PL,PL,2022,Q1,Young Adult
204187162,20418716,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,D,,,,,0.5,MG,,,2022,Q1,Myopathy,,2022,Q1,2,F,,20220204.0,20220202,20220213,EXP,,PL-BAXTER-2022BAX001920,BAXTER,"WORON J, SIWEK M. PHARMACOLOGICAL TREATMENT OF OBESITY AND HEALTH- AND LIFE-THREATENING DRUG INTERACTIONS. PRACTICAL MEDICINE - PSYCHIATRY. 2021;83(6):49-51.",29.0,YR,,F,Y,,,20220213,,MD,PL,PL,2022,Q1,Young Adult
204187162,20418716,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,D,,,,,0.5,MG,,,2022,Q1,Serotonin syndrome,,2022,Q1,2,F,,20220204.0,20220202,20220213,EXP,,PL-BAXTER-2022BAX001920,BAXTER,"WORON J, SIWEK M. PHARMACOLOGICAL TREATMENT OF OBESITY AND HEALTH- AND LIFE-THREATENING DRUG INTERACTIONS. PRACTICAL MEDICINE - PSYCHIATRY. 2021;83(6):49-51.",29.0,YR,,F,Y,,,20220213,,MD,PL,PL,2022,Q1,Young Adult
204187162,20418716,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,D,,,,,0.5,MG,,,2022,Q1,Renal failure,,2022,Q1,2,F,,20220204.0,20220202,20220213,EXP,,PL-BAXTER-2022BAX001920,BAXTER,"WORON J, SIWEK M. PHARMACOLOGICAL TREATMENT OF OBESITY AND HEALTH- AND LIFE-THREATENING DRUG INTERACTIONS. PRACTICAL MEDICINE - PSYCHIATRY. 2021;83(6):49-51.",29.0,YR,,F,Y,,,20220213,,MD,PL,PL,2022,Q1,Young Adult
204288881,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,,,2022,Q1,Drug interaction,,2022,Q1,1,I,,20220124.0,20220204,20220204,EXP,,PL-Accord-252187,ACCORD,"Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51.",29.0,YR,,F,Y,,,20220204,,MD,PL,PL,2022,Q1,Young Adult
204288881,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,,,2022,Q1,Serotonin syndrome,,2022,Q1,1,I,,20220124.0,20220204,20220204,EXP,,PL-Accord-252187,ACCORD,"Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51.",29.0,YR,,F,Y,,,20220204,,MD,PL,PL,2022,Q1,Young Adult
204288881,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,,,2022,Q1,Myoglobinuria,,2022,Q1,1,I,,20220124.0,20220204,20220204,EXP,,PL-Accord-252187,ACCORD,"Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51.",29.0,YR,,F,Y,,,20220204,,MD,PL,PL,2022,Q1,Young Adult
204288881,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,,,2022,Q1,Renal failure,,2022,Q1,1,I,,20220124.0,20220204,20220204,EXP,,PL-Accord-252187,ACCORD,"Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51.",29.0,YR,,F,Y,,,20220204,,MD,PL,PL,2022,Q1,Young Adult
204288881,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,,,2022,Q1,Myopathy,,2022,Q1,1,I,,20220124.0,20220204,20220204,EXP,,PL-Accord-252187,ACCORD,"Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51.",29.0,YR,,F,Y,,,20220204,,MD,PL,PL,2022,Q1,Young Adult
204366531,20436653,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,MSK,,,U,,,,,,,,,2022,Q1,Dehydration,,2022,Q1,1,I,20210525.0,20220131.0,20220207,20220207,EXP,,NO-Accord-252563,ACCORD,,69.0,YR,,F,Y,85.0,KG,20220207,,MD,NO,NO,2022,Q1,Elderly
204497741,20449774,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Nausea,,2022,Q1,1,I,20210322.0,20220131.0,20220209,20220209,EXP,,NO-Fresenius Kabi-FK202201417,FRESENIUS KABI,,69.0,YR,,F,Y,85.0,KG,20220209,,HP,NO,,2022,Q1,Elderly
204497741,20449774,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,1,I,20210322.0,20220131.0,20220209,20220209,EXP,,NO-Fresenius Kabi-FK202201417,FRESENIUS KABI,,69.0,YR,,F,Y,85.0,KG,20220209,,HP,NO,,2022,Q1,Elderly
204497741,20449774,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20210322.0,20220131.0,20220209,20220209,EXP,,NO-Fresenius Kabi-FK202201417,FRESENIUS KABI,,69.0,YR,,F,Y,85.0,KG,20220209,,HP,NO,,2022,Q1,Elderly
204497741,20449774,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Vomiting,,2022,Q1,1,I,20210322.0,20220131.0,20220209,20220209,EXP,,NO-Fresenius Kabi-FK202201417,FRESENIUS KABI,,69.0,YR,,F,Y,85.0,KG,20220209,,HP,NO,,2022,Q1,Elderly
204497741,20449774,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Malaise,,2022,Q1,1,I,20210322.0,20220131.0,20220209,20220209,EXP,,NO-Fresenius Kabi-FK202201417,FRESENIUS KABI,,69.0,YR,,F,Y,85.0,KG,20220209,,HP,NO,,2022,Q1,Elderly
204497741,20449774,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Dehydration,,2022,Q1,1,I,20210322.0,20220131.0,20220209,20220209,EXP,,NO-Fresenius Kabi-FK202201417,FRESENIUS KABI,,69.0,YR,,F,Y,85.0,KG,20220209,,HP,NO,,2022,Q1,Elderly
204542151,20454215,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q1,Arthritis,,2022,Q1,1,I,,20220201.0,20220210,20220210,EXP,CA-MHPD-E2B_03589562,CA-Accord-253064,ACCORD,,61.0,YR,,F,Y,,,20220210,,HP,CA,CA,2022,Q1,Adult
204542151,20454215,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q1,Hepatic enzyme increased,,2022,Q1,1,I,,20220201.0,20220210,20220210,EXP,CA-MHPD-E2B_03589562,CA-Accord-253064,ACCORD,,61.0,YR,,F,Y,,,20220210,,HP,CA,CA,2022,Q1,Adult
204542151,20454215,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q1,Type 2 diabetes mellitus,,2022,Q1,1,I,,20220201.0,20220210,20220210,EXP,CA-MHPD-E2B_03589562,CA-Accord-253064,ACCORD,,61.0,YR,,F,Y,,,20220210,,HP,CA,CA,2022,Q1,Adult
204545792,20454579,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,4Mg/3Ml,,,,,,,,,,Injection,,2022,Q1,COVID-19,,2022,Q1,2,F,20220109.0,20220310.0,20220210,20220313,PER,,US-CELGENEUS-USA-20220201634,CELGENE,,62.0,YR,,M,Y,106.24,KG,20220313,,PH,US,US,2022,Q1,Adult
204573942,20457394,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,MSK,,,U,,UNKNOWN,,,,,Unknown,,2022,Q1,Dehydration,,2022,Q1,2,F,20210525.0,20220214.0,20220210,20220216,EXP,,NO-Fresenius Kabi-FK202201548,FRESENIUS KABI,,69.0,YR,,F,Y,85.0,KG,20220217,,HP,NL,,2022,Q1,Elderly
204574081,20457408,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,UNK,,,,,Solution subcutaneous,,2022,Q1,Vasodilatation,,2022,Q1,1,I,,20220209.0,20220210,20220210,EXP,,CA-Fresenius Kabi-FK202201594,FRESENIUS KABI,,65.0,YR,,M,Y,,,20220211,,HP,CA,,2022,Q1,Elderly
204574081,20457408,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,UNK,,,,,Solution subcutaneous,,2022,Q1,Nausea,,2022,Q1,1,I,,20220209.0,20220210,20220210,EXP,,CA-Fresenius Kabi-FK202201594,FRESENIUS KABI,,65.0,YR,,M,Y,,,20220211,,HP,CA,,2022,Q1,Elderly
204574081,20457408,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,UNK,,,,,Solution subcutaneous,,2022,Q1,Anaphylactic reaction,,2022,Q1,1,I,,20220209.0,20220210,20220210,EXP,,CA-Fresenius Kabi-FK202201594,FRESENIUS KABI,,65.0,YR,,M,Y,,,20220211,,HP,CA,,2022,Q1,Elderly
204574081,20457408,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,UNK,,,,,Solution subcutaneous,,2022,Q1,Hypotension,,2022,Q1,1,I,,20220209.0,20220210,20220210,EXP,,CA-Fresenius Kabi-FK202201594,FRESENIUS KABI,,65.0,YR,,M,Y,,,20220211,,HP,CA,,2022,Q1,Elderly
204574081,20457408,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,UNK,,,,,Solution subcutaneous,,2022,Q1,Urticaria,,2022,Q1,1,I,,20220209.0,20220210,20220210,EXP,,CA-Fresenius Kabi-FK202201594,FRESENIUS KABI,,65.0,YR,,M,Y,,,20220211,,HP,CA,,2022,Q1,Elderly
204574081,20457408,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,UNK,,,,,Solution subcutaneous,,2022,Q1,Lip swelling,,2022,Q1,1,I,,20220209.0,20220210,20220210,EXP,,CA-Fresenius Kabi-FK202201594,FRESENIUS KABI,,65.0,YR,,M,Y,,,20220211,,HP,CA,,2022,Q1,Elderly
204574081,20457408,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,UNK,,,,,Solution subcutaneous,,2022,Q1,Abdominal pain,,2022,Q1,1,I,,20220209.0,20220210,20220210,EXP,,CA-Fresenius Kabi-FK202201594,FRESENIUS KABI,,65.0,YR,,M,Y,,,20220211,,HP,CA,,2022,Q1,Elderly
204574081,20457408,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,UNK,,,,,Solution subcutaneous,,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220209.0,20220210,20220210,EXP,,CA-Fresenius Kabi-FK202201594,FRESENIUS KABI,,65.0,YR,,M,Y,,,20220211,,HP,CA,,2022,Q1,Elderly
204589521,20458952,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Treatment failure,,2022,Q1,1,I,,20220208.0,20220211,20220211,PER,,US-GILEAD-2022-0569134,GILEAD,,62.0,YR,A,M,Y,,,20220211,,HP,US,US,2022,Q1,Adult
204589521,20458952,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Product use issue,,2022,Q1,1,I,,20220208.0,20220211,20220211,PER,,US-GILEAD-2022-0569134,GILEAD,,62.0,YR,A,M,Y,,,20220211,,HP,US,US,2022,Q1,Adult
204607062,20460706,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,1.0,MG,,,2022,Q1,Diarrhoea,,2022,Q1,2,F,20220202.0,20220223.0,20220211,20220302,PER,,IT-Eisai Medical Research-EC-2022-108315,EISAI,,66.0,YR,E,M,Y,89.0,KG,20220302,,MD,IT,,2022,Q1,Elderly
204625691,20462569,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, SEMAGLUTIDE B 3.0 mg/ml PDS290, Placebo PDS290",,,U,,,,,,,,,2022,Q1,Dehydration,,2022,Q1,1,I,20210525.0,20220210.0,20220211,20220211,EXP,,NVSC2022NO030722,NOVARTIS,,69.0,YR,,F,Y,85.0,KG,20220211,,MD,NO,NO,2022,Q1,Elderly
204672702,20467270,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,10276.0,MG,D,,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis,,2022,Q1,2,F,20211218.0,20220317.0,20220214,20220323,EXP,,US-NOVOPROD-887936,NOVO NORDISK,,73.0,YR,,M,Y,131.0,KG,20220323,,MD,US,US,2022,Q1,Elderly
204672702,20467270,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14.0,mg,qd",10276.0,MG,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis,,2022,Q1,2,F,20211218.0,20220317.0,20220214,20220323,EXP,,US-NOVOPROD-887936,NOVO NORDISK,,73.0,YR,,M,Y,131.0,KG,20220323,,MD,US,US,2022,Q1,Elderly
204672702,20467270,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,10276.0,MG,D,,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis,,2022,Q1,2,F,20211218.0,20220317.0,20220214,20220323,EXP,,US-NOVOPROD-887936,NOVO NORDISK,,73.0,YR,,M,Y,131.0,KG,20220323,,MD,US,US,2022,Q1,Elderly
204672702,20467270,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,10276.0,MG,D,,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis,,2022,Q1,2,F,20211218.0,20220317.0,20220214,20220323,EXP,,US-NOVOPROD-887936,NOVO NORDISK,,73.0,YR,,M,Y,131.0,KG,20220323,,MD,US,US,2022,Q1,Elderly
204672772,20467277,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,4928.0,MG,N,,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis,,2022,Q1,2,F,20220127.0,20220303.0,20220214,20220311,EXP,,FR-NOVOPROD-888830,NOVO NORDISK,,63.0,YR,,M,Y,126.0,KG,20220311,,MD,FR,FR,2022,Q1,Adult
204672772,20467277,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",4928.0,MG,N,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis,,2022,Q1,2,F,20220127.0,20220303.0,20220214,20220311,EXP,,FR-NOVOPROD-888830,NOVO NORDISK,,63.0,YR,,M,Y,126.0,KG,20220311,,MD,FR,FR,2022,Q1,Adult
204672772,20467277,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",4928.0,MG,N,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis,,2022,Q1,2,F,20220127.0,20220303.0,20220214,20220311,EXP,,FR-NOVOPROD-888830,NOVO NORDISK,,63.0,YR,,M,Y,126.0,KG,20220311,,MD,FR,FR,2022,Q1,Adult
204672772,20467277,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,4928.0,MG,N,,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis,,2022,Q1,2,F,20220127.0,20220303.0,20220214,20220311,EXP,,FR-NOVOPROD-888830,NOVO NORDISK,,63.0,YR,,M,Y,126.0,KG,20220311,,MD,FR,FR,2022,Q1,Adult
204683961,20468396,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20211008.0,,20220211,20220211,DIR,603037,,FDA-CTU,,77.0,YR,,M,N,124.2,KG,20220211,N,MD,US,,2022,Q1,Elderly
204683961,20468396,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Nonspecific reaction,,2022,Q1,1,I,20211008.0,,20220211,20220211,DIR,603037,,FDA-CTU,,77.0,YR,,M,N,124.2,KG,20220211,N,MD,US,,2022,Q1,Elderly
204683961,20468396,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Rash pruritic,,2022,Q1,1,I,20211008.0,,20220211,20220211,DIR,603037,,FDA-CTU,,77.0,YR,,M,N,124.2,KG,20220211,N,MD,US,,2022,Q1,Elderly
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,Diabetes mellitus,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,Confusional state,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,Bedridden,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,Neutropenia,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,Tremor,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,General physical health deterioration,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,Salivary hypersecretion,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,White blood cell count decreased,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,Hypoglycaemia,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,Somnolence,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204755283,20475528,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,on Monday,,,,,,,,0.5,MG,,,2022,Q1,Ecchymosis,,2022,Q1,3,F,20220131.0,20220316.0,20220215,20220327,EXP,,CA-HLS-202200251,HLS THERAPEUTICS,,29.0,YR,A,F,Y,90.0,KG,20220327,,CN,CA,CA,2022,Q1,Young Adult
204774621,20477462,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week (0.5 mg subcutaneously 1 * week)",,,U,,,,,0.5,MG,,/WK,2022,Q1,Myopathy,,2022,Q1,1,I,,20220205.0,20220216,20220216,EXP,,PL-AUROBINDO-AUR-APL-2022-004522,AUROBINDO,"Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220216,,MD,PL,PL,2022,Q1,Young Adult
204774621,20477462,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week (0.5 mg subcutaneously 1 * week)",,,U,,,,,0.5,MG,,/WK,2022,Q1,Renal failure,,2022,Q1,1,I,,20220205.0,20220216,20220216,EXP,,PL-AUROBINDO-AUR-APL-2022-004522,AUROBINDO,"Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220216,,MD,PL,PL,2022,Q1,Young Adult
204774621,20477462,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week (0.5 mg subcutaneously 1 * week)",,,U,,,,,0.5,MG,,/WK,2022,Q1,Myoglobinuria,,2022,Q1,1,I,,20220205.0,20220216,20220216,EXP,,PL-AUROBINDO-AUR-APL-2022-004522,AUROBINDO,"Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220216,,MD,PL,PL,2022,Q1,Young Adult
204774621,20477462,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week (0.5 mg subcutaneously 1 * week)",,,U,,,,,0.5,MG,,/WK,2022,Q1,Drug interaction,,2022,Q1,1,I,,20220205.0,20220216,20220216,EXP,,PL-AUROBINDO-AUR-APL-2022-004522,AUROBINDO,"Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220216,,MD,PL,PL,2022,Q1,Young Adult
204774621,20477462,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week (0.5 mg subcutaneously 1 * week)",,,U,,,,,0.5,MG,,/WK,2022,Q1,Serotonin syndrome,,2022,Q1,1,I,,20220205.0,20220216,20220216,EXP,,PL-AUROBINDO-AUR-APL-2022-004522,AUROBINDO,"Dr Woron J, Dr Siwek M. Pharmacological treatment of obesity and drug interactions that are dangerous for health and life. MEDYCYNA PRAKTYCZNA - PSYCHIATRIA. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220216,,MD,PL,PL,2022,Q1,Young Adult
204808071,20480807,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20210322.0,20220214.0,20220216,20220216,EXP,,NVSC2022NO034903,NOVARTIS,,69.0,YR,,F,Y,85.0,KG,20220216,,HP,NO,NO,2022,Q1,Elderly
204808071,20480807,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Dehydration,,2022,Q1,1,I,20210322.0,20220214.0,20220216,20220216,EXP,,NVSC2022NO034903,NOVARTIS,,69.0,YR,,F,Y,85.0,KG,20220216,,HP,NO,NO,2022,Q1,Elderly
204808071,20480807,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,1,I,20210322.0,20220214.0,20220216,20220216,EXP,,NVSC2022NO034903,NOVARTIS,,69.0,YR,,F,Y,85.0,KG,20220216,,HP,NO,NO,2022,Q1,Elderly
204808071,20480807,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Malaise,,2022,Q1,1,I,20210322.0,20220214.0,20220216,20220216,EXP,,NVSC2022NO034903,NOVARTIS,,69.0,YR,,F,Y,85.0,KG,20220216,,HP,NO,NO,2022,Q1,Elderly
204808071,20480807,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Nausea,,2022,Q1,1,I,20210322.0,20220214.0,20220216,20220216,EXP,,NVSC2022NO034903,NOVARTIS,,69.0,YR,,F,Y,85.0,KG,20220216,,HP,NO,NO,2022,Q1,Elderly
204808071,20480807,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"Semaglutide B 3.0 mg/ml PDS290, Placebo PDS290",,,D,,UNKNOWN,,,,,,,2022,Q1,Vomiting,,2022,Q1,1,I,20210322.0,20220214.0,20220216,20220216,EXP,,NVSC2022NO034903,NOVARTIS,,69.0,YR,,F,Y,85.0,KG,20220216,,HP,NO,NO,2022,Q1,Elderly
204821322,20482132,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,2,F,,20220209.0,20220216,20220216,PER,,US-GILEAD-2022-0569427,GILEAD,,59.0,YR,A,M,Y,,,20220216,,MD,US,US,2022,Q1,Adult
204821322,20482132,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,2,F,,20220209.0,20220216,20220216,PER,,US-GILEAD-2022-0569427,GILEAD,,59.0,YR,A,M,Y,,,20220216,,MD,US,US,2022,Q1,Adult
204821322,20482132,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Genotype drug resistance test positive,,2022,Q1,2,F,,20220209.0,20220216,20220216,PER,,US-GILEAD-2022-0569427,GILEAD,,59.0,YR,A,M,Y,,,20220216,,MD,US,US,2022,Q1,Adult
204821322,20482132,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,2,F,,20220209.0,20220216,20220216,PER,,US-GILEAD-2022-0569427,GILEAD,,59.0,YR,A,M,Y,,,20220216,,MD,US,US,2022,Q1,Adult
204910241,20491024,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,unk,,,,,,,,,,Solution for injection,,2022,Q1,Swollen tongue,,2022,Q1,1,I,,20220210.0,20220218,20220218,EXP,,CA-Fresenius Kabi-FK202201808,FRESENIUS KABI,,68.0,YR,,F,Y,,,20220218,,HP,CA,,2022,Q1,Elderly
204910241,20491024,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,unk,,,,,,,,,,Solution for injection,,2022,Q1,Dysphonia,,2022,Q1,1,I,,20220210.0,20220218,20220218,EXP,,CA-Fresenius Kabi-FK202201808,FRESENIUS KABI,,68.0,YR,,F,Y,,,20220218,,HP,CA,,2022,Q1,Elderly
204910241,20491024,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,unk,,,,,,,,,,Solution for injection,,2022,Q1,Dysphagia,,2022,Q1,1,I,,20220210.0,20220218,20220218,EXP,,CA-Fresenius Kabi-FK202201808,FRESENIUS KABI,,68.0,YR,,F,Y,,,20220218,,HP,CA,,2022,Q1,Elderly
204910241,20491024,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,unk,,,,,,,,,,Solution for injection,,2022,Q1,Stridor,,2022,Q1,1,I,,20220210.0,20220218,20220218,EXP,,CA-Fresenius Kabi-FK202201808,FRESENIUS KABI,,68.0,YR,,F,Y,,,20220218,,HP,CA,,2022,Q1,Elderly
204910241,20491024,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,unk,,,,,,,,,,Solution for injection,,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220210.0,20220218,20220218,EXP,,CA-Fresenius Kabi-FK202201808,FRESENIUS KABI,,68.0,YR,,F,Y,,,20220218,,HP,CA,,2022,Q1,Elderly
204910241,20491024,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,unk,,,,,,,,,,Solution for injection,,2022,Q1,Endotracheal intubation,,2022,Q1,1,I,,20220210.0,20220218,20220218,EXP,,CA-Fresenius Kabi-FK202201808,FRESENIUS KABI,,68.0,YR,,F,Y,,,20220218,,HP,CA,,2022,Q1,Elderly
204910241,20491024,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,unk,,,,,,,,,,Solution for injection,,2022,Q1,Malaise,,2022,Q1,1,I,,20220210.0,20220218,20220218,EXP,,CA-Fresenius Kabi-FK202201808,FRESENIUS KABI,,68.0,YR,,F,Y,,,20220218,,HP,CA,,2022,Q1,Elderly
205103161,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q1,Macular oedema,,2022,Q1,1,I,20220120.0,20220214.0,20220224,20220224,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220224,,MD,GB,GB,2022,Q1,Adult
205103161,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q1,Retinopathy proliferative,,2022,Q1,1,I,20220120.0,20220214.0,20220224,20220224,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220224,,MD,GB,GB,2022,Q1,Adult
205103161,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q1,Macular oedema,,2022,Q1,1,I,20220120.0,20220214.0,20220224,20220224,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220224,,MD,GB,GB,2022,Q1,Adult
205103161,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q1,Retinopathy proliferative,,2022,Q1,1,I,20220120.0,20220214.0,20220224,20220224,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220224,,MD,GB,GB,2022,Q1,Adult
205103161,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q1,Macular oedema,,2022,Q1,1,I,20220120.0,20220214.0,20220224,20220224,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220224,,MD,GB,GB,2022,Q1,Adult
205103161,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q1,Retinopathy proliferative,,2022,Q1,1,I,20220120.0,20220214.0,20220224,20220224,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220224,,MD,GB,GB,2022,Q1,Adult
205103161,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q1,Macular oedema,,2022,Q1,1,I,20220120.0,20220214.0,20220224,20220224,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220224,,MD,GB,GB,2022,Q1,Adult
205103161,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q1,Retinopathy proliferative,,2022,Q1,1,I,20220120.0,20220214.0,20220224,20220224,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220224,,MD,GB,GB,2022,Q1,Adult
205103541,20510354,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.75 mg, total",,,N,,Unknown,,,,,Injection,,2022,Q1,Proteinuria,,2022,Q1,1,I,,20220217.0,20220224,20220224,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-02262,LUPIN,"Leehey DJ, Rahman MA, Borys E, Picken MM, Clise CE. Acute kidney injury associated with Semaglutide. Kidney Medicine. 2021;3(2):282-285",7.0,DEC,,M,Y,,,20220224,,MD,US,US,2022,Q1,Child
205103541,20510354,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.75 mg, total",,,N,,Unknown,,,,,Injection,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220217.0,20220224,20220224,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-02262,LUPIN,"Leehey DJ, Rahman MA, Borys E, Picken MM, Clise CE. Acute kidney injury associated with Semaglutide. Kidney Medicine. 2021;3(2):282-285",7.0,DEC,,M,Y,,,20220224,,MD,US,US,2022,Q1,Child
205103541,20510354,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly",,,N,,Unknown,,,,,Injection,,2022,Q1,Proteinuria,,2022,Q1,1,I,,20220217.0,20220224,20220224,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-02262,LUPIN,"Leehey DJ, Rahman MA, Borys E, Picken MM, Clise CE. Acute kidney injury associated with Semaglutide. Kidney Medicine. 2021;3(2):282-285",7.0,DEC,,M,Y,,,20220224,,MD,US,US,2022,Q1,Child
205103541,20510354,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly",,,N,,Unknown,,,,,Injection,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220217.0,20220224,20220224,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-02262,LUPIN,"Leehey DJ, Rahman MA, Borys E, Picken MM, Clise CE. Acute kidney injury associated with Semaglutide. Kidney Medicine. 2021;3(2):282-285",7.0,DEC,,M,Y,,,20220224,,MD,US,US,2022,Q1,Child
205103541,20510354,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly",,,N,,Unknown,,,,,Injection,,2022,Q1,Proteinuria,,2022,Q1,1,I,,20220217.0,20220224,20220224,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-02262,LUPIN,"Leehey DJ, Rahman MA, Borys E, Picken MM, Clise CE. Acute kidney injury associated with Semaglutide. Kidney Medicine. 2021;3(2):282-285",7.0,DEC,,M,Y,,,20220224,,MD,US,US,2022,Q1,Child
205103541,20510354,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly",,,N,,Unknown,,,,,Injection,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220217.0,20220224,20220224,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-02262,LUPIN,"Leehey DJ, Rahman MA, Borys E, Picken MM, Clise CE. Acute kidney injury associated with Semaglutide. Kidney Medicine. 2021;3(2):282-285",7.0,DEC,,M,Y,,,20220224,,MD,US,US,2022,Q1,Child
205180391,20518039,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,,,,,0.5,MG,,QW,2022,Q1,Constipation,,2022,Q1,1,I,20200619.0,,20220224,20220224,DIR,FDA-CDER-CTU-2022-15781,,FDA-CTU,,69.0,YR,,M,N,134.0,KG,20200917,N,PH,US,,2022,Q1,Elderly
205180391,20518039,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,,,,,0.5,MG,,QW,2022,Q1,Vision blurred,,2022,Q1,1,I,20200619.0,,20220224,20220224,DIR,FDA-CDER-CTU-2022-15781,,FDA-CTU,,69.0,YR,,M,N,134.0,KG,20200917,N,PH,US,,2022,Q1,Elderly
205180391,20518039,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,,,,,0.5,MG,,QW,2022,Q1,Abdominal pain upper,,2022,Q1,1,I,20200619.0,,20220224,20220224,DIR,FDA-CDER-CTU-2022-15781,,FDA-CTU,,69.0,YR,,M,N,134.0,KG,20200917,N,PH,US,,2022,Q1,Elderly
205231931,20523193,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,,20220216.0,20220227,20220227,EXP,,US-JNJFOC-20220244841,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20220228,,MD,US,US,2022,Q1,Adult
205231931,20523193,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Weight increased,,2022,Q1,1,I,,20220216.0,20220227,20220227,EXP,,US-JNJFOC-20220244841,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20220228,,MD,US,US,2022,Q1,Adult
205231931,20523193,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Decreased appetite,,2022,Q1,1,I,,20220216.0,20220227,20220227,EXP,,US-JNJFOC-20220244841,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20220228,,MD,US,US,2022,Q1,Adult
205231931,20523193,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Hepatitis B,,2022,Q1,1,I,,20220216.0,20220227,20220227,EXP,,US-JNJFOC-20220244841,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20220228,,MD,US,US,2022,Q1,Adult
205231931,20523193,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Genotype drug resistance test positive,,2022,Q1,1,I,,20220216.0,20220227,20220227,EXP,,US-JNJFOC-20220244841,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20220228,,MD,US,US,2022,Q1,Adult
205235381,20523538,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"14 mg, qd",7322.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis acute,,2022,Q1,1,I,20220201.0,20220216.0,20220228,20220228,EXP,,GB-NOVOPROD-892419,NOVO NORDISK,,72.0,YR,,M,Y,98.0,KG,20220228,,MD,GB,GB,2022,Q1,Elderly
205235381,20523538,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",7322.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Cholecystitis acute,,2022,Q1,1,I,20220201.0,20220216.0,20220228,20220228,EXP,,GB-NOVOPROD-892419,NOVO NORDISK,,72.0,YR,,M,Y,98.0,KG,20220228,,MD,GB,GB,2022,Q1,Elderly
205235381,20523538,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,7322.0,MG,Y,N,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis acute,,2022,Q1,1,I,20220201.0,20220216.0,20220228,20220228,EXP,,GB-NOVOPROD-892419,NOVO NORDISK,,72.0,YR,,M,Y,98.0,KG,20220228,,MD,GB,GB,2022,Q1,Elderly
205235381,20523538,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,7322.0,MG,Y,N,,,213051.0,,,Tablet,,2022,Q1,Cholecystitis acute,,2022,Q1,1,I,20220201.0,20220216.0,20220228,20220228,EXP,,GB-NOVOPROD-892419,NOVO NORDISK,,72.0,YR,,M,Y,98.0,KG,20220228,,MD,GB,GB,2022,Q1,Elderly
205282831,20528283,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly",,,,,Unknown,,,,,,,2022,Q1,Nausea,,2022,Q1,1,I,,20220216.0,20220228,20220228,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-02425,LUPIN,Miles JM. Side effect synergism between metformin and glp-1 receptor agonists- And a solution. Journal of Investigative Medicine. 2021;70:297,68.0,YR,,F,Y,,,20220228,,HP,US,US,2022,Q1,Elderly
205282831,20528283,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly",,,,,Unknown,,,,,,,2022,Q1,Nausea,,2022,Q1,1,I,,20220216.0,20220228,20220228,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-02425,LUPIN,Miles JM. Side effect synergism between metformin and glp-1 receptor agonists- And a solution. Journal of Investigative Medicine. 2021;70:297,68.0,YR,,F,Y,,,20220228,,HP,US,US,2022,Q1,Elderly
205319134,20531913,1,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.34 mg/ml PDS290, Placebo PDS290",,,,,,,,,,UNK,,2022,Q1,Large intestine polyp,,2022,Q1,4,F,20200322.0,20220317.0,20220301,20220325,EXP,DE-TORRENT-00022126,DE-TORRENT-00022126,TORRENT,,69.0,YR,E,M,Y,101.0,KG,20220325,,MD,DE,DE,2022,Q1,Elderly
205319134,20531913,1,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.34 mg/ml PDS290, Placebo PDS290",,,,,,,,,,UNK,,2022,Q1,Small intestine polyp,,2022,Q1,4,F,20200322.0,20220317.0,20220301,20220325,EXP,DE-TORRENT-00022126,DE-TORRENT-00022126,TORRENT,,69.0,YR,E,M,Y,101.0,KG,20220325,,MD,DE,DE,2022,Q1,Elderly
205319134,20531913,1,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.34 mg/ml PDS290, Placebo PDS290",,,,,,,,,,UNK,,2022,Q1,Gingival bleeding,,2022,Q1,4,F,20200322.0,20220317.0,20220301,20220325,EXP,DE-TORRENT-00022126,DE-TORRENT-00022126,TORRENT,,69.0,YR,E,M,Y,101.0,KG,20220325,,MD,DE,DE,2022,Q1,Elderly
205319134,20531913,1,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.34 mg/ml PDS290, Placebo PDS290",,,,,,,,,,UNK,,2022,Q1,Diverticulum,,2022,Q1,4,F,20200322.0,20220317.0,20220301,20220325,EXP,DE-TORRENT-00022126,DE-TORRENT-00022126,TORRENT,,69.0,YR,E,M,Y,101.0,KG,20220325,,MD,DE,DE,2022,Q1,Elderly
205319134,20531913,1,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.34 mg/ml PDS290, Placebo PDS290",,,,,,,,,,UNK,,2022,Q1,Periodontitis,,2022,Q1,4,F,20200322.0,20220317.0,20220301,20220325,EXP,DE-TORRENT-00022126,DE-TORRENT-00022126,TORRENT,,69.0,YR,E,M,Y,101.0,KG,20220325,,MD,DE,DE,2022,Q1,Elderly
205319134,20531913,1,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.34 mg/ml PDS290, Placebo PDS290",,,,,,,,,,UNK,,2022,Q1,Iron deficiency anaemia,,2022,Q1,4,F,20200322.0,20220317.0,20220301,20220325,EXP,DE-TORRENT-00022126,DE-TORRENT-00022126,TORRENT,,69.0,YR,E,M,Y,101.0,KG,20220325,,MD,DE,DE,2022,Q1,Elderly
205319134,20531913,1,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.34 mg/ml PDS290, Placebo PDS290",,,,,,,,,,UNK,,2022,Q1,Hiatus hernia,,2022,Q1,4,F,20200322.0,20220317.0,20220301,20220325,EXP,DE-TORRENT-00022126,DE-TORRENT-00022126,TORRENT,,69.0,YR,E,M,Y,101.0,KG,20220325,,MD,DE,DE,2022,Q1,Elderly
205319134,20531913,1,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.34 mg/ml PDS290, Placebo PDS290",,,,,,,,,,UNK,,2022,Q1,Melaena,,2022,Q1,4,F,20200322.0,20220317.0,20220301,20220325,EXP,DE-TORRENT-00022126,DE-TORRENT-00022126,TORRENT,,69.0,YR,E,M,Y,101.0,KG,20220325,,MD,DE,DE,2022,Q1,Elderly
205319134,20531913,1,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.34 mg/ml PDS290, Placebo PDS290",,,,,,,,,,UNK,,2022,Q1,Intestinal haemorrhage,,2022,Q1,4,F,20200322.0,20220317.0,20220301,20220325,EXP,DE-TORRENT-00022126,DE-TORRENT-00022126,TORRENT,,69.0,YR,E,M,Y,101.0,KG,20220325,,MD,DE,DE,2022,Q1,Elderly
205325101,20532510,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,,,,,,0.25,MG,,QW,2022,Q1,Tinnitus,,2022,Q1,1,I,20211223.0,,20220301,20220301,DIR,FDA-CDER-CTU-2022-16675,,FDA-CTU,,72.0,YR,,M,N,,,20220113,N,HP,US,,2022,Q1,Elderly
205343401,20534340,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.75 milligram,,,D,,,,,0.75,MG,Injection,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220217.0,20220302,20220302,EXP,,US-AUROBINDO-AUR-APL-2022-005704,AUROBINDO,"Leehey DJ, Rahman MA, Borys E, Picken MM, Clise CE.. Acute Kidney Injury Associated With Semaglutide.. Kidney Medicine. 2021;3(2):282-5",7.0,DEC,,M,Y,,,20220302,,MD,US,US,2022,Q1,Child
205343401,20534340,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,Injection,/WK,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220217.0,20220302,20220302,EXP,,US-AUROBINDO-AUR-APL-2022-005704,AUROBINDO,"Leehey DJ, Rahman MA, Borys E, Picken MM, Clise CE.. Acute Kidney Injury Associated With Semaglutide.. Kidney Medicine. 2021;3(2):282-5",7.0,DEC,,M,Y,,,20220302,,MD,US,US,2022,Q1,Child
205343401,20534340,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, Every Week",,,D,,,,,0.25,MG,Injection,/WK,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220217.0,20220302,20220302,EXP,,US-AUROBINDO-AUR-APL-2022-005704,AUROBINDO,"Leehey DJ, Rahman MA, Borys E, Picken MM, Clise CE.. Acute Kidney Injury Associated With Semaglutide.. Kidney Medicine. 2021;3(2):282-5",7.0,DEC,,M,Y,,,20220302,,MD,US,US,2022,Q1,Child
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Chills,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Troponin increased,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Hyponatraemia,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,C-reactive protein increased,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Myocarditis,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Hypothyroidism,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Pyrexia,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Pericardial effusion,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Dyspnoea,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Mean cell haemoglobin concentration decreased,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Neutrophil count increased,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205360482,20536048,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,,,,,,,,,1.0,MG,,,2022,Q1,Fatigue,,2022,Q1,2,F,20220209.0,20220227.0,20220302,20220311,EXP,,CA-HLS-202200475,HLS THERAPEUTICS,,51.0,YR,A,F,Y,,,20220311,,MD,CA,CA,2022,Q1,Adult
205380921,20538092,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,LP59361,20240731.0,,1.0,MG,,QW,2022,Q1,Pancreatitis,,2022,Q1,1,I,20220223.0,,20220302,20220302,DIR,FDA-CDER-CTU-2022-17005,,FDA-CTU,,52.0,YR,,M,N,126.55,KG,20220224,N,PH,US,,2022,Q1,Adult
205405621,20540562,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q1,Malaise,,2022,Q1,1,I,,20211111.0,20220302,20220302,EXP,,AU-JNJFOC-20211130071,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,91.0,KG,20220302,,PH,AU,AU,2022,Q1,Elderly
205421321,20542132,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0 mg/ml,,,,,,,,,,,,2022,Q1,Pericardial effusion,,2022,Q1,1,I,20210917.0,20220221.0,20220302,20220302,EXP,,DE-DSJP-DSE-2022-106415,DAIICHI,,62.0,YR,,M,Y,112.0,KG,20220302,,MD,DE,DE,2022,Q1,Adult
205438781,20543878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14.0,mg,Once per day",,,,,,,213051.0,14.0,MG,Tablet,QD,2022,Q1,Vitreous haemorrhage,,2022,Q1,1,I,20211202.0,20220222.0,20220303,20220303,EXP,,GB-NOVOPROD-882757,NOVO NORDISK,,62.0,YR,,M,Y,81.0,KG,20220303,,MD,GB,GB,2022,Q1,Adult
205445581,20544558,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Off label use,,2022,Q1,1,I,,20220222.0,20220303,20220303,PER,,GB-LUPIN PHARMACEUTICALS INC.-2022-02725,LUPIN,"Vutipongsatorn K, Isaacs A, Farah Z. Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports. Journal of Medical Case Reports. 2022;16(57):1-5",55.0,YR,,F,Y,,,20220303,,HP,GB,GB,2022,Q1,Adult
205445581,20544558,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Drug ineffective for unapproved indication,,2022,Q1,1,I,,20220222.0,20220303,20220303,PER,,GB-LUPIN PHARMACEUTICALS INC.-2022-02725,LUPIN,"Vutipongsatorn K, Isaacs A, Farah Z. Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports. Journal of Medical Case Reports. 2022;16(57):1-5",55.0,YR,,F,Y,,,20220303,,HP,GB,GB,2022,Q1,Adult
205516881,20551688,5,C,Semaglutide B,,2,Unknown,,,,,,,,,,,,,2022,Q1,Diverticulum,,2022,Q1,1,I,20200322.0,20220221.0,20220304,20220304,EXP,,DE-TEVA-2022-DE-2010938,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205516881,20551688,5,C,Semaglutide B,,2,Unknown,,,,,,,,,,,,,2022,Q1,Large intestine polyp,,2022,Q1,1,I,20200322.0,20220221.0,20220304,20220304,EXP,,DE-TEVA-2022-DE-2010938,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205516881,20551688,5,C,Semaglutide B,,2,Unknown,,,,,,,,,,,,,2022,Q1,Hiatus hernia,,2022,Q1,1,I,20200322.0,20220221.0,20220304,20220304,EXP,,DE-TEVA-2022-DE-2010938,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205516881,20551688,5,C,Semaglutide B,,2,Unknown,,,,,,,,,,,,,2022,Q1,Melaena,,2022,Q1,1,I,20200322.0,20220221.0,20220304,20220304,EXP,,DE-TEVA-2022-DE-2010938,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205516881,20551688,5,C,Semaglutide B,,2,Unknown,,,,,,,,,,,,,2022,Q1,Small intestine polyp,,2022,Q1,1,I,20200322.0,20220221.0,20220304,20220304,EXP,,DE-TEVA-2022-DE-2010938,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205516881,20551688,5,C,Semaglutide B,,2,Unknown,,,,,,,,,,,,,2022,Q1,Gingival bleeding,,2022,Q1,1,I,20200322.0,20220221.0,20220304,20220304,EXP,,DE-TEVA-2022-DE-2010938,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205516881,20551688,5,C,Semaglutide B,,2,Unknown,,,,,,,,,,,,,2022,Q1,Iron deficiency anaemia,,2022,Q1,1,I,20200322.0,20220221.0,20220304,20220304,EXP,,DE-TEVA-2022-DE-2010938,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205533111,20553311,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Vertigo,,2022,Q1,1,I,20200601.0,20220225.0,20220304,20220304,EXP,,DE-GLAXOSMITHKLINE-DE2020EME262135,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205533111,20553311,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Overdose,,2022,Q1,1,I,20200601.0,20220225.0,20220304,20220304,EXP,,DE-GLAXOSMITHKLINE-DE2020EME262135,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205533111,20553311,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,1,I,20200601.0,20220225.0,20220304,20220304,EXP,,DE-GLAXOSMITHKLINE-DE2020EME262135,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205533111,20553311,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Hypertensive crisis,,2022,Q1,1,I,20200601.0,20220225.0,20220304,20220304,EXP,,DE-GLAXOSMITHKLINE-DE2020EME262135,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20220304,,MD,DE,DE,2022,Q1,Elderly
205570911,20557091,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,blinded (information withheld),,,U,,,,,,,,,2022,Q1,Chest pain,,2022,Q1,1,I,20210517.0,20220222.0,20220307,20220307,EXP,,RO-AUROBINDO-AUR-APL-2022-006564,AUROBINDO,,63.0,YR,,M,Y,113.0,KG,20220305,,HP,RO,RO,2022,Q1,Adult
205570911,20557091,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,blinded (information withheld),,,U,,,,,,,,,2022,Q1,Atrioventricular block complete,,2022,Q1,1,I,20210517.0,20220222.0,20220307,20220307,EXP,,RO-AUROBINDO-AUR-APL-2022-006564,AUROBINDO,,63.0,YR,,M,Y,113.0,KG,20220305,,HP,RO,RO,2022,Q1,Adult
205570911,20557091,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,blinded (information withheld),,,U,,,,,,,,,2022,Q1,Angina unstable,,2022,Q1,1,I,20210517.0,20220222.0,20220307,20220307,EXP,,RO-AUROBINDO-AUR-APL-2022-006564,AUROBINDO,,63.0,YR,,M,Y,113.0,KG,20220305,,HP,RO,RO,2022,Q1,Adult
205570911,20557091,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,blinded (information withheld),,,U,,,,,,,,,2022,Q1,Chest pain,,2022,Q1,1,I,20210517.0,20220222.0,20220307,20220307,EXP,,RO-AUROBINDO-AUR-APL-2022-006564,AUROBINDO,,63.0,YR,,M,Y,113.0,KG,20220305,,HP,RO,RO,2022,Q1,Adult
205570911,20557091,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,blinded (information withheld),,,U,,,,,,,,,2022,Q1,Atrioventricular block complete,,2022,Q1,1,I,20210517.0,20220222.0,20220307,20220307,EXP,,RO-AUROBINDO-AUR-APL-2022-006564,AUROBINDO,,63.0,YR,,M,Y,113.0,KG,20220305,,HP,RO,RO,2022,Q1,Adult
205570911,20557091,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,blinded (information withheld),,,U,,,,,,,,,2022,Q1,Angina unstable,,2022,Q1,1,I,20210517.0,20220222.0,20220307,20220307,EXP,,RO-AUROBINDO-AUR-APL-2022-006564,AUROBINDO,,63.0,YR,,M,Y,113.0,KG,20220305,,HP,RO,RO,2022,Q1,Adult
205613971,20561397,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,1,I,,20201214.0,20220307,20220307,EXP,GB-MHRA-EYC 00234299,NVSC2020GB331970,NOVARTIS,,44.0,YR,,M,Y,,,20220307,,PH,GB,GB,2022,Q1,Adult
205613971,20561397,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20201214.0,20220307,20220307,EXP,GB-MHRA-EYC 00234299,NVSC2020GB331970,NOVARTIS,,44.0,YR,,M,Y,,,20220307,,PH,GB,GB,2022,Q1,Adult
205619171,20561917,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Haemoptysis,,2022,Q1,1,I,20201011.0,20220228.0,20220307,20220307,EXP,,NL-JNJFOC-20220260198,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,105.0,KG,20220307,,HP,NL,NL,2022,Q1,Elderly
205619171,20561917,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20201011.0,20220228.0,20220307,20220307,EXP,,NL-JNJFOC-20220260198,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,105.0,KG,20220307,,HP,NL,NL,2022,Q1,Elderly
205619171,20561917,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Haemoptysis,,2022,Q1,1,I,20201011.0,20220228.0,20220307,20220307,EXP,,NL-JNJFOC-20220260198,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,105.0,KG,20220307,,HP,NL,NL,2022,Q1,Elderly
205619171,20561917,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20201011.0,20220228.0,20220307,20220307,EXP,,NL-JNJFOC-20220260198,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,105.0,KG,20220307,,HP,NL,NL,2022,Q1,Elderly
205638664,20563866,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Every Week (1.34 mg/ml PDS290, Placebo PDS290)",,,,,,,,,,,/WK,2022,Q1,Small intestine polyp,,2022,Q1,4,F,20200322.0,20220316.0,20220308,20220328,EXP,,DE-AUROBINDO-AUR-APL-2022-006952,AUROBINDO,,69.0,YR,,M,Y,101.0,KG,20220328,,MD,DE,DE,2022,Q1,Elderly
205638664,20563866,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Every Week (1.34 mg/ml PDS290, Placebo PDS290)",,,,,,,,,,,/WK,2022,Q1,Melaena,,2022,Q1,4,F,20200322.0,20220316.0,20220308,20220328,EXP,,DE-AUROBINDO-AUR-APL-2022-006952,AUROBINDO,,69.0,YR,,M,Y,101.0,KG,20220328,,MD,DE,DE,2022,Q1,Elderly
205638664,20563866,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Every Week (1.34 mg/ml PDS290, Placebo PDS290)",,,,,,,,,,,/WK,2022,Q1,Intestinal haemorrhage,,2022,Q1,4,F,20200322.0,20220316.0,20220308,20220328,EXP,,DE-AUROBINDO-AUR-APL-2022-006952,AUROBINDO,,69.0,YR,,M,Y,101.0,KG,20220328,,MD,DE,DE,2022,Q1,Elderly
205638664,20563866,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Every Week (1.34 mg/ml PDS290, Placebo PDS290)",,,,,,,,,,,/WK,2022,Q1,Diverticulum,,2022,Q1,4,F,20200322.0,20220316.0,20220308,20220328,EXP,,DE-AUROBINDO-AUR-APL-2022-006952,AUROBINDO,,69.0,YR,,M,Y,101.0,KG,20220328,,MD,DE,DE,2022,Q1,Elderly
205638664,20563866,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Every Week (1.34 mg/ml PDS290, Placebo PDS290)",,,,,,,,,,,/WK,2022,Q1,Hiatus hernia,,2022,Q1,4,F,20200322.0,20220316.0,20220308,20220328,EXP,,DE-AUROBINDO-AUR-APL-2022-006952,AUROBINDO,,69.0,YR,,M,Y,101.0,KG,20220328,,MD,DE,DE,2022,Q1,Elderly
205638664,20563866,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Every Week (1.34 mg/ml PDS290, Placebo PDS290)",,,,,,,,,,,/WK,2022,Q1,Periodontitis,,2022,Q1,4,F,20200322.0,20220316.0,20220308,20220328,EXP,,DE-AUROBINDO-AUR-APL-2022-006952,AUROBINDO,,69.0,YR,,M,Y,101.0,KG,20220328,,MD,DE,DE,2022,Q1,Elderly
205638664,20563866,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Every Week (1.34 mg/ml PDS290, Placebo PDS290)",,,,,,,,,,,/WK,2022,Q1,Gingival bleeding,,2022,Q1,4,F,20200322.0,20220316.0,20220308,20220328,EXP,,DE-AUROBINDO-AUR-APL-2022-006952,AUROBINDO,,69.0,YR,,M,Y,101.0,KG,20220328,,MD,DE,DE,2022,Q1,Elderly
205638664,20563866,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Every Week (1.34 mg/ml PDS290, Placebo PDS290)",,,,,,,,,,,/WK,2022,Q1,Iron deficiency anaemia,,2022,Q1,4,F,20200322.0,20220316.0,20220308,20220328,EXP,,DE-AUROBINDO-AUR-APL-2022-006952,AUROBINDO,,69.0,YR,,M,Y,101.0,KG,20220328,,MD,DE,DE,2022,Q1,Elderly
205638664,20563866,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Every Week (1.34 mg/ml PDS290, Placebo PDS290)",,,,,,,,,,,/WK,2022,Q1,Large intestine polyp,,2022,Q1,4,F,20200322.0,20220316.0,20220308,20220328,EXP,,DE-AUROBINDO-AUR-APL-2022-006952,AUROBINDO,,69.0,YR,,M,Y,101.0,KG,20220328,,MD,DE,DE,2022,Q1,Elderly
205655681,20565568,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Presyncope,,2022,Q1,1,I,20210317.0,20220228.0,20220308,20220308,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-032299,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,94.0,KG,20220308,,HP,ES,ES,2022,Q1,Elderly
205655681,20565568,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Coronary artery occlusion,,2022,Q1,1,I,20210317.0,20220228.0,20220308,20220308,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-032299,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,94.0,KG,20220308,,HP,ES,ES,2022,Q1,Elderly
205736641,20573664,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Solution for injection,,2022,Q1,Breast abscess,,2022,Q1,1,I,,20220224.0,20220309,20220309,EXP,,CA-PFIZER INC-202200332304,PFIZER,,35.0,YR,,F,Y,,,20220309,,HP,CA,CA,2022,Q1,Adult
205752551,20575255,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,1,I,,20220228.0,20220310,20220310,EXP,,GB-TEVA-2022-GB-2014660,TEVA,"Vutipongsatorn K, Farah Z. Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports. J-Med-Case-Rep. 2022;16:.",55.0,YR,A,F,Y,,,20220310,,HP,GB,GB,2022,Q1,Adult
205752551,20575255,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q1,Idiopathic inflammatory myopathy,,2022,Q1,1,I,,20220228.0,20220310,20220310,EXP,,GB-TEVA-2022-GB-2014660,TEVA,"Vutipongsatorn K, Farah Z. Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports. J-Med-Case-Rep. 2022;16:.",55.0,YR,A,F,Y,,,20220310,,HP,GB,GB,2022,Q1,Adult
205767961,20576796,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, qwk",,,,,,,,,,,/WK,2022,Q1,Pyrexia,,2022,Q1,1,I,20200804.0,20220304.0,20220310,20220310,EXP,,AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-034472,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,92.0,KG,20220310,,HP,AU,AU,2022,Q1,Elderly
205767961,20576796,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, qwk",,,,,,,,,,,/WK,2022,Q1,Rectal haemorrhage,,2022,Q1,1,I,20200804.0,20220304.0,20220310,20220310,EXP,,AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-034472,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,92.0,KG,20220310,,HP,AU,AU,2022,Q1,Elderly
205767961,20576796,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, qwk",,,,,,,,,,,/WK,2022,Q1,Confusional state,,2022,Q1,1,I,20200804.0,20220304.0,20220310,20220310,EXP,,AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-034472,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,92.0,KG,20220310,,HP,AU,AU,2022,Q1,Elderly
205781101,20578110,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,D,,,,,0.5,MG,,QW,2022,Q1,Pancreatitis,,2022,Q1,1,I,20220215.0,,20220310,20220310,DIR,FDA-CDER-CTU-2022-19435,,FDA-CTU,,74.0,YR,,M,N,,,20220228,N,PH,US,,2022,Q1,Elderly
205818452,20581845,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"UNK, Q8D",,,U,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,2,F,20211228.0,20220317.0,20220311,20220328,EXP,,"CO-REGENERON PHARMACEUTICALS, INC.-2022-015775",REGENERON,,66.0,YR,,M,Y,,,20220328,,CN,CO,CO,2022,Q1,Elderly
205818452,20581845,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"UNK, Q8D",,,U,,,,,,,,,2022,Q1,Chills,,2022,Q1,2,F,20211228.0,20220317.0,20220311,20220328,EXP,,"CO-REGENERON PHARMACEUTICALS, INC.-2022-015775",REGENERON,,66.0,YR,,M,Y,,,20220328,,CN,CO,CO,2022,Q1,Elderly
205818452,20581845,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"UNK, Q8D",,,U,,,,,,,,,2022,Q1,Syncope,,2022,Q1,2,F,20211228.0,20220317.0,20220311,20220328,EXP,,"CO-REGENERON PHARMACEUTICALS, INC.-2022-015775",REGENERON,,66.0,YR,,M,Y,,,20220328,,CN,CO,CO,2022,Q1,Elderly
205818452,20581845,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"UNK, Q8D",,,U,,,,,,,,,2022,Q1,Urinary tract infection,,2022,Q1,2,F,20211228.0,20220317.0,20220311,20220328,EXP,,"CO-REGENERON PHARMACEUTICALS, INC.-2022-015775",REGENERON,,66.0,YR,,M,Y,,,20220328,,CN,CO,CO,2022,Q1,Elderly
205818452,20581845,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"UNK, Q8D",,,U,,,,,,,,,2022,Q1,Myocardial infarction,,2022,Q1,2,F,20211228.0,20220317.0,20220311,20220328,EXP,,"CO-REGENERON PHARMACEUTICALS, INC.-2022-015775",REGENERON,,66.0,YR,,M,Y,,,20220328,,CN,CO,CO,2022,Q1,Elderly
205818452,20581845,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"UNK, Q8D",,,U,,,,,,,,,2022,Q1,Pyrexia,,2022,Q1,2,F,20211228.0,20220317.0,20220311,20220328,EXP,,"CO-REGENERON PHARMACEUTICALS, INC.-2022-015775",REGENERON,,66.0,YR,,M,Y,,,20220328,,CN,CO,CO,2022,Q1,Elderly
205818452,20581845,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"UNK, Q8D",,,U,,,,,,,,,2022,Q1,Peripheral coldness,,2022,Q1,2,F,20211228.0,20220317.0,20220311,20220328,EXP,,"CO-REGENERON PHARMACEUTICALS, INC.-2022-015775",REGENERON,,66.0,YR,,M,Y,,,20220328,,CN,CO,CO,2022,Q1,Elderly
205818452,20581845,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"UNK, Q8D",,,U,,,,,,,,,2022,Q1,Blood pressure decreased,,2022,Q1,2,F,20211228.0,20220317.0,20220311,20220328,EXP,,"CO-REGENERON PHARMACEUTICALS, INC.-2022-015775",REGENERON,,66.0,YR,,M,Y,,,20220328,,CN,CO,CO,2022,Q1,Elderly
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Atrial flutter,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Oedema peripheral,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Neuropathy peripheral,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Dyslipidaemia,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Injection site plaque,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Obesity,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Vitamin D deficiency,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Hypertension,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Diabetic neuropathy,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Cardiac failure chronic,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Diabetic retinopathy,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Atrial fibrillation,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Hyperglycaemia,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Cellulitis,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Contusion,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Bowen's disease,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Visual acuity reduced,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Upper respiratory tract infection,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205823191,20582319,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK UNK, unknown",,,Y,,,,,,,,,2022,Q1,Gout,,2022,Q1,1,I,20041112.0,20220307.0,20220311,20220311,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203003308,ELI LILLY AND CO,,63.0,YR,,M,Y,119.0,KG,20220311,,CN,DK,GB,2022,Q1,Adult
205825071,20582507,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,D,D,,,,1.0,MG,,QW,2022,Q1,Vomiting,,2022,Q1,1,I,20220128.0,,20220311,20220311,DIR,FDA-CDER-CTU-2022-19789,,FDA-CTU,,68.0,YR,,M,N,89.0,KG,20220223,N,PH,US,,2022,Q1,Elderly
205825071,20582507,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,D,D,,,,1.0,MG,,QW,2022,Q1,Pancreatitis,,2022,Q1,1,I,20220128.0,,20220311,20220311,DIR,FDA-CDER-CTU-2022-19789,,FDA-CTU,,68.0,YR,,M,N,89.0,KG,20220223,N,PH,US,,2022,Q1,Elderly
205825071,20582507,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,D,D,,,,1.0,MG,,QW,2022,Q1,Abdominal pain,,2022,Q1,1,I,20220128.0,,20220311,20220311,DIR,FDA-CDER-CTU-2022-19789,,FDA-CTU,,68.0,YR,,M,N,89.0,KG,20220223,N,PH,US,,2022,Q1,Elderly
205825071,20582507,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,D,D,,,,1.0,MG,,QW,2022,Q1,Amylase increased,,2022,Q1,1,I,20220128.0,,20220311,20220311,DIR,FDA-CDER-CTU-2022-19789,,FDA-CTU,,68.0,YR,,M,N,89.0,KG,20220223,N,PH,US,,2022,Q1,Elderly
205825071,20582507,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,D,D,,,,1.0,MG,,QW,2022,Q1,Nausea,,2022,Q1,1,I,20220128.0,,20220311,20220311,DIR,FDA-CDER-CTU-2022-19789,,FDA-CTU,,68.0,YR,,M,N,89.0,KG,20220223,N,PH,US,,2022,Q1,Elderly
205825071,20582507,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,D,D,,,,1.0,MG,,QW,2022,Q1,Therapy change,,2022,Q1,1,I,20220128.0,,20220311,20220311,DIR,FDA-CDER-CTU-2022-19789,,FDA-CTU,,68.0,YR,,M,N,89.0,KG,20220223,N,PH,US,,2022,Q1,Elderly
205840271,20584027,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,,,,,1.0,MG,,QW,2022,Q1,Diarrhoea,,2022,Q1,1,I,20211223.0,,20220311,20220311,DIR,FDA-CDER-CTU-2022-19914,,FDA-CTU,,76.0,YR,,M,N,104.0,KG,20220301,N,PH,US,,2022,Q1,Elderly
205840271,20584027,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,,,,,1.0,MG,,QW,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20211223.0,,20220311,20220311,DIR,FDA-CDER-CTU-2022-19914,,FDA-CTU,,76.0,YR,,M,N,104.0,KG,20220301,N,PH,US,,2022,Q1,Elderly
205840271,20584027,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,,,,,1.0,MG,,QW,2022,Q1,Dehydration,,2022,Q1,1,I,20211223.0,,20220311,20220311,DIR,FDA-CDER-CTU-2022-19914,,FDA-CTU,,76.0,YR,,M,N,104.0,KG,20220301,N,PH,US,,2022,Q1,Elderly
205840711,20584071,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2022,Q1,Cellulitis,,2022,Q1,1,I,20210513.0,20220304.0,20220311,20220311,EXP,,US-AstraZeneca-2022A106963,ASTRAZENECA,,69.0,YR,,F,Y,107.0,KG,20220311,,HP,US,,2022,Q1,Elderly
205840711,20584071,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,1,I,20210513.0,20220304.0,20220311,20220311,EXP,,US-AstraZeneca-2022A106963,ASTRAZENECA,,69.0,YR,,F,Y,107.0,KG,20220311,,HP,US,,2022,Q1,Elderly
205840711,20584071,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2022,Q1,Hypertension,,2022,Q1,1,I,20210513.0,20220304.0,20220311,20220311,EXP,,US-AstraZeneca-2022A106963,ASTRAZENECA,,69.0,YR,,F,Y,107.0,KG,20220311,,HP,US,,2022,Q1,Elderly
205840711,20584071,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,1,I,20210513.0,20220304.0,20220311,20220311,EXP,,US-AstraZeneca-2022A106963,ASTRAZENECA,,69.0,YR,,F,Y,107.0,KG,20220311,,HP,US,,2022,Q1,Elderly
205840711,20584071,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20210513.0,20220304.0,20220311,20220311,EXP,,US-AstraZeneca-2022A106963,ASTRAZENECA,,69.0,YR,,F,Y,107.0,KG,20220311,,HP,US,,2022,Q1,Elderly
205840711,20584071,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2022,Q1,Blood creatine increased,,2022,Q1,1,I,20210513.0,20220304.0,20220311,20220311,EXP,,US-AstraZeneca-2022A106963,ASTRAZENECA,,69.0,YR,,F,Y,107.0,KG,20220311,,HP,US,,2022,Q1,Elderly
205840711,20584071,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,20210513.0,20220304.0,20220311,20220311,EXP,,US-AstraZeneca-2022A106963,ASTRAZENECA,,69.0,YR,,F,Y,107.0,KG,20220311,,HP,US,,2022,Q1,Elderly
205840711,20584071,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20210513.0,20220304.0,20220311,20220311,EXP,,US-AstraZeneca-2022A106963,ASTRAZENECA,,69.0,YR,,F,Y,107.0,KG,20220311,,HP,US,,2022,Q1,Elderly
205840711,20584071,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,1,I,20210513.0,20220304.0,20220311,20220311,EXP,,US-AstraZeneca-2022A106963,ASTRAZENECA,,69.0,YR,,F,Y,107.0,KG,20220311,,HP,US,,2022,Q1,Elderly
205840711,20584071,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNKNOWN,,,,,,,,,,,,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,20210513.0,20220304.0,20220311,20220311,EXP,,US-AstraZeneca-2022A106963,ASTRAZENECA,,69.0,YR,,F,Y,107.0,KG,20220311,,HP,US,,2022,Q1,Elderly
205842551,20584255,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,N,,,,,,,,,2022,Q1,Anaemia,,2022,Q1,1,I,,20220301.0,20220311,20220311,EXP,,RO-SA-2022SA072122,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20220311,,MD,RO,RO,2022,Q1,Elderly
205859021,20585902,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hypertensive crisis,,2022,Q1,1,I,20200601.0,20220309.0,20220312,20220312,EXP,,NVSC2022DE055737,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20220312,,MD,DE,DE,2022,Q1,Elderly
205859021,20585902,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,1,I,20200601.0,20220309.0,20220312,20220312,EXP,,NVSC2022DE055737,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20220312,,MD,DE,DE,2022,Q1,Elderly
205859021,20585902,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Vertigo,,2022,Q1,1,I,20200601.0,20220309.0,20220312,20220312,EXP,,NVSC2022DE055737,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20220312,,MD,DE,DE,2022,Q1,Elderly
205859021,20585902,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Overdose,,2022,Q1,1,I,20200601.0,20220309.0,20220312,20220312,EXP,,NVSC2022DE055737,NOVARTIS,,70.0,YR,,F,Y,82.0,KG,20220312,,MD,DE,DE,2022,Q1,Elderly
205870811,20587081,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0,mg,Once per week",42.0,MG,Y,N,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q1,Cholecystitis acute,,2022,Q1,1,I,20220114.0,20220303.0,20220314,20220314,EXP,,CA-NOVOPROD-897310,NOVO NORDISK,,63.0,YR,,M,Y,71.0,KG,20220314,,MD,CA,CA,2022,Q1,Adult
205870811,20587081,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",42.0,MG,Y,N,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q1,Cholecystitis acute,,2022,Q1,1,I,20220114.0,20220303.0,20220314,20220314,EXP,,CA-NOVOPROD-897310,NOVO NORDISK,,63.0,YR,,M,Y,71.0,KG,20220314,,MD,CA,CA,2022,Q1,Adult
205955781,20595578,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Labelled drug-drug interaction medication error,,2022,Q1,1,I,20210302.0,20220307.0,20220315,20220315,EXP,,DE-AstraZeneca-2022A101752,ASTRAZENECA,,66.0,YR,,M,Y,135.0,KG,20220315,,MD,DE,,2022,Q1,Elderly
205955781,20595578,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Epistaxis,,2022,Q1,1,I,20210302.0,20220307.0,20220315,20220315,EXP,,DE-AstraZeneca-2022A101752,ASTRAZENECA,,66.0,YR,,M,Y,135.0,KG,20220315,,MD,DE,,2022,Q1,Elderly
206063191,20606319,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,20220208.0,20220315.0,20220317,20220317,EXP,,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-159643",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20220317,,PH,GB,GB,2022,Q1,Adult
206097201,20609720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q1,Cholecystitis,,2022,Q1,1,I,20211220.0,20220309.0,20220318,20220318,EXP,,BG-NOVOPROD-899140,NOVO NORDISK,,52.0,YR,,M,Y,84.0,KG,20220318,,MD,BG,BG,2022,Q1,Adult
206120331,20612033,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Metabolic acidosis,,2022,Q1,1,I,20220310.0,20220311.0,20220318,20220318,EXP,,GB-JNJFOC-20220327909,JOHNSON AND JOHNSON,,54.0,YR,A,M,Y,,,20220318,,HP,GB,GB,2022,Q1,Adult
206120331,20612033,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Medication error,,2022,Q1,1,I,20220310.0,20220311.0,20220318,20220318,EXP,,GB-JNJFOC-20220327909,JOHNSON AND JOHNSON,,54.0,YR,A,M,Y,,,20220318,,HP,GB,GB,2022,Q1,Adult
206157332,20615733,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Hypotension,,2022,Q1,2,F,20220217.0,20220318.0,20220321,20220325,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220325,,MD,GB,GB,2022,Q1,Adult
206157332,20615733,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Pyrexia,,2022,Q1,2,F,20220217.0,20220318.0,20220321,20220325,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220325,,MD,GB,GB,2022,Q1,Adult
206157332,20615733,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Diarrhoea,,2022,Q1,2,F,20220217.0,20220318.0,20220321,20220325,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220325,,MD,GB,GB,2022,Q1,Adult
206157332,20615733,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Vomiting,,2022,Q1,2,F,20220217.0,20220318.0,20220321,20220325,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220325,,MD,GB,GB,2022,Q1,Adult
206157332,20615733,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Sepsis,,2022,Q1,2,F,20220217.0,20220318.0,20220321,20220325,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220325,,MD,GB,GB,2022,Q1,Adult
206157332,20615733,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Infusion related reaction,,2022,Q1,2,F,20220217.0,20220318.0,20220321,20220325,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220325,,MD,GB,GB,2022,Q1,Adult
206157592,20615759,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,UNKNOWN,,,,,,,2022,Q1,Off label use,,2022,Q1,2,F,20210901.0,20220308.0,20220321,20220323,PER,,NVSC2022US026702,NOVARTIS,,56.0,YR,,M,Y,,,20220323,,CN,US,US,2022,Q1,Adult
206157592,20615759,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,UNKNOWN,,,,,,,2022,Q1,Weight decreased,,2022,Q1,2,F,20210901.0,20220308.0,20220321,20220323,PER,,NVSC2022US026702,NOVARTIS,,56.0,YR,,M,Y,,,20220323,,CN,US,US,2022,Q1,Adult
206179491,20617949,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,20211205.0,20220311.0,20220321,20220321,EXP,,CA-TEVA-2022-CA-2017518,TEVA,,78.0,YR,E,F,Y,96.0,KG,20220321,,HP,CA,CA,2022,Q1,Elderly
206179491,20617949,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,/WK,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20211205.0,20220311.0,20220321,20220321,EXP,,CA-TEVA-2022-CA-2017518,TEVA,,78.0,YR,E,F,Y,96.0,KG,20220321,,HP,CA,CA,2022,Q1,Elderly
206197981,20619798,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,D,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,1,I,20210311.0,20220310.0,20220322,20220322,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220322,,HP,CA,CA,2022,Q1,Elderly
206197981,20619798,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,D,,,,,,,,,2022,Q1,Fall,,2022,Q1,1,I,20210311.0,20220310.0,20220322,20220322,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220322,,HP,CA,CA,2022,Q1,Elderly
206197981,20619798,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,D,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,1,I,20210311.0,20220310.0,20220322,20220322,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220322,,HP,CA,CA,2022,Q1,Elderly
206197981,20619798,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,D,,,,,,,,,2022,Q1,Fall,,2022,Q1,1,I,20210311.0,20220310.0,20220322,20220322,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220322,,HP,CA,CA,2022,Q1,Elderly
206200741,20620074,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q1,Toxicity to various agents,,2022,Q1,1,I,20200125.0,20220310.0,20220322,20220322,EXP,,CA-APOTEX-2022AP004822,APOTEX,,73.0,YR,,M,Y,82.0,KG,20220322,,HP,CA,CA,2022,Q1,Elderly
206200741,20620074,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20200125.0,20220310.0,20220322,20220322,EXP,,CA-APOTEX-2022AP004822,APOTEX,,73.0,YR,,M,Y,82.0,KG,20220322,,HP,CA,CA,2022,Q1,Elderly
206234352,20623435,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, 1 WEEK, Blinded Semaglutide (Code not broken)",,,,,Unknown,,,,,,,2022,Q1,Melaena,,2022,Q1,2,F,20200322.0,20220316.0,20220322,20220324,EXP,,DE-TEVA-2022-DE-2018564,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206234352,20623435,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, 1 WEEK, Blinded Semaglutide (Code not broken)",,,,,Unknown,,,,,,,2022,Q1,Large intestine polyp,,2022,Q1,2,F,20200322.0,20220316.0,20220322,20220324,EXP,,DE-TEVA-2022-DE-2018564,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206234352,20623435,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, 1 WEEK, Blinded Semaglutide (Code not broken)",,,,,Unknown,,,,,,,2022,Q1,Hiatus hernia,,2022,Q1,2,F,20200322.0,20220316.0,20220322,20220324,EXP,,DE-TEVA-2022-DE-2018564,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206234352,20623435,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, 1 WEEK, Blinded Semaglutide (Code not broken)",,,,,Unknown,,,,,,,2022,Q1,Iron deficiency anaemia,,2022,Q1,2,F,20200322.0,20220316.0,20220322,20220324,EXP,,DE-TEVA-2022-DE-2018564,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206234352,20623435,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, 1 WEEK, Blinded Semaglutide (Code not broken)",,,,,Unknown,,,,,,,2022,Q1,Large intestine polyp,,2022,Q1,2,F,20200322.0,20220316.0,20220322,20220324,EXP,,DE-TEVA-2022-DE-2018564,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206234352,20623435,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, 1 WEEK, Blinded Semaglutide (Code not broken)",,,,,Unknown,,,,,,,2022,Q1,Diverticulum,,2022,Q1,2,F,20200322.0,20220316.0,20220322,20220324,EXP,,DE-TEVA-2022-DE-2018564,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206234352,20623435,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, 1 WEEK, Blinded Semaglutide (Code not broken)",,,,,Unknown,,,,,,,2022,Q1,Periodontitis,,2022,Q1,2,F,20200322.0,20220316.0,20220322,20220324,EXP,,DE-TEVA-2022-DE-2018564,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206234352,20623435,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, 1 WEEK, Blinded Semaglutide (Code not broken)",,,,,Unknown,,,,,,,2022,Q1,Gingival bleeding,,2022,Q1,2,F,20200322.0,20220316.0,20220322,20220324,EXP,,DE-TEVA-2022-DE-2018564,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206234352,20623435,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, 1 WEEK, Blinded Semaglutide (Code not broken)",,,,,Unknown,,,,,,,2022,Q1,Large intestine polyp,,2022,Q1,2,F,20200322.0,20220316.0,20220322,20220324,EXP,,DE-TEVA-2022-DE-2018564,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206250401,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Angina unstable,,2022,Q1,1,I,20210727.0,20220310.0,20220323,20220323,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220323,,HP,CA,CA,2022,Q1,Elderly
206250401,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Asthenia,,2022,Q1,1,I,20210727.0,20220310.0,20220323,20220323,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220323,,HP,CA,CA,2022,Q1,Elderly
206250401,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,1,I,20210727.0,20220310.0,20220323,20220323,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220323,,HP,CA,CA,2022,Q1,Elderly
206250401,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Acute myocardial infarction,,2022,Q1,1,I,20210727.0,20220310.0,20220323,20220323,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220323,,HP,CA,CA,2022,Q1,Elderly
206250401,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,1,I,20210727.0,20220310.0,20220323,20220323,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220323,,HP,CA,CA,2022,Q1,Elderly
206250401,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,1,I,20210727.0,20220310.0,20220323,20220323,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220323,,HP,CA,CA,2022,Q1,Elderly
206300261,20630026,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Cardiac failure acute,,2022,Q1,1,I,20210309.0,20220314.0,20220324,20220324,EXP,,FR-AUROBINDO-AUR-APL-2022-009234,AUROBINDO,,76.0,YR,,M,Y,90.0,KG,20220324,,HP,FR,FR,2022,Q1,Elderly
206300261,20630026,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,1,I,20210309.0,20220314.0,20220324,20220324,EXP,,FR-AUROBINDO-AUR-APL-2022-009234,AUROBINDO,,76.0,YR,,M,Y,90.0,KG,20220324,,HP,FR,FR,2022,Q1,Elderly
206300261,20630026,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Cardiac failure acute,,2022,Q1,1,I,20210309.0,20220314.0,20220324,20220324,EXP,,FR-AUROBINDO-AUR-APL-2022-009234,AUROBINDO,,76.0,YR,,M,Y,90.0,KG,20220324,,HP,FR,FR,2022,Q1,Elderly
206300261,20630026,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,1,I,20210309.0,20220314.0,20220324,20220324,EXP,,FR-AUROBINDO-AUR-APL-2022-009234,AUROBINDO,,76.0,YR,,M,Y,90.0,KG,20220324,,HP,FR,FR,2022,Q1,Elderly
206305971,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Pruritus,,2022,Q1,1,I,20210529.0,20220310.0,20220324,20220324,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220324,,MD,CA,CA,2022,Q1,Elderly
206305971,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Paraesthesia,,2022,Q1,1,I,20210529.0,20220310.0,20220324,20220324,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220324,,MD,CA,CA,2022,Q1,Elderly
206305971,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,1,I,20210529.0,20220310.0,20220324,20220324,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220324,,MD,CA,CA,2022,Q1,Elderly
206305971,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hypersensitivity,,2022,Q1,1,I,20210529.0,20220310.0,20220324,20220324,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220324,,MD,CA,CA,2022,Q1,Elderly
206305971,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Urticaria,,2022,Q1,1,I,20210529.0,20220310.0,20220324,20220324,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220324,,MD,CA,CA,2022,Q1,Elderly
206305971,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Angioedema,,2022,Q1,1,I,20210529.0,20220310.0,20220324,20220324,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220324,,MD,CA,CA,2022,Q1,Elderly
206305971,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Syncope,,2022,Q1,1,I,20210529.0,20220310.0,20220324,20220324,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220324,,MD,CA,CA,2022,Q1,Elderly
206305971,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Presyncope,,2022,Q1,1,I,20210529.0,20220310.0,20220324,20220324,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220324,,MD,CA,CA,2022,Q1,Elderly
206316461,20631646,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.34 mg/ml PDS290, placebo PDS290",,,,,Unknown,,,,,,,2022,Q1,Intestinal haemorrhage,,2022,Q1,1,I,,20220317.0,20220324,20220324,EXP,,DE-TEVA-2022-DE-2019821,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,CN,DE,DE,2022,Q1,Elderly
206316461,20631646,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.34 mg/ml PDS290, placebo PDS290",,,,,Unknown,,,,,,,2022,Q1,Iron deficiency anaemia,,2022,Q1,1,I,,20220317.0,20220324,20220324,EXP,,DE-TEVA-2022-DE-2019821,TEVA,,69.0,YR,E,M,Y,101.0,KG,20220324,,CN,DE,DE,2022,Q1,Elderly
206321691,20632169,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,"UNKNOWN,UNKNOWN",,,,,,,2022,Q1,Cardiac failure acute,,2022,Q1,1,I,20210309.0,20220314.0,20220324,20220324,EXP,,FR-Fresenius Kabi-FK202203276,FRESENIUS KABI,,76.0,YR,,M,Y,90.0,KG,20220324,,HP,NL,,2022,Q1,Elderly
206321691,20632169,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,"UNKNOWN,UNKNOWN",,,,,,,2022,Q1,Weight increased,,2022,Q1,1,I,20210309.0,20220314.0,20220324,20220324,EXP,,FR-Fresenius Kabi-FK202203276,FRESENIUS KABI,,76.0,YR,,M,Y,90.0,KG,20220324,,HP,NL,,2022,Q1,Elderly
206321691,20632169,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,"UNKNOWN,UNKNOWN",,,,,,,2022,Q1,Cardiac failure acute,,2022,Q1,1,I,20210309.0,20220314.0,20220324,20220324,EXP,,FR-Fresenius Kabi-FK202203276,FRESENIUS KABI,,76.0,YR,,M,Y,90.0,KG,20220324,,HP,NL,,2022,Q1,Elderly
206321691,20632169,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,"UNKNOWN,UNKNOWN",,,,,,,2022,Q1,Weight increased,,2022,Q1,1,I,20210309.0,20220314.0,20220324,20220324,EXP,,FR-Fresenius Kabi-FK202203276,FRESENIUS KABI,,76.0,YR,,M,Y,90.0,KG,20220324,,HP,NL,,2022,Q1,Elderly
206366901,20636690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q1,Infusion related reaction,,2022,Q1,1,I,20220217.0,20220316.0,20220325,20220325,EXP,,GB-TEVA-2022-GB-2017685,TEVA,,62.0,YR,A,M,Y,115.9,KG,20220325,,MD,GB,GB,2022,Q1,Adult
206386721,20638672,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,Unknown,,,,,,,2022,Q1,Weight increased,,2022,Q1,1,I,20210309.0,20220315.0,20220325,20220325,EXP,,FR-PFIZER INC-202200414191,PFIZER,,76.0,YR,,M,Y,90.0,KG,20220325,,HP,FR,FR,2022,Q1,Elderly
206386721,20638672,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,Unknown,,,,,,,2022,Q1,Cardiac failure acute,,2022,Q1,1,I,20210309.0,20220315.0,20220325,20220325,EXP,,FR-PFIZER INC-202200414191,PFIZER,,76.0,YR,,M,Y,90.0,KG,20220325,,HP,FR,FR,2022,Q1,Elderly
206386721,20638672,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,Unknown,,,,,,,2022,Q1,Weight increased,,2022,Q1,1,I,20210309.0,20220315.0,20220325,20220325,EXP,,FR-PFIZER INC-202200414191,PFIZER,,76.0,YR,,M,Y,90.0,KG,20220325,,HP,FR,FR,2022,Q1,Elderly
206386721,20638672,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,Unknown,,,,,,,2022,Q1,Cardiac failure acute,,2022,Q1,1,I,20210309.0,20220315.0,20220325,20220325,EXP,,FR-PFIZER INC-202200414191,PFIZER,,76.0,YR,,M,Y,90.0,KG,20220325,,HP,FR,FR,2022,Q1,Elderly
206554101,20655410,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN",,,,,,,2022,Q1,Pneumonia,,2022,Q1,1,I,20211009.0,20220318.0,20220330,20220330,EXP,,DK-ROCHE-3056126,ROCHE,,67.0,YR,,M,Y,90.0,KG,20220330,,MD,DK,,2022,Q1,Elderly
206554101,20655410,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN",,,,,,,2022,Q1,Asthma,,2022,Q1,1,I,20211009.0,20220318.0,20220330,20220330,EXP,,DK-ROCHE-3056126,ROCHE,,67.0,YR,,M,Y,90.0,KG,20220330,,MD,DK,,2022,Q1,Elderly
206554101,20655410,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN",,,,,,,2022,Q1,Pneumonia,,2022,Q1,1,I,20211009.0,20220318.0,20220330,20220330,EXP,,DK-ROCHE-3056126,ROCHE,,67.0,YR,,M,Y,90.0,KG,20220330,,MD,DK,,2022,Q1,Elderly
206554101,20655410,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,"UNKNOWN,UNKNOWN",,,,,,,2022,Q1,Asthma,,2022,Q1,1,I,20211009.0,20220318.0,20220330,20220330,EXP,,DK-ROCHE-3056126,ROCHE,,67.0,YR,,M,Y,90.0,KG,20220330,,MD,DK,,2022,Q1,Elderly
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Productive cough,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Mean cell haemoglobin decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Abdominal pain upper,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Respiratory tract congestion,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Throat irritation,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Optic neuritis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Arthropod sting,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Ulcer,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pain in extremity,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Acne cystic,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Body temperature decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Dyspnoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lymphadenopathy,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Diplopia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Injection site pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Paranasal sinus discomfort,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Myalgia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pruritus,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Fibromyalgia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Vision blurred,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Nasal congestion,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Injection site discomfort,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Food allergy,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Diarrhoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Electrocardiogram T wave abnormal,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Back pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Nausea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Hypersensitivity,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Alopecia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Oropharyngeal pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Haemoptysis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Chest pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Tachycardia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Gastrointestinal motility disorder,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Blood pressure increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Cough,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Red cell distribution width increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Insomnia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lower respiratory tract congestion,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lethargy,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,C-reactive protein increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Allergy to chemicals,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Type 2 diabetes mellitus,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Injury,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Malaise,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Illness,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Stress,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lung disorder,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Choking,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Fatigue,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Anaphylactic shock,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Loss of consciousness,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Arthropod bite,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Balance disorder,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Chills,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Migraine,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Oxygen saturation decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Sinusitis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Eye pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Psoriasis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Drug ineffective,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Diarrhoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Anxiety,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Asthma,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Haemorrhage,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Platelet count increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Vomiting,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Weight decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Influenza,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Oedema peripheral,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Swelling,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Claustrophobia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Infection,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Muscle spasms,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Chest discomfort,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Headache,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Wheezing,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Product dose omission issue,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Dizziness,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Heart rate increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pyrexia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,63,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q2,Rash,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Productive cough,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Mean cell haemoglobin decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Abdominal pain upper,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Respiratory tract congestion,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Throat irritation,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Optic neuritis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Arthropod sting,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Ulcer,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pain in extremity,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Acne cystic,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Body temperature decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Dyspnoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lymphadenopathy,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Diplopia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Injection site pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Paranasal sinus discomfort,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Myalgia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pruritus,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Fibromyalgia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Vision blurred,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Nasal congestion,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Injection site discomfort,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Food allergy,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Diarrhoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Electrocardiogram T wave abnormal,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Back pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Nausea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Hypersensitivity,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Alopecia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Oropharyngeal pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Haemoptysis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Chest pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Tachycardia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Gastrointestinal motility disorder,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Blood pressure increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Cough,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Red cell distribution width increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Insomnia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lower respiratory tract congestion,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lethargy,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,C-reactive protein increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Allergy to chemicals,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Type 2 diabetes mellitus,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Injury,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Malaise,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Illness,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Stress,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lung disorder,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Choking,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Fatigue,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Anaphylactic shock,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Loss of consciousness,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Arthropod bite,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Balance disorder,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Chills,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Migraine,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Oxygen saturation decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Sinusitis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Eye pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Psoriasis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Drug ineffective,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Diarrhoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Anxiety,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Asthma,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Haemorrhage,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Platelet count increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Vomiting,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Weight decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Influenza,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Oedema peripheral,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Swelling,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Claustrophobia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Infection,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Muscle spasms,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Chest discomfort,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Headache,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Wheezing,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Product dose omission issue,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Dizziness,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Heart rate increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pyrexia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Rash,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Productive cough,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Mean cell haemoglobin decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Abdominal pain upper,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Respiratory tract congestion,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Throat irritation,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Optic neuritis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Arthropod sting,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Ulcer,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pain in extremity,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Acne cystic,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Body temperature decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Dyspnoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lymphadenopathy,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Diplopia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Injection site pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Paranasal sinus discomfort,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Myalgia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pruritus,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Fibromyalgia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Vision blurred,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Nasal congestion,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Injection site discomfort,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Food allergy,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Diarrhoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Electrocardiogram T wave abnormal,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Back pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Nausea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Hypersensitivity,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Alopecia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Oropharyngeal pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Haemoptysis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Chest pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Tachycardia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Gastrointestinal motility disorder,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Blood pressure increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Cough,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Red cell distribution width increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Insomnia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lower respiratory tract congestion,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lethargy,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,C-reactive protein increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Allergy to chemicals,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Type 2 diabetes mellitus,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Injury,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Malaise,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Illness,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Stress,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lung disorder,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Choking,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Fatigue,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Anaphylactic shock,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Loss of consciousness,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Arthropod bite,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Balance disorder,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Chills,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Migraine,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Oxygen saturation decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Sinusitis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Eye pain,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Psoriasis,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Drug ineffective,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Diarrhoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Anxiety,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Asthma,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Haemorrhage,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Platelet count increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Vomiting,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Weight decreased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Influenza,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Oedema peripheral,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Swelling,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Claustrophobia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Infection,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Muscle spasms,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Chest discomfort,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Headache,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Wheezing,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Product dose omission issue,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Dizziness,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Heart rate increased,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Pyrexia,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1670401327,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q2,Rash,,2022,Q2,27,F,20170215.0,20220615.0,20190814,20220628,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20220629,,CN,CA,CA,2022,Q2,Young Adult
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Conjunctivitis,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Serum amyloid A protein increased,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Glaucoma,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Rash,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Decreased appetite,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Amnesia,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Dementia,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Delirium,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Agitation,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Ocular hyperaemia,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Eye inflammation,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Pneumonia,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Joint swelling,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Autoinflammatory disease,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Drug intolerance,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Muscular weakness,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Arthralgia,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Treatment failure,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Hypertension,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Mood swings,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Blood pressure systolic increased,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Chills,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Urticaria,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Gene mutation,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Arthralgia,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Eye pain,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Drug ineffective,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Paranoia,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Myalgia,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Lethargy,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Bronchitis,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Weight decreased,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Ocular discomfort,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Pyrexia,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Fatigue,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Illness,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Dyspnoea,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Deafness neurosensory,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Asthenia,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Cryopyrin associated periodic syndrome,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Vascular cognitive impairment,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Skin disorder,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
1672248914,16722489,26,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, QW (Brand name: Ozempic)",,,U,,,,,,,,/WK,2022,Q2,Fatigue,,2022,Q2,14,F,20190301.0,20220519.0,20190820,20220525,EXP,,PHHY2019CA193318,NOVARTIS,,82.0,YR,,M,Y,,,20220525,,MD,CA,CA,2022,Q2,Elderly
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Rales,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Productive cough,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Fall,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Pyrexia,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Dyspnoea,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Cough,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Stress,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Appetite disorder,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Weight decreased,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Heart sounds,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Chest pain,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Angina pectoris,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Malaise,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Depressive symptom,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Influenza,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Depressed mood,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Asthma,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Nasal congestion,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Injury,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Insomnia,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Flank pain,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Chest discomfort,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
175684665,17568466,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,Unknown,,,1.25,MG,,/WK,2022,Q2,Wheezing,,2022,Q2,5,F,,20220510.0,20200320,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-014878",BOEHRINGER INGELHEIM,,61.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Appetite disorder,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Malaise,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Injury,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Rales,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Fall,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Stress,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Depressive symptom,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Influenza,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Insomnia,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Cough,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Heart sounds,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Asthma,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Angina pectoris,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Productive cough,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Chest pain,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Wheezing,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Nasal congestion,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Depressed mood,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,48,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q2,Flank pain,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Appetite disorder,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Malaise,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Injury,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Rales,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Fall,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Stress,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Depressive symptom,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Influenza,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Insomnia,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Cough,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Heart sounds,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Asthma,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Angina pectoris,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Productive cough,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Chest pain,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Wheezing,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Nasal congestion,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Depressed mood,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q2,Flank pain,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Appetite disorder,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Malaise,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Injury,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Rales,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Fall,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Stress,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Depressive symptom,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Influenza,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Insomnia,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Cough,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Heart sounds,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Asthma,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Angina pectoris,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Productive cough,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Chest pain,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Wheezing,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Nasal congestion,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Depressed mood,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
177196113,17719611,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q2,Flank pain,,2022,Q2,3,F,,20220511.0,20200428,20220516,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Pain,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Weight increased,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Hepatic cancer,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Neoplasm malignant,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Malaise,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Hypertonic bladder,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Depression,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Insomnia,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Limb injury,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Migraine,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Blood pressure increased,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Fall,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Second primary malignancy,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Headache,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Restless legs syndrome,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Gastrooesophageal reflux disease,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Hypersensitivity,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Constipation,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Musculoskeletal chest pain,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Rib fracture,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
1792066912,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q2,Heart valve incompetence,,2022,Q2,12,F,20200201.0,20220527.0,20200621,20220601,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20220601,,CN,CA,CA,2022,Q2,Adult
179240134,17924013,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Days,,,U,,,,,0.5,MG,,,2022,Q2,Aspartate aminotransferase increased,,2022,Q2,4,F,,20220426.0,20200622,20220504,EXP,E2B_02979743,CA-Accord-185974,ACCORD,,59.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
179240134,17924013,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Days,,,U,,,,,0.5,MG,,,2022,Q2,Alanine aminotransferase increased,,2022,Q2,4,F,,20220426.0,20200622,20220504,EXP,E2B_02979743,CA-Accord-185974,ACCORD,,59.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
179240134,17924013,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Days,,,U,,,,,0.5,MG,,,2022,Q2,Weight decreased,,2022,Q2,4,F,,20220426.0,20200622,20220504,EXP,E2B_02979743,CA-Accord-185974,ACCORD,,59.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
179240134,17924013,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Days,,,U,,,,,0.5,MG,,,2022,Q2,Blood creatine phosphokinase increased,,2022,Q2,4,F,,20220426.0,20200622,20220504,EXP,E2B_02979743,CA-Accord-185974,ACCORD,,59.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
179240134,17924013,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 every 1 Days,,,U,,,,,0.5,MG,,,2022,Q2,Malaise,,2022,Q2,4,F,,20220426.0,20200622,20220504,EXP,E2B_02979743,CA-Accord-185974,ACCORD,,59.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Fall,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Depressed mood,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Chest pain,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Asthma,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Injury,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Chest discomfort,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Flank pain,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Stress,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Angina pectoris,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Pyrexia,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Productive cough,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Cough,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Insomnia,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Wheezing,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Malaise,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Weight decreased,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Prolonged expiration,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Rales,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Nasal congestion,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Appetite disorder,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Respiration abnormal,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Influenza,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Depressive symptom,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Heart sounds,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181601216,18160121,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, Every Week",,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Dyspnoea,,2022,Q2,6,F,,20220516.0,20200818,20220530,EXP,,CA-AUROBINDO-AUR-APL-2020-038692,AUROBINDO,,61.0,YR,,F,Y,,,20220530,,HP,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Nasal congestion,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Chest discomfort,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Asthma,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Chest pain,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Dyspnoea exertional,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Wheezing,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Rales,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Nasopharyngitis,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Rhinorrhoea,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Flank pain,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Cough,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Angina pectoris,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Malaise,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Heart sounds,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Lower respiratory tract infection,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Insomnia,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Prolonged expiration,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Appetite disorder,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Injury,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Fall,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Stress,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Respiration abnormal,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Productive cough,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Depressed mood,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Upper respiratory tract infection,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Weight decreased,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Influenza,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Pyrexia,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
181801442,18180144,37,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q2,Depressive symptom,,2022,Q2,2,F,,20220406.0,20200821,20220412,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20220412,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Insomnia,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Prolonged expiration,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Appetite disorder,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Productive cough,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Malaise,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Rales,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Fall,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Injury,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Angina pectoris,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Stress,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Chest pain,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Depressive symptom,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Influenza,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Respiration abnormal,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Asthma,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Heart sounds,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Wheezing,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Flank pain,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Cough,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Depressed mood,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Nasal congestion,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Insomnia,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Appetite disorder,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Productive cough,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Malaise,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Rales,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Fall,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Injury,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Angina pectoris,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Stress,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Chest pain,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Depressive symptom,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Influenza,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Asthma,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Heart sounds,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Wheezing,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Flank pain,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Cough,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Depressed mood,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Nasal congestion,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Insomnia,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Appetite disorder,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Productive cough,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Malaise,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Rales,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Fall,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Injury,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Angina pectoris,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Stress,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Chest pain,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Depressive symptom,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Influenza,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Asthma,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Heart sounds,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Wheezing,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Flank pain,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Cough,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Depressed mood,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Nasal congestion,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Insomnia,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Prolonged expiration,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Appetite disorder,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Productive cough,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Malaise,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Rales,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Fall,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Injury,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Angina pectoris,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Stress,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Chest pain,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Depressive symptom,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Upper respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Lower respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Influenza,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Respiration abnormal,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Asthma,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Heart sounds,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Wheezing,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Flank pain,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Cough,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Depressed mood,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Rhinorrhoea,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Nasal congestion,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,57,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Insomnia,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Prolonged expiration,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Appetite disorder,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Productive cough,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Malaise,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Rales,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Fall,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Injury,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Angina pectoris,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Stress,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Chest pain,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Depressive symptom,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Influenza,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Respiration abnormal,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Asthma,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Heart sounds,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Wheezing,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Flank pain,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Cough,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Depressed mood,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Nasal congestion,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182657233,18265723,58,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220511.0,20200915,20220516,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220517,,CN,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Fall,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Pyrexia,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Chest discomfort,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Nasal congestion,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Asthma,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Insomnia,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Cough,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Heart sounds,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Malaise,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Chest pain,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Wheezing,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Depressed mood,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Weight decreased,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Appetite disorder,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Injury,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Angina pectoris,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Stress,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Influenza,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Dyspnoea,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Flank pain,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Productive cough,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Rales,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
182808894,18280889,95,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Depressive symptom,,2022,Q2,4,F,,20220526.0,20200918,20220608,EXP,,CA-drreddys-USA/CAN/20/0126946,DR REDDYS,,61.0,YR,A,F,Y,,,20220608,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Cough,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Dyspnoea,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Malaise,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Chest pain,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Stress,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Fall,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Wheezing,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Weight decreased,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Respiration abnormal,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Depressive symptom,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Flank pain,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Insomnia,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Injury,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Angina pectoris,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Chest discomfort,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Nasal congestion,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Rales,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Depressed mood,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Influenza,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Appetite disorder,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Asthma,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Productive cough,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Heart sounds,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Prolonged expiration,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183019477,18301947,60,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 milligram, q.wk.",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Pyrexia,,2022,Q2,7,F,,20220510.0,20200923,20220518,EXP,,CA-APOTEX-2020AP018305,APOTEX,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Urinary tract infection,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Cystitis,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Intentional product use issue,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Lower respiratory tract infection,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Oropharyngeal pain,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Constipation,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Red blood cell count increased,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Arthralgia,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Chest pain,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Psoriatic arthropathy,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Feeling abnormal,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Pain in extremity,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Red blood cell sedimentation rate increased,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Abdominal pain,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Ear pain,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Bacterial vaginosis,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Migraine,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183092693,18309269,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"Unknown, Solution subcutaneous",,,,,,,,,,,,2022,Q2,Hypertension,,2022,Q2,3,F,,20220502.0,20200925,20220512,EXP,,CA-SAMSUNG BIOEPIS-SB-2020-29203,SAMSUNG BIOEPIS,,58.0,YR,A,F,Y,90.0,KG,20220512,,HP,CA,CA,2022,Q2,Adult
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Urticaria,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Serum amyloid A protein increased,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Pneumonia,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Paranoia,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Blood pressure systolic increased,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Hypertension,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Weight decreased,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Eye pain,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Mood swings,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Deafness neurosensory,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Asthenia,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Lethargy,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Delirium,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Fatigue,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Arthralgia,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Treatment failure,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Rash,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Drug ineffective,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Cryopyrin associated periodic syndrome,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Skin disorder,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Decreased appetite,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Bronchitis,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Dementia,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Illness,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Muscular weakness,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Arthralgia,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Drug intolerance,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Amnesia,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Agitation,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Fatigue,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Eye inflammation,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Ill-defined disorder,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Chills,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Glaucoma,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Autoinflammatory disease,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Joint swelling,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Vascular cognitive impairment,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Conjunctivitis,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Myalgia,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Gene mutation,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Ocular hyperaemia,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Pyrexia,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
183655332,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q2,Ocular discomfort,,2022,Q2,2,F,,20220330.0,20201009,20220401,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Gastric disorder,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Anaemia,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Arthropathy,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,White blood cell count increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Hepatic enzyme increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Fatigue,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Nasal congestion,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Pain,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Synovitis,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Rheumatoid arthritis,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Lymphocyte count increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Neutrophil count increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Osteopenia,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Gait disturbance,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Weight decreased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Treatment failure,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Heart rate increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Infusion related reaction,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Femur fracture,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Joint stiffness,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Drug intolerance,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Off label use,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Red cell distribution width increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Insomnia,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Tooth disorder,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Pyrexia,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Tooth abscess,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Joint swelling,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Arthralgia,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Nausea,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Nasopharyngitis,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Musculoskeletal stiffness,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Drug ineffective,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Blood pressure increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Red blood cell sedimentation rate increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Infection,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
186473412,18647341,32,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Weight increased,,2022,Q2,2,F,,20220401.0,20201222,20220407,EXP,,CA-APOTEX-2020AP024198,APOTEX,,54.0,YR,,F,Y,112.0,KG,20220407,,HP,CA,CA,2022,Q2,Adult
187388969,18738896,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Once a week: every Monday morning,,,,,,,,1.0,MG,,,2022,Q2,Arthralgia,,2022,Q2,9,F,20210101.0,20220525.0,20210114,20220530,EXP,,FR-ABBVIE-21K-056-3729449-00,ABBVIE,,62.0,YR,,F,Y,75.0,KG,20220530,,MD,COUNTRY NOT SPECIFIED,FR,2022,Q2,Adult
187388969,18738896,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Once a week: every Monday morning,,,,,,,,1.0,MG,,,2022,Q2,Interstitial lung disease,,2022,Q2,9,F,20210101.0,20220525.0,20210114,20220530,EXP,,FR-ABBVIE-21K-056-3729449-00,ABBVIE,,62.0,YR,,F,Y,75.0,KG,20220530,,MD,COUNTRY NOT SPECIFIED,FR,2022,Q2,Adult
187388969,18738896,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Once a week: every Monday morning,,,,,,,,1.0,MG,,,2022,Q2,Myopericarditis,,2022,Q2,9,F,20210101.0,20220525.0,20210114,20220530,EXP,,FR-ABBVIE-21K-056-3729449-00,ABBVIE,,62.0,YR,,F,Y,75.0,KG,20220530,,MD,COUNTRY NOT SPECIFIED,FR,2022,Q2,Adult
187388969,18738896,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Once a week: every Monday morning,,,,,,,,1.0,MG,,,2022,Q2,Pleural effusion,,2022,Q2,9,F,20210101.0,20220525.0,20210114,20220530,EXP,,FR-ABBVIE-21K-056-3729449-00,ABBVIE,,62.0,YR,,F,Y,75.0,KG,20220530,,MD,COUNTRY NOT SPECIFIED,FR,2022,Q2,Adult
187388969,18738896,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Once a week: every Monday morning,,,,,,,,1.0,MG,,,2022,Q2,Acute coronary syndrome,,2022,Q2,9,F,20210101.0,20220525.0,20210114,20220530,EXP,,FR-ABBVIE-21K-056-3729449-00,ABBVIE,,62.0,YR,,F,Y,75.0,KG,20220530,,MD,COUNTRY NOT SPECIFIED,FR,2022,Q2,Adult
187388969,18738896,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Once a week: every Monday morning,,,,,,,,1.0,MG,,,2022,Q2,Scar pain,,2022,Q2,9,F,20210101.0,20220525.0,20210114,20220530,EXP,,FR-ABBVIE-21K-056-3729449-00,ABBVIE,,62.0,YR,,F,Y,75.0,KG,20220530,,MD,COUNTRY NOT SPECIFIED,FR,2022,Q2,Adult
187388969,18738896,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Once a week: every Monday morning,,,,,,,,1.0,MG,,,2022,Q2,Abdominal distension,,2022,Q2,9,F,20210101.0,20220525.0,20210114,20220530,EXP,,FR-ABBVIE-21K-056-3729449-00,ABBVIE,,62.0,YR,,F,Y,75.0,KG,20220530,,MD,COUNTRY NOT SPECIFIED,FR,2022,Q2,Adult
187388969,18738896,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Once a week: every Monday morning,,,,,,,,1.0,MG,,,2022,Q2,Troponin increased,,2022,Q2,9,F,20210101.0,20220525.0,20210114,20220530,EXP,,FR-ABBVIE-21K-056-3729449-00,ABBVIE,,62.0,YR,,F,Y,75.0,KG,20220530,,MD,COUNTRY NOT SPECIFIED,FR,2022,Q2,Adult
187388969,18738896,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Once a week: every Monday morning,,,,,,,,1.0,MG,,,2022,Q2,Chest pain,,2022,Q2,9,F,20210101.0,20220525.0,20210114,20220530,EXP,,FR-ABBVIE-21K-056-3729449-00,ABBVIE,,62.0,YR,,F,Y,75.0,KG,20220530,,MD,COUNTRY NOT SPECIFIED,FR,2022,Q2,Adult
190093925,19009392,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",81.152,MG,Y,U,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q2,Cholecystitis acute,,2022,Q2,5,F,20210226.0,20220509.0,20210315,20220519,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20220519,,MD,GB,GB,2022,Q2,Adult
190093925,19009392,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 mg, qw",81.152,MG,Y,U,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q2,Cholecystitis acute,,2022,Q2,5,F,20210226.0,20220509.0,20210315,20220519,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20220519,,MD,GB,GB,2022,Q2,Adult
190093925,19009392,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,81.152,MG,Y,U,,,209637.0,,,Solution for injection,,2022,Q2,Cholecystitis acute,,2022,Q2,5,F,20210226.0,20220509.0,20210315,20220519,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20220519,,MD,GB,GB,2022,Q2,Adult
190093925,19009392,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,81.152,MG,Y,U,,,209637.0,,,Solution for injection,,2022,Q2,Cholecystitis acute,,2022,Q2,5,F,20210226.0,20220509.0,20210315,20220519,EXP,,GB-NOVOPROD-793195,NOVO NORDISK,,61.0,YR,,M,Y,104.0,KG,20220519,,MD,GB,GB,2022,Q2,Adult
191402624,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q2,Wheezing,,2022,Q2,4,F,,20220517.0,20210415,20220527,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20220527,,MD,CA,CA,2022,Q2,Adult
191402624,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q2,Hypoacusis,,2022,Q2,4,F,,20220517.0,20210415,20220527,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20220527,,MD,CA,CA,2022,Q2,Adult
191402624,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q2,Asthma,,2022,Q2,4,F,,20220517.0,20210415,20220527,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20220527,,MD,CA,CA,2022,Q2,Adult
191402624,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q2,Diabetes mellitus,,2022,Q2,4,F,,20220517.0,20210415,20220527,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20220527,,MD,CA,CA,2022,Q2,Adult
191402624,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q2,Depression,,2022,Q2,4,F,,20220517.0,20210415,20220527,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20220527,,MD,CA,CA,2022,Q2,Adult
191402624,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,4,F,,20220517.0,20210415,20220527,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20220527,,MD,CA,CA,2022,Q2,Adult
191402624,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,4,F,,20220517.0,20210415,20220527,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20220527,,MD,CA,CA,2022,Q2,Adult
191402624,19140262,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q2,Dyspnoea,,2022,Q2,4,F,,20220517.0,20210415,20220527,EXP,,CA-APOTEX-2021AP008607,APOTEX,,51.0,YR,,F,Y,,,20220527,,MD,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Stress,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Malaise,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Cough,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Fall,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Injury,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Depressed mood,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Heart sounds,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Depressive symptom,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Angina pectoris,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Influenza,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Insomnia,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Rales,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Appetite disorder,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Asthma,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Flank pain,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Chest pain,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Wheezing,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Nasal congestion,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
193555913,19355591,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,U,UNKNOWN,,,1.25,MG,,/WK,2022,Q2,Productive cough,,2022,Q2,3,F,,20220608.0,20210601,20220617,EXP,,CA-drreddys-USA/CAN/21/0136009,DR REDDYS,,61.0,YR,A,F,Y,,,20220617,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Urinary incontinence,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Hypertension,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Hyperlipidaemia,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Pharyngitis,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Chronic kidney disease,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Productive cough,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Asthma,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Nasopharyngitis,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Oropharyngeal pain,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Lower respiratory tract infection,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Type 2 diabetes mellitus,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Sleep apnoea syndrome,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
197080932,19708093,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Days,,,U,,,,,0.25,MG,,,2022,Q2,Nasal congestion,,2022,Q2,2,F,,20220615.0,20210817,20220622,EXP,CA-MHPD-E2B-03434660,CA-Accord-235248,ACCORD,,51.0,YR,,F,Y,,,20220622,,HP,CA,CA,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Body surface area increased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Blood glucose increased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Sinusitis,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Pyrexia,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Cough,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Blood alkaline phosphatase increased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Urine leukocyte esterase positive,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,C-reactive protein increased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Total cholesterol/HDL ratio increased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Nasal ulcer,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Urine albumin/creatinine ratio increased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Bursitis,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Myalgia,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Weight increased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,C-reactive protein,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Creatinine urine decreased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Blood creatinine increased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Urine abnormality,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Osteoarthritis,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199108722,19910872,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,"Injection, Solution",,2022,Q2,Red cell distribution width increased,,2022,Q2,2,F,,20220624.0,20211004,20220629,EXP,,CA-ROCHE-2923675,ROCHE,,58.0,YR,,F,Y,91.0,KG,20220629,,HP,CA,,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Angina pectoris,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Nasal congestion,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Fall,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Stress,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Asthma,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Chest pain,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Heart sounds,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Weight decreased,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Cough,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Flank pain,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Depressed mood,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Appetite disorder,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Wheezing,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Influenza,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Rales,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Malaise,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Productive cough,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Pyrexia,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Depressive symptom,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Injury,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Chest discomfort,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
199676582,19967658,50,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0 DF, QW",,,U,,,,,,,,/WK,2022,Q2,Insomnia,,2022,Q2,2,F,,20220511.0,20211019,20220517,EXP,,NVSC2021CA234236,NOVARTIS,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
201037272,20103727,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Fall,,2022,Q2,2,F,20200601.0,20220404.0,20211123,20220407,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20220407,,HP,DE,DE,2022,Q2,Elderly
201037272,20103727,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Hypertensive crisis,,2022,Q2,2,F,20200601.0,20220404.0,20211123,20220407,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20220407,,HP,DE,DE,2022,Q2,Elderly
201037272,20103727,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Overdose,,2022,Q2,2,F,20200601.0,20220404.0,20211123,20220407,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20220407,,HP,DE,DE,2022,Q2,Elderly
201037272,20103727,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Gait disturbance,,2022,Q2,2,F,20200601.0,20220404.0,20211123,20220407,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20220407,,HP,DE,DE,2022,Q2,Elderly
201037272,20103727,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Vertigo,,2022,Q2,2,F,20200601.0,20220404.0,20211123,20220407,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20220407,,HP,DE,DE,2022,Q2,Elderly
201037272,20103727,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Deafness,,2022,Q2,2,F,20200601.0,20220404.0,20211123,20220407,EXP,,DE-MYLANLABS-2021M1085527,MYLAN,,70.0,YR,,F,Y,82.0,KG,20220407,,HP,DE,DE,2022,Q2,Elderly
201235864,20123586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q2,Diabetic retinal oedema,,2022,Q2,4,F,20211117.0,20220616.0,20211129,20220623,EXP,,RU-NOVOPROD-868163,NOVO NORDISK,,71.0,YR,,F,Y,69.0,KG,20220623,,MD,RU,RU,2022,Q2,Elderly
201235864,20123586,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q2,Diabetic retinal oedema,,2022,Q2,4,F,20211117.0,20220616.0,20211129,20220623,EXP,,RU-NOVOPROD-868163,NOVO NORDISK,,71.0,YR,,F,Y,69.0,KG,20220623,,MD,RU,RU,2022,Q2,Elderly
201741304,20174130,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5,mg,Once per week",4.5,MG,Y,,,,209637.0,0.5,MG,Solution for injection,/WK,2022,Q2,Loss of consciousness,,2022,Q2,4,F,20211123.0,20220415.0,20211213,20220425,EXP,,US-NOVOPROD-872485,NOVO NORDISK,,58.0,YR,,M,Y,95.0,KG,20220425,,MD,US,US,2022,Q2,Adult
202356045,20235604,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.7 mg, qw",,,,,,,215256.0,1.7,MG,Solution for injection,/WK,2022,Q2,Bile duct stone,,2022,Q2,5,F,20211218.0,20220408.0,20211228,20220419,EXP,,GR-NOVOPROD-877957,NOVO NORDISK,,69.0,YR,,M,Y,99.0,KG,20220419,,MD,GR,GR,2022,Q2,Elderly
202356403,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220517.0,20211228,20220601,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20220601,,HP,CA,CA,2022,Q2,Adult
202356403,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Depression,,2022,Q2,3,F,,20220517.0,20211228,20220601,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20220601,,HP,CA,CA,2022,Q2,Adult
202356403,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Wheezing,,2022,Q2,3,F,,20220517.0,20211228,20220601,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20220601,,HP,CA,CA,2022,Q2,Adult
202356403,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220517.0,20211228,20220601,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20220601,,HP,CA,CA,2022,Q2,Adult
202356403,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,3,F,,20220517.0,20211228,20220601,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20220601,,HP,CA,CA,2022,Q2,Adult
202356403,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220517.0,20211228,20220601,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20220601,,HP,CA,CA,2022,Q2,Adult
202356403,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Asthma,,2022,Q2,3,F,,20220517.0,20211228,20220601,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20220601,,HP,CA,CA,2022,Q2,Adult
202356403,20235640,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Hypoacusis,,2022,Q2,3,F,,20220517.0,20211228,20220601,EXP,,CA-AUROBINDO-AUR-APL-2021-052727,AUROBINDO,,51.0,YR,,F,Y,,,20220601,,HP,CA,CA,2022,Q2,Adult
202392553,20239255,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220513.0,20211228,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
202392553,20239255,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q2,Asthma,,2022,Q2,3,F,,20220513.0,20211228,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
202392553,20239255,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220513.0,20211228,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
202392553,20239255,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220513.0,20211228,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
202392553,20239255,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,3,F,,20220513.0,20211228,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
202392553,20239255,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q2,Hypoacusis,,2022,Q2,3,F,,20220513.0,20211228,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
202392553,20239255,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q2,Wheezing,,2022,Q2,3,F,,20220513.0,20211228,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
202392553,20239255,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q2,Depression,,2022,Q2,3,F,,20220513.0,20211228,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220519,,MD,CA,CA,2022,Q2,Adult
202440623,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q2,Diabetes mellitus,,2022,Q2,3,F,,20220518.0,20211228,20220524,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20220524,,CN,CA,CA,2022,Q2,Adult
202440623,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q2,Wheezing,,2022,Q2,3,F,,20220518.0,20211228,20220524,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20220524,,CN,CA,CA,2022,Q2,Adult
202440623,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q2,Asthma,,2022,Q2,3,F,,20220518.0,20211228,20220524,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20220524,,CN,CA,CA,2022,Q2,Adult
202440623,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q2,Hypoacusis,,2022,Q2,3,F,,20220518.0,20211228,20220524,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20220524,,CN,CA,CA,2022,Q2,Adult
202440623,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,3,F,,20220518.0,20211228,20220524,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20220524,,CN,CA,CA,2022,Q2,Adult
202440623,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220518.0,20211228,20220524,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20220524,,CN,CA,CA,2022,Q2,Adult
202440623,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q2,Depression,,2022,Q2,3,F,,20220518.0,20211228,20220524,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20220524,,CN,CA,CA,2022,Q2,Adult
202440623,20244062,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,3,F,,20220518.0,20211228,20220524,EXP,,CA-JNJFOC-20211252916,JOHNSON AND JOHNSON,,51.0,YR,A,F,Y,,,20220524,,CN,CA,CA,2022,Q2,Adult
202669072,20266907,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Wheezing,,2022,Q2,2,F,,20220516.0,20211231,20220523,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220523,,CN,CA,CA,2022,Q2,Adult
202669072,20266907,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,2,F,,20220516.0,20211231,20220523,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220523,,CN,CA,CA,2022,Q2,Adult
202669072,20266907,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Depression,,2022,Q2,2,F,,20220516.0,20211231,20220523,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220523,,CN,CA,CA,2022,Q2,Adult
202669072,20266907,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Asthma,,2022,Q2,2,F,,20220516.0,20211231,20220523,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220523,,CN,CA,CA,2022,Q2,Adult
202669072,20266907,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,2,F,,20220516.0,20211231,20220523,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220523,,CN,CA,CA,2022,Q2,Adult
202669072,20266907,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,2,F,,20220516.0,20211231,20220523,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220523,,CN,CA,CA,2022,Q2,Adult
202669072,20266907,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220516.0,20211231,20220523,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220523,,CN,CA,CA,2022,Q2,Adult
202669072,20266907,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Hypoacusis,,2022,Q2,2,F,,20220516.0,20211231,20220523,EXP,,CA-BAUSCH-BL-2021-042654,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220523,,CN,CA,CA,2022,Q2,Adult
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Fall,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Angina pectoris,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Syncope,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Blood creatinine increased,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Blood bicarbonate decreased,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Neutrophil count decreased,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Hypoalbuminaemia,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Supraventricular tachycardia,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Troponin I increased,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Atrial flutter,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Sepsis,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Hypophosphataemia,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Haemorrhage intracranial,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Chills,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203117464,20311746,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,White blood cell count decreased,,2022,Q2,4,F,20210815.0,20220506.0,20220108,20220511,EXP,,US-ROCHE-2993041,ROCHE,,80.0,YR,,M,Y,69.9,KG,20220511,,MD,US,,2022,Q2,Elderly
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Labelled drug-drug interaction medication error,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Drug interaction,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Myalgia,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Product use in unapproved indication,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Rhabdomyolysis,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Myopathy,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Urine output decreased,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Urine flow decreased,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Muscle spasms,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Renal failure,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Contraindicated product prescribed,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Serotonin syndrome,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Product prescribing error,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Contraindicated product administered,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Body temperature increased,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Off label use,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Myoglobinuria,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Drug titration error,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Hyperhidrosis,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Chills,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
203130018,20313001,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,U,,,,,0.5,MG,,/WK,2022,Q2,Headache,,2022,Q2,8,F,,20220331.0,20220109,20220414,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220414,,MD,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Labelled drug-drug interaction medication error,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Headache,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Chills,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Contraindicated product administered,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Drug interaction,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Product prescribing error,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Urine output decreased,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Myopathy,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Muscle spasms,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Serotonin syndrome,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Renal failure,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Off label use,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Hyperhidrosis,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Body temperature increased,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Rhabdomyolysis,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Micturition frequency decreased,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Myoglobinuria,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Product use in unapproved indication,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Urine flow decreased,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Contraindicated product prescribed,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Drug titration error,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,U,U,,,,0.5,MG,Injection,/WK,2022,Q2,Myalgia,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Labelled drug-drug interaction medication error,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Headache,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Chills,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Contraindicated product administered,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Drug interaction,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Product prescribing error,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Urine output decreased,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Myopathy,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Muscle spasms,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Serotonin syndrome,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Renal failure,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Off label use,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Hyperhidrosis,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Body temperature increased,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Rhabdomyolysis,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Micturition frequency decreased,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Myoglobinuria,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Product use in unapproved indication,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Urine flow decreased,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Contraindicated product prescribed,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Drug titration error,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
2034676811,20346768,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,U,,,,,,Injection,,2022,Q2,Myalgia,,2022,Q2,11,F,,20220420.0,20220118,20220422,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20220422,,HP,PL,PL,2022,Q2,Young Adult
204672703,20467270,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,10276.0,MG,D,,,,213051.0,,,Tablet,,2022,Q2,Cholecystitis acute,,2022,Q2,3,F,20211218.0,20220509.0,20220214,20220517,EXP,,US-NOVOPROD-887936,NOVO NORDISK,,73.0,YR,,M,Y,131.0,KG,20220517,,MD,US,US,2022,Q2,Elderly
204672703,20467270,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",10276.0,MG,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q2,Cholecystitis acute,,2022,Q2,3,F,20211218.0,20220509.0,20220214,20220517,EXP,,US-NOVOPROD-887936,NOVO NORDISK,,73.0,YR,,M,Y,131.0,KG,20220517,,MD,US,US,2022,Q2,Elderly
204672703,20467270,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,10276.0,MG,D,,,,213051.0,,,Tablet,,2022,Q2,Cholecystitis acute,,2022,Q2,3,F,20211218.0,20220509.0,20220214,20220517,EXP,,US-NOVOPROD-887936,NOVO NORDISK,,73.0,YR,,M,Y,131.0,KG,20220517,,MD,US,US,2022,Q2,Elderly
204672703,20467270,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,10276.0,MG,D,,,,213051.0,,,Tablet,,2022,Q2,Cholecystitis acute,,2022,Q2,3,F,20211218.0,20220509.0,20220214,20220517,EXP,,US-NOVOPROD-887936,NOVO NORDISK,,73.0,YR,,M,Y,131.0,KG,20220517,,MD,US,US,2022,Q2,Elderly
204672773,20467277,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,4928.0,MG,Y,N,,,213051.0,,,Tablet,,2022,Q2,Cholecystitis,,2022,Q2,3,F,20220127.0,20220506.0,20220214,20220517,EXP,,FR-NOVOPROD-888830,NOVO NORDISK,,63.0,YR,,M,Y,126.0,KG,20220517,,MD,FR,FR,2022,Q2,Adult
204672773,20467277,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",4928.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2022,Q2,Cholecystitis,,2022,Q2,3,F,20220127.0,20220506.0,20220214,20220517,EXP,,FR-NOVOPROD-888830,NOVO NORDISK,,63.0,YR,,M,Y,126.0,KG,20220517,,MD,FR,FR,2022,Q2,Adult
204672773,20467277,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",4928.0,MG,Y,N,,,213051.0,14.0,MG,Tablet,QD,2022,Q2,Cholecystitis,,2022,Q2,3,F,20220127.0,20220506.0,20220214,20220517,EXP,,FR-NOVOPROD-888830,NOVO NORDISK,,63.0,YR,,M,Y,126.0,KG,20220517,,MD,FR,FR,2022,Q2,Adult
204672773,20467277,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,4928.0,MG,Y,N,,,213051.0,,,Tablet,,2022,Q2,Cholecystitis,,2022,Q2,3,F,20220127.0,20220506.0,20220214,20220517,EXP,,FR-NOVOPROD-888830,NOVO NORDISK,,63.0,YR,,M,Y,126.0,KG,20220517,,MD,FR,FR,2022,Q2,Adult
204672773,20467277,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,4928.0,MG,Y,N,,,213051.0,,,Tablet,,2022,Q2,Cholecystitis,,2022,Q2,3,F,20220127.0,20220506.0,20220214,20220517,EXP,,FR-NOVOPROD-888830,NOVO NORDISK,,63.0,YR,,M,Y,126.0,KG,20220517,,MD,FR,FR,2022,Q2,Adult
205103163,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q2,Macular oedema,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q2,Macular oedema,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q2,Retinopathy proliferative,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q2,Macular oedema,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q2,Macular oedema,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q2,Retinopathy proliferative,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q2,Macular oedema,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q2,Macular oedema,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q2,Retinopathy proliferative,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q2,Macular oedema,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q2,Macular oedema,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205103163,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q2,Retinopathy proliferative,,2022,Q2,3,F,20210712.0,20220525.0,20220224,20220606,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20220606,,MD,GB,GB,2022,Q2,Adult
205566712,20556671,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly",,,,,,,,,,,,2022,Q2,Hiatus hernia,,2022,Q2,2,F,20200322.0,20220317.0,20220307,20220401,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328752,RANBAXY,,69.0,YR,,M,Y,101.0,KG,20220401,,CN,DE,DE,2022,Q2,Elderly
205566712,20556671,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly",,,,,,,,,,,,2022,Q2,Large intestine polyp,,2022,Q2,2,F,20200322.0,20220317.0,20220307,20220401,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328752,RANBAXY,,69.0,YR,,M,Y,101.0,KG,20220401,,CN,DE,DE,2022,Q2,Elderly
205566712,20556671,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly",,,,,,,,,,,,2022,Q2,Intestinal haemorrhage,,2022,Q2,2,F,20200322.0,20220317.0,20220307,20220401,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328752,RANBAXY,,69.0,YR,,M,Y,101.0,KG,20220401,,CN,DE,DE,2022,Q2,Elderly
205566712,20556671,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly",,,,,,,,,,,,2022,Q2,Periodontitis,,2022,Q2,2,F,20200322.0,20220317.0,20220307,20220401,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328752,RANBAXY,,69.0,YR,,M,Y,101.0,KG,20220401,,CN,DE,DE,2022,Q2,Elderly
205566712,20556671,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly",,,,,,,,,,,,2022,Q2,Melaena,,2022,Q2,2,F,20200322.0,20220317.0,20220307,20220401,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328752,RANBAXY,,69.0,YR,,M,Y,101.0,KG,20220401,,CN,DE,DE,2022,Q2,Elderly
205566712,20556671,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly",,,,,,,,,,,,2022,Q2,Diverticulum,,2022,Q2,2,F,20200322.0,20220317.0,20220307,20220401,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328752,RANBAXY,,69.0,YR,,M,Y,101.0,KG,20220401,,CN,DE,DE,2022,Q2,Elderly
205566712,20556671,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly",,,,,,,,,,,,2022,Q2,Iron deficiency anaemia,,2022,Q2,2,F,20200322.0,20220317.0,20220307,20220401,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328752,RANBAXY,,69.0,YR,,M,Y,101.0,KG,20220401,,CN,DE,DE,2022,Q2,Elderly
205566712,20556671,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly",,,,,,,,,,,,2022,Q2,Large intestine polyp,,2022,Q2,2,F,20200322.0,20220317.0,20220307,20220401,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328752,RANBAXY,,69.0,YR,,M,Y,101.0,KG,20220401,,CN,DE,DE,2022,Q2,Elderly
205566712,20556671,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly",,,,,,,,,,,,2022,Q2,Large intestine polyp,,2022,Q2,2,F,20200322.0,20220317.0,20220307,20220401,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328752,RANBAXY,,69.0,YR,,M,Y,101.0,KG,20220401,,CN,DE,DE,2022,Q2,Elderly
205566712,20556671,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, Weekly",,,,,,,,,,,,2022,Q2,Gingival bleeding,,2022,Q2,2,F,20200322.0,20220317.0,20220307,20220401,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328752,RANBAXY,,69.0,YR,,M,Y,101.0,KG,20220401,,CN,DE,DE,2022,Q2,Elderly
205636003,20563600,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",30.343,MG,N,,,,215256.0,0.24,MG,Solution for injection,/WK,2022,Q2,Autoimmune thyroiditis,,2022,Q2,3,F,20220221.0,20220331.0,20220308,20220411,EXP,,CA-NOVOPROD-895493,NOVO NORDISK,,77.0,YR,,F,Y,77.0,KG,20220411,,MD,CA,CA,2022,Q2,Elderly
205636003,20563600,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,30.343,MG,N,,,,215256.0,,,Solution for injection,,2022,Q2,Autoimmune thyroiditis,,2022,Q2,3,F,20220221.0,20220331.0,20220308,20220411,EXP,,CA-NOVOPROD-895493,NOVO NORDISK,,77.0,YR,,F,Y,77.0,KG,20220411,,MD,CA,CA,2022,Q2,Elderly
205636003,20563600,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,30.343,MG,N,,,,215256.0,,,Solution for injection,,2022,Q2,Autoimmune thyroiditis,,2022,Q2,3,F,20220221.0,20220331.0,20220308,20220411,EXP,,CA-NOVOPROD-895493,NOVO NORDISK,,77.0,YR,,F,Y,77.0,KG,20220411,,MD,CA,CA,2022,Q2,Elderly
205695722,20569572,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,N,,,,213051.0,14.0,MG,Tablet,QD,2022,Q2,Cholelithiasis,,2022,Q2,2,F,20220225.0,20220321.0,20220309,20220401,EXP,,GB-NOVOPROD-895521,NOVO NORDISK,,63.0,YR,,F,Y,95.0,KG,20220401,,MD,GB,GB,2022,Q2,Adult
206097202,20609720,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0,mg,Once per week",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q2,Cholecystitis acute,,2022,Q2,2,F,20211220.0,20220512.0,20220318,20220520,EXP,,BG-NOVOPROD-899140,NOVO NORDISK,,52.0,YR,,M,Y,84.0,KG,20220520,,MD,BG,BG,2022,Q2,Adult
206106263,20610626,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7 milligram, qd",,,,,,,,7.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,3,F,20211203.0,20220524.0,20220318,20220531,EXP,,JP-TAKEDA-2022TJP008898,TAKEDA,,29.0,YR,,M,Y,110.6,KG,20220531,,MD,JP,JP,2022,Q2,Young Adult
206106263,20610626,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"7 milligram, qd",,,,,,,,7.0,MG,Tablet,QD,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,20211203.0,20220524.0,20220318,20220531,EXP,,JP-TAKEDA-2022TJP008898,TAKEDA,,29.0,YR,,M,Y,110.6,KG,20220531,,MD,JP,JP,2022,Q2,Young Adult
206148214,20614821,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",51.071,MG,Y,U,,,215256.0,0.5,MG,Solution for injection,/WK,2022,Q2,Drug-induced liver injury,,2022,Q2,4,F,20220201.0,20220425.0,20220321,20220506,EXP,,US-NOVOPROD-889513,NOVO NORDISK,,70.0,YR,,M,Y,93.0,KG,20220506,,MD,US,US,2022,Q2,Elderly
206157333,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q2,Infusion related reaction,,2022,Q2,3,F,20220217.0,20220415.0,20220321,20220429,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220429,,MD,GB,GB,2022,Q2,Adult
206157333,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q2,Vomiting,,2022,Q2,3,F,20220217.0,20220415.0,20220321,20220429,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220429,,MD,GB,GB,2022,Q2,Adult
206157333,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q2,Hypotension,,2022,Q2,3,F,20220217.0,20220415.0,20220321,20220429,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220429,,MD,GB,GB,2022,Q2,Adult
206157333,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q2,Diarrhoea,,2022,Q2,3,F,20220217.0,20220415.0,20220321,20220429,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220429,,MD,GB,GB,2022,Q2,Adult
206157333,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q2,Sepsis,,2022,Q2,3,F,20220217.0,20220415.0,20220321,20220429,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220429,,MD,GB,GB,2022,Q2,Adult
206157333,20615733,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q2,Pyrexia,,2022,Q2,3,F,20220217.0,20220415.0,20220321,20220429,EXP,,GB-Hikma Pharmaceuticals USA Inc.-GB-H14001-22-57076,HIKMA,,62.0,YR,,M,Y,115.9,KG,20220429,,MD,GB,GB,2022,Q2,Adult
206342593,20634259,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",10010.0,MG,Y,,,,213051.0,14.0,MG,Tablet,QD,2022,Q2,Jaundice cholestatic,,2022,Q2,3,F,20220226.0,20220329.0,20220325,20220404,EXP,,SK-NOVOPROD-902700,NOVO NORDISK,,72.0,YR,,M,Y,101.0,KG,20220404,,MD,SK,SK,2022,Q2,Elderly
206342593,20634259,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,10010.0,MG,Y,,,,213051.0,,,Tablet,,2022,Q2,Jaundice cholestatic,,2022,Q2,3,F,20220226.0,20220329.0,20220325,20220404,EXP,,SK-NOVOPROD-902700,NOVO NORDISK,,72.0,YR,,M,Y,101.0,KG,20220404,,MD,SK,SK,2022,Q2,Elderly
206342593,20634259,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,10010.0,MG,Y,,,,213051.0,,,Tablet,,2022,Q2,Jaundice cholestatic,,2022,Q2,3,F,20220226.0,20220329.0,20220325,20220404,EXP,,SK-NOVOPROD-902700,NOVO NORDISK,,72.0,YR,,M,Y,101.0,KG,20220404,,MD,SK,SK,2022,Q2,Elderly
206366902,20636690,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Infusion related reaction,,2022,Q2,2,F,20220217.0,20220415.0,20220325,20220425,EXP,,GB-TEVA-2022-GB-2017685,TEVA,,62.0,YR,A,M,Y,115.9,KG,20220425,,MD,GB,GB,2022,Q2,Adult
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Pruritus,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Speech disorder,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Hypoaesthesia,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Blood immunoglobulin G decreased,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Lip swelling,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Feeling abnormal,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Migraine,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Mouth swelling,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Headache,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Chest discomfort,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Blepharospasm,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Formication,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Facial paralysis,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Facial paralysis,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Bell's palsy,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Flushing,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Eyelid ptosis,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Product use complaint,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Eyelid disorder,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206516704,20651670,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Swelling face,,2022,Q2,4,F,20220320.0,20220531.0,20220330,20220608,EXP,,US-BEH-2022143416,CSL BEHRING,,67.0,YR,E,F,Y,,,20220608,,MD,US,US,2022,Q2,Elderly
206669181,20666918,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q2,Crohn's disease,,2022,Q2,1,I,,20220328.0,20220403,20220403,EXP,,CA-JNJFOC-20220363295,JOHNSON AND JOHNSON,,52.0,YR,A,F,Y,53.0,KG,20220404,,HP,CA,CA,2022,Q2,Adult
206669181,20666918,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q2,Heart rate increased,,2022,Q2,1,I,,20220328.0,20220403,20220403,EXP,,CA-JNJFOC-20220363295,JOHNSON AND JOHNSON,,52.0,YR,A,F,Y,53.0,KG,20220404,,HP,CA,CA,2022,Q2,Adult
206734351,20673435,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Sublingual,F0.5 MG QWEEK SUBLINGUAL,,,Y,D,LP58500,20231231.0,,0.5,MG,,QW,2022,Q2,Pancreatitis,,2022,Q2,1,I,20220101.0,,20220403,20220403,DIR,FDA-CDER-CTU-2022-25498,,FDA-CTU,,55.0,YR,,M,N,77.0,KG,20220318,N,PH,US,,2022,Q2,Adult
206734401,20673440,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Nausea,,2022,Q2,1,I,20211115.0,,20220403,20220403,DIR,FDA-CDER-CTU-2022-25524,,FDA-CTU,,51.0,YR,,M,N,126.0,KG,20220118,N,PH,US,,2022,Q2,Adult
206734401,20673440,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Cholelithiasis,,2022,Q2,1,I,20211115.0,,20220403,20220403,DIR,FDA-CDER-CTU-2022-25524,,FDA-CTU,,51.0,YR,,M,N,126.0,KG,20220118,N,PH,US,,2022,Q2,Adult
206734401,20673440,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Tachycardia,,2022,Q2,1,I,20211115.0,,20220403,20220403,DIR,FDA-CDER-CTU-2022-25524,,FDA-CTU,,51.0,YR,,M,N,126.0,KG,20220118,N,PH,US,,2022,Q2,Adult
206734401,20673440,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Chills,,2022,Q2,1,I,20211115.0,,20220403,20220403,DIR,FDA-CDER-CTU-2022-25524,,FDA-CTU,,51.0,YR,,M,N,126.0,KG,20220118,N,PH,US,,2022,Q2,Adult
206734401,20673440,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Vomiting,,2022,Q2,1,I,20211115.0,,20220403,20220403,DIR,FDA-CDER-CTU-2022-25524,,FDA-CTU,,51.0,YR,,M,N,126.0,KG,20220118,N,PH,US,,2022,Q2,Adult
206734401,20673440,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Infection,,2022,Q2,1,I,20211115.0,,20220403,20220403,DIR,FDA-CDER-CTU-2022-25524,,FDA-CTU,,51.0,YR,,M,N,126.0,KG,20220118,N,PH,US,,2022,Q2,Adult
206734401,20673440,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Diarrhoea,,2022,Q2,1,I,20211115.0,,20220403,20220403,DIR,FDA-CDER-CTU-2022-25524,,FDA-CTU,,51.0,YR,,M,N,126.0,KG,20220118,N,PH,US,,2022,Q2,Adult
206792475,20679247,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Febrile bone marrow aplasia,,2022,Q2,5,F,20220323.0,20220525.0,20220406,20220526,EXP,,FR-GILEAD-2022-0575736,GILEAD,,67.0,YR,E,F,Y,75.0,KG,20220526,,MD,FR,FR,2022,Q2,Elderly
206792475,20679247,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Malaise,,2022,Q2,5,F,20220323.0,20220525.0,20220406,20220526,EXP,,FR-GILEAD-2022-0575736,GILEAD,,67.0,YR,E,F,Y,75.0,KG,20220526,,MD,FR,FR,2022,Q2,Elderly
206792475,20679247,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,5,F,20220323.0,20220525.0,20220406,20220526,EXP,,FR-GILEAD-2022-0575736,GILEAD,,67.0,YR,E,F,Y,75.0,KG,20220526,,MD,FR,FR,2022,Q2,Elderly
206792475,20679247,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Sepsis,,2022,Q2,5,F,20220323.0,20220525.0,20220406,20220526,EXP,,FR-GILEAD-2022-0575736,GILEAD,,67.0,YR,E,F,Y,75.0,KG,20220526,,MD,FR,FR,2022,Q2,Elderly
206792475,20679247,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Septic shock,,2022,Q2,5,F,20220323.0,20220525.0,20220406,20220526,EXP,,FR-GILEAD-2022-0575736,GILEAD,,67.0,YR,E,F,Y,75.0,KG,20220526,,MD,FR,FR,2022,Q2,Elderly
206805751,20680575,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous, 0.25MG QWEEK SQ,,,,,,,,0.25,MG,,QW,2022,Q2,Anxiety,,2022,Q2,1,I,20220228.0,,20220405,20220405,DIR,FDA-CDER-CTU-2022-25871,,FDA-CTU,,37.0,YR,,M,N,113.0,KG,20220329,N,PH,US,,2022,Q2,Adult
206805751,20680575,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous, 0.25MG QWEEK SQ,,,,,,,,0.25,MG,,QW,2022,Q2,Constipation,,2022,Q2,1,I,20220228.0,,20220405,20220405,DIR,FDA-CDER-CTU-2022-25871,,FDA-CTU,,37.0,YR,,M,N,113.0,KG,20220329,N,PH,US,,2022,Q2,Adult
206805751,20680575,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous, 0.25MG QWEEK SQ,,,,,,,,0.25,MG,,QW,2022,Q2,Diplopia,,2022,Q2,1,I,20220228.0,,20220405,20220405,DIR,FDA-CDER-CTU-2022-25871,,FDA-CTU,,37.0,YR,,M,N,113.0,KG,20220329,N,PH,US,,2022,Q2,Adult
206805751,20680575,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous, 0.25MG QWEEK SQ,,,,,,,,0.25,MG,,QW,2022,Q2,Sleep disorder,,2022,Q2,1,I,20220228.0,,20220405,20220405,DIR,FDA-CDER-CTU-2022-25871,,FDA-CTU,,37.0,YR,,M,N,113.0,KG,20220329,N,PH,US,,2022,Q2,Adult
206904331,20690433,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Blood potassium increased,,2022,Q2,1,I,20201124.0,20220404.0,20220408,20220408,EXP,,DK-MYLANLABS-2022M1025439,MYLAN,,72.0,YR,,M,Y,111.0,KG,20220408,,HP,DK,DK,2022,Q2,Elderly
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Insomnia,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Heart sounds,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Wheezing,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Nasal congestion,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Depressive symptom,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Cough,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Angina pectoris,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Rales,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Stress,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Fall,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Pyrexia,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Influenza,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Weight decreased,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Asthma,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Malaise,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Appetite disorder,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Injury,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Chest discomfort,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Flank pain,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Chest pain,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Productive cough,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,100,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 mL, weekly",,,U,,,,,125.0,ML,,/WK,2022,Q2,Depressed mood,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Insomnia,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Heart sounds,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Wheezing,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Nasal congestion,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Depressive symptom,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Cough,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Angina pectoris,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Rales,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Stress,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Fall,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Pyrexia,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Influenza,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Weight decreased,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Asthma,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Malaise,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Appetite disorder,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Injury,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Chest discomfort,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Flank pain,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Chest pain,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Productive cough,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,101,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,,/WK,2022,Q2,Depressed mood,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Insomnia,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Heart sounds,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Wheezing,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Nasal congestion,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Depressive symptom,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Cough,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Angina pectoris,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Rales,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Stress,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Fall,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Pyrexia,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Respiration abnormal,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Influenza,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Weight decreased,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Asthma,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Prolonged expiration,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Malaise,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Appetite disorder,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Injury,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Chest discomfort,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Flank pain,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Chest pain,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Productive cough,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206906022,20690602,102,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, weekly",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q2,Depressed mood,,2022,Q2,2,F,,20220510.0,20220408,20220517,EXP,,CA-PFIZER INC-2020147397,PFIZER,,61.0,YR,,F,Y,,,20220517,,HP,CA,CA,2022,Q2,Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Contraindicated product administered,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Myopathy,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Labelled drug-drug interaction medication error,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Contraindicated product prescribed,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Drug titration error,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Serotonin syndrome,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Renal failure,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Myoglobinuria,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206940591,20694059,5,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Weekly",,,U,,,,,0.5,MG,,,2022,Q2,Product prescribing error,,2022,Q2,1,I,,20220330.0,20220411,20220411,EXP,PL-EMA-2022227-AUTODUP-1645994332218,PL-Accord-260197,ACCORD,,29.0,YR,A,F,Y,,,20220411,,MD,PL,PL,2022,Q2,Young Adult
206975401,20697540,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Haemorrhoids,,2022,Q2,1,I,20211101.0,20220405.0,20220411,20220411,EXP,,DE-DSJP-DSE-2022-112351,DAIICHI,,77.0,YR,,F,Y,102.0,KG,20220411,,MD,DE,DE,2022,Q2,Elderly
207001961,20700196,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,0.25,MG,U,,202110AHN1,,,0.25,MG,Injection,QD,2022,Q2,Ketoacidosis,,2022,Q2,1,I,20220322.0,20220404.0,20220412,20220412,EXP,,CN-AstraZeneca-2022A141735,ASTRAZENECA,,13540.0,DY,,M,Y,,,20220412,,MD,CN,,2022,Q2,Elderly
207001961,20700196,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,0.25,MG,U,,202110AHN1,,,0.25,MG,Injection,QD,2022,Q2,Ulnar nerve injury,,2022,Q2,1,I,20220322.0,20220404.0,20220412,20220412,EXP,,CN-AstraZeneca-2022A141735,ASTRAZENECA,,13540.0,DY,,M,Y,,,20220412,,MD,CN,,2022,Q2,Elderly
207003431,20700343,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Cardiac failure acute,,2022,Q2,1,I,20210309.0,20220407.0,20220412,20220412,EXP,,FR-MYLANLABS-2022M1026228,MYLAN,,76.0,YR,,M,Y,90.0,KG,20220412,,HP,FR,FR,2022,Q2,Elderly
207003431,20700343,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Weight increased,,2022,Q2,1,I,20210309.0,20220407.0,20220412,20220412,EXP,,FR-MYLANLABS-2022M1026228,MYLAN,,76.0,YR,,M,Y,90.0,KG,20220412,,HP,FR,FR,2022,Q2,Elderly
207003431,20700343,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Cardiac failure acute,,2022,Q2,1,I,20210309.0,20220407.0,20220412,20220412,EXP,,FR-MYLANLABS-2022M1026228,MYLAN,,76.0,YR,,M,Y,90.0,KG,20220412,,HP,FR,FR,2022,Q2,Elderly
207003431,20700343,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Weight increased,,2022,Q2,1,I,20210309.0,20220407.0,20220412,20220412,EXP,,FR-MYLANLABS-2022M1026228,MYLAN,,76.0,YR,,M,Y,90.0,KG,20220412,,HP,FR,FR,2022,Q2,Elderly
207081521,20708152,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, qd",1392.0,MG,D,,,,213051.0,3.0,MG,Tablet,QD,2022,Q2,Cholecystitis acute,,2022,Q2,1,I,20220404.0,20220405.0,20220414,20220414,EXP,,JP-NOVOPROD-906721,NOVO NORDISK,,72.0,YR,,M,Y,76.0,KG,20220414,,MD,JP,JP,2022,Q2,Elderly
207095791,20709579,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,1.0,MG,,,2022,Q2,Myoclonus,,2022,Q2,1,I,20220308.0,20220404.0,20220414,20220414,EXP,IT-MINISAL02-852099,IT-Accord-260491,ACCORD,,74.0,YR,,F,Y,100.0,KG,20220414,,MD,IT,IT,2022,Q2,Elderly
207102741,20710274,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Presyncope,,2022,Q2,1,I,20210317.0,20220411.0,20220414,20220414,EXP,,ES-MYLANLABS-2022M1026794,MYLAN,,68.0,YR,,M,Y,94.0,KG,20220414,,HP,ES,ES,2022,Q2,Elderly
207102741,20710274,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Coronary artery occlusion,,2022,Q2,1,I,20210317.0,20220411.0,20220414,20220414,EXP,,ES-MYLANLABS-2022M1026794,MYLAN,,68.0,YR,,M,Y,94.0,KG,20220414,,HP,ES,ES,2022,Q2,Elderly
207106061,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,1,I,,20220405.0,20220414,20220414,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207106061,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220405.0,20220414,20220414,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207106061,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Hypoacusis,,2022,Q2,1,I,,20220405.0,20220414,20220414,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207106061,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Asthma,,2022,Q2,1,I,,20220405.0,20220414,20220414,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207106061,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,1,I,,20220405.0,20220414,20220414,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207106061,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Wheezing,,2022,Q2,1,I,,20220405.0,20220414,20220414,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207106061,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220405.0,20220414,20220414,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207111561,20711156,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,1,I,,20220411.0,20220414,20220414,EXP,,CA-BAUSCH-BL-2022-009084,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207111561,20711156,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,1,I,,20220411.0,20220414,20220414,EXP,,CA-BAUSCH-BL-2022-009084,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207111561,20711156,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Hypoacusis,,2022,Q2,1,I,,20220411.0,20220414,20220414,EXP,,CA-BAUSCH-BL-2022-009084,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207111561,20711156,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220411.0,20220414,20220414,EXP,,CA-BAUSCH-BL-2022-009084,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207111561,20711156,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Wheezing,,2022,Q2,1,I,,20220411.0,20220414,20220414,EXP,,CA-BAUSCH-BL-2022-009084,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207111561,20711156,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Asthma,,2022,Q2,1,I,,20220411.0,20220414,20220414,EXP,,CA-BAUSCH-BL-2022-009084,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207111561,20711156,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220411.0,20220414,20220414,EXP,,CA-BAUSCH-BL-2022-009084,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207111561,20711156,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Depression,,2022,Q2,1,I,,20220411.0,20220414,20220414,EXP,,CA-BAUSCH-BL-2022-009084,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220414,,CN,CA,CA,2022,Q2,Adult
207140692,20714069,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,209637.0,,,,,2022,Q2,Product use in unapproved indication,,2022,Q2,2,F,20210310.0,20220405.0,20220415,20220419,EXP,GB-MHRA-ADR 26634107,GB-NOVOPROD-907482,NOVO NORDISK,,58.0,YR,,M,Y,103.0,KG,20220419,,HP,GB,GB,2022,Q2,Adult
207140692,20714069,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,209637.0,,,,,2022,Q2,Cellulitis,,2022,Q2,2,F,20210310.0,20220405.0,20220415,20220419,EXP,GB-MHRA-ADR 26634107,GB-NOVOPROD-907482,NOVO NORDISK,,58.0,YR,,M,Y,103.0,KG,20220419,,HP,GB,GB,2022,Q2,Adult
207140692,20714069,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,209637.0,,,,,2022,Q2,Leukocytosis,,2022,Q2,2,F,20210310.0,20220405.0,20220415,20220419,EXP,GB-MHRA-ADR 26634107,GB-NOVOPROD-907482,NOVO NORDISK,,58.0,YR,,M,Y,103.0,KG,20220419,,HP,GB,GB,2022,Q2,Adult
207140692,20714069,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,209637.0,,,,,2022,Q2,Drug reaction with eosinophilia and systemic symptoms,,2022,Q2,2,F,20210310.0,20220405.0,20220415,20220419,EXP,GB-MHRA-ADR 26634107,GB-NOVOPROD-907482,NOVO NORDISK,,58.0,YR,,M,Y,103.0,KG,20220419,,HP,GB,GB,2022,Q2,Adult
207140741,20714074,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,2.4 milligram,907.2,MG,Y,U,,,209637.0,2.4,MG,,QD,2022,Q2,Diplopia,,2022,Q2,1,I,20191128.0,20220405.0,20220415,20220415,EXP,GB-MHRA-ADR 26724191,GB-NOVOPROD-907910,NOVO NORDISK,,78.0,YR,,M,Y,76.0,KG,20220415,,MD,GB,CA,2022,Q2,Elderly
207140741,20714074,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,2.4 milligram,907.2,MG,Y,U,,,209637.0,2.4,MG,,QD,2022,Q2,Dysphagia,,2022,Q2,1,I,20191128.0,20220405.0,20220415,20220415,EXP,GB-MHRA-ADR 26724191,GB-NOVOPROD-907910,NOVO NORDISK,,78.0,YR,,M,Y,76.0,KG,20220415,,MD,GB,CA,2022,Q2,Elderly
207140741,20714074,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,2.4 milligram,907.2,MG,Y,U,,,209637.0,2.4,MG,,QD,2022,Q2,Muscular weakness,,2022,Q2,1,I,20191128.0,20220405.0,20220415,20220415,EXP,GB-MHRA-ADR 26724191,GB-NOVOPROD-907910,NOVO NORDISK,,78.0,YR,,M,Y,76.0,KG,20220415,,MD,GB,CA,2022,Q2,Elderly
207140741,20714074,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,2.4 milligram,907.2,MG,Y,U,,,209637.0,2.4,MG,,QD,2022,Q2,Product use in unapproved indication,,2022,Q2,1,I,20191128.0,20220405.0,20220415,20220415,EXP,GB-MHRA-ADR 26724191,GB-NOVOPROD-907910,NOVO NORDISK,,78.0,YR,,M,Y,76.0,KG,20220415,,MD,GB,CA,2022,Q2,Elderly
207140741,20714074,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,2.4 milligram,907.2,MG,Y,U,,,209637.0,2.4,MG,,QD,2022,Q2,Myasthenia gravis,,2022,Q2,1,I,20191128.0,20220405.0,20220415,20220415,EXP,GB-MHRA-ADR 26724191,GB-NOVOPROD-907910,NOVO NORDISK,,78.0,YR,,M,Y,76.0,KG,20220415,,MD,GB,CA,2022,Q2,Elderly
207140843,20714084,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.24 mg, qw",28.56,MG,D,,,,215256.0,0.24,MG,Solution for injection,/WK,2022,Q2,Biliary obstruction,,2022,Q2,3,F,20220124.0,20220606.0,20220415,20220615,EXP,,GB-NOVOPROD-907366,NOVO NORDISK,,68.0,YR,,M,Y,113.0,KG,20220615,,MD,GB,GB,2022,Q2,Elderly
207140843,20714084,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,28.56,MG,D,,,,215256.0,,,Solution for injection,,2022,Q2,Biliary obstruction,,2022,Q2,3,F,20220124.0,20220606.0,20220415,20220615,EXP,,GB-NOVOPROD-907366,NOVO NORDISK,,68.0,YR,,M,Y,113.0,KG,20220615,,MD,GB,GB,2022,Q2,Elderly
207140843,20714084,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,28.56,MG,D,,,,215256.0,,,Solution for injection,,2022,Q2,Biliary obstruction,,2022,Q2,3,F,20220124.0,20220606.0,20220415,20220615,EXP,,GB-NOVOPROD-907366,NOVO NORDISK,,68.0,YR,,M,Y,113.0,KG,20220615,,MD,GB,GB,2022,Q2,Elderly
207140843,20714084,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,28.56,MG,D,,,,215256.0,,,Solution for injection,,2022,Q2,Biliary obstruction,,2022,Q2,3,F,20220124.0,20220606.0,20220415,20220615,EXP,,GB-NOVOPROD-907366,NOVO NORDISK,,68.0,YR,,M,Y,113.0,KG,20220615,,MD,GB,GB,2022,Q2,Elderly
207140843,20714084,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,28.56,MG,D,,,,215256.0,,,Solution for injection,,2022,Q2,Biliary obstruction,,2022,Q2,3,F,20220124.0,20220606.0,20220415,20220615,EXP,,GB-NOVOPROD-907366,NOVO NORDISK,,68.0,YR,,M,Y,113.0,KG,20220615,,MD,GB,GB,2022,Q2,Elderly
207230031,20723003,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,U,,,209637.0,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,,20220405.0,20220419,20220419,EXP,GB-MHRA-ADR 26713346,GB-NOVOPROD-907914,NOVO NORDISK,,63.0,YR,,M,Y,119.0,KG,20220419,,HP,GB,GB,2022,Q2,Adult
207230031,20723003,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,U,,,209637.0,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220405.0,20220419,20220419,EXP,GB-MHRA-ADR 26713346,GB-NOVOPROD-907914,NOVO NORDISK,,63.0,YR,,M,Y,119.0,KG,20220419,,HP,GB,GB,2022,Q2,Adult
207230031,20723003,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,U,,,209637.0,,,,,2022,Q2,Upper respiratory tract infection,,2022,Q2,1,I,,20220405.0,20220419,20220419,EXP,GB-MHRA-ADR 26713346,GB-NOVOPROD-907914,NOVO NORDISK,,63.0,YR,,M,Y,119.0,KG,20220419,,HP,GB,GB,2022,Q2,Adult
207230031,20723003,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,U,,,209637.0,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,,20220405.0,20220419,20220419,EXP,GB-MHRA-ADR 26713346,GB-NOVOPROD-907914,NOVO NORDISK,,63.0,YR,,M,Y,119.0,KG,20220419,,HP,GB,GB,2022,Q2,Adult
207230031,20723003,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,U,,,209637.0,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220405.0,20220419,20220419,EXP,GB-MHRA-ADR 26713346,GB-NOVOPROD-907914,NOVO NORDISK,,63.0,YR,,M,Y,119.0,KG,20220419,,HP,GB,GB,2022,Q2,Adult
207230031,20723003,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,U,,,209637.0,,,,,2022,Q2,Upper respiratory tract infection,,2022,Q2,1,I,,20220405.0,20220419,20220419,EXP,GB-MHRA-ADR 26713346,GB-NOVOPROD-907914,NOVO NORDISK,,63.0,YR,,M,Y,119.0,KG,20220419,,HP,GB,GB,2022,Q2,Adult
207230181,20723018,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",,,,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q2,Bile duct stone,,2022,Q2,1,I,20220207.0,20220408.0,20220419,20220419,EXP,,CA-NOVOPROD-893368,NOVO NORDISK,,62.0,YR,,M,Y,92.0,KG,20220419,,MD,CA,CA,2022,Q2,Adult
207240431,20724043,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Headache,,2022,Q2,1,I,,20220411.0,20220419,20220419,EXP,,CA-APOTEX-2022AP006149,APOTEX,,51.0,YR,,F,Y,,,20220419,,MD,CA,CA,2022,Q2,Adult
207240431,20724043,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220411.0,20220419,20220419,EXP,,CA-APOTEX-2022AP006149,APOTEX,,51.0,YR,,F,Y,,,20220419,,MD,CA,CA,2022,Q2,Adult
207240431,20724043,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Abdominal discomfort,,2022,Q2,1,I,,20220411.0,20220419,20220419,EXP,,CA-APOTEX-2022AP006149,APOTEX,,51.0,YR,,F,Y,,,20220419,,MD,CA,CA,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Neutrophil count increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Protein total increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Vitreous detachment,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Blood glucose increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Oedema,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Red cell distribution width increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Eosinophil count increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,White blood cell count increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Off label use,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Red blood cell count increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Proteinuria,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Arthralgia,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Granulomatosis with polyangiitis,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Renal vasculitis,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,C-reactive protein increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Blood pressure diastolic abnormal,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Intentional product use issue,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Cushingoid,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Herpes zoster,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Renal impairment,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Musculoskeletal stiffness,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Contusion,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Dehydration,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Blood osmolarity decreased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Mean cell haemoglobin concentration decreased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Blood pressure systolic increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Cataract,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Vasculitis,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Musculoskeletal pain,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Mean cell volume decreased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Blood albumin decreased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Episcleritis,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Weight increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207269291,20726929,36,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,,/WK,2022,Q2,Monocyte count increased,,2022,Q2,1,I,,20220412.0,20220419,20220419,EXP,,CA-ROCHE-3075907,ROCHE,,60.0,YR,,F,Y,,,20220419,,HP,CA,,2022,Q2,Adult
207377621,20737762,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2022,Q2,Haemorrhoids,,2022,Q2,1,I,20211101.0,20220412.0,20220422,20220422,EXP,,DE-AUROBINDO-AUR-APL-2022-013598,AUROBINDO,,77.0,YR,,F,Y,102.0,KG,20220422,,MD,DE,DE,2022,Q2,Elderly
207433312,20743331,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"25.0,mg,Once per day",3325.0,MG,Y,,,,213051.0,25.0,MG,Tablet,QD,2022,Q2,Dehydration,,2022,Q2,2,F,20220307.0,20220503.0,20220425,20220510,EXP,,CA-NOVOPROD-909213,NOVO NORDISK,,73.0,YR,,F,Y,130.0,KG,20220510,,MD,CA,CA,2022,Q2,Elderly
207583501,20758350,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 dosage form,,,Y,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220225.0,20220423.0,20220427,20220427,EXP,,NVSC2022CA096918,NOVARTIS,,85.0,YR,,M,Y,117.0,KG,20220427,,MD,CA,CA,2022,Q2,Elderly
207583501,20758350,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 dosage form,,,Y,,,,,,,,,2022,Q2,Cardiac failure congestive,,2022,Q2,1,I,20220225.0,20220423.0,20220427,20220427,EXP,,NVSC2022CA096918,NOVARTIS,,85.0,YR,,M,Y,117.0,KG,20220427,,MD,CA,CA,2022,Q2,Elderly
207583501,20758350,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 dosage form,,,Y,,,,,,,,,2022,Q2,Hypotension,,2022,Q2,1,I,20220225.0,20220423.0,20220427,20220427,EXP,,NVSC2022CA096918,NOVARTIS,,85.0,YR,,M,Y,117.0,KG,20220427,,MD,CA,CA,2022,Q2,Elderly
207583501,20758350,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 dosage form,,,Y,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220225.0,20220423.0,20220427,20220427,EXP,,NVSC2022CA096918,NOVARTIS,,85.0,YR,,M,Y,117.0,KG,20220427,,MD,CA,CA,2022,Q2,Elderly
207583501,20758350,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 dosage form,,,Y,,,,,,,,,2022,Q2,Cardiac failure congestive,,2022,Q2,1,I,20220225.0,20220423.0,20220427,20220427,EXP,,NVSC2022CA096918,NOVARTIS,,85.0,YR,,M,Y,117.0,KG,20220427,,MD,CA,CA,2022,Q2,Elderly
207583501,20758350,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 dosage form,,,Y,,,,,,,,,2022,Q2,Hypotension,,2022,Q2,1,I,20220225.0,20220423.0,20220427,20220427,EXP,,NVSC2022CA096918,NOVARTIS,,85.0,YR,,M,Y,117.0,KG,20220427,,MD,CA,CA,2022,Q2,Elderly
207680221,20768022,17,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Vascular device infection,,2022,Q2,1,I,20220201.0,20220422.0,20220429,20220429,EXP,,NVSC2022GB094922,NOVARTIS,,62.0,YR,,M,Y,113.0,KG,20220429,,MD,GB,GB,2022,Q2,Adult
207688151,20768815,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Infusion related reaction,,2022,Q2,1,I,20220217.0,20220415.0,20220429,20220429,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-335014,RANBAXY,,62.0,YR,,M,Y,115.9,KG,20220429,,MD,GB,GB,2022,Q2,Adult
207758421,20775842,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3.0 mg, qd",1725.0,MG,D,,,,213051.0,3.0,MG,Tablet,QD,2022,Q2,Cholecystitis acute,,2022,Q2,1,I,20211205.0,20211220.0,20220502,20220502,EXP,,ES-NOVOPROD-877975,NOVO NORDISK,,79.0,YR,,M,Y,76.0,KG,20220502,,MD,ES,ES,2022,Q2,Elderly
207788482,20778848,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.7 mg, qw",,,N,U,,,,1.7,MG,,/WK,2022,Q2,Delusion,,2022,Q2,2,F,,20220428.0,20220503,20220506,EXP,,US-SUNOVION-2022SUN001388,SUNOVION,,21.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Youth
207788482,20778848,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.7 mg, qw",,,N,U,,,,1.7,MG,,/WK,2022,Q2,Drug interaction,,2022,Q2,2,F,,20220428.0,20220503,20220506,EXP,,US-SUNOVION-2022SUN001388,SUNOVION,,21.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Youth
207788482,20778848,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.7 mg, qw",,,N,U,,,,1.7,MG,,/WK,2022,Q2,Weight increased,,2022,Q2,2,F,,20220428.0,20220503,20220506,EXP,,US-SUNOVION-2022SUN001388,SUNOVION,,21.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Youth
207788482,20778848,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.7 mg, qw",,,N,U,,,,1.7,MG,,/WK,2022,Q2,Drug ineffective,,2022,Q2,2,F,,20220428.0,20220503,20220506,EXP,,US-SUNOVION-2022SUN001388,SUNOVION,,21.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Youth
207788482,20778848,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.7 mg, qw",,,N,U,,,,1.7,MG,,/WK,2022,Q2,Malaise,,2022,Q2,2,F,,20220428.0,20220503,20220506,EXP,,US-SUNOVION-2022SUN001388,SUNOVION,,21.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Youth
207788482,20778848,4,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.7 mg, qw",,,N,U,,,,1.7,MG,,/WK,2022,Q2,Bipolar disorder,,2022,Q2,2,F,,20220428.0,20220503,20220506,EXP,,US-SUNOVION-2022SUN001388,SUNOVION,,21.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Youth
207806131,20780613,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,209637.0,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,20220420.0,20220424.0,20220504,20220504,EXP,GB-MHRA-ADR 26863987,GB-NOVOPROD-912584,NOVO NORDISK,,76.0,YR,,F,Y,80.0,KG,20220504,,HP,GB,GB,2022,Q2,Elderly
207828841,20782884,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"Injectievloeistof, 1 mg/dosis (milligram per dosis)",,,,,,,,,,,,2022,Q2,Necrotising fasciitis,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207828841,20782884,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"Injectievloeistof, 1 mg/dosis (milligram per dosis)",,,,,,,,,,,,2022,Q2,Groin abscess,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207828841,20782884,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"Injectievloeistof, 1 mg/dosis (milligram per dosis)",,,,,,,,,,,,2022,Q2,Vulvovaginal mycotic infection,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207832421,20783242,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,Solution,,2022,Q2,Headache,,2022,Q2,1,I,,20220427.0,20220504,20220504,EXP,,CA-BAUSCH-BL-2022-010685,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
207832421,20783242,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,Solution,,2022,Q2,Abdominal discomfort,,2022,Q2,1,I,,20220427.0,20220504,20220504,EXP,,CA-BAUSCH-BL-2022-010685,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
207832421,20783242,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,Solution,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220427.0,20220504,20220504,EXP,,CA-BAUSCH-BL-2022-010685,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
207832421,20783242,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Unknown,,,,,,,,,,,,2022,Q2,Headache,,2022,Q2,1,I,,20220427.0,20220504,20220504,EXP,,CA-BAUSCH-BL-2022-010685,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
207832421,20783242,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Unknown,,,,,,,,,,,,2022,Q2,Abdominal discomfort,,2022,Q2,1,I,,20220427.0,20220504,20220504,EXP,,CA-BAUSCH-BL-2022-010685,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
207832421,20783242,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,Unknown,,,,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220427.0,20220504,20220504,EXP,,CA-BAUSCH-BL-2022-010685,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220504,,MD,CA,CA,2022,Q2,Adult
207875531,20787553,4,C,subcutaneous semaglutide,,2,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,1,I,20200116.0,20220428.0,20220505,20220505,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-168004",BOEHRINGER INGELHEIM,"Osafehinti D, Okoli O, Karam J. a case of SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis following coronary artery bypass surgery. AACE clinical case reports. 2021; 7:1: 20-22.",60.0,YR,A,M,Y,,,20220505,,MD,US,US,2022,Q2,Adult
207934923,20793492,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q2,Blood loss anaemia,,2022,Q2,3,F,20220423.0,20220512.0,20220506,20220523,EXP,,US-NOVOPROD-913207,NOVO NORDISK,,59.0,YR,,M,Y,86.0,KG,20220523,,MD,US,US,2022,Q2,Adult
207934923,20793492,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q2,Metabolic encephalopathy,,2022,Q2,3,F,20220423.0,20220512.0,20220506,20220523,EXP,,US-NOVOPROD-913207,NOVO NORDISK,,59.0,YR,,M,Y,86.0,KG,20220523,,MD,US,US,2022,Q2,Adult
207934923,20793492,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q2,Sepsis,,2022,Q2,3,F,20220423.0,20220512.0,20220506,20220523,EXP,,US-NOVOPROD-913207,NOVO NORDISK,,59.0,YR,,M,Y,86.0,KG,20220523,,MD,US,US,2022,Q2,Adult
207934923,20793492,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q2,Cholecystitis infective,,2022,Q2,3,F,20220423.0,20220512.0,20220506,20220523,EXP,,US-NOVOPROD-913207,NOVO NORDISK,,59.0,YR,,M,Y,86.0,KG,20220523,,MD,US,US,2022,Q2,Adult
207939571,20793957,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Vascular device infection,,2022,Q2,1,I,20220201.0,20220422.0,20220506,20220506,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-335828,RANBAXY,,62.0,YR,,M,Y,113.0,KG,20220506,,MD,GB,GB,2022,Q2,Adult
208026671,20802667,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.25MG;?Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2022,Q2,Nausea,,2022,Q2,1,I,20220325.0,,20220509,20220509,DIR,FDA-CDER-CTU-2022-35479,,FDA-CTU,,64.0,YR,,M,N,,,20220411,N,PH,US,,2022,Q2,Adult
208026671,20802667,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 0.25MG;?Frequency : Weekly;?,,,,,,,,0.25,MG,,QW,2022,Q2,Vomiting,,2022,Q2,1,I,20220325.0,,20220509,20220509,DIR,FDA-CDER-CTU-2022-35479,,FDA-CTU,,64.0,YR,,M,N,,,20220411,N,PH,US,,2022,Q2,Adult
208026691,20802669,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"OTHER STRENGTH : 1MG/0.75M, 1.5ML;?Frequency : Weekly;?",,,,,,,,1.0,MG,,QW,2022,Q2,Vomiting,,2022,Q2,1,I,20220220.0,,20220509,20220509,DIR,FDA-CDER-CTU-2022-35486,,FDA-CTU,,72.0,YR,,M,N,91.0,KG,20220411,N,PH,US,,2022,Q2,Elderly
208026691,20802669,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"OTHER STRENGTH : 1MG/0.75M, 1.5ML;?Frequency : Weekly;?",,,,,,,,1.0,MG,,QW,2022,Q2,Nausea,,2022,Q2,1,I,20220220.0,,20220509,20220509,DIR,FDA-CDER-CTU-2022-35486,,FDA-CTU,,72.0,YR,,M,N,91.0,KG,20220411,N,PH,US,,2022,Q2,Elderly
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Irregular sleep phase,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Product availability issue,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Haemorrhagic ovarian cyst,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Menstrual disorder,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Suicidal ideation,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Apathy,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Muscle spasms,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Pain,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Headache,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Mood altered,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Vomiting,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Gallbladder disorder,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Depression,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Appendix disorder,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Sleep-related eating disorder,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Nausea,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Crying,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Menstruation irregular,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Stress,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Urinary tract infection,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Paraesthesia,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Dissociation,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208134611,20813461,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 every 1 Weeks,,,U,,,,,1.0,MG,,,2022,Q2,Sleep apnoea syndrome,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,CA-MHPD-E2B_03950595,CA-Accord-263009,ACCORD,,24.0,YR,,F,Y,,,20220511,,HP,CA,,2022,Q2,Young Adult
208187941,20818794,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"mg,Once per day",,,D,,,,213051.0,,,Tablet,,2022,Q2,Cholecystitis acute,,2022,Q2,1,I,20220407.0,20220503.0,20220512,20220512,EXP,,BG-NOVOPROD-915230,NOVO NORDISK,,50.0,YR,,F,Y,72.0,KG,20220512,,MD,BG,BG,2022,Q2,Adult
208244451,20824445,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg (weekly),,,D,,Unknown,,,,,Injection,,2022,Q2,Somnolence,,2022,Q2,1,I,,20220428.0,20220513,20220513,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-06816,LUPIN,"Goldman VE, Naguib MN, Vidmar A. Anti-obesity medication use in children and adolescents with prader-willi syndrome: Case review and literature search. Journal of Clinical Medicine. 2021;10(19):4540:1-16",12.0,YR,,M,Y,,,20220513,,HP,US,US,2022,Q2,Child
208244451,20824445,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg (weekly),,,D,,Unknown,,,,,Injection,,2022,Q2,Off label use,,2022,Q2,1,I,,20220428.0,20220513,20220513,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-06816,LUPIN,"Goldman VE, Naguib MN, Vidmar A. Anti-obesity medication use in children and adolescents with prader-willi syndrome: Case review and literature search. Journal of Clinical Medicine. 2021;10(19):4540:1-16",12.0,YR,,M,Y,,,20220513,,HP,US,US,2022,Q2,Child
208244461,20824446,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg (weekly),,,D,,Unknown,,,,,Injection,,2022,Q2,Hyperphagia,,2022,Q2,1,I,,20220428.0,20220513,20220513,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-06815,LUPIN,"Goldman VE, Naguib MN, Vidmar A. Anti-obesity medication use in children and adolescents with prader-willi syndrome: Case review and literature search. Journal of Clinical Medicine. 2021;10(19):4540:1-16",12.0,YR,,M,Y,,,20220513,,HP,US,US,2022,Q2,Child
208244461,20824446,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg (weekly),,,D,,Unknown,,,,,Injection,,2022,Q2,Off label use,,2022,Q2,1,I,,20220428.0,20220513,20220513,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-06815,LUPIN,"Goldman VE, Naguib MN, Vidmar A. Anti-obesity medication use in children and adolescents with prader-willi syndrome: Case review and literature search. Journal of Clinical Medicine. 2021;10(19):4540:1-16",12.0,YR,,M,Y,,,20220513,,HP,US,US,2022,Q2,Child
208244461,20824446,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 mg (weekly),,,D,,Unknown,,,,,Injection,,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220428.0,20220513,20220513,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-06815,LUPIN,"Goldman VE, Naguib MN, Vidmar A. Anti-obesity medication use in children and adolescents with prader-willi syndrome: Case review and literature search. Journal of Clinical Medicine. 2021;10(19):4540:1-16",12.0,YR,,M,Y,,,20220513,,HP,US,US,2022,Q2,Child
208336771,20833677,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Blood glucose decreased,,2022,Q2,1,I,,20220510.0,20220516,20220516,EXP,,CA-BAYER-2022A068526,BAYER,,73.0,YR,E,F,Y,,,20220516,,CN,CA,CA,2022,Q2,Elderly
208375801,20837580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q2,Flank pain,,2022,Q2,1,I,,20220507.0,20220517,20220517,EXP,CA-MHPD-000948322,CA-Accord-263290,ACCORD,,61.0,YR,,F,Y,79.0,KG,20220517,,HP,CA,CA,2022,Q2,Adult
208375801,20837580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q2,Decreased appetite,,2022,Q2,1,I,,20220507.0,20220517,20220517,EXP,CA-MHPD-000948322,CA-Accord-263290,ACCORD,,61.0,YR,,F,Y,79.0,KG,20220517,,HP,CA,CA,2022,Q2,Adult
208375801,20837580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q2,Muscle spasms,,2022,Q2,1,I,,20220507.0,20220517,20220517,EXP,CA-MHPD-000948322,CA-Accord-263290,ACCORD,,61.0,YR,,F,Y,79.0,KG,20220517,,HP,CA,CA,2022,Q2,Adult
208375801,20837580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,,20220507.0,20220517,20220517,EXP,CA-MHPD-000948322,CA-Accord-263290,ACCORD,,61.0,YR,,F,Y,79.0,KG,20220517,,HP,CA,CA,2022,Q2,Adult
208375801,20837580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q2,Fatigue,,2022,Q2,1,I,,20220507.0,20220517,20220517,EXP,CA-MHPD-000948322,CA-Accord-263290,ACCORD,,61.0,YR,,F,Y,79.0,KG,20220517,,HP,CA,CA,2022,Q2,Adult
208375801,20837580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q2,Blood creatine increased,,2022,Q2,1,I,,20220507.0,20220517,20220517,EXP,CA-MHPD-000948322,CA-Accord-263290,ACCORD,,61.0,YR,,F,Y,79.0,KG,20220517,,HP,CA,CA,2022,Q2,Adult
208375801,20837580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q2,Blood creatine phosphokinase increased,,2022,Q2,1,I,,20220507.0,20220517,20220517,EXP,CA-MHPD-000948322,CA-Accord-263290,ACCORD,,61.0,YR,,F,Y,79.0,KG,20220517,,HP,CA,CA,2022,Q2,Adult
208404751,20840475,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,U,Unknown,,,,,Unknown,,2022,Q2,Faeces discoloured,,2022,Q2,1,I,20211012.0,20220318.0,20220517,20220517,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-040739,BRISTOL MYERS SQUIBB,,83.0,YR,E,F,Y,71.0,KG,20220517,,CN,US,US,2022,Q2,Elderly
208404751,20840475,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,U,Unknown,,,,,Unknown,,2022,Q2,Fatigue,,2022,Q2,1,I,20211012.0,20220318.0,20220517,20220517,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-040739,BRISTOL MYERS SQUIBB,,83.0,YR,E,F,Y,71.0,KG,20220517,,CN,US,US,2022,Q2,Elderly
208404751,20840475,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,U,Unknown,,,,,Unknown,,2022,Q2,Anaemia,,2022,Q2,1,I,20211012.0,20220318.0,20220517,20220517,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-040739,BRISTOL MYERS SQUIBB,,83.0,YR,E,F,Y,71.0,KG,20220517,,CN,US,US,2022,Q2,Elderly
208404751,20840475,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,U,Unknown,,,,,Unknown,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20211012.0,20220318.0,20220517,20220517,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-040739,BRISTOL MYERS SQUIBB,,83.0,YR,E,F,Y,71.0,KG,20220517,,CN,US,US,2022,Q2,Elderly
208404751,20840475,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,U,Unknown,,,,,Unknown,,2022,Q2,Abdominal pain,,2022,Q2,1,I,20211012.0,20220318.0,20220517,20220517,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-040739,BRISTOL MYERS SQUIBB,,83.0,YR,E,F,Y,71.0,KG,20220517,,CN,US,US,2022,Q2,Elderly
208404751,20840475,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,U,Unknown,,,,,Unknown,,2022,Q2,Asthenia,,2022,Q2,1,I,20211012.0,20220318.0,20220517,20220517,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-040739,BRISTOL MYERS SQUIBB,,83.0,YR,E,F,Y,71.0,KG,20220517,,CN,US,US,2022,Q2,Elderly
208404751,20840475,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,U,Unknown,,,,,Unknown,,2022,Q2,Upper gastrointestinal haemorrhage,,2022,Q2,1,I,20211012.0,20220318.0,20220517,20220517,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-040739,BRISTOL MYERS SQUIBB,,83.0,YR,E,F,Y,71.0,KG,20220517,,CN,US,US,2022,Q2,Elderly
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Malaise,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Productive cough,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Stress,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Wheezing,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Depressive symptom,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Influenza,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Chest discomfort,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Cough,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Fall,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Nasal congestion,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Heart sounds,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Angina pectoris,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Depressed mood,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Pyrexia,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Appetite disorder,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Chest pain,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Weight decreased,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Injury,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Rales,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Asthma,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208448961,20844896,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q2,Insomnia,,2022,Q2,1,I,,20220511.0,20220518,20220518,EXP,,CA-BAUSCH-BL-2022-011758,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220518,,HP,CA,CA,2022,Q2,Adult
208515251,20851525,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg/week,,,,,,,,0.25,MG,,,2022,Q2,Drug ineffective for unapproved indication,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg/week,,,,,,,,0.25,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg/week,,,,,,,,0.25,MG,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 mg/week,,,,,,,,0.25,MG,,,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg/week,,,U,,,,,0.5,MG,,,2022,Q2,Drug ineffective for unapproved indication,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg/week,,,U,,,,,0.5,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg/week,,,U,,,,,0.5,MG,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg/week,,,U,,,,,0.5,MG,,,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208543144,20854314,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Visual impairment,,2022,Q2,4,F,20220513.0,20220526.0,20220520,20220603,EXP,,NVSC2022US114416,NOVARTIS,,74.0,YR,,M,Y,118.5,KG,20220603,,MD,US,US,2022,Q2,Elderly
208607831,20860783,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,,/WK,2022,Q2,Hyperphagia,,2022,Q2,1,I,,20220428.0,20220523,20220523,PER,,US-APOTEX-2022AP007189,APOTEX,"Goldman VE, Naguib MN, Vidmar AP. Anti-obesity medication use in children and adolescents with prader-willi syndrome: Case review and literature search. Journal of clinical medicine. 2021;10(19): 4540:1-16",12.0,YR,,M,Y,,,20220523,,HP,US,US,2022,Q2,Child
208607831,20860783,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 milligram, q.wk.",,,D,,,,,1.0,MG,,/WK,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220428.0,20220523,20220523,PER,,US-APOTEX-2022AP007189,APOTEX,"Goldman VE, Naguib MN, Vidmar AP. Anti-obesity medication use in children and adolescents with prader-willi syndrome: Case review and literature search. Journal of clinical medicine. 2021;10(19): 4540:1-16",12.0,YR,,M,Y,,,20220523,,HP,US,US,2022,Q2,Child
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Decreased appetite,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Dizziness,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Bradycardia,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Eating disorder,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Haematemesis,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Vomiting,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Headache,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Hypophagia,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Chills,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Acidosis,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Nausea,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Dehydration,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Asthenia,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208624381,20862438,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,,,MP5A207,20240930.0,,0.5,MG,,QW,2022,Q2,Rhinorrhoea,,2022,Q2,1,I,20220403.0,,20220523,20220523,DIR,FDA-CDER-CTU-2022-39817,,FDA-CTU,,81.0,YR,,M,N,75.0,KG,20220519,N,HP,US,,2022,Q2,Elderly
208675701,20867570,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Every 7 days;?,,,,,,,,0.5,MG,,999,2022,Q2,Pancreatitis,,2022,Q2,1,I,20220130.0,,20220523,20220523,DIR,616199,,FDA-CTU,,55.0,YR,,F,N,,,20220523,N,PH,US,,2022,Q2,Adult
208700281,20870028,2,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, q.wk.",,,U,,,,,0.25,MG,,/WK,2022,Q2,Nausea,,2022,Q2,1,I,,20220216.0,20220525,20220525,PER,,US-APOTEX-2022AP003797,APOTEX,Miles JM.. SIDE EFFECT SYNERGISM between METFORMIN and GLP-1 RECEPTOR AGONISTS - And A SOLUTION. Journal of Investigative Medicine. 2021;70:297,68.0,YR,,F,Y,,,20220525,,HP,US,US,2022,Q2,Elderly
208700281,20870028,2,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 milligram, q.wk.",,,U,,,,,0.25,MG,,/WK,2022,Q2,Drug interaction,,2022,Q2,1,I,,20220216.0,20220525,20220525,PER,,US-APOTEX-2022AP003797,APOTEX,Miles JM.. SIDE EFFECT SYNERGISM between METFORMIN and GLP-1 RECEPTOR AGONISTS - And A SOLUTION. Journal of Investigative Medicine. 2021;70:297,68.0,YR,,F,Y,,,20220525,,HP,US,US,2022,Q2,Elderly
208700281,20870028,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 milligram,,,U,,,,,0.5,MG,,,2022,Q2,Nausea,,2022,Q2,1,I,,20220216.0,20220525,20220525,PER,,US-APOTEX-2022AP003797,APOTEX,Miles JM.. SIDE EFFECT SYNERGISM between METFORMIN and GLP-1 RECEPTOR AGONISTS - And A SOLUTION. Journal of Investigative Medicine. 2021;70:297,68.0,YR,,F,Y,,,20220525,,HP,US,US,2022,Q2,Elderly
208700281,20870028,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 milligram,,,U,,,,,0.5,MG,,,2022,Q2,Drug interaction,,2022,Q2,1,I,,20220216.0,20220525,20220525,PER,,US-APOTEX-2022AP003797,APOTEX,Miles JM.. SIDE EFFECT SYNERGISM between METFORMIN and GLP-1 RECEPTOR AGONISTS - And A SOLUTION. Journal of Investigative Medicine. 2021;70:297,68.0,YR,,F,Y,,,20220525,,HP,US,US,2022,Q2,Elderly
208701141,20870114,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q2,Abdominal discomfort,,2022,Q2,1,I,,20220515.0,20220525,20220525,EXP,,CA-TEVA-2022-CA-2038560,TEVA,,51.0,YR,A,F,Y,,,20220525,,MD,CA,CA,2022,Q2,Adult
208701141,20870114,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220515.0,20220525,20220525,EXP,,CA-TEVA-2022-CA-2038560,TEVA,,51.0,YR,A,F,Y,,,20220525,,MD,CA,CA,2022,Q2,Adult
208701141,20870114,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q2,Headache,,2022,Q2,1,I,,20220515.0,20220525,20220525,EXP,,CA-TEVA-2022-CA-2038560,TEVA,,51.0,YR,A,F,Y,,,20220525,,MD,CA,CA,2022,Q2,Adult
208701141,20870114,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q2,Abdominal discomfort,,2022,Q2,1,I,,20220515.0,20220525,20220525,EXP,,CA-TEVA-2022-CA-2038560,TEVA,,51.0,YR,A,F,Y,,,20220525,,MD,CA,CA,2022,Q2,Adult
208701141,20870114,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220515.0,20220525,20220525,EXP,,CA-TEVA-2022-CA-2038560,TEVA,,51.0,YR,A,F,Y,,,20220525,,MD,CA,CA,2022,Q2,Adult
208701141,20870114,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q2,Headache,,2022,Q2,1,I,,20220515.0,20220525,20220525,EXP,,CA-TEVA-2022-CA-2038560,TEVA,,51.0,YR,A,F,Y,,,20220525,,MD,CA,CA,2022,Q2,Adult
208709041,20870904,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q2,Death,,2022,Q2,1,I,20220514.0,20220520.0,20220525,20220525,EXP,,DE-SA-2022SA190330,SANOFI AVENTIS,,52.0,YR,A,M,Y,108.0,KG,20220525,,MD,DE,DE,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Sinus tachycardia,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Mitral valve thickening,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Bundle branch block left,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Atrioventricular block first degree,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Mitral valve incompetence,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Trifascicular block,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,QRS axis abnormal,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Electrocardiogram PR prolongation,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Left ventricular hypertrophy,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Electrocardiogram abnormal,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Cardiac disorder,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208795542,20879554,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q2,Bundle branch block right,,2022,Q2,2,F,,20220604.0,20220526,20220608,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220608,,MD,AU,AU,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Injury,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Respiration abnormal,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Flank pain,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Depressed mood,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Prolonged expiration,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Nasal congestion,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Stress,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Insomnia,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Heart sounds,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Angina pectoris,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Asthma,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Wheezing,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Upper respiratory tract infection,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Malaise,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Appetite disorder,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Weight decreased,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Chest pain,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Chest discomfort,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Depressive symptom,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Productive cough,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Rales,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Pyrexia,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Lower respiratory tract infection,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Dyspnoea exertional,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Influenza,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Fall,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Rhinorrhoea,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Nasopharyngitis,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208964031,20896403,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, qw",,,U,,,,,1.25,MG,,/WK,2022,Q2,Cough,,2022,Q2,1,I,,20220411.0,20220531,20220531,EXP,CA-HEALTHCANVIG- E2B04700139,CA-NOVOPROD-921067,NOVO NORDISK,,61.0,YR,,F,Y,,,20220531,,HP,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Angina pectoris,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Stress,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Insomnia,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Depressed mood,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Rhinorrhoea,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Dyspnoea exertional,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Lower respiratory tract infection,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Chest pain,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Nasal congestion,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Injury,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Respiration abnormal,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Heart sounds,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Malaise,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Appetite disorder,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Nasopharyngitis,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Cough,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Rales,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Weight decreased,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Depressive symptom,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Upper respiratory tract infection,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Chest discomfort,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Wheezing,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Influenza,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Fall,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Asthma,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Prolonged expiration,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208965281,20896528,25,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Productive cough,,2022,Q2,1,I,,20220518.0,20220531,20220531,EXP,,CA-B.Braun Medical Inc.-2129350,B BRAUN,,61.0,YR,,F,Y,,,20220531,,,CA,CA,2022,Q2,Adult
208977711,20897771,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220519.0,20220527.0,20220531,20220531,EXP,,US-PFIZER INC-202200771533,PFIZER,,57.0,YR,,M,Y,,,20220531,,PH,US,US,2022,Q2,Adult
208977711,20897771,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Drug interaction,,2022,Q2,1,I,20220519.0,20220527.0,20220531,20220531,EXP,,US-PFIZER INC-202200771533,PFIZER,,57.0,YR,,M,Y,,,20220531,,PH,US,US,2022,Q2,Adult
208977711,20897771,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Nausea,,2022,Q2,1,I,20220519.0,20220527.0,20220531,20220531,EXP,,US-PFIZER INC-202200771533,PFIZER,,57.0,YR,,M,Y,,,20220531,,PH,US,US,2022,Q2,Adult
208977711,20897771,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,1,I,20220519.0,20220527.0,20220531,20220531,EXP,,US-PFIZER INC-202200771533,PFIZER,,57.0,YR,,M,Y,,,20220531,,PH,US,US,2022,Q2,Adult
208977711,20897771,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Toxicity to various agents,,2022,Q2,1,I,20220519.0,20220527.0,20220531,20220531,EXP,,US-PFIZER INC-202200771533,PFIZER,,57.0,YR,,M,Y,,,20220531,,PH,US,US,2022,Q2,Adult
209056901,20905690,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,COVID-19,,2022,Q2,1,I,20220528.0,20220531.0,20220602,20220602,PER,,US-PFIZER INC-202200786200,PFIZER,,37.0,YR,,M,Y,,,20220602,,MD,US,US,2022,Q2,Adult
209056901,20905690,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Disease recurrence,,2022,Q2,1,I,20220528.0,20220531.0,20220602,20220602,PER,,US-PFIZER INC-202200786200,PFIZER,,37.0,YR,,M,Y,,,20220602,,MD,US,US,2022,Q2,Adult
209127302,20912730,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.0,mg,Once per week",,,,,,,215256.0,1.0,MG,Solution for injection,/WK,2022,Q2,Chest pain,,2022,Q2,2,F,20220508.0,20220602.0,20220603,20220613,EXP,,US-NOVOPROD-919724,NOVO NORDISK,,58.0,YR,,M,Y,97.0,KG,20220613,,MD,US,US,2022,Q2,Adult
209127302,20912730,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,Solution for injection,,2022,Q2,Chest pain,,2022,Q2,2,F,20220508.0,20220602.0,20220603,20220613,EXP,,US-NOVOPROD-919724,NOVO NORDISK,,58.0,YR,,M,Y,97.0,KG,20220613,,MD,US,US,2022,Q2,Adult
209127302,20912730,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,Solution for injection,,2022,Q2,Chest pain,,2022,Q2,2,F,20220508.0,20220602.0,20220603,20220613,EXP,,US-NOVOPROD-919724,NOVO NORDISK,,58.0,YR,,M,Y,97.0,KG,20220613,,MD,US,US,2022,Q2,Adult
209174931,20917493,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,3 mg/ml,,,,U,Unknown,,,,,,,2022,Q2,Chronic obstructive pulmonary disease,,2022,Q2,1,I,20210601.0,20220414.0,20220606,20220606,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-039013,BRISTOL MYERS SQUIBB,,67.0,YR,E,M,Y,121.0,KG,20220606,,HP,DE,DE,2022,Q2,Elderly
209174931,20917493,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,3 mg/ml,,,,U,Unknown,,,,,,,2022,Q2,Tracheobronchitis,,2022,Q2,1,I,20210601.0,20220414.0,20220606,20220606,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-039013,BRISTOL MYERS SQUIBB,,67.0,YR,E,M,Y,121.0,KG,20220606,,HP,DE,DE,2022,Q2,Elderly
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Crystalluria,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Ketonuria,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Headache,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Blood insulin decreased,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Constipation,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Urinary tract infection,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Laryngitis,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Cortisol increased,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Anaemia,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Klebsiella infection,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Specific gravity urine abnormal,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Proteinuria,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Hepatitis B surface antigen positive,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Fibromyalgia,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209176841,20917684,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, qd",,,U,,,,209637.0,1.25,MG,,QD,2022,Q2,Autoimmune thyroiditis,,2022,Q2,1,I,,20220525.0,20220606,20220606,EXP,CA-HEALTHCANVIG-E2B-04800187,CA-NOVOPROD-922607,NOVO NORDISK,,49.0,YR,,F,Y,74.0,KG,20220606,,CN,CA,CA,2022,Q2,Adult
209202871,20920287,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ?,,,Y,Y,,,,1.0,MG,,QW,2022,Q2,Pancreatitis acute,,2022,Q2,1,I,20220323.0,,20220606,20220606,DIR,FDA-CDER-CTU-2022-44557,,FDA-CTU,,66.0,YR,,M,N,,,20220602,N,HP,US,,2022,Q2,Elderly
209202871,20920287,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ?,,,Y,Y,,,,1.0,MG,,QW,2022,Q2,Hepatic steatosis,,2022,Q2,1,I,20220323.0,,20220606,20220606,DIR,FDA-CDER-CTU-2022-44557,,FDA-CTU,,66.0,YR,,M,N,,,20220602,N,HP,US,,2022,Q2,Elderly
209208681,20920868,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Frequency : Daily;?,,,Y,D,,,,3.0,MG,,QD,2022,Q2,Pancreatitis acute,,2022,Q2,1,I,20220529.0,,20220606,20220606,DIR,618176,,FDA-CTU,,40.0,YR,,M,N,102.0,KG,20220606,N,PH,US,,2022,Q2,Adult
209208681,20920868,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Frequency : Daily;?,,,Y,D,,,,3.0,MG,,QD,2022,Q2,Tachycardia,,2022,Q2,1,I,20220529.0,,20220606,20220606,DIR,618176,,FDA-CTU,,40.0,YR,,M,N,102.0,KG,20220606,N,PH,US,,2022,Q2,Adult
209208681,20920868,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,Frequency : Daily;?,,,Y,D,,,,3.0,MG,,QD,2022,Q2,Gastritis,,2022,Q2,1,I,20220529.0,,20220606,20220606,DIR,618176,,FDA-CTU,,40.0,YR,,M,N,102.0,KG,20220606,N,PH,US,,2022,Q2,Adult
209222291,20922229,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,D,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,,20220518.0,20220607,20220607,PER,,US-STRIDES ARCOLAB LIMITED-2022SP006035,STRIDES,"Farasat S, McCallum J. Abstract #1161775: Semaglutide-induced leukocytoclastic vasculitis. Endocr-Pract. 2022;28(Suppl.)(5):S21-S22 abstr. 1161775",65.0,YR,,M,Y,,,20220607,,MD,US,US,2022,Q2,Elderly
209222291,20922229,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,D,,,,,,,,,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220518.0,20220607,20220607,PER,,US-STRIDES ARCOLAB LIMITED-2022SP006035,STRIDES,"Farasat S, McCallum J. Abstract #1161775: Semaglutide-induced leukocytoclastic vasculitis. Endocr-Pract. 2022;28(Suppl.)(5):S21-S22 abstr. 1161775",65.0,YR,,M,Y,,,20220607,,MD,US,US,2022,Q2,Elderly
209251031,20925103,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,1,I,,20220530.0,20220607,20220607,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20220607,,HP,CA,CA,2022,Q2,Adult
209251031,20925103,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Hypoacusis,,2022,Q2,1,I,,20220530.0,20220607,20220607,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20220607,,HP,CA,CA,2022,Q2,Adult
209251031,20925103,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220530.0,20220607,20220607,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20220607,,HP,CA,CA,2022,Q2,Adult
209251031,20925103,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220530.0,20220607,20220607,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20220607,,HP,CA,CA,2022,Q2,Adult
209251031,20925103,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Asthma,,2022,Q2,1,I,,20220530.0,20220607,20220607,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20220607,,HP,CA,CA,2022,Q2,Adult
209251031,20925103,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Depression,,2022,Q2,1,I,,20220530.0,20220607,20220607,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20220607,,HP,CA,CA,2022,Q2,Adult
209251031,20925103,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Sleep disorder due to a general medical condition,,2022,Q2,1,I,,20220530.0,20220607,20220607,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20220607,,HP,CA,CA,2022,Q2,Adult
209251031,20925103,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q2,Wheezing,,2022,Q2,1,I,,20220530.0,20220607,20220607,EXP,,CA-TEVA-2021-CA-1994804,TEVA,,51.0,YR,A,F,Y,,,20220607,,HP,CA,CA,2022,Q2,Adult
209405352,20940535,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,,,,,,,,2022,Q2,Cutaneous vasculitis,,2022,Q2,2,F,,20220616.0,20220609,20220625,EXP,,US-TEVA-2022-US-2043543,TEVA,"Farasat S, McCallum J. Abstract #1161775: Semaglutide-induced leukocytoclastic vasculitis. Endocr-Pract 2022;28 (Suppl.)(5):S21-S22 abstr. 1161775.",65.0,YR,E,M,Y,,,20220625,,MD,US,US,2022,Q2,Elderly
209405352,20940535,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,Y,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,2,F,,20220616.0,20220609,20220625,EXP,,US-TEVA-2022-US-2043543,TEVA,"Farasat S, McCallum J. Abstract #1161775: Semaglutide-induced leukocytoclastic vasculitis. Endocr-Pract 2022;28 (Suppl.)(5):S21-S22 abstr. 1161775.",65.0,YR,E,M,Y,,,20220625,,MD,US,US,2022,Q2,Elderly
209451411,20945141,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Swelling,,2022,Q2,1,I,20220401.0,20220603.0,20220610,20220610,EXP,,US-Accord-265749,ACCORD,,67.0,YR,,M,Y,127.01,KG,20220610,,CN,US,US,2022,Q2,Elderly
209451411,20945141,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Cardiac failure congestive,,2022,Q2,1,I,20220401.0,20220603.0,20220610,20220610,EXP,,US-Accord-265749,ACCORD,,67.0,YR,,M,Y,127.01,KG,20220610,,CN,US,US,2022,Q2,Elderly
209451411,20945141,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Blood potassium decreased,,2022,Q2,1,I,20220401.0,20220603.0,20220610,20220610,EXP,,US-Accord-265749,ACCORD,,67.0,YR,,M,Y,127.01,KG,20220610,,CN,US,US,2022,Q2,Elderly
209451411,20945141,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Fluid retention,,2022,Q2,1,I,20220401.0,20220603.0,20220610,20220610,EXP,,US-Accord-265749,ACCORD,,67.0,YR,,M,Y,127.01,KG,20220610,,CN,US,US,2022,Q2,Elderly
209524051,20952405,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Frequency text: not provided,,,,,,,,,,Unknown,,2022,Q2,Staphylococcal bacteraemia,,2022,Q2,1,I,20211117.0,20220602.0,20220613,20220613,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211108161,BRISTOL MYERS SQUIBB,,78.0,YR,E,M,Y,,,20220613,,MD,US,US,2022,Q2,Elderly
209762182,20976218,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20220224.0,20220617.0,20220617,20220620,EXP,,US-PFIZER INC-202200691680,PFIZER,,47.0,YR,,F,Y,90.9,KG,20220620,,HP,US,US,2022,Q2,Adult
209762182,20976218,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Dizziness,,2022,Q2,2,F,20220224.0,20220617.0,20220617,20220620,EXP,,US-PFIZER INC-202200691680,PFIZER,,47.0,YR,,F,Y,90.9,KG,20220620,,HP,US,US,2022,Q2,Adult
209817201,20981720,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,0.25,MG,,/WK,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,20220611.0,20220615.0,20220620,20220620,EXP,GB-MHRA-MIDB-5066969e-16c7-4f13-b73d-2aaed8ae812c,GB-JNJFOC-20220636821,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,,,20220620,,PH,GB,GB,2022,Q2,Adult
209933381,20993338,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Every Friday;?,,,N,D,,,,1.0,MG,,999,2022,Q2,Pancreatitis acute,,2022,Q2,1,I,20220407.0,,20220621,20220621,DIR,620132,,FDA-CTU,,63.0,YR,,F,N,86.8,KG,20220621,N,PH,US,,2022,Q2,Adult
209933381,20993338,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Every Friday;?,,,N,D,,,,1.0,MG,,999,2022,Q2,Shock,,2022,Q2,1,I,20220407.0,,20220621,20220621,DIR,620132,,FDA-CTU,,63.0,YR,,F,N,86.8,KG,20220621,N,PH,US,,2022,Q2,Adult
209937031,20993703,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q2,Oxygen saturation decreased,,2022,Q2,1,I,20220620.0,20220621.0,20220622,20220622,EXP,,US-PFIZER INC-202200865830,PFIZER,,64.0,YR,,M,Y,,,20220622,,PH,US,US,2022,Q2,Adult
209937031,20993703,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220620.0,20220621.0,20220622,20220622,EXP,,US-PFIZER INC-202200865830,PFIZER,,64.0,YR,,M,Y,,,20220622,,PH,US,US,2022,Q2,Adult
209994661,20999466,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220620.0,20220622.0,20220623,20220623,PER,,US-PFIZER INC-202200876789,PFIZER,,48.0,YR,,F,Y,,,20220623,,PH,US,US,2022,Q2,Adult
209994661,20999466,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Wheezing,,2022,Q2,1,I,20220620.0,20220622.0,20220623,20220623,PER,,US-PFIZER INC-202200876789,PFIZER,,48.0,YR,,F,Y,,,20220623,,PH,US,US,2022,Q2,Adult
209994661,20999466,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Nausea,,2022,Q2,1,I,20220620.0,20220622.0,20220623,20220623,PER,,US-PFIZER INC-202200876789,PFIZER,,48.0,YR,,F,Y,,,20220623,,PH,US,US,2022,Q2,Adult
209994661,20999466,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Chest discomfort,,2022,Q2,1,I,20220620.0,20220622.0,20220623,20220623,PER,,US-PFIZER INC-202200876789,PFIZER,,48.0,YR,,F,Y,,,20220623,,PH,US,US,2022,Q2,Adult
209994661,20999466,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Cough,,2022,Q2,1,I,20220620.0,20220622.0,20220623,20220623,PER,,US-PFIZER INC-202200876789,PFIZER,,48.0,YR,,F,Y,,,20220623,,PH,US,US,2022,Q2,Adult
209994661,20999466,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Pain,,2022,Q2,1,I,20220620.0,20220622.0,20220623,20220623,PER,,US-PFIZER INC-202200876789,PFIZER,,48.0,YR,,F,Y,,,20220623,,PH,US,US,2022,Q2,Adult
210230301,21023030,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5/0.375 ML QWEEK SQ? ?,,,Y,,,,,,,,QW,2022,Q2,Diarrhoea,,2022,Q2,1,I,20220607.0,,20220629,20220629,DIR,FDA-CDER-CTU-2022-51242,,FDA-CTU,,69.0,YR,,M,N,,,20220627,N,HP,US,,2022,Q2,Elderly
210238621,21023862,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Nausea,,2022,Q2,1,I,,20220624.0,20220629,20220629,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20220629,,CN,CA,,2022,Q2,Adult
210238621,21023862,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Blood pressure systolic abnormal,,2022,Q2,1,I,,20220624.0,20220629,20220629,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20220629,,CN,CA,,2022,Q2,Adult
210238621,21023862,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220624.0,20220629,20220629,EXP,,CA-ROCHE-3124891,ROCHE,,40.0,YR,,F,Y,,,20220629,,CN,CA,,2022,Q2,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Lung disorder,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Drug hypersensitivity,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Periarthritis,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Middle insomnia,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Rales,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Sputum discoloured,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Bronchospasm,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Nerve injury,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Eye pain,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Wheezing,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Muscle spasms,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Nervous system disorder,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Myalgia,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Visual impairment,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Nasal discharge discolouration,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Inappropriate schedule of product administration,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Optic nerve disorder,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Nerve compression,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Weight decreased,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Heart rate increased,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Paranasal sinus discomfort,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Sinusitis,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Blood cholesterol increased,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Eye disorder,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Gastroenteritis,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Cervical spinal stenosis,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Asthma,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Musculoskeletal stiffness,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Blindness,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Forced expiratory volume decreased,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Visual field defect,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Neuritis,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Nasal congestion,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
1177931128,11779311,34,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Blood pressure systolic increased,,2022,Q3,28,F,20120306.0,20220720.0,20151125,20220725,EXP,,PHHY2012CA021236,NOVARTIS,,47.0,YR,,M,Y,,,20220725,,MD,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Nasal congestion,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Asthma,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Malaise,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Respiration abnormal,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Productive cough,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Fall,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Wheezing,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Depressed mood,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Depressive symptom,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Weight decreased,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Injury,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Cough,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Appetite disorder,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Rales,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Influenza,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Prolonged expiration,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Pyrexia,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Flank pain,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Heart sounds,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Chest discomfort,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Insomnia,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Dyspnoea,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Stress,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Chest pain,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,54,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, QW",,,U,,,,,1.25,MG,,/WK,2022,Q3,Angina pectoris,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Nasal congestion,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Asthma,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Malaise,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Respiration abnormal,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Productive cough,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Fall,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Wheezing,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Depressed mood,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Depressive symptom,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Weight decreased,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Injury,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Cough,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Appetite disorder,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Rales,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Influenza,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Prolonged expiration,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Pyrexia,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Flank pain,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Heart sounds,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Chest discomfort,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Insomnia,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Dyspnoea,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Stress,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Chest pain,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,55,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,,/WK,2022,Q3,Angina pectoris,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Nasal congestion,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Asthma,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Malaise,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Respiration abnormal,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Productive cough,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Fall,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Wheezing,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Depressed mood,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Depressive symptom,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Weight decreased,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Injury,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Cough,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Appetite disorder,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Rales,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Influenza,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Prolonged expiration,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Pyrexia,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Flank pain,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Heart sounds,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Chest discomfort,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Insomnia,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Dyspnoea,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Stress,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Chest pain,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
177196114,17719611,56,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW (solution subcutaneous)",,,U,,,,,125.0,ML,,/WK,2022,Q3,Angina pectoris,,2022,Q3,4,F,,20220922.0,20200428,20220928,EXP,,NVSC2020CA111078,NOVARTIS,,61.0,YR,,F,Y,,,20220928,,CN,CA,CA,2022,Q3,Adult
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Acute kidney injury,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Depression,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Sleep disorder,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Hypertension,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Chronic kidney disease,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Constipation,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Off label use,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Malaise,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Product use issue,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Blood magnesium decreased,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Urinary tract infection,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
181468777,18146877,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q3,Hypotension,,2022,Q3,7,F,,20220919.0,20200813,20220927,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20220927,,HP,CA,CA,2022,Q3,Elderly
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Depressed mood,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Injury,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Asthma,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Nasal congestion,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Rales,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Weight decreased,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Productive cough,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Heart sounds,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Insomnia,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Chest pain,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Appetite disorder,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Respiration abnormal,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Influenza,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Angina pectoris,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Flank pain,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Prolonged expiration,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Fall,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Pyrexia,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Depressive symptom,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Chest discomfort,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Wheezing,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Cough,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Stress,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q3,Malaise,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Depressed mood,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Injury,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Asthma,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Nasal congestion,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Rales,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Weight decreased,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Productive cough,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Heart sounds,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Insomnia,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Chest pain,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Appetite disorder,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Respiration abnormal,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Influenza,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Angina pectoris,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Flank pain,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Prolonged expiration,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Fall,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Pyrexia,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Depressive symptom,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Chest discomfort,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Wheezing,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Cough,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Stress,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,78,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q3,Malaise,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Depressed mood,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Injury,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Asthma,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Nasal congestion,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Rales,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Weight decreased,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Productive cough,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Heart sounds,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Insomnia,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Chest pain,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Appetite disorder,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Respiration abnormal,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Influenza,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Angina pectoris,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Flank pain,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Prolonged expiration,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Fall,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Pyrexia,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Depressive symptom,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Chest discomfort,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Wheezing,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Cough,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Stress,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,79,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q3,Malaise,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Depressed mood,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Injury,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Asthma,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Nasal congestion,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Rales,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Weight decreased,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Productive cough,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Heart sounds,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Insomnia,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Chest pain,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Appetite disorder,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Respiration abnormal,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Influenza,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Angina pectoris,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Flank pain,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Prolonged expiration,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Fall,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Pyrexia,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Depressive symptom,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Chest discomfort,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Wheezing,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Cough,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Stress,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Malaise,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Depressed mood,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Injury,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Asthma,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Nasal congestion,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Rales,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Weight decreased,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Productive cough,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Heart sounds,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Insomnia,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Chest pain,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Appetite disorder,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Respiration abnormal,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Influenza,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Angina pectoris,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Flank pain,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Prolonged expiration,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Fall,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Pyrexia,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Depressive symptom,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Chest discomfort,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Wheezing,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Cough,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Stress,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
182657235,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q3,Malaise,,2022,Q3,5,F,,20220912.0,20200915,20220915,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20220915,,CN,CA,CA,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Musculoskeletal stiffness,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Lumbar radiculopathy,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Liver function test abnormal,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Neuralgia,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Urinary tract infection,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Loss of bladder sensation,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Intervertebral disc degeneration,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Anal incontinence,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Urinary retention,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,White blood cell count decreased,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Neurogenic bladder,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Fatigue,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Temperature intolerance,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191065039,19106503,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form (0.25 mg or 0.5 mg (2 mg/ 1.5 mL)), QW",,,U,,UNK,,,,,Injection,/WK,2022,Q3,Progressive multiple sclerosis,,2022,Q3,9,F,20210405.0,20220719.0,20210407,20220725,EXP,,NVSC2021US078795,NOVARTIS,,54.0,YR,,F,Y,101.7,KG,20220725,,CN,US,US,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Stress,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Rales,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Wheezing,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Cough,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Depressive symptom,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Fall,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Pyrexia,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Influenza,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Respiration abnormal,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Insomnia,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Asthma,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Depressed mood,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Productive cough,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Flank pain,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Malaise,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Angina pectoris,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Weight decreased,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Injury,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Appetite disorder,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Chest discomfort,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Chest pain,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Heart sounds,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Prolonged expiration,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,161,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1.25 mg, weekly",,,U,U,,,,1.25,MG,Solution for injection,/WK,2022,Q3,Nasal congestion,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Stress,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Rales,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Wheezing,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Cough,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Depressive symptom,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Fall,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Pyrexia,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Influenza,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Respiration abnormal,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Insomnia,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Asthma,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Depressed mood,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Productive cough,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Flank pain,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Malaise,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Angina pectoris,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Weight decreased,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Injury,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Appetite disorder,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Chest discomfort,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Chest pain,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Heart sounds,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Prolonged expiration,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,162,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, weekly",,,U,U,,,,125.0,ML,Solution for injection,/WK,2022,Q3,Nasal congestion,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Stress,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Rales,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Wheezing,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Cough,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Depressive symptom,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Fall,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Dyspnoea exertional,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Pyrexia,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Nasopharyngitis,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Influenza,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Respiration abnormal,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Insomnia,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Asthma,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Depressed mood,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Productive cough,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Flank pain,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Malaise,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Angina pectoris,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Rhinorrhoea,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Weight decreased,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Injury,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Appetite disorder,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Lower respiratory tract infection,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Chest discomfort,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Chest pain,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Heart sounds,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Prolonged expiration,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Upper respiratory tract infection,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,163,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,Unknown,,,,,Solution for injection,,2022,Q3,Nasal congestion,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Stress,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Rales,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Wheezing,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Cough,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Depressive symptom,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Fall,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Dyspnoea exertional,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Pyrexia,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Nasopharyngitis,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Influenza,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Respiration abnormal,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Insomnia,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Asthma,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Depressed mood,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Productive cough,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Flank pain,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Malaise,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Angina pectoris,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Rhinorrhoea,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Weight decreased,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Injury,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Appetite disorder,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Lower respiratory tract infection,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Chest discomfort,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Chest pain,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Heart sounds,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Prolonged expiration,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Upper respiratory tract infection,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
191958365,19195836,164,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 dosage form, weekly",,,U,U,,,,,,Solution for injection,/WK,2022,Q3,Nasal congestion,,2022,Q3,5,F,,20220706.0,20210429,20220712,EXP,,CA-PURDUE-USA-2021-0252046,PURDUE,,61.0,YR,,F,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
192520999,19252099,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",1904.0,MG,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q3,Bile duct stone,,2022,Q3,9,F,20210413.0,20220713.0,20210513,20220720,EXP,,GB-NOVOPROD-810168,NOVO NORDISK,,71.0,YR,,F,Y,,,20220721,,MD,GB,GB,2022,Q3,Elderly
194320012,19432001,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,3.0,MG,UNK,,2022,Q3,Diabetes mellitus,,2022,Q3,2,F,20181002.0,20220825.0,20210617,20220909,EXP,,JP-ABBVIE-19P-087-2886963-00,ABBVIE,,57.0,YR,,M,Y,57.0,KG,20220902,,MD,COUNTRY NOT SPECIFIED,JP,2022,Q3,Adult
194320012,19432001,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,3.0,MG,UNK,,2022,Q3,Diabetes mellitus,,2022,Q3,2,F,20181002.0,20220825.0,20210617,20220909,EXP,,JP-ABBVIE-19P-087-2886963-00,ABBVIE,,57.0,YR,,M,Y,57.0,KG,20220902,,MD,COUNTRY NOT SPECIFIED,JP,2022,Q3,Adult
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Amnesia,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Rhinorrhoea,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Nausea,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Weight decreased,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Product dose omission issue,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Cough,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Productive cough,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Pulmonary mass,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Fall,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Laziness,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Asthenia,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Gait disturbance,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Myalgia,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Nasopharyngitis,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Blood sodium decreased,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Wrong technique in product usage process,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Headache,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Hypokinesia,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1965031413,19650314,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Dysphonia,,2022,Q3,13,F,20210724.0,20220707.0,20210802,20220708,EXP,,NVSC2021US173999,NOVARTIS,,80.0,YR,,M,Y,,,20220708,,CN,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Malaise,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Treatment noncompliance,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Infusion site swelling,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Dysphonia,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Injection site infection,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Injection site pruritus,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Blood glucose increased,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Infusion site extravasation,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Blood glucose decreased,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Infusion site extravasation,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Blood immunoglobulin A decreased,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Blood immunoglobulin M decreased,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Swelling,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Infusion site pain,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Tenderness,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Tinnitus,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Infusion site scar,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Blood pressure increased,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Injection site erythema,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Blood pressure systolic increased,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,Erythema,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
1967798210,19677982,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, qw",,,,,,,,,,Injection,/WK,2022,Q3,No adverse event,,2022,Q3,10,F,20210804.0,20220822.0,20210810,20220829,PER,,US-BEH-2021134720,CSL BEHRING,,81.0,YR,E,F,Y,59.864,KG,20220829,,MD,US,US,2022,Q3,Elderly
202255686,20225568,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2022,Q3,Cholecystitis acute,,2022,Q3,6,F,20211024.0,20220621.0,20211224,20220704,EXP,,CA-NOVOPROD-876341,NOVO NORDISK,,78.0,YR,,M,Y,96.0,KG,20220704,,MD,CA,CA,2022,Q3,Elderly
202392554,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q3,Depression,,2022,Q3,4,F,,20220809.0,20211228,20220816,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220816,,MD,CA,CA,2022,Q3,Adult
202392554,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,4,F,,20220809.0,20211228,20220816,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220816,,MD,CA,CA,2022,Q3,Adult
202392554,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q3,Hypoacusis,,2022,Q3,4,F,,20220809.0,20211228,20220816,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220816,,MD,CA,CA,2022,Q3,Adult
202392554,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q3,Wheezing,,2022,Q3,4,F,,20220809.0,20211228,20220816,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220816,,MD,CA,CA,2022,Q3,Adult
202392554,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,4,F,,20220809.0,20211228,20220816,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220816,,MD,CA,CA,2022,Q3,Adult
202392554,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,4,F,,20220809.0,20211228,20220816,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220816,,MD,CA,CA,2022,Q3,Adult
202392554,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,4,F,,20220809.0,20211228,20220816,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220816,,MD,CA,CA,2022,Q3,Adult
202392554,20239255,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,dosage form- NOT SPECIFIED,,,U,,Unknown,,,,,,,2022,Q3,Asthma,,2022,Q3,4,F,,20220809.0,20211228,20220816,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-145300",BOEHRINGER INGELHEIM,,51.0,YR,A,F,Y,,,20220816,,MD,CA,CA,2022,Q3,Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Urinary retention,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Myopathy,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Myoglobinuria,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Body temperature increased,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Chills,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Headache,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Muscle spasms,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Hyperhidrosis,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Urine flow decreased,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Product prescribing error,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Off label use,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Myalgia,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Rhabdomyolysis,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Contraindicated product prescribed,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Drug interaction,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Drug titration error,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Renal failure,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Product use in unapproved indication,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Urine output decreased,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Contraindicated product administered,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q3,Serotonin syndrome,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Urinary retention,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Myopathy,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Myoglobinuria,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Body temperature increased,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Chills,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Headache,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Muscle spasms,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Hyperhidrosis,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Urine flow decreased,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Product prescribing error,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Off label use,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Myalgia,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Rhabdomyolysis,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Contraindicated product prescribed,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Drug titration error,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Renal failure,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Product use in unapproved indication,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Urine output decreased,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Contraindicated product administered,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
2031300110,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Serotonin syndrome,,2022,Q3,10,F,,20220912.0,20220109,20220927,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Myopathy,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Off label use,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Body temperature increased,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Rhabdomyolysis,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Muscle spasms,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Drug interaction,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Urine output decreased,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Renal failure,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Urinary retention,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Hyperhidrosis,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Product use in unapproved indication,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Chills,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Myalgia,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Contraindicated product administered,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Myoglobinuria,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Drug titration,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Serotonin syndrome,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Urine flow decreased,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Contraindicated product prescribed,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Headache,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Product prescribing error,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,15,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Myopathy,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Off label use,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Body temperature increased,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Rhabdomyolysis,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Muscle spasms,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Drug interaction,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Urine output decreased,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Renal failure,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Urinary retention,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Hyperhidrosis,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Product use in unapproved indication,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Chills,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Myalgia,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Contraindicated product administered,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Myoglobinuria,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Drug titration,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Serotonin syndrome,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Urine flow decreased,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Contraindicated product prescribed,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Headache,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Product prescribing error,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Myopathy,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Off label use,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Body temperature increased,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Rhabdomyolysis,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Muscle spasms,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Drug interaction,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Urine output decreased,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Renal failure,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Urinary retention,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Hyperhidrosis,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Product use in unapproved indication,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Chills,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Myalgia,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Contraindicated product administered,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Myoglobinuria,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Drug titration,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Serotonin syndrome,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Urine flow decreased,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Contraindicated product prescribed,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Headache,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Product prescribing error,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204119876,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,UNK,/WK,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,6,F,,20220829.0,20220201,20220905,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20220905,,HP,PL,PL,2022,Q3,Young Adult
204130684,20413068,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 mg,,,,,,,,7.0,MG,Tablet,,2022,Q3,Dyspnoea,,2022,Q3,4,F,20211006.0,20220308.0,20220201,20220711,EXP,,NVSJ2022JP002194,NOVARTIS,,81.0,YR,,F,Y,,,20220711,,MD,JP,JP,2022,Q3,Elderly
204130684,20413068,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 mg,,,,,,,,7.0,MG,Tablet,,2022,Q3,Interstitial lung disease,,2022,Q3,4,F,20211006.0,20220308.0,20220201,20220711,EXP,,NVSJ2022JP002194,NOVARTIS,,81.0,YR,,F,Y,,,20220711,,MD,JP,JP,2022,Q3,Elderly
204187163,20418716,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 Milligram,Prn",,,D,,,,,,,,,2022,Q3,Myoglobinuria,,2022,Q3,3,F,,20220830.0,20220202,20220908,EXP,,PL-BAXTER-2022BAX001920,BAXTER,"Woron J., Siwek M.Pharmacological treatment of obesity and drug interactions dangerous to health and life.Psychiatria 2021;6 (83):.",29.0,YR,,F,Y,,,20220908,,MD,PL,PL,2022,Q3,Young Adult
204187163,20418716,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 Milligram,Prn",,,D,,,,,,,,,2022,Q3,Myopathy,,2022,Q3,3,F,,20220830.0,20220202,20220908,EXP,,PL-BAXTER-2022BAX001920,BAXTER,"Woron J., Siwek M.Pharmacological treatment of obesity and drug interactions dangerous to health and life.Psychiatria 2021;6 (83):.",29.0,YR,,F,Y,,,20220908,,MD,PL,PL,2022,Q3,Young Adult
204187163,20418716,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 Milligram,Prn",,,D,,,,,,,,,2022,Q3,Serotonin syndrome,,2022,Q3,3,F,,20220830.0,20220202,20220908,EXP,,PL-BAXTER-2022BAX001920,BAXTER,"Woron J., Siwek M.Pharmacological treatment of obesity and drug interactions dangerous to health and life.Psychiatria 2021;6 (83):.",29.0,YR,,F,Y,,,20220908,,MD,PL,PL,2022,Q3,Young Adult
204187163,20418716,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 Milligram,Prn",,,D,,,,,,,,,2022,Q3,Renal failure,,2022,Q3,3,F,,20220830.0,20220202,20220908,EXP,,PL-BAXTER-2022BAX001920,BAXTER,"Woron J., Siwek M.Pharmacological treatment of obesity and drug interactions dangerous to health and life.Psychiatria 2021;6 (83):.",29.0,YR,,F,Y,,,20220908,,MD,PL,PL,2022,Q3,Young Adult
205438782,20543878,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2022,Q3,Vitreous haemorrhage,,2022,Q3,2,F,20211202.0,20220816.0,20220303,20220824,EXP,,GB-NOVOPROD-882757,NOVO NORDISK,,62.0,YR,,M,Y,81.0,KG,20220824,,MD,GB,GB,2022,Q3,Adult
205979005,20597900,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly",,,U,,,,,1.0,MG,,/WK,2022,Q3,Dizziness,,2022,Q3,5,F,,20220726.0,20220315,20220801,EXP,,AU-PFIZER INC-202200398004,PFIZER,,48.0,YR,,M,Y,90.0,KG,20220801,,MD,AU,AU,2022,Q3,Adult
205979005,20597900,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly",,,U,,,,,1.0,MG,,/WK,2022,Q3,Schizophrenia,,2022,Q3,5,F,,20220726.0,20220315,20220801,EXP,,AU-PFIZER INC-202200398004,PFIZER,,48.0,YR,,M,Y,90.0,KG,20220801,,MD,AU,AU,2022,Q3,Adult
205979005,20597900,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly",,,U,,,,,1.0,MG,,/WK,2022,Q3,Blood pressure decreased,,2022,Q3,5,F,,20220726.0,20220315,20220801,EXP,,AU-PFIZER INC-202200398004,PFIZER,,48.0,YR,,M,Y,90.0,KG,20220801,,MD,AU,AU,2022,Q3,Adult
205979005,20597900,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly",,,U,,,,,1.0,MG,,/WK,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220726.0,20220315,20220801,EXP,,AU-PFIZER INC-202200398004,PFIZER,,48.0,YR,,M,Y,90.0,KG,20220801,,MD,AU,AU,2022,Q3,Adult
205979005,20597900,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly",,,U,,,,,1.0,MG,,/WK,2022,Q3,Mental disorder,,2022,Q3,5,F,,20220726.0,20220315,20220801,EXP,,AU-PFIZER INC-202200398004,PFIZER,,48.0,YR,,M,Y,90.0,KG,20220801,,MD,AU,AU,2022,Q3,Adult
206197982,20619798,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Fall,,2022,Q3,2,F,20210311.0,20220728.0,20220322,20220802,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220802,,HP,CA,CA,2022,Q3,Elderly
206197982,20619798,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,2,F,20210311.0,20220728.0,20220322,20220802,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220802,,HP,CA,CA,2022,Q3,Elderly
206197982,20619798,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Fall,,2022,Q3,2,F,20210311.0,20220728.0,20220322,20220802,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220802,,HP,CA,CA,2022,Q3,Elderly
206197982,20619798,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,2,F,20210311.0,20220728.0,20220322,20220802,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220802,,HP,CA,CA,2022,Q3,Elderly
206197982,20619798,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,D,,,,,,,,,2022,Q3,Fall,,2022,Q3,2,F,20210311.0,20220728.0,20220322,20220802,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220802,,HP,CA,CA,2022,Q3,Elderly
206197982,20619798,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,D,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,2,F,20210311.0,20220728.0,20220322,20220802,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220802,,HP,CA,CA,2022,Q3,Elderly
206197982,20619798,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,D,,,,,,,,,2022,Q3,Fall,,2022,Q3,2,F,20210311.0,20220728.0,20220322,20220802,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220802,,HP,CA,CA,2022,Q3,Elderly
206197982,20619798,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,D,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,2,F,20210311.0,20220728.0,20220322,20220802,EXP,,CA-APOTEX-2022AP004826,APOTEX,,68.0,YR,,M,Y,87.0,KG,20220802,,HP,CA,CA,2022,Q3,Elderly
206250402,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Acute myocardial infarction,,2022,Q3,2,F,20210727.0,20220720.0,20220323,20220801,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220801,,HP,CA,CA,2022,Q3,Elderly
206250402,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Vomiting,,2022,Q3,2,F,20210727.0,20220720.0,20220323,20220801,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220801,,HP,CA,CA,2022,Q3,Elderly
206250402,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Angina unstable,,2022,Q3,2,F,20210727.0,20220720.0,20220323,20220801,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220801,,HP,CA,CA,2022,Q3,Elderly
206250402,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Asthenia,,2022,Q3,2,F,20210727.0,20220720.0,20220323,20220801,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220801,,HP,CA,CA,2022,Q3,Elderly
206250402,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Dizziness,,2022,Q3,2,F,20210727.0,20220720.0,20220323,20220801,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220801,,HP,CA,CA,2022,Q3,Elderly
206250402,20625040,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Hypotension,,2022,Q3,2,F,20210727.0,20220720.0,20220323,20220801,EXP,,CA-AUROBINDO-AUR-APL-2022-008335,AUROBINDO,,67.0,YR,,M,Y,122.0,KG,20220801,,HP,CA,CA,2022,Q3,Elderly
206305973,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,,,,,2022,Q3,Syncope,,2022,Q3,3,F,20210329.0,20220812.0,20220324,20220824,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220824,,MD,CA,CA,2022,Q3,Elderly
206305973,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,,,,,2022,Q3,Urticaria,,2022,Q3,3,F,20210329.0,20220812.0,20220324,20220824,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220824,,MD,CA,CA,2022,Q3,Elderly
206305973,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,,,,,2022,Q3,Pruritus,,2022,Q3,3,F,20210329.0,20220812.0,20220324,20220824,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220824,,MD,CA,CA,2022,Q3,Elderly
206305973,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,,,,,2022,Q3,Angioedema,,2022,Q3,3,F,20210329.0,20220812.0,20220324,20220824,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220824,,MD,CA,CA,2022,Q3,Elderly
206305973,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,,,,,2022,Q3,Paraesthesia,,2022,Q3,3,F,20210329.0,20220812.0,20220324,20220824,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220824,,MD,CA,CA,2022,Q3,Elderly
206305973,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,,,,,2022,Q3,Drug hypersensitivity,,2022,Q3,3,F,20210329.0,20220812.0,20220324,20220824,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220824,,MD,CA,CA,2022,Q3,Elderly
206305973,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,3,F,20210329.0,20220812.0,20220324,20220824,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220824,,MD,CA,CA,2022,Q3,Elderly
206305973,20630597,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3 milligram,,,,,,,,,,,,2022,Q3,Presyncope,,2022,Q3,3,F,20210329.0,20220812.0,20220324,20220824,EXP,,CA-AUROBINDO-AUR-APL-2022-008332,AUROBINDO,,72.0,YR,,M,Y,112.0,KG,20220824,,MD,CA,CA,2022,Q3,Elderly
206939532,20693953,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",12866.0,MG,N,,,,213051.0,14.0,MG,Tablet,QD,2022,Q3,Cholecystitis,,2022,Q3,2,F,20220330.0,20220620.0,20220411,20220701,EXP,,IL-NOVOPROD-905451,NOVO NORDISK,,82.0,YR,,F,Y,57.0,KG,20220701,,MD,IL,IL,2022,Q3,Elderly
207934925,20793492,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q3,Blood loss anaemia,,2022,Q3,5,F,20220423.0,20220913.0,20220506,20220923,EXP,,US-NOVOPROD-913207,NOVO NORDISK,,59.0,YR,,M,Y,86.0,KG,20220923,,MD,US,US,2022,Q3,Adult
207934925,20793492,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q3,Cholecystitis infective,,2022,Q3,5,F,20220423.0,20220913.0,20220506,20220923,EXP,,US-NOVOPROD-913207,NOVO NORDISK,,59.0,YR,,M,Y,86.0,KG,20220923,,MD,US,US,2022,Q3,Adult
207934925,20793492,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q3,Metabolic encephalopathy,,2022,Q3,5,F,20220423.0,20220913.0,20220506,20220923,EXP,,US-NOVOPROD-913207,NOVO NORDISK,,59.0,YR,,M,Y,86.0,KG,20220923,,MD,US,US,2022,Q3,Adult
207934925,20793492,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,D,,,,213051.0,14.0,MG,Tablet,QD,2022,Q3,Sepsis,,2022,Q3,5,F,20220423.0,20220913.0,20220506,20220923,EXP,,US-NOVOPROD-913207,NOVO NORDISK,,59.0,YR,,M,Y,86.0,KG,20220923,,MD,US,US,2022,Q3,Adult
208471942,20847194,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Confusional state,,2022,Q3,2,F,20210101.0,20220708.0,20220519,20220719,EXP,,US-BEH-2022145512,CSL BEHRING,,25.0,YR,A,F,Y,,,20220719,,CN,US,US,2022,Q3,Young Adult
208471942,20847194,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Confusional state,,2022,Q3,2,F,20210101.0,20220708.0,20220519,20220719,EXP,,US-BEH-2022145512,CSL BEHRING,,25.0,YR,A,F,Y,,,20220719,,CN,US,US,2022,Q3,Young Adult
208471942,20847194,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Dizziness,,2022,Q3,2,F,20210101.0,20220708.0,20220519,20220719,EXP,,US-BEH-2022145512,CSL BEHRING,,25.0,YR,A,F,Y,,,20220719,,CN,US,US,2022,Q3,Young Adult
208471942,20847194,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Fatigue,,2022,Q3,2,F,20210101.0,20220708.0,20220519,20220719,EXP,,US-BEH-2022145512,CSL BEHRING,,25.0,YR,A,F,Y,,,20220719,,CN,US,US,2022,Q3,Young Adult
208471942,20847194,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Hereditary angioedema,,2022,Q3,2,F,20210101.0,20220708.0,20220519,20220719,EXP,,US-BEH-2022145512,CSL BEHRING,,25.0,YR,A,F,Y,,,20220719,,CN,US,US,2022,Q3,Young Adult
208471942,20847194,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Dizziness,,2022,Q3,2,F,20210101.0,20220708.0,20220519,20220719,EXP,,US-BEH-2022145512,CSL BEHRING,,25.0,YR,A,F,Y,,,20220719,,CN,US,US,2022,Q3,Young Adult
208471942,20847194,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Fatigue,,2022,Q3,2,F,20210101.0,20220708.0,20220519,20220719,EXP,,US-BEH-2022145512,CSL BEHRING,,25.0,YR,A,F,Y,,,20220719,,CN,US,US,2022,Q3,Young Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Bundle branch block left,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,QRS axis abnormal,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Mitral valve incompetence,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Electrocardiogram PR prolongation,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Bundle branch block right,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Cardiac disorder,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Electrocardiogram abnormal,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Mitral valve thickening,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Sinus tachycardia,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Trifascicular block,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Atrioventricular block first degree,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208795544,20879554,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Injection,,2022,Q3,Left ventricular hypertrophy,,2022,Q3,4,F,20220303.0,20220720.0,20220526,20220725,EXP,,AU-PFIZER INC-202200714391,PFIZER,,46.0,YR,,M,Y,,,20220725,,MD,AU,AU,2022,Q3,Adult
208971922,20897192,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Disease recurrence,,2022,Q3,2,F,20220521.0,20220627.0,20220531,20220701,EXP,,US-PFIZER INC-202200759525,PFIZER,,66.0,YR,,F,Y,,,20220701,,MD,US,US,2022,Q3,Elderly
208971922,20897192,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,COVID-19,,2022,Q3,2,F,20220521.0,20220627.0,20220531,20220701,EXP,,US-PFIZER INC-202200759525,PFIZER,,66.0,YR,,F,Y,,,20220701,,MD,US,US,2022,Q3,Elderly
208977712,20897771,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Toxicity to various agents,,2022,Q3,2,F,20220519.0,20220804.0,20220531,20220805,EXP,,US-PFIZER INC-202200771533,PFIZER,,57.0,YR,,M,Y,,,20220805,,PH,US,US,2022,Q3,Adult
208977712,20897771,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,2,F,20220519.0,20220804.0,20220531,20220805,EXP,,US-PFIZER INC-202200771533,PFIZER,,57.0,YR,,M,Y,,,20220805,,PH,US,US,2022,Q3,Adult
208977712,20897771,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,2,F,20220519.0,20220804.0,20220531,20220805,EXP,,US-PFIZER INC-202200771533,PFIZER,,57.0,YR,,M,Y,,,20220805,,PH,US,US,2022,Q3,Adult
208977712,20897771,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Nausea,,2022,Q3,2,F,20220519.0,20220804.0,20220531,20220805,EXP,,US-PFIZER INC-202200771533,PFIZER,,57.0,YR,,M,Y,,,20220805,,PH,US,US,2022,Q3,Adult
208977712,20897771,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Asthenia,,2022,Q3,2,F,20220519.0,20220804.0,20220531,20220805,EXP,,US-PFIZER INC-202200771533,PFIZER,,57.0,YR,,M,Y,,,20220805,,PH,US,US,2022,Q3,Adult
209127303,20912730,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,215256.0,1.0,MG,Solution for injection,/WK,2022,Q3,Chest pain,,2022,Q3,3,F,20220508.0,20220831.0,20220603,20220909,EXP,,US-NOVOPROD-919724,NOVO NORDISK,,58.0,YR,,M,Y,97.0,KG,20220909,,MD,US,US,2022,Q3,Adult
209127303,20912730,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,Solution for injection,,2022,Q3,Chest pain,,2022,Q3,3,F,20220508.0,20220831.0,20220603,20220909,EXP,,US-NOVOPROD-919724,NOVO NORDISK,,58.0,YR,,M,Y,97.0,KG,20220909,,MD,US,US,2022,Q3,Adult
209127303,20912730,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,215256.0,,,Solution for injection,,2022,Q3,Chest pain,,2022,Q3,3,F,20220508.0,20220831.0,20220603,20220909,EXP,,US-NOVOPROD-919724,NOVO NORDISK,,58.0,YR,,M,Y,97.0,KG,20220909,,MD,US,US,2022,Q3,Adult
209762184,20976218,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,4,F,20220224.0,20220912.0,20220617,20220913,EXP,,US-PFIZER INC-202200691680,PFIZER,,47.0,YR,,F,Y,90.9,KG,20220913,,HP,US,US,2022,Q3,Adult
209762184,20976218,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,4,F,20220224.0,20220912.0,20220617,20220913,EXP,,US-PFIZER INC-202200691680,PFIZER,,47.0,YR,,F,Y,90.9,KG,20220913,,HP,US,US,2022,Q3,Adult
210376601,21037660,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 Milligram,,,,,,,,7.0,MG,Unknown,QD,2022,Q3,Gastrointestinal haemorrhage,,2022,Q3,1,I,20210721.0,20220622.0,20220704,20220704,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210800566,BRISTOL MYERS SQUIBB,,74.0,YR,E,M,Y,90.0,KG,20220704,,MD,US,US,2022,Q3,Elderly
210392331,21039233,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"solution for injection in pre-filled pen, strength 0.5 mg",,,Y,,,,,,,Solution for injection,,2022,Q3,Confusional state,,2022,Q3,1,I,20220320.0,20220624.0,20220704,20220704,EXP,FR-AFSSAPS-AM20221322,FR-Accord-268039,ACCORD,,93.0,YR,E,F,Y,61.0,KG,20220704,,PH,FR,FR,2022,Q3,Elderly
210392331,21039233,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"solution for injection in pre-filled pen, strength 0.5 mg",,,Y,,,,,,,Solution for injection,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220320.0,20220624.0,20220704,20220704,EXP,FR-AFSSAPS-AM20221322,FR-Accord-268039,ACCORD,,93.0,YR,E,F,Y,61.0,KG,20220704,,PH,FR,FR,2022,Q3,Elderly
210392331,21039233,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"solution for injection in pre-filled pen, strength 0.5 mg",,,Y,,,,,,,Solution for injection,,2022,Q3,Constipation,,2022,Q3,1,I,20220320.0,20220624.0,20220704,20220704,EXP,FR-AFSSAPS-AM20221322,FR-Accord-268039,ACCORD,,93.0,YR,E,F,Y,61.0,KG,20220704,,PH,FR,FR,2022,Q3,Elderly
210435341,21043534,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q3,Serotonin syndrome,,2022,Q3,1,I,20210424.0,20220628.0,20220705,20220705,EXP,,BR-ROCHE-3132261,ROCHE,,24.0,YR,,F,Y,,,20220705,,CN,BR,,2022,Q3,Young Adult
210435341,21043534,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q3,Prescription drug used without a prescription,,2022,Q3,1,I,20210424.0,20220628.0,20220705,20220705,EXP,,BR-ROCHE-3132261,ROCHE,,24.0,YR,,F,Y,,,20220705,,CN,BR,,2022,Q3,Young Adult
210490881,21049088,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20220630.0,20220706.0,20220706,20220706,EXP,,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-180223",BOEHRINGER INGELHEIM,,69.0,YR,E,M,Y,,,20220706,,HP,GB,GB,2022,Q3,Elderly
210494031,21049403,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,COVID-19,,2022,Q3,1,I,20220101.0,20220704.0,20220706,20220706,PER,,US-PFIZER INC-202200925519,PFIZER,,59.0,YR,,F,Y,,,20220706,,CN,US,US,2022,Q3,Adult
210494031,21049403,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Disease recurrence,,2022,Q3,1,I,20220101.0,20220704.0,20220706,20220706,PER,,US-PFIZER INC-202200925519,PFIZER,,59.0,YR,,F,Y,,,20220706,,CN,US,US,2022,Q3,Adult
210535991,21053599,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Serotonin syndrome,,2022,Q3,1,I,,20220628.0,20220707,20220707,EXP,,NVSC2022BR154648,NOVARTIS,,24.0,YR,,F,Y,,,20220707,,CN,BR,BR,2022,Q3,Young Adult
210535991,21053599,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Prescription drug used without a prescription,,2022,Q3,1,I,,20220628.0,20220707,20220707,EXP,,NVSC2022BR154648,NOVARTIS,,24.0,YR,,F,Y,,,20220707,,CN,BR,BR,2022,Q3,Young Adult
210586762,21058676,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Papilloedema,,2022,Q3,2,F,20211101.0,20220714.0,20220708,20220725,EXP,,US-BAYER-2022A091455,BAYER,Ebbert P; Pace A. Feeling the pressure: New onset IIH post hysterectomy-A case report. 64th Annual Scientific Meeting of the American Headache Society (AHS);. 2022;xx:ABSTR P-17,21.0,YR,A,F,Y,,,20220725,,HP,US,US,2022,Q3,Youth
210586762,21058676,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Idiopathic intracranial hypertension,,2022,Q3,2,F,20211101.0,20220714.0,20220708,20220725,EXP,,US-BAYER-2022A091455,BAYER,Ebbert P; Pace A. Feeling the pressure: New onset IIH post hysterectomy-A case report. 64th Annual Scientific Meeting of the American Headache Society (AHS);. 2022;xx:ABSTR P-17,21.0,YR,A,F,Y,,,20220725,,HP,US,US,2022,Q3,Youth
210628811,21062881,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,Therapy Duration: 1 Years,,,U,,,,209637.0,,,,,2022,Q3,Dyspnoea exertional,,2022,Q3,1,I,,20220630.0,20220711,20220711,EXP,CA- HEALTHCANVIG- E2B_05082215,CA-NOVOPROD-935689,NOVO NORDISK,,85.0,YR,,M,Y,117.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
210628811,21062881,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,Therapy Duration: 1 Years,,,U,,,,209637.0,,,,,2022,Q3,Abdominal discomfort,,2022,Q3,1,I,,20220630.0,20220711,20220711,EXP,CA- HEALTHCANVIG- E2B_05082215,CA-NOVOPROD-935689,NOVO NORDISK,,85.0,YR,,M,Y,117.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
210628811,21062881,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,Therapy Duration: 1 Years,,,U,,,,209637.0,,,,,2022,Q3,Cardiac failure congestive,,2022,Q3,1,I,,20220630.0,20220711,20220711,EXP,CA- HEALTHCANVIG- E2B_05082215,CA-NOVOPROD-935689,NOVO NORDISK,,85.0,YR,,M,Y,117.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
210628811,21062881,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,Therapy Duration: 1 Years,,,U,,,,209637.0,,,,,2022,Q3,Chest discomfort,,2022,Q3,1,I,,20220630.0,20220711,20220711,EXP,CA- HEALTHCANVIG- E2B_05082215,CA-NOVOPROD-935689,NOVO NORDISK,,85.0,YR,,M,Y,117.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
210646641,21064664,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1.5 Injection(s);?OTHER FREQUENCY : Weekly;?,,,,,Mp5b494,20250131.0,,,,,999,2022,Q3,Anorgasmia,,2022,Q3,1,I,20220615.0,,20220710,20220710,DIR,622466,,FDA-CTU,,44.0,YR,,F,N,87.75,KG,20220710,N,CN,US,,2022,Q3,Adult
210646641,21064664,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER QUANTITY : 1.5 Injection(s);?OTHER FREQUENCY : Weekly;?,,,,,Mp5b494,20250131.0,,,,,999,2022,Q3,Sexual dysfunction,,2022,Q3,1,I,20220615.0,,20220710,20220710,DIR,622466,,FDA-CTU,,44.0,YR,,F,N,87.75,KG,20220710,N,CN,US,,2022,Q3,Adult
210646731,21064673,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,unknown,,,0.25,MG,,QW,2022,Q3,Bile duct stone,,2022,Q3,1,I,20220621.0,,20220710,20220710,DIR,622504,,FDA-CTU,,67.0,YR,,M,N,140.0,KG,20220710,N,,US,,2022,Q3,Elderly
210646731,21064673,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,unknown,,,0.25,MG,,QW,2022,Q3,Escherichia bacteraemia,,2022,Q3,1,I,20220621.0,,20220710,20220710,DIR,622504,,FDA-CTU,,67.0,YR,,M,N,140.0,KG,20220710,N,,US,,2022,Q3,Elderly
210646731,21064673,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,unknown,,,0.25,MG,,QW,2022,Q3,Cholelithiasis,,2022,Q3,1,I,20220621.0,,20220710,20220710,DIR,622504,,FDA-CTU,,67.0,YR,,M,N,140.0,KG,20220710,N,,US,,2022,Q3,Elderly
210739885,21073988,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg/dose (4mg/3 ml), qwk",,,,,,,,,,,/WK,2022,Q3,Pain in extremity,,2022,Q3,5,F,20220606.0,20220906.0,20220713,20220914,PER,,US-AMGEN-USASP2022116440,AMGEN,,59.0,YR,A,M,Y,102.5,KG,20220913,,HP,US,US,2022,Q3,Adult
210739885,21073988,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg/dose (4mg/3 ml), qwk",,,,,,,,,,,/WK,2022,Q3,Headache,,2022,Q3,5,F,20220606.0,20220906.0,20220713,20220914,PER,,US-AMGEN-USASP2022116440,AMGEN,,59.0,YR,A,M,Y,102.5,KG,20220913,,HP,US,US,2022,Q3,Adult
210739885,21073988,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg/dose (4mg/3 ml), qwk",,,,,,,,,,,/WK,2022,Q3,Gastrooesophageal reflux disease,,2022,Q3,5,F,20220606.0,20220906.0,20220713,20220914,PER,,US-AMGEN-USASP2022116440,AMGEN,,59.0,YR,A,M,Y,102.5,KG,20220913,,HP,US,US,2022,Q3,Adult
210739885,21073988,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg/dose (4mg/3 ml), qwk",,,,,,,,,,,/WK,2022,Q3,Gastritis,,2022,Q3,5,F,20220606.0,20220906.0,20220713,20220914,PER,,US-AMGEN-USASP2022116440,AMGEN,,59.0,YR,A,M,Y,102.5,KG,20220913,,HP,US,US,2022,Q3,Adult
210739885,21073988,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg/dose (4mg/3 ml), qwk",,,,,,,,,,,/WK,2022,Q3,Burning sensation,,2022,Q3,5,F,20220606.0,20220906.0,20220713,20220914,PER,,US-AMGEN-USASP2022116440,AMGEN,,59.0,YR,A,M,Y,102.5,KG,20220913,,HP,US,US,2022,Q3,Adult
210739885,21073988,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg/dose (4mg/3 ml), qwk",,,,,,,,,,,/WK,2022,Q3,Device difficult to use,,2022,Q3,5,F,20220606.0,20220906.0,20220713,20220914,PER,,US-AMGEN-USASP2022116440,AMGEN,,59.0,YR,A,M,Y,102.5,KG,20220913,,HP,US,US,2022,Q3,Adult
210739885,21073988,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg/dose (4mg/3 ml), qwk",,,,,,,,,,,/WK,2022,Q3,Memory impairment,,2022,Q3,5,F,20220606.0,20220906.0,20220713,20220914,PER,,US-AMGEN-USASP2022116440,AMGEN,,59.0,YR,A,M,Y,102.5,KG,20220913,,HP,US,US,2022,Q3,Adult
210827831,21082783,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Disease recurrence,,2022,Q3,1,I,20220704.0,20220712.0,20220714,20220714,PER,,US-PFIZER INC-202200952659,PFIZER,,52.0,YR,,F,Y,,,20220714,,MD,US,US,2022,Q3,Adult
210827831,21082783,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,COVID-19,,2022,Q3,1,I,20220704.0,20220712.0,20220714,20220714,PER,,US-PFIZER INC-202200952659,PFIZER,,52.0,YR,,F,Y,,,20220714,,MD,US,US,2022,Q3,Adult
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Oedema,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Blood potassium decreased,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Pleural effusion,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Blood sodium decreased,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Sleep apnoea syndrome,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Blood iron decreased,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Decreased appetite,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Blood magnesium decreased,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Decreased appetite,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Asthenia,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Hypovolaemia,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Cerebral haemorrhage,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Fatigue,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Nausea,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Gastrooesophageal reflux disease,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Vomiting,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Delirium,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210876311,21087631,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"solution subcutaneous, multidose prefilled pen dispenses 0.25mg or 0.5mg dose",,,U,,,,,0.25,MG,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,1,I,,20220711.0,20220715,20220715,EXP,CA-MHPD-000953858,CA-Accord-269254,ACCORD,,64.0,YR,A,M,Y,74.0,KG,20220715,,MD,CA,CA,2022,Q3,Adult
210879151,21087915,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,COVID-19,,2022,Q3,1,I,20220710.0,20220712.0,20220715,20220715,PER,,US-PFIZER INC-202200954680,PFIZER,,52.0,YR,,F,Y,,,20220715,,MD,US,US,2022,Q3,Adult
210879151,21087915,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Disease recurrence,,2022,Q3,1,I,20220710.0,20220712.0,20220715,20220715,PER,,US-PFIZER INC-202200954680,PFIZER,,52.0,YR,,F,Y,,,20220715,,MD,US,US,2022,Q3,Adult
210879151,21087915,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Therapeutic product effect incomplete,,2022,Q3,1,I,20220710.0,20220712.0,20220715,20220715,PER,,US-PFIZER INC-202200954680,PFIZER,,52.0,YR,,F,Y,,,20220715,,MD,US,US,2022,Q3,Adult
210879151,21087915,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Incorrect product administration duration,,2022,Q3,1,I,20220710.0,20220712.0,20220715,20220715,PER,,US-PFIZER INC-202200954680,PFIZER,,52.0,YR,,F,Y,,,20220715,,MD,US,US,2022,Q3,Adult
210929081,21092908,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 mg,,,U,,,,209637.0,,,,,2022,Q3,Diabetic retinal oedema,,2022,Q3,1,I,20210801.0,20220707.0,20220718,20220718,EXP,DE-BFARM-22004912,DE-NOVOPROD-938183,NOVO NORDISK,,59.0,YR,,M,Y,135.0,KG,20220718,,MD,DE,DE,2022,Q3,Adult
210929081,21092908,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 mg,,,U,,,,209637.0,,,,,2022,Q3,Condition aggravated,,2022,Q3,1,I,20210801.0,20220707.0,20220718,20220718,EXP,DE-BFARM-22004912,DE-NOVOPROD-938183,NOVO NORDISK,,59.0,YR,,M,Y,135.0,KG,20220718,,MD,DE,DE,2022,Q3,Adult
210929081,21092908,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 mg,,,U,,,,209637.0,,,,,2022,Q3,Diabetic retinopathy,,2022,Q3,1,I,20210801.0,20220707.0,20220718,20220718,EXP,DE-BFARM-22004912,DE-NOVOPROD-938183,NOVO NORDISK,,59.0,YR,,M,Y,135.0,KG,20220718,,MD,DE,DE,2022,Q3,Adult
211124151,21112415,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown. Solution subcutaneous,,,,,,,,,,,,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220714.0,20220721,20220721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-17426,SAMSUNG BIOEPIS,,52.0,YR,A,F,Y,53.0,KG,20220721,,HP,CA,CA,2022,Q3,Adult
211124151,21112415,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown. Solution subcutaneous,,,,,,,,,,,,2022,Q3,Infection,,2022,Q3,1,I,,20220714.0,20220721,20220721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-17426,SAMSUNG BIOEPIS,,52.0,YR,A,F,Y,53.0,KG,20220721,,HP,CA,CA,2022,Q3,Adult
211124151,21112415,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown. Solution subcutaneous,,,,,,,,,,,,2022,Q3,Crohn's disease,,2022,Q3,1,I,,20220714.0,20220721,20220721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-17426,SAMSUNG BIOEPIS,,52.0,YR,A,F,Y,53.0,KG,20220721,,HP,CA,CA,2022,Q3,Adult
211124151,21112415,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Unknown. Solution subcutaneous,,,,,,,,,,,,2022,Q3,Heart rate increased,,2022,Q3,1,I,,20220714.0,20220721,20220721,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-17426,SAMSUNG BIOEPIS,,52.0,YR,A,F,Y,53.0,KG,20220721,,HP,CA,CA,2022,Q3,Adult
211180722,21118072,4,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,,,,Y,,,,,,,,,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,2,F,,20220801.0,20220722,20220803,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183146",BOEHRINGER INGELHEIM,,28.0,YR,A,M,Y,,,20220803,,MD,JP,JP,2022,Q3,Young Adult
211199371,21119937,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Breast abscess,,2022,Q3,1,I,,20220721.0,20220722,20220722,EXP,,CA-ROCHE-3145226,ROCHE,,35.0,YR,,F,Y,,,20220722,,HP,CA,,2022,Q3,Adult
211346721,21134672,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183417",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,60.0,KG,20220727,,PH,CA,CA,2022,Q3,Elderly
211346721,21134672,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183417",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,60.0,KG,20220727,,PH,CA,CA,2022,Q3,Elderly
211346721,21134672,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Lethargy,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183417",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,60.0,KG,20220727,,PH,CA,CA,2022,Q3,Elderly
211346721,21134672,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Urinary tract infection,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183417",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,60.0,KG,20220727,,PH,CA,CA,2022,Q3,Elderly
211346721,21134672,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Fungal test positive,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183417",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,60.0,KG,20220727,,PH,CA,CA,2022,Q3,Elderly
211346721,21134672,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Mental status changes,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183417",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,60.0,KG,20220727,,PH,CA,CA,2022,Q3,Elderly
211346721,21134672,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Sepsis,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-183417",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,60.0,KG,20220727,,PH,CA,CA,2022,Q3,Elderly
211364251,21136425,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 milligram, qw",,,D,,,,,2.0,MG,,/WK,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220719.0,20220727,20220727,EXP,,US-MYLANLABS-2022M1081178,MYLAN,"Valtis YK, Barlowe T, Young JH, Lichtman AH, Zhao L, Hornick JL, et al. A woman presenting with an unusual cause of fulminant liver failure and sepsis. Clin-Res-Hepatol-Gastroenterol 2022;46:No. 3.",61.0,YR,,F,Y,,,20220727,,HP,US,US,2022,Q3,Adult
211398662,21139866,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,2,F,20220709.0,20220806.0,20220728,20220818,EXP,,PT-AUROBINDO-AUR-APL-2022-029157,AUROBINDO,,65.0,YR,,F,Y,106.0,KG,20220818,,MD,PT,PT,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Hip arthroplasty,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Hepatic mass,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Weight increased,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Mobility decreased,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Headache,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Pain in extremity,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Knee arthroplasty,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Retinal detachment,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Sleep disorder,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Appetite disorder,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Arterial disorder,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Joint stiffness,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Fatigue,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Feeling abnormal,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Contraindicated product administered,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Myalgia,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Muscle spasms,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Chest pain,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Nausea,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Product prescribing error,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Anxiety,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Blood pressure increased,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Product use in unapproved indication,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Abdominal distension,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Drug titration error,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211406251,21140625,15,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qd",,,U,,,,,0.5,MG,Solution for injection,,2022,Q3,Abnormal dreams,,2022,Q3,1,I,,20220722.0,20220728,20220728,EXP,,CA-APOTEX-2022AP010320,APOTEX,,69.0,YR,,M,Y,144.0,KG,20220728,,HP,CA,CA,2022,Q3,Elderly
211439771,21143977,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Rash,,2022,Q3,1,I,20220717.0,20220727.0,20220728,20220728,EXP,,NVSC2022GB170630,NOVARTIS,,53.0,YR,,M,Y,,,20220728,,HP,GB,GB,2022,Q3,Adult
211473771,21147377,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 mg, UNK",,,,,,,,,,,,2022,Q3,Drug ineffective for unapproved indication,,2022,Q3,1,I,,20220719.0,20220729,20220729,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-09796,LUPIN,"Valtis YK, Barlowe T, Young JH, Lichtman AH, Zhao L, Hornick JL, et al. A woman presenting with an unusual cause of fulminant liver failure and sepsis. Clinics and Research in Hepatology and Gastroenterology. 2022;46:101836:1-7",61.0,YR,,F,Y,,,20220729,,MD,US,US,2022,Q3,Adult
211473771,21147377,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"2 mg, UNK",,,,,,,,,,,,2022,Q3,Off label use,,2022,Q3,1,I,,20220719.0,20220729,20220729,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-09796,LUPIN,"Valtis YK, Barlowe T, Young JH, Lichtman AH, Zhao L, Hornick JL, et al. A woman presenting with an unusual cause of fulminant liver failure and sepsis. Clinics and Research in Hepatology and Gastroenterology. 2022;46:101836:1-7",61.0,YR,,F,Y,,,20220729,,MD,US,US,2022,Q3,Adult
211485981,21148598,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Vasculitic rash,,2022,Q3,1,I,20220717.0,20220727.0,20220729,20220729,EXP,,GB-PFIZER INC-202201014232,PFIZER,,53.0,YR,,M,Y,,,20220729,,HP,GB,GB,2022,Q3,Adult
211485981,21148598,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q3,Skin lesion,,2022,Q3,1,I,20220717.0,20220727.0,20220729,20220729,EXP,,GB-PFIZER INC-202201014232,PFIZER,,53.0,YR,,M,Y,,,20220729,,HP,GB,GB,2022,Q3,Adult
211500561,21150056,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",,,N,,,,209637.0,0.5,MG,Solution for injection,/WK,2022,Q3,Insomnia,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",,,N,,,,209637.0,0.5,MG,Solution for injection,/WK,2022,Q3,Drug interaction,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",,,N,,,,209637.0,0.5,MG,Solution for injection,/WK,2022,Q3,Weight loss poor,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, qw",,,N,,,,209637.0,0.5,MG,Solution for injection,/WK,2022,Q3,Condition aggravated,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.75 mg, qw",,,N,,,,209637.0,0.75,MG,Solution for injection,/WK,2022,Q3,Insomnia,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.75 mg, qw",,,N,,,,209637.0,0.75,MG,Solution for injection,/WK,2022,Q3,Drug interaction,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.75 mg, qw",,,N,,,,209637.0,0.75,MG,Solution for injection,/WK,2022,Q3,Weight loss poor,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.75 mg, qw",,,N,,,,209637.0,0.75,MG,Solution for injection,/WK,2022,Q3,Condition aggravated,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,N,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q3,Insomnia,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,N,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q3,Drug interaction,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,N,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q3,Weight loss poor,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,N,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q3,Condition aggravated,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw divided in two doses",,,N,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q3,Insomnia,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw divided in two doses",,,N,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q3,Drug interaction,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw divided in two doses",,,N,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q3,Weight loss poor,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw divided in two doses",,,N,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q3,Condition aggravated,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,20 IU,,,N,,,,209637.0,20.0,IU,Solution for injection,/WK,2022,Q3,Insomnia,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,20 IU,,,N,,,,209637.0,20.0,IU,Solution for injection,/WK,2022,Q3,Drug interaction,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,20 IU,,,N,,,,209637.0,20.0,IU,Solution for injection,/WK,2022,Q3,Weight loss poor,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211500561,21150056,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,20 IU,,,N,,,,209637.0,20.0,IU,Solution for injection,/WK,2022,Q3,Condition aggravated,,2022,Q3,1,I,20220101.0,20220222.0,20220729,20220729,PER,,US-NOVOPROD-894560,NOVO NORDISK,,49.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Adult
211549781,21154978,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,Unknown,,,,,,,2022,Q3,Hormone level abnormal,,2022,Q3,1,I,20210101.0,20220718.0,20220801,20220801,EXP,,US-EPICPHARMA-US-2022EPCLIT01076,EPIC PHARM,P Ebbert.Feeling the pressure: New onset IIH post hysterectomy-A case report.Headache.MAY-2022;62 (Suppl. 1):abstr. P-17,21.0,YR,A,F,Y,,,20220801,,HP,US,US,2022,Q3,Youth
211549781,21154978,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,Unknown,,,,,,,2022,Q3,Idiopathic intracranial hypertension,,2022,Q3,1,I,20210101.0,20220718.0,20220801,20220801,EXP,,US-EPICPHARMA-US-2022EPCLIT01076,EPIC PHARM,P Ebbert.Feeling the pressure: New onset IIH post hysterectomy-A case report.Headache.MAY-2022;62 (Suppl. 1):abstr. P-17,21.0,YR,A,F,Y,,,20220801,,HP,US,US,2022,Q3,Youth
211580472,21158047,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,D,,,,,2.0,MG,,/WK,2022,Q3,Drug ineffective,,2022,Q3,2,F,,20220805.0,20220801,20220810,EXP,,US-TEVA-2022-US-2060112,TEVA,,61.0,YR,A,F,Y,,,20220810,,HP,US,US,2022,Q3,Adult
211590631,21159063,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"3 mg, qd",63.0,MG,Y,,,,209637.0,3.0,MG,,QD,2022,Q3,Anxiety,,2022,Q3,1,I,20220531.0,20220722.0,20220802,20220802,EXP,GB-MHRA-ADR 27131574,GB-NOVOPROD-941694,NOVO NORDISK,,49.0,YR,,F,Y,76.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211590631,21159063,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"3 mg, qd",63.0,MG,Y,,,,209637.0,3.0,MG,,QD,2022,Q3,Product use in unapproved indication,,2022,Q3,1,I,20220531.0,20220722.0,20220802,20220802,EXP,GB-MHRA-ADR 27131574,GB-NOVOPROD-941694,NOVO NORDISK,,49.0,YR,,F,Y,76.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211590631,21159063,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"3 mg, qd",63.0,MG,Y,,,,209637.0,3.0,MG,,QD,2022,Q3,Malaise,,2022,Q3,1,I,20220531.0,20220722.0,20220802,20220802,EXP,GB-MHRA-ADR 27131574,GB-NOVOPROD-941694,NOVO NORDISK,,49.0,YR,,F,Y,76.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211590631,21159063,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"3 mg, qd",63.0,MG,Y,,,,209637.0,3.0,MG,,QD,2022,Q3,Headache,,2022,Q3,1,I,20220531.0,20220722.0,20220802,20220802,EXP,GB-MHRA-ADR 27131574,GB-NOVOPROD-941694,NOVO NORDISK,,49.0,YR,,F,Y,76.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211590631,21159063,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"3 mg, qd",63.0,MG,Y,,,,209637.0,3.0,MG,,QD,2022,Q3,Nausea,,2022,Q3,1,I,20220531.0,20220722.0,20220802,20220802,EXP,GB-MHRA-ADR 27131574,GB-NOVOPROD-941694,NOVO NORDISK,,49.0,YR,,F,Y,76.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211604103,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,3,F,,20220829.0,20220802,20220912,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20220912,,HP,CA,CA,2022,Q3,Adult
211604103,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Asthma,,2022,Q3,3,F,,20220829.0,20220802,20220912,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20220912,,HP,CA,CA,2022,Q3,Adult
211604103,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Wheezing,,2022,Q3,3,F,,20220829.0,20220802,20220912,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20220912,,HP,CA,CA,2022,Q3,Adult
211604103,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,3,F,,20220829.0,20220802,20220912,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20220912,,HP,CA,CA,2022,Q3,Adult
211604103,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Hypoacusis,,2022,Q3,3,F,,20220829.0,20220802,20220912,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20220912,,HP,CA,CA,2022,Q3,Adult
211604103,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Depression,,2022,Q3,3,F,,20220829.0,20220802,20220912,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20220912,,HP,CA,CA,2022,Q3,Adult
211604103,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,3,F,,20220829.0,20220802,20220912,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20220912,,HP,CA,CA,2022,Q3,Adult
211604103,21160410,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,3,F,,20220829.0,20220802,20220912,EXP,CA-MHPD-E2B_04528744,CA-Accord-271138,ACCORD,,51.0,YR,A,F,Y,,,20220912,,HP,CA,CA,2022,Q3,Adult
211639091,21163909,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 milligram,,,Y,,,,,7.0,MG,,,2022,Q3,Hypotension,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,7 milligram,,,Y,,,,,7.0,MG,,,2022,Q3,Fall,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3 milligram,,,Y,,,,,3.0,MG,,,2022,Q3,Hypotension,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,3 milligram,,,Y,,,,,3.0,MG,,,2022,Q3,Fall,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 milligram,,,Y,,,,,14.0,MG,,,2022,Q3,Hypotension,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,14 milligram,,,Y,,,,,14.0,MG,,,2022,Q3,Fall,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,6,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, Once a Day",,,Y,,,,,,,,QD,2022,Q3,Hypotension,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,7,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, Once a Day",,,Y,,,,,,,,QD,2022,Q3,Fall,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,8,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211639091,21163909,9,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,20210311.0,20220720.0,20220803,20220803,EXP,,CA-AUROBINDO-AUR-APL-2022-008319,AUROBINDO,,68.0,YR,,M,Y,87.0,KG,20220803,,HP,CA,CA,2022,Q3,Elderly
211684061,21168406,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,2.4,MG,,/WK,2022,Q3,Acute kidney injury,,2022,Q3,1,I,,20220802.0,20220803,20220803,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185166",BOEHRINGER INGELHEIM,,73.0,YR,E,M,Y,82.0,KG,20220803,,MD,CA,CA,2022,Q3,Elderly
211684061,21168406,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,2.4,MG,,/WK,2022,Q3,Toxicity to various agents,,2022,Q3,1,I,,20220802.0,20220803,20220803,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185166",BOEHRINGER INGELHEIM,,73.0,YR,E,M,Y,82.0,KG,20220803,,MD,CA,CA,2022,Q3,Elderly
211715532,21171553,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Acute myocardial infarction,,2022,Q3,2,F,20210829.0,20220809.0,20220804,20220821,EXP,,CA-APOTEX-2022AP004829,APOTEX,,67.0,YR,,M,Y,122.0,KG,20220821,,HP,CA,CA,2022,Q3,Elderly
211715532,21171553,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Vomiting,,2022,Q3,2,F,20210829.0,20220809.0,20220804,20220821,EXP,,CA-APOTEX-2022AP004829,APOTEX,,67.0,YR,,M,Y,122.0,KG,20220821,,HP,CA,CA,2022,Q3,Elderly
211715532,21171553,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Angina unstable,,2022,Q3,2,F,20210829.0,20220809.0,20220804,20220821,EXP,,CA-APOTEX-2022AP004829,APOTEX,,67.0,YR,,M,Y,122.0,KG,20220821,,HP,CA,CA,2022,Q3,Elderly
211715532,21171553,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Asthenia,,2022,Q3,2,F,20210829.0,20220809.0,20220804,20220821,EXP,,CA-APOTEX-2022AP004829,APOTEX,,67.0,YR,,M,Y,122.0,KG,20220821,,HP,CA,CA,2022,Q3,Elderly
211715532,21171553,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Hypotension,,2022,Q3,2,F,20210829.0,20220809.0,20220804,20220821,EXP,,CA-APOTEX-2022AP004829,APOTEX,,67.0,YR,,M,Y,122.0,KG,20220821,,HP,CA,CA,2022,Q3,Elderly
211715532,21171553,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2.4 milligram,,,,,,,,2.4,MG,,,2022,Q3,Dizziness,,2022,Q3,2,F,20210829.0,20220809.0,20220804,20220821,EXP,,CA-APOTEX-2022AP004829,APOTEX,,67.0,YR,,M,Y,122.0,KG,20220821,,HP,CA,CA,2022,Q3,Elderly
211795932,21179593,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,2 milligram weekly,,,,,,,,2.0,MG,,,2022,Q3,Drug ineffective,,2022,Q3,2,F,,20220907.0,20220805,20220915,EXP,,US-AMERICAN REGENT INC-2022002191,AMERICAN REGENT,"Valtis YK, Barlowe T, Young JH, Lichtman AH, Zhao L, Hornick JL, et al.. A woman presenting with an unusual cause of fulminant liver failure and sepsis. Clinics and Research in Hepatology and Gastroenterology. 2022;46(3):101836",61.0,YR,,F,Y,,,20220915,,MD,US,US,2022,Q3,Adult
211795932,21179593,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,2 milligram weekly,,,,,,,,2.0,MG,,,2022,Q3,Shock,,2022,Q3,2,F,,20220907.0,20220805,20220915,EXP,,US-AMERICAN REGENT INC-2022002191,AMERICAN REGENT,"Valtis YK, Barlowe T, Young JH, Lichtman AH, Zhao L, Hornick JL, et al.. A woman presenting with an unusual cause of fulminant liver failure and sepsis. Clinics and Research in Hepatology and Gastroenterology. 2022;46(3):101836",61.0,YR,,F,Y,,,20220915,,MD,US,US,2022,Q3,Adult
211795932,21179593,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,2 milligram weekly,,,,,,,,2.0,MG,,,2022,Q3,Product use in unapproved indication,,2022,Q3,2,F,,20220907.0,20220805,20220915,EXP,,US-AMERICAN REGENT INC-2022002191,AMERICAN REGENT,"Valtis YK, Barlowe T, Young JH, Lichtman AH, Zhao L, Hornick JL, et al.. A woman presenting with an unusual cause of fulminant liver failure and sepsis. Clinics and Research in Hepatology and Gastroenterology. 2022;46(3):101836",61.0,YR,,F,Y,,,20220915,,MD,US,US,2022,Q3,Adult
211800581,21180058,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : 4 times a day;?,,,D,D,,,,0.5,MG,,QID,2022,Q3,Blood pressure abnormal,,2022,Q3,1,I,20220331.0,,20220805,20220805,DIR,FDA-CDER-CTU-2022-62504,,FDA-CTU,,52.0,YR,,M,N,131.09,KG,20220519,N,PH,US,,2022,Q3,Adult
211800581,21180058,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : 4 times a day;?,,,D,D,,,,0.5,MG,,QID,2022,Q3,Pain in extremity,,2022,Q3,1,I,20220331.0,,20220805,20220805,DIR,FDA-CDER-CTU-2022-62504,,FDA-CTU,,52.0,YR,,M,N,131.09,KG,20220519,N,PH,US,,2022,Q3,Adult
211800581,21180058,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : 4 times a day;?,,,D,D,,,,0.5,MG,,QID,2022,Q3,Pain in extremity,,2022,Q3,1,I,20220331.0,,20220805,20220805,DIR,FDA-CDER-CTU-2022-62504,,FDA-CTU,,52.0,YR,,M,N,131.09,KG,20220519,N,PH,US,,2022,Q3,Adult
211800581,21180058,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : 4 times a day;?,,,D,D,,,,0.5,MG,,QID,2022,Q3,Headache,,2022,Q3,1,I,20220331.0,,20220805,20220805,DIR,FDA-CDER-CTU-2022-62504,,FDA-CTU,,52.0,YR,,M,N,131.09,KG,20220519,N,PH,US,,2022,Q3,Adult
211800581,21180058,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : 4 times a day;?,,,D,D,,,,0.5,MG,,QID,2022,Q3,Myalgia,,2022,Q3,1,I,20220331.0,,20220805,20220805,DIR,FDA-CDER-CTU-2022-62504,,FDA-CTU,,52.0,YR,,M,N,131.09,KG,20220519,N,PH,US,,2022,Q3,Adult
211800581,21180058,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : 4 times a day;?,,,D,D,,,,0.5,MG,,QID,2022,Q3,Pancreatitis,,2022,Q3,1,I,20220331.0,,20220805,20220805,DIR,FDA-CDER-CTU-2022-62504,,FDA-CTU,,52.0,YR,,M,N,131.09,KG,20220519,N,PH,US,,2022,Q3,Adult
211800781,21180078,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,D,D,,,,1.0,MG,,QW,2022,Q3,Injection site pain,,2022,Q3,1,I,20200720.0,,20220805,20220805,DIR,FDA-CDER-CTU-2022-62541,,FDA-CTU,,74.0,YR,,M,N,68.0,KG,20200803,N,HP,US,,2022,Q3,Elderly
211800781,21180078,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 MG QWEEK SQ,,,D,D,,,,1.0,MG,,QW,2022,Q3,Injection site mass,,2022,Q3,1,I,20200720.0,,20220805,20220805,DIR,FDA-CDER-CTU-2022-62541,,FDA-CTU,,74.0,YR,,M,N,68.0,KG,20200803,N,HP,US,,2022,Q3,Elderly
211829802,21182980,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q3,C-reactive protein increased,,2022,Q3,2,F,20220802.0,20220804.0,20220808,20220810,EXP,,NVSC2022CA177792,NOVARTIS,,19.0,YR,,F,Y,,,20220810,,MD,CA,CA,2022,Q3,Youth
211829802,21182980,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q3,Ankylosing spondylitis,,2022,Q3,2,F,20220802.0,20220804.0,20220808,20220810,EXP,,NVSC2022CA177792,NOVARTIS,,19.0,YR,,F,Y,,,20220810,,MD,CA,CA,2022,Q3,Youth
211829802,21182980,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220802.0,20220804.0,20220808,20220810,EXP,,NVSC2022CA177792,NOVARTIS,,19.0,YR,,F,Y,,,20220810,,MD,CA,CA,2022,Q3,Youth
211835751,21183575,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,NN9535,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220727.0,20220808,20220808,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-07995,ALKEM,,48.0,YR,,M,Y,,,20220808,,HP,AU,AU,2022,Q3,Adult
211835751,21183575,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,NN9535,,,,,,,2022,Q3,Mental disorder,,2022,Q3,1,I,,20220727.0,20220808,20220808,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-07995,ALKEM,,48.0,YR,,M,Y,,,20220808,,HP,AU,AU,2022,Q3,Adult
211835751,21183575,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,NN9535,,,,,,,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,,20220727.0,20220808,20220808,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-07995,ALKEM,,48.0,YR,,M,Y,,,20220808,,HP,AU,AU,2022,Q3,Adult
211835751,21183575,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,NN9535,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220727.0,20220808,20220808,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-07995,ALKEM,,48.0,YR,,M,Y,,,20220808,,HP,AU,AU,2022,Q3,Adult
211835751,21183575,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,NN9535,,,,,,,2022,Q3,Schizophrenia,,2022,Q3,1,I,,20220727.0,20220808,20220808,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-07995,ALKEM,,48.0,YR,,M,Y,,,20220808,,HP,AU,AU,2022,Q3,Adult
211846501,21184650,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Incorrect product administration duration,,2022,Q3,1,I,20220720.0,20220728.0,20220808,20220808,PER,,US-BEH-2022148153,CSL BEHRING,,62.0,YR,A,F,Y,,,20220808,,CN,US,US,2022,Q3,Adult
211846501,21184650,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Patient dissatisfaction with treatment,,2022,Q3,1,I,20220720.0,20220728.0,20220808,20220808,PER,,US-BEH-2022148153,CSL BEHRING,,62.0,YR,A,F,Y,,,20220808,,CN,US,US,2022,Q3,Adult
211846501,21184650,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Hypertension,,2022,Q3,1,I,20220720.0,20220728.0,20220808,20220808,PER,,US-BEH-2022148153,CSL BEHRING,,62.0,YR,A,F,Y,,,20220808,,CN,US,US,2022,Q3,Adult
211846501,21184650,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,Injection,,2022,Q3,Headache,,2022,Q3,1,I,20220720.0,20220728.0,20220808,20220808,PER,,US-BEH-2022148153,CSL BEHRING,,62.0,YR,A,F,Y,,,20220808,,CN,US,US,2022,Q3,Adult
211882331,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2022,Q3,Type 2 diabetes mellitus,,2022,Q3,1,I,,20220802.0,20220809,20220809,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,89.0,KG,20220809,,HP,CA,CA,2022,Q3,Elderly
211882331,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2022,Q3,Blood pressure fluctuation,,2022,Q3,1,I,,20220802.0,20220809,20220809,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,89.0,KG,20220809,,HP,CA,CA,2022,Q3,Elderly
211882331,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2022,Q3,Blood pressure diastolic abnormal,,2022,Q3,1,I,,20220802.0,20220809,20220809,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,89.0,KG,20220809,,HP,CA,CA,2022,Q3,Elderly
211882331,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2022,Q3,Blood pressure systolic increased,,2022,Q3,1,I,,20220802.0,20220809,20220809,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,89.0,KG,20220809,,HP,CA,CA,2022,Q3,Elderly
211882331,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220802.0,20220809,20220809,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,89.0,KG,20220809,,HP,CA,CA,2022,Q3,Elderly
211882331,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2022,Q3,Blood pressure diastolic decreased,,2022,Q3,1,I,,20220802.0,20220809,20220809,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,89.0,KG,20220809,,HP,CA,CA,2022,Q3,Elderly
211882331,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2022,Q3,Weight increased,,2022,Q3,1,I,,20220802.0,20220809,20220809,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,89.0,KG,20220809,,HP,CA,CA,2022,Q3,Elderly
211882331,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220802.0,20220809,20220809,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,89.0,KG,20220809,,HP,CA,CA,2022,Q3,Elderly
211882331,21188233,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution,,,U,,Unknown,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,1,I,,20220802.0,20220809,20220809,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-185417",BOEHRINGER INGELHEIM,,66.0,YR,E,F,Y,89.0,KG,20220809,,HP,CA,CA,2022,Q3,Elderly
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,COVID-19,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Nasal congestion,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Feeling cold,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Exposure to SARS-CoV-2,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Off label use,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Drug intolerance,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,C-reactive protein increased,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Intentional product use issue,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Therapeutic response shortened,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Fatigue,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Heart rate increased,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Cough,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Hypertension,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Oropharyngeal pain,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211927961,21192796,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q3,Inappropriate schedule of product administration,,2022,Q3,1,I,,20220731.0,20220810,20220810,EXP,,CA-SAMSUNG BIOEPIS-SB-2021-21075,SAMSUNG BIOEPIS,,49.0,YR,A,F,Y,110.0,KG,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Nausea,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Blood pressure systolic increased,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Blood pressure diastolic abnormal,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Discomfort,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Off label use,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Product preparation issue,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Asthenia,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Heart rate increased,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Blood pressure systolic abnormal,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Blood pressure fluctuation,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Anxiety,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211964901,21196490,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,Solution for injection,,2022,Q3,Diabetes mellitus,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-2021530748,PFIZER,,40.0,YR,,F,Y,,,20220810,,HP,CA,CA,2022,Q3,Adult
211971921,21197192,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220810.0,20220810,20220810,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186460",BOEHRINGER INGELHEIM,,61.0,YR,A,M,Y,59.0,KG,20220810,,CN,CA,CA,2022,Q3,Adult
211971921,21197192,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220810.0,20220810,20220810,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186460",BOEHRINGER INGELHEIM,,61.0,YR,A,M,Y,59.0,KG,20220810,,CN,CA,CA,2022,Q3,Adult
211971921,21197192,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,1.0,MG,,/WK,2022,Q3,Flatulence,,2022,Q3,1,I,,20220810.0,20220810,20220810,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-186460",BOEHRINGER INGELHEIM,,61.0,YR,A,M,Y,59.0,KG,20220810,,CN,CA,CA,2022,Q3,Adult
211972481,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Blood pressure diastolic decreased,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20220810,,HP,CA,CA,2022,Q3,Elderly
211972481,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20220810,,HP,CA,CA,2022,Q3,Elderly
211972481,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Blood pressure systolic increased,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20220810,,HP,CA,CA,2022,Q3,Elderly
211972481,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Blood pressure increased,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20220810,,HP,CA,CA,2022,Q3,Elderly
211972481,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20220810,,HP,CA,CA,2022,Q3,Elderly
211972481,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Blood pressure fluctuation,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20220810,,HP,CA,CA,2022,Q3,Elderly
211972481,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Blood pressure diastolic abnormal,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20220810,,HP,CA,CA,2022,Q3,Elderly
211972481,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Weight increased,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20220810,,HP,CA,CA,2022,Q3,Elderly
211972481,21197248,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Type 2 diabetes mellitus,,2022,Q3,1,I,,20220805.0,20220810,20220810,EXP,,CA-PFIZER INC-202201041435,PFIZER,,66.0,YR,,F,Y,89.0,KG,20220810,,HP,CA,CA,2022,Q3,Elderly
212243712,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Asthma,,2022,Q3,2,F,,20220812.0,20220817,20220819,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212243712,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,2,F,,20220812.0,20220817,20220819,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212243712,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,2,F,,20220812.0,20220817,20220819,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212243712,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Hypoacusis,,2022,Q3,2,F,,20220812.0,20220817,20220819,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212243712,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,2,F,,20220812.0,20220817,20220819,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212243712,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,2,F,,20220812.0,20220817,20220819,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212243712,21224371,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Wheezing,,2022,Q3,2,F,,20220812.0,20220817,20220819,EXP,,CA-BAUSCH-BL-2022-020141,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212272741,21227274,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q3,Tooth disorder,,2022,Q3,1,I,,20220812.0,20220818,20220818,EXP,,CA-ROCHE-3160731,ROCHE,,52.0,YR,,F,Y,108.0,KG,20220818,,HP,CA,,2022,Q3,Adult
212272741,21227274,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q3,Gastrointestinal disorder,,2022,Q3,1,I,,20220812.0,20220818,20220818,EXP,,CA-ROCHE-3160731,ROCHE,,52.0,YR,,F,Y,108.0,KG,20220818,,HP,CA,,2022,Q3,Adult
212272741,21227274,19,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q3,Polypectomy,,2022,Q3,1,I,,20220812.0,20220818,20220818,EXP,,CA-ROCHE-3160731,ROCHE,,52.0,YR,,F,Y,108.0,KG,20220818,,HP,CA,,2022,Q3,Adult
212294371,21229437,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q3,Weight increased,,2022,Q3,1,I,,20220815.0,20220818,20220818,EXP,,CA-JNJFOC-20220835578,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,57.0,KG,20220818,,HP,CA,CA,2022,Q3,Adult
212294371,21229437,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,,20220815.0,20220818,20220818,EXP,,CA-JNJFOC-20220835578,JOHNSON AND JOHNSON,,64.0,YR,A,F,Y,57.0,KG,20220818,,HP,CA,CA,2022,Q3,Adult
212316171,21231617,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,1,I,,20220809.0,20220819,20220819,EXP,,CA-AUROBINDO-AUR-APL-2022-032512,AUROBINDO,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212316171,21231617,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,1,I,,20220809.0,20220819,20220819,EXP,,CA-AUROBINDO-AUR-APL-2022-032512,AUROBINDO,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212316171,21231617,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220809.0,20220819,20220819,EXP,,CA-AUROBINDO-AUR-APL-2022-032512,AUROBINDO,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212316171,21231617,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Asthma,,2022,Q3,1,I,,20220809.0,20220819,20220819,EXP,,CA-AUROBINDO-AUR-APL-2022-032512,AUROBINDO,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212316171,21231617,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypoacusis,,2022,Q3,1,I,,20220809.0,20220819,20220819,EXP,,CA-AUROBINDO-AUR-APL-2022-032512,AUROBINDO,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212316171,21231617,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,1,I,,20220809.0,20220819,20220819,EXP,,CA-AUROBINDO-AUR-APL-2022-032512,AUROBINDO,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212316171,21231617,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Wheezing,,2022,Q3,1,I,,20220809.0,20220819,20220819,EXP,,CA-AUROBINDO-AUR-APL-2022-032512,AUROBINDO,,51.0,YR,,F,Y,,,20220819,,HP,CA,CA,2022,Q3,Adult
212319051,21231905,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000765,ALIGNSCIENCE PHARMA,"Kellerer M., Kaltoft M.S., Lawson J., Nielsen L.L., Strojek K., Tabak O. et.al. Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to Metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial. Diabetes Obes Metab 2022; 24(9):1788-99. doi:10.1111/dom.14765",71.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319051,21231905,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Cardiopulmonary failure,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000765,ALIGNSCIENCE PHARMA,"Kellerer M., Kaltoft M.S., Lawson J., Nielsen L.L., Strojek K., Tabak O. et.al. Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to Metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial. Diabetes Obes Metab 2022; 24(9):1788-99. doi:10.1111/dom.14765",71.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319351,21231935,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Cardiac arrest,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000767,ALIGNSCIENCE PHARMA,,51.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319351,21231935,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000767,ALIGNSCIENCE PHARMA,,51.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319361,21231936,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Oesophageal carcinoma,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000773,ALIGNSCIENCE PHARMA,,61.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319361,21231936,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Oesophageal stenosis,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000773,ALIGNSCIENCE PHARMA,,61.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319361,21231936,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000773,ALIGNSCIENCE PHARMA,,61.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319361,21231936,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Oesophageal squamous cell carcinoma,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000773,ALIGNSCIENCE PHARMA,,61.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319371,21231937,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000776,ALIGNSCIENCE PHARMA,,66.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319371,21231937,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,COVID-19 pneumonia,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000776,ALIGNSCIENCE PHARMA,,66.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319371,21231937,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Cardiopulmonary failure,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000776,ALIGNSCIENCE PHARMA,,66.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319371,21231937,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Acute respiratory failure,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000776,ALIGNSCIENCE PHARMA,,66.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319371,21231937,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg OW (Once a week),,,D,,,,,0.5,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000776,ALIGNSCIENCE PHARMA,,66.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319371,21231937,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg OW (Once a week),,,D,,,,,0.5,MG,Injection,,2022,Q3,COVID-19 pneumonia,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000776,ALIGNSCIENCE PHARMA,,66.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319371,21231937,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg OW (Once a week),,,D,,,,,0.5,MG,Injection,,2022,Q3,Cardiopulmonary failure,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000776,ALIGNSCIENCE PHARMA,,66.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319371,21231937,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg OW (Once a week),,,D,,,,,0.5,MG,Injection,,2022,Q3,Acute respiratory failure,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000776,ALIGNSCIENCE PHARMA,,66.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319381,21231938,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Lung adenocarcinoma,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000772,ALIGNSCIENCE PHARMA,,78.0,YR,E,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319381,21231938,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000772,ALIGNSCIENCE PHARMA,,78.0,YR,E,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319391,21231939,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Haemorrhagic stroke,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000771,ALIGNSCIENCE PHARMA,,66.0,YR,E,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319391,21231939,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Sepsis,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000771,ALIGNSCIENCE PHARMA,,66.0,YR,E,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319391,21231939,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000771,ALIGNSCIENCE PHARMA,,66.0,YR,E,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319391,21231939,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Multiple organ dysfunction syndrome,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000771,ALIGNSCIENCE PHARMA,,66.0,YR,E,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319401,21231940,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000768,ALIGNSCIENCE PHARMA,,64.0,YR,A,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319401,21231940,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Death,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000768,ALIGNSCIENCE PHARMA,,64.0,YR,A,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319411,21231941,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg q.w.,,,D,,,,,1.0,MG,Injection,,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000775,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319411,21231941,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg q.w.,,,D,,,,,1.0,MG,Injection,,2022,Q3,Brain oedema,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000775,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319411,21231941,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg q.w.,,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000775,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319411,21231941,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg q.w.,,,D,,,,,1.0,MG,Injection,,2022,Q3,Electric shock,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000775,ALIGNSCIENCE PHARMA,,57.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319421,21231942,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Pulmonary embolism,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000770,ALIGNSCIENCE PHARMA,,62.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319421,21231942,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000770,ALIGNSCIENCE PHARMA,,62.0,YR,A,M,Y,,,20220818,,MD,DE,DE,2022,Q3,Adult
212319441,21231944,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,U,,,,,1.0,MG,Injection,,2022,Q3,Cardiogenic shock,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000766,ALIGNSCIENCE PHARMA,,75.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319441,21231944,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,U,,,,,1.0,MG,Injection,,2022,Q3,Cardio-respiratory arrest,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000766,ALIGNSCIENCE PHARMA,,75.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319441,21231944,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,U,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000766,ALIGNSCIENCE PHARMA,,75.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319441,21231944,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg OW (Once a week),,,U,,,,,1.0,MG,Injection,,2022,Q3,Acute myocardial infarction,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000766,ALIGNSCIENCE PHARMA,,75.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319451,21231945,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg Q.W.,,,D,,,,,1.0,MG,Injection,,2022,Q3,Metastases to gastrointestinal tract,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000774,ALIGNSCIENCE PHARMA,,78.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319451,21231945,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg Q.W.,,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000774,ALIGNSCIENCE PHARMA,,78.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319461,21231946,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000769,ALIGNSCIENCE PHARMA,,73.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212319461,21231946,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1.0 mg (Once a week),,,D,,,,,1.0,MG,Injection,,2022,Q3,Death,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,DE-ALS-000769,ALIGNSCIENCE PHARMA,,73.0,YR,E,F,Y,,,20220818,,MD,DE,DE,2022,Q3,Elderly
212346081,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,1,I,,20220809.0,20220820,20220820,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20220820,,CN,CA,CA,2022,Q3,Adult
212346081,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Wheezing,,2022,Q3,1,I,,20220809.0,20220820,20220820,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20220820,,CN,CA,CA,2022,Q3,Adult
212346081,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,1,I,,20220809.0,20220820,20220820,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20220820,,CN,CA,CA,2022,Q3,Adult
212346081,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypoacusis,,2022,Q3,1,I,,20220809.0,20220820,20220820,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20220820,,CN,CA,CA,2022,Q3,Adult
212346081,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,1,I,,20220809.0,20220820,20220820,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20220820,,CN,CA,CA,2022,Q3,Adult
212346081,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Asthma,,2022,Q3,1,I,,20220809.0,20220820,20220820,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20220820,,CN,CA,CA,2022,Q3,Adult
212346081,21234608,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220809.0,20220820,20220820,EXP,,CA-AUROBINDO-AUR-APL-2022-032499,AUROBINDO,,51.0,YR,,F,Y,,,20220820,,CN,CA,CA,2022,Q3,Adult
212410891,21241089,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Therapy duration : 27.0 Days,,,U,,,,,2.4,MG,,/WK,2022,Q3,Sinus bradycardia,,2022,Q3,1,I,,20220813.0,20220823,20220823,EXP,,CA-TEVA-2022-CA-2065825,TEVA,,78.0,YR,E,F,Y,65.0,KG,20220823,,HP,CA,CA,2022,Q3,Elderly
212410891,21241089,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Therapy duration : 27.0 Days,,,U,,,,,2.4,MG,,/WK,2022,Q3,Chest pain,,2022,Q3,1,I,,20220813.0,20220823,20220823,EXP,,CA-TEVA-2022-CA-2065825,TEVA,,78.0,YR,E,F,Y,65.0,KG,20220823,,HP,CA,CA,2022,Q3,Elderly
212445691,21244569,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,,20220814.0,20220823,20220823,EXP,,CA-TEVA-2022-CA-2066136,TEVA,,67.0,YR,E,M,Y,122.0,KG,20220823,,HP,CA,CA,2022,Q3,Elderly
212445691,21244569,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220814.0,20220823,20220823,EXP,,CA-TEVA-2022-CA-2066136,TEVA,,67.0,YR,E,M,Y,122.0,KG,20220823,,HP,CA,CA,2022,Q3,Elderly
212445691,21244569,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Angina unstable,,2022,Q3,1,I,,20220814.0,20220823,20220823,EXP,,CA-TEVA-2022-CA-2066136,TEVA,,67.0,YR,E,M,Y,122.0,KG,20220823,,HP,CA,CA,2022,Q3,Elderly
212445691,21244569,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Acute myocardial infarction,,2022,Q3,1,I,,20220814.0,20220823,20220823,EXP,,CA-TEVA-2022-CA-2066136,TEVA,,67.0,YR,E,M,Y,122.0,KG,20220823,,HP,CA,CA,2022,Q3,Elderly
212445691,21244569,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Vomiting,,2022,Q3,1,I,,20220814.0,20220823,20220823,EXP,,CA-TEVA-2022-CA-2066136,TEVA,,67.0,YR,E,M,Y,122.0,KG,20220823,,HP,CA,CA,2022,Q3,Elderly
212445691,21244569,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Asthenia,,2022,Q3,1,I,,20220814.0,20220823,20220823,EXP,,CA-TEVA-2022-CA-2066136,TEVA,,67.0,YR,E,M,Y,122.0,KG,20220823,,HP,CA,CA,2022,Q3,Elderly
212462581,21246258,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,260.0 Days,,,,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,,20220814.0,20220824,20220824,EXP,,CA-TEVA-2022-CA-2066135,TEVA,,68.0,YR,E,M,Y,87.0,KG,20220824,,HP,CA,CA,2022,Q3,Elderly
212462581,21246258,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,260.0 Days,,,,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,,20220814.0,20220824,20220824,EXP,,CA-TEVA-2022-CA-2066135,TEVA,,68.0,YR,E,M,Y,87.0,KG,20220824,,HP,CA,CA,2022,Q3,Elderly
212462581,21246258,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,,20220814.0,20220824,20220824,EXP,,CA-TEVA-2022-CA-2066135,TEVA,,68.0,YR,E,M,Y,87.0,KG,20220824,,HP,CA,CA,2022,Q3,Elderly
212462581,21246258,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,,20220814.0,20220824,20220824,EXP,,CA-TEVA-2022-CA-2066135,TEVA,,68.0,YR,E,M,Y,87.0,KG,20220824,,HP,CA,CA,2022,Q3,Elderly
212462781,21246278,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Urinary tract infection bacterial,,2022,Q3,1,I,,20220816.0,20220824,20220824,EXP,,CA-TEVA-2022-CA-2067110,TEVA,,76.0,YR,E,F,Y,95.0,KG,20220824,,HP,CA,CA,2022,Q3,Elderly
212462781,21246278,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Febrile neutropenia,,2022,Q3,1,I,,20220816.0,20220824,20220824,EXP,,CA-TEVA-2022-CA-2067110,TEVA,,76.0,YR,E,F,Y,95.0,KG,20220824,,HP,CA,CA,2022,Q3,Elderly
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Tenderness,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Psoriatic arthropathy,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Cholelithiasis,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Musculoskeletal stiffness,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Back pain,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Joint swelling,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Psoriasis,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Insomnia,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Arthralgia,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Musculoskeletal pain,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212483731,21248373,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK UNK, QW",,,U,,,,,,,,/WK,2022,Q3,Exposure to SARS-CoV-2,,2022,Q3,1,I,20211111.0,20220817.0,20220824,20220824,EXP,,NVSC2022CA002071,NOVARTIS,,47.0,YR,,M,Y,,,20220824,,MD,CA,CA,2022,Q3,Adult
212492942,21249294,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, qw",,,,,,,,,,,/WK,2022,Q3,Skin exfoliation,,2022,Q3,2,F,20210928.0,20220908.0,20220824,20220920,EXP,,CH-BEH-2022148958,CSL BEHRING,,68.0,YR,E,M,Y,79.0,KG,20220920,,MD,CH,CH,2022,Q3,Elderly
212492942,21249294,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, qw",,,,,,,,,,,/WK,2022,Q3,Pain,,2022,Q3,2,F,20210928.0,20220908.0,20220824,20220920,EXP,,CH-BEH-2022148958,CSL BEHRING,,68.0,YR,E,M,Y,79.0,KG,20220920,,MD,CH,CH,2022,Q3,Elderly
212492942,21249294,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, qw",,,,,,,,,,,/WK,2022,Q3,Dermatitis allergic,,2022,Q3,2,F,20210928.0,20220908.0,20220824,20220920,EXP,,CH-BEH-2022148958,CSL BEHRING,,68.0,YR,E,M,Y,79.0,KG,20220920,,MD,CH,CH,2022,Q3,Elderly
212534621,21253462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,"LITUS, OBESITY",,,0.5,MG,,QW,2022,Q3,Hypertransaminasaemia,,2022,Q3,1,I,20220728.0,,20220824,20220824,DIR,FDA-CDER-CTU-2022-67703,,FDA-CTU,,74.0,YR,,M,N,,,20220819,N,PH,US,,2022,Q3,Elderly
212534621,21253462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,"LITUS, OBESITY",,,0.5,MG,,QW,2022,Q3,Bile duct stone,,2022,Q3,1,I,20220728.0,,20220824,20220824,DIR,FDA-CDER-CTU-2022-67703,,FDA-CTU,,74.0,YR,,M,N,,,20220819,N,PH,US,,2022,Q3,Elderly
212534621,21253462,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,"LITUS, OBESITY",,,0.5,MG,,QW,2022,Q3,Rash pruritic,,2022,Q3,1,I,20220728.0,,20220824,20220824,DIR,FDA-CDER-CTU-2022-67703,,FDA-CTU,,74.0,YR,,M,N,,,20220819,N,PH,US,,2022,Q3,Elderly
212535201,21253520,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,0.5,MG,,QW,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220708.0,,20220824,20220824,DIR,FDA-CDER-CTU-2022-67681,,FDA-CTU,,80.0,YR,,M,N,98.0,KG,20220822,N,PH,US,,2022,Q3,Elderly
212535201,21253520,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,0.5,MG,,QW,2022,Q3,Dehydration,,2022,Q3,1,I,20220708.0,,20220824,20220824,DIR,FDA-CDER-CTU-2022-67681,,FDA-CTU,,80.0,YR,,M,N,98.0,KG,20220822,N,PH,US,,2022,Q3,Elderly
212535201,21253520,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,Y,D,,,,0.5,MG,,QW,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220708.0,,20220824,20220824,DIR,FDA-CDER-CTU-2022-67681,,FDA-CTU,,80.0,YR,,M,N,98.0,KG,20220822,N,PH,US,,2022,Q3,Elderly
212540121,21254012,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q3,Anaemia,,2022,Q3,1,I,20211213.0,20220817.0,20220825,20220825,EXP,,CA-SA-2022SA348977,SANOFI AVENTIS,,69.0,YR,E,M,Y,75.0,KG,20220825,,HP,CA,CA,2022,Q3,Elderly
212540121,21254012,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,20211213.0,20220817.0,20220825,20220825,EXP,,CA-SA-2022SA348977,SANOFI AVENTIS,,69.0,YR,E,M,Y,75.0,KG,20220825,,HP,CA,CA,2022,Q3,Elderly
212540121,21254012,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q3,Orthostatic hypotension,,2022,Q3,1,I,20211213.0,20220817.0,20220825,20220825,EXP,,CA-SA-2022SA348977,SANOFI AVENTIS,,69.0,YR,E,M,Y,75.0,KG,20220825,,HP,CA,CA,2022,Q3,Elderly
212540121,21254012,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q3,Confusional state,,2022,Q3,1,I,20211213.0,20220817.0,20220825,20220825,EXP,,CA-SA-2022SA348977,SANOFI AVENTIS,,69.0,YR,E,M,Y,75.0,KG,20220825,,HP,CA,CA,2022,Q3,Elderly
212540121,21254012,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,20211213.0,20220817.0,20220825,20220825,EXP,,CA-SA-2022SA348977,SANOFI AVENTIS,,69.0,YR,E,M,Y,75.0,KG,20220825,,HP,CA,CA,2022,Q3,Elderly
212540121,21254012,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q3,Haematoma,,2022,Q3,1,I,20211213.0,20220817.0,20220825,20220825,EXP,,CA-SA-2022SA348977,SANOFI AVENTIS,,69.0,YR,E,M,Y,75.0,KG,20220825,,HP,CA,CA,2022,Q3,Elderly
212593031,21259303,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,,20220824.0,20220826,20220826,EXP,,CA-PFIZER INC-202201093404,PFIZER,,68.0,YR,,M,Y,87.0,KG,20220826,,HP,CA,CA,2022,Q3,Elderly
212593031,21259303,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,,20220824.0,20220826,20220826,EXP,,CA-PFIZER INC-202201093404,PFIZER,,68.0,YR,,M,Y,87.0,KG,20220826,,HP,CA,CA,2022,Q3,Elderly
212593031,21259303,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK, 1x/day",,,U,,,,,,,,QD,2022,Q3,Fall,,2022,Q3,1,I,,20220824.0,20220826,20220826,EXP,,CA-PFIZER INC-202201093404,PFIZER,,68.0,YR,,M,Y,87.0,KG,20220826,,HP,CA,CA,2022,Q3,Elderly
212593031,21259303,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"UNK, 1x/day",,,U,,,,,,,,QD,2022,Q3,Hypotension,,2022,Q3,1,I,,20220824.0,20220826,20220826,EXP,,CA-PFIZER INC-202201093404,PFIZER,,68.0,YR,,M,Y,87.0,KG,20220826,,HP,CA,CA,2022,Q3,Elderly
212610571,21261057,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,,20220824.0,20220826,20220826,EXP,,CA-PFIZER INC-202201093549,PFIZER,,68.0,YR,,M,Y,87.0,KG,20220826,,HP,CA,CA,2022,Q3,Elderly
212610571,21261057,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,,20220824.0,20220826,20220826,EXP,,CA-PFIZER INC-202201093549,PFIZER,,68.0,YR,,M,Y,87.0,KG,20220826,,HP,CA,CA,2022,Q3,Elderly
212610571,21261057,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,,20220824.0,20220826,20220826,EXP,,CA-PFIZER INC-202201093549,PFIZER,,68.0,YR,,M,Y,87.0,KG,20220826,,HP,CA,CA,2022,Q3,Elderly
212610571,21261057,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,,20220824.0,20220826,20220826,EXP,,CA-PFIZER INC-202201093549,PFIZER,,68.0,YR,,M,Y,87.0,KG,20220826,,HP,CA,CA,2022,Q3,Elderly
212640502,21264050,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",,,,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q3,Cholelithiasis,,2022,Q3,2,F,20220725.0,20220825.0,20220829,20220905,EXP,,NO-NOVOPROD-949768,NOVO NORDISK,,61.0,YR,,M,Y,114.0,KG,20220905,,MD,NO,NO,2022,Q3,Adult
212640502,21264050,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",,,,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q3,Cholangitis,,2022,Q3,2,F,20220725.0,20220825.0,20220829,20220905,EXP,,NO-NOVOPROD-949768,NOVO NORDISK,,61.0,YR,,M,Y,114.0,KG,20220905,,MD,NO,NO,2022,Q3,Adult
212659001,21265900,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,,20220824.0,20220829,20220829,EXP,,CA-PFIZER INC-202201093560,PFIZER,,67.0,YR,,M,Y,122.0,KG,20220829,,HP,CA,CA,2022,Q3,Elderly
212659001,21265900,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2022,Q3,Angina unstable,,2022,Q3,1,I,,20220824.0,20220829,20220829,EXP,,CA-PFIZER INC-202201093560,PFIZER,,67.0,YR,,M,Y,122.0,KG,20220829,,HP,CA,CA,2022,Q3,Elderly
212659001,21265900,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2022,Q3,Acute myocardial infarction,,2022,Q3,1,I,,20220824.0,20220829,20220829,EXP,,CA-PFIZER INC-202201093560,PFIZER,,67.0,YR,,M,Y,122.0,KG,20220829,,HP,CA,CA,2022,Q3,Elderly
212659001,21265900,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2022,Q3,Vomiting,,2022,Q3,1,I,,20220824.0,20220829,20220829,EXP,,CA-PFIZER INC-202201093560,PFIZER,,67.0,YR,,M,Y,122.0,KG,20220829,,HP,CA,CA,2022,Q3,Elderly
212659001,21265900,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220824.0,20220829,20220829,EXP,,CA-PFIZER INC-202201093560,PFIZER,,67.0,YR,,M,Y,122.0,KG,20220829,,HP,CA,CA,2022,Q3,Elderly
212659001,21265900,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,U,,,,,,,,,2022,Q3,Asthenia,,2022,Q3,1,I,,20220824.0,20220829,20220829,EXP,,CA-PFIZER INC-202201093560,PFIZER,,67.0,YR,,M,Y,122.0,KG,20220829,,HP,CA,CA,2022,Q3,Elderly
212680723,21268072,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg,,,,,,,,1.0,MG,Injection,,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,20220218.0,20220906.0,20220829,20220914,EXP,,NVSJ2022JP089015,NOVARTIS,,63.0,YR,,F,Y,54.0,KG,20220915,,MD,JP,JP,2022,Q3,Adult
212685351,21268535,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Syncope,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067396,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,HP,CA,CA,2022,Q3,Elderly
212685351,21268535,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Presyncope,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067396,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,HP,CA,CA,2022,Q3,Elderly
212685351,21268535,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Angioedema,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067396,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,HP,CA,CA,2022,Q3,Elderly
212685351,21268535,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Drug hypersensitivity,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067396,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,HP,CA,CA,2022,Q3,Elderly
212685351,21268535,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067396,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,HP,CA,CA,2022,Q3,Elderly
212685351,21268535,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Paraesthesia,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067396,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,HP,CA,CA,2022,Q3,Elderly
212685351,21268535,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Urticaria,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067396,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,HP,CA,CA,2022,Q3,Elderly
212685351,21268535,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Pruritus,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067396,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,HP,CA,CA,2022,Q3,Elderly
212685481,21268548,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Angioedema,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067401,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,MD,CA,CA,2022,Q3,Elderly
212685481,21268548,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Paraesthesia,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067401,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,MD,CA,CA,2022,Q3,Elderly
212685481,21268548,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Syncope,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067401,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,MD,CA,CA,2022,Q3,Elderly
212685481,21268548,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067401,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,MD,CA,CA,2022,Q3,Elderly
212685481,21268548,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Hypersensitivity,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067401,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,MD,CA,CA,2022,Q3,Elderly
212685481,21268548,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Presyncope,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067401,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,MD,CA,CA,2022,Q3,Elderly
212685481,21268548,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Urticaria,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067401,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,MD,CA,CA,2022,Q3,Elderly
212685481,21268548,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Pruritus,,2022,Q3,1,I,,20220820.0,20220830,20220830,EXP,,CA-TEVA-2022-CA-2067401,TEVA,,72.0,YR,E,M,Y,112.0,KG,20220830,,MD,CA,CA,2022,Q3,Elderly
212987321,21298732,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,Y,D,,,,0.5,MG,,QW,2022,Q3,Chest injury,,2022,Q3,1,I,20220513.0,,20220905,20220905,DIR,FDA-CDER-CTU-2022-70971,,FDA-CTU,,80.0,YR,,M,N,39.92,KG,20220609,N,HP,US,,2022,Q3,Elderly
212987321,21298732,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,Y,D,,,,0.5,MG,,QW,2022,Q3,Pancreatitis acute,,2022,Q3,1,I,20220513.0,,20220905,20220905,DIR,FDA-CDER-CTU-2022-70971,,FDA-CTU,,80.0,YR,,M,N,39.92,KG,20220609,N,HP,US,,2022,Q3,Elderly
212987321,21298732,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,Y,D,,,,0.5,MG,,QW,2022,Q3,Fall,,2022,Q3,1,I,20220513.0,,20220905,20220905,DIR,FDA-CDER-CTU-2022-70971,,FDA-CTU,,80.0,YR,,M,N,39.92,KG,20220609,N,HP,US,,2022,Q3,Elderly
213007712,21300771,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,419.319,MG,,,,,215256.0,,,Solution for injection,,2022,Q3,Bile duct stone,,2022,Q3,2,F,20220726.0,20220906.0,20220907,20220919,EXP,,US-NOVOPROD-953437,NOVO NORDISK,,75.0,YR,,M,Y,118.0,KG,20220919,,MD,US,US,2022,Q3,Elderly
213007712,21300771,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",419.319,MG,,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q3,Bile duct stone,,2022,Q3,2,F,20220726.0,20220906.0,20220907,20220919,EXP,,US-NOVOPROD-953437,NOVO NORDISK,,75.0,YR,,M,Y,118.0,KG,20220919,,MD,US,US,2022,Q3,Elderly
213007712,21300771,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,419.319,MG,,,,,215256.0,,,Solution for injection,,2022,Q3,Bile duct stone,,2022,Q3,2,F,20220726.0,20220906.0,20220907,20220919,EXP,,US-NOVOPROD-953437,NOVO NORDISK,,75.0,YR,,M,Y,118.0,KG,20220919,,MD,US,US,2022,Q3,Elderly
213007712,21300771,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,419.319,MG,,,,,215256.0,,,Solution for injection,,2022,Q3,Bile duct stone,,2022,Q3,2,F,20220726.0,20220906.0,20220907,20220919,EXP,,US-NOVOPROD-953437,NOVO NORDISK,,75.0,YR,,M,Y,118.0,KG,20220919,,MD,US,US,2022,Q3,Elderly
213029431,21302943,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q3,Urinary tract infection bacterial,,2022,Q3,1,I,,20220831.0,20220907,20220907,EXP,,CA-JNJFOC-20220904987,JOHNSON AND JOHNSON,,68.0,YR,E,F,Y,,,20220907,,HP,CA,CA,2022,Q3,Elderly
213029431,21302943,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q3,Intentional product use issue,,2022,Q3,1,I,,20220831.0,20220907,20220907,EXP,,CA-JNJFOC-20220904987,JOHNSON AND JOHNSON,,68.0,YR,E,F,Y,,,20220907,,HP,CA,CA,2022,Q3,Elderly
213029431,21302943,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q3,Off label use,,2022,Q3,1,I,,20220831.0,20220907,20220907,EXP,,CA-JNJFOC-20220904987,JOHNSON AND JOHNSON,,68.0,YR,E,F,Y,,,20220907,,HP,CA,CA,2022,Q3,Elderly
213029431,21302943,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q3,Erythema,,2022,Q3,1,I,,20220831.0,20220907,20220907,EXP,,CA-JNJFOC-20220904987,JOHNSON AND JOHNSON,,68.0,YR,E,F,Y,,,20220907,,HP,CA,CA,2022,Q3,Elderly
213029431,21302943,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,,2022,Q3,Pruritus,,2022,Q3,1,I,,20220831.0,20220907,20220907,EXP,,CA-JNJFOC-20220904987,JOHNSON AND JOHNSON,,68.0,YR,E,F,Y,,,20220907,,HP,CA,CA,2022,Q3,Elderly
213030491,21303049,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2022,Q3,Blood cholesterol increased,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2022,Q3,Blood glucose abnormal,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2022,Q3,Transient ischaemic attack,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.25,MG,SOLUTION SUBCUTANEOUS,,2022,Q3,Hypertension,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2022,Q3,Blood cholesterol increased,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2022,Q3,Blood glucose abnormal,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2022,Q3,Transient ischaemic attack,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,0.5,MG,,,2022,Q3,Hypertension,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2022,Q3,Blood cholesterol increased,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2022,Q3,Blood glucose abnormal,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2022,Q3,Transient ischaemic attack,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213030491,21303049,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,"UNKNOWN,UNKNOWN,UNKNOWN",,,1.0,MG,,,2022,Q3,Hypertension,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-ROCHE-3173358,ROCHE,,47.0,YR,,F,Y,,,20220907,,HP,CA,,2022,Q3,Adult
213079471,21307947,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.7,MG,,,2022,Q3,Nausea,,2022,Q3,1,I,20220812.0,,20220907,20220907,DIR,630431,,FDA-CTU,,33.0,YR,,F,N,,,20220907,N,,US,,2022,Q3,Young Adult
213079471,21307947,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.7,MG,,,2022,Q3,Headache,,2022,Q3,1,I,20220812.0,,20220907,20220907,DIR,630431,,FDA-CTU,,33.0,YR,,F,N,,,20220907,N,,US,,2022,Q3,Young Adult
213079471,21307947,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.7,MG,,,2022,Q3,Tachycardia,,2022,Q3,1,I,20220812.0,,20220907,20220907,DIR,630431,,FDA-CTU,,33.0,YR,,F,N,,,20220907,N,,US,,2022,Q3,Young Adult
213079471,21307947,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.7,MG,,,2022,Q3,Vomiting,,2022,Q3,1,I,20220812.0,,20220907,20220907,DIR,630431,,FDA-CTU,,33.0,YR,,F,N,,,20220907,N,,US,,2022,Q3,Young Adult
213079471,21307947,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.7,MG,,,2022,Q3,Dizziness,,2022,Q3,1,I,20220812.0,,20220907,20220907,DIR,630431,,FDA-CTU,,33.0,YR,,F,N,,,20220907,N,,US,,2022,Q3,Young Adult
213079471,21307947,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,Y,,,,,1.7,MG,,,2022,Q3,Abdominal tenderness,,2022,Q3,1,I,20220812.0,,20220907,20220907,DIR,630431,,FDA-CTU,,33.0,YR,,F,N,,,20220907,N,,US,,2022,Q3,Young Adult
213286661,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Asthma,,2022,Q3,1,I,,20220905.0,20220913,20220913,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20220913,,MD,CA,,2022,Q3,Adult
213286661,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220905.0,20220913,20220913,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20220913,,MD,CA,,2022,Q3,Adult
213286661,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,1,I,,20220905.0,20220913,20220913,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20220913,,MD,CA,,2022,Q3,Adult
213286661,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Hypoacusis,,2022,Q3,1,I,,20220905.0,20220913,20220913,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20220913,,MD,CA,,2022,Q3,Adult
213286661,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,1,I,,20220905.0,20220913,20220913,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20220913,,MD,CA,,2022,Q3,Adult
213286661,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Wheezing,,2022,Q3,1,I,,20220905.0,20220913,20220913,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20220913,,MD,CA,,2022,Q3,Adult
213286661,21328666,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,1,I,,20220905.0,20220913,20220913,EXP,,CA-AstraZeneca-2022A308823,ASTRAZENECA,,51.0,YR,,F,Y,,,20220913,,MD,CA,,2022,Q3,Adult
213329861,21332986,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,57.0,KG,20220914,,HP,CA,CA,2022,Q3,Adult
213329861,21332986,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,solution subcutaneous,,,,,,,,,,,,2022,Q3,Weight increased,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-22600,SAMSUNG BIOEPIS,,64.0,YR,A,F,Y,57.0,KG,20220914,,HP,CA,CA,2022,Q3,Adult
213358221,21335822,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4,mg,Once per week",86.4,MG,Y,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q3,Cholecystitis,,2022,Q3,1,I,20220606.0,20220905.0,20220915,20220915,EXP,,GB-NOVOPROD-927307,NOVO NORDISK,,80.0,YR,,M,Y,97.0,KG,20220915,,MD,GB,GB,2022,Q3,Elderly
213358221,21335822,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4,mg,Once per week",86.4,MG,Y,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q3,Bile duct stone,,2022,Q3,1,I,20220606.0,20220905.0,20220915,20220915,EXP,,GB-NOVOPROD-927307,NOVO NORDISK,,80.0,YR,,M,Y,97.0,KG,20220915,,MD,GB,GB,2022,Q3,Elderly
213379151,21337915,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Weekly;?,,,Y,D,,,,1.0,MG,,999,2022,Q3,Lipase increased,,2022,Q3,1,I,20220908.0,,20220915,20220915,DIR,631437,,FDA-CTU,,47.0,YR,,M,N,98.73,KG,20220915,N,,US,,2022,Q3,Adult
213382311,21338231,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,20220902.0,20220907.0,20220915,20220915,EXP,,US-MYOVANT SCIENCES GMBH-2022MYSCI0900129,MYOVANT SCIENCES,,65.0,YR,,M,Y,,,20220915,,CN,US,US,2022,Q3,Elderly
213527741,21352774,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107217,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Adult
213527741,21352774,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Asthenia,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107217,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Adult
213527741,21352774,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Tachycardia,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107217,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Adult
213527741,21352774,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Pruritus,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107217,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Adult
213527741,21352774,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107217,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Adult
213527741,21352774,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Clostridium difficile colitis,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107217,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Adult
213527741,21352774,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Malaise,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107217,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Adult
213527741,21352774,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,COVID-19,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107217,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Adult
213540101,21354010,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 mg / once a week,,,,,,,,1.0,MG,,,2022,Q3,Oral pain,,2022,Q3,1,I,20220725.0,20220912.0,20220920,20220920,EXP,IT-MINISAL02-880012,IT-Accord-277969,ACCORD,,66.0,YR,E,M,Y,64.0,KG,20220920,,PH,IT,IT,2022,Q3,Elderly
213540101,21354010,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 mg / once a week,,,,,,,,1.0,MG,,,2022,Q3,Decreased appetite,,2022,Q3,1,I,20220725.0,20220912.0,20220920,20220920,EXP,IT-MINISAL02-880012,IT-Accord-277969,ACCORD,,66.0,YR,E,M,Y,64.0,KG,20220920,,PH,IT,IT,2022,Q3,Elderly
213540101,21354010,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 mg / once a week,,,,,,,,1.0,MG,,,2022,Q3,Asthenia,,2022,Q3,1,I,20220725.0,20220912.0,20220920,20220920,EXP,IT-MINISAL02-880012,IT-Accord-277969,ACCORD,,66.0,YR,E,M,Y,64.0,KG,20220920,,PH,IT,IT,2022,Q3,Elderly
213621371,21362137,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Pulmonary embolism,,2022,Q3,1,I,20220912.0,20220914.0,20220922,20220922,EXP,,NVSC2022ES212570,NOVARTIS,,66.0,YR,,M,Y,89.0,KG,20220922,,MD,ES,ES,2022,Q3,Elderly
213653421,21365342,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.14,MG,Unknown,,2022,Q3,Death,,2022,Q3,1,I,20220918.0,20220921.0,20220922,20220922,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-109812,BRISTOL MYERS SQUIBB,,73.0,YR,E,F,Y,100.0,KG,20220922,,HP,CA,CA,2022,Q3,Elderly
213678331,21367833,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q3,Cholestatic liver injury,,2022,Q3,1,I,20220825.0,20220916.0,20220923,20220923,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-101586,BRISTOL MYERS SQUIBB,,70.0,YR,E,F,Y,,,20220923,,HP,US,US,2022,Q3,Elderly
213678331,21367833,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q3,Febrile neutropenia,,2022,Q3,1,I,20220825.0,20220916.0,20220923,20220923,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-101586,BRISTOL MYERS SQUIBB,,70.0,YR,E,F,Y,,,20220923,,HP,US,US,2022,Q3,Elderly
213678331,21367833,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20220825.0,20220916.0,20220923,20220923,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-101586,BRISTOL MYERS SQUIBB,,70.0,YR,E,F,Y,,,20220923,,HP,US,US,2022,Q3,Elderly
213756061,21375606,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Malaise,,2022,Q3,1,I,,20220920.0,20220926,20220926,EXP,,AU-JNJFOC-20220942914,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20220926,,PH,AU,AU,2022,Q3,Elderly
213756061,21375606,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q3,Off label use,,2022,Q3,1,I,,20220920.0,20220926,20220926,EXP,,AU-JNJFOC-20220942914,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20220926,,PH,AU,AU,2022,Q3,Elderly
213756281,21375628,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly (1/W)",,,U,,,,,0.25,MG,,/WK,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly (1/W)",,,U,,,,,0.25,MG,,/WK,2022,Q3,Large intestine perforation,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly (1/W)",,,U,,,,,0.25,MG,,/WK,2022,Q3,Pancreatitis,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly (1/W)",,,U,,,,,0.25,MG,,/WK,2022,Q3,Multiple organ dysfunction syndrome,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly (1/W)",,,U,,,,,0.25,MG,,/WK,2022,Q3,Systemic inflammatory response syndrome,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly (1/W)",,,U,,,,,0.25,MG,,/WK,2022,Q3,Hypotension,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly (1/W)",,,U,,,,,0.25,MG,,/WK,2022,Q3,Intestinal ischaemia,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.25 mg, weekly (1/W)",,,U,,,,,0.25,MG,,/WK,2022,Q3,Blood lactic acid increased,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly (1/W)",,,U,,,,,0.5,MG,,/WK,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly (1/W)",,,U,,,,,0.5,MG,,/WK,2022,Q3,Large intestine perforation,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly (1/W)",,,U,,,,,0.5,MG,,/WK,2022,Q3,Pancreatitis,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly (1/W)",,,U,,,,,0.5,MG,,/WK,2022,Q3,Multiple organ dysfunction syndrome,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly (1/W)",,,U,,,,,0.5,MG,,/WK,2022,Q3,Systemic inflammatory response syndrome,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly (1/W)",,,U,,,,,0.5,MG,,/WK,2022,Q3,Hypotension,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly (1/W)",,,U,,,,,0.5,MG,,/WK,2022,Q3,Intestinal ischaemia,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756281,21375628,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, weekly (1/W)",,,U,,,,,0.5,MG,,/WK,2022,Q3,Blood lactic acid increased,,2022,Q3,1,I,20210620.0,20220920.0,20220926,20220926,EXP,,AU-ELI_LILLY_AND_COMPANY-AU202209009401,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220926,,CN,AU,AU,2022,Q3,Elderly
213756431,21375643,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075477,TEVA,,51.0,YR,A,F,Y,,,20220926,,HP,CA,CA,2022,Q3,Adult
213756431,21375643,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Hypoacusis,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075477,TEVA,,51.0,YR,A,F,Y,,,20220926,,HP,CA,CA,2022,Q3,Adult
213756431,21375643,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075477,TEVA,,51.0,YR,A,F,Y,,,20220926,,HP,CA,CA,2022,Q3,Adult
213756431,21375643,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075477,TEVA,,51.0,YR,A,F,Y,,,20220926,,HP,CA,CA,2022,Q3,Adult
213756431,21375643,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Wheezing,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075477,TEVA,,51.0,YR,A,F,Y,,,20220926,,HP,CA,CA,2022,Q3,Adult
213756431,21375643,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Asthma,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075477,TEVA,,51.0,YR,A,F,Y,,,20220926,,HP,CA,CA,2022,Q3,Adult
213756431,21375643,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075477,TEVA,,51.0,YR,A,F,Y,,,20220926,,HP,CA,CA,2022,Q3,Adult
213756521,21375652,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,113.0 Days,,,U,,,,,,,,,2022,Q3,Thrombocytopenia,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075476,TEVA,,85.0,YR,E,M,Y,117.0,KG,20220926,,HP,CA,CA,2022,Q3,Elderly
213756521,21375652,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,113.0 Days,,,U,,,,,,,,,2022,Q3,Chronic kidney disease,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075476,TEVA,,85.0,YR,E,M,Y,117.0,KG,20220926,,HP,CA,CA,2022,Q3,Elderly
213756521,21375652,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1.0 Years,,,U,,,,,,,,,2022,Q3,Thrombocytopenia,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075476,TEVA,,85.0,YR,E,M,Y,117.0,KG,20220926,,HP,CA,CA,2022,Q3,Elderly
213756521,21375652,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1.0 Years,,,U,,,,,,,,,2022,Q3,Chronic kidney disease,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,CA-TEVA-2022-CA-2075476,TEVA,,85.0,YR,E,M,Y,117.0,KG,20220926,,HP,CA,CA,2022,Q3,Elderly
213834271,21383427,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,NOT SPECIFIED,,,U,,,,,,,,,2022,Q3,Asthma,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,NOT SPECIFIED,,,U,,,,,,,,,2022,Q3,Hypoacusis,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,NOT SPECIFIED,,,U,,,,,,,,,2022,Q3,Depression,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,NOT SPECIFIED,,,U,,,,,,,,,2022,Q3,Wheezing,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,NOT SPECIFIED,,,U,,,,,,,,,2022,Q3,Sleep disorder,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,NOT SPECIFIED,,,U,,,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,NOT SPECIFIED,,,U,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,NOT SPECIFIED,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,Solution,,2022,Q3,Asthma,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,Solution,,2022,Q3,Hypoacusis,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,Solution,,2022,Q3,Depression,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,Solution,,2022,Q3,Wheezing,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,Solution,,2022,Q3,Sleep disorder,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,Solution,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,Solution,,2022,Q3,Diabetes mellitus,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213834271,21383427,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,SOLUTION SUBCUTANEOUS,,,U,,,,,,,Solution,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220919.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022214,BAUSCH AND LOMB,,51.0,YR,,F,Y,,,20220927,,CN,CA,CA,2022,Q3,Adult
213859251,21385925,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,D,,Unknown,,,,,,/WK,2022,Q3,Nausea,,2022,Q3,1,I,20220906.0,20220927.0,20220928,20220928,EXP,,"SG-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194429",BOEHRINGER INGELHEIM,,42.0,YR,A,F,Y,75.6,KG,20220928,,HP,SG,SG,2022,Q3,Adult
213859251,21385925,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,D,,Unknown,,,,,,/WK,2022,Q3,Vomiting,,2022,Q3,1,I,20220906.0,20220927.0,20220928,20220928,EXP,,"SG-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194429",BOEHRINGER INGELHEIM,,42.0,YR,A,F,Y,75.6,KG,20220928,,HP,SG,SG,2022,Q3,Adult
213859251,21385925,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,D,,Unknown,,,,,,/WK,2022,Q3,Off label use,,2022,Q3,1,I,20220906.0,20220927.0,20220928,20220928,EXP,,"SG-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194429",BOEHRINGER INGELHEIM,,42.0,YR,A,F,Y,75.6,KG,20220928,,HP,SG,SG,2022,Q3,Adult
213859251,21385925,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,D,,Unknown,,,,,,/WK,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20220906.0,20220927.0,20220928,20220928,EXP,,"SG-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194429",BOEHRINGER INGELHEIM,,42.0,YR,A,F,Y,75.6,KG,20220928,,HP,SG,SG,2022,Q3,Adult
213859251,21385925,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220906.0,20220927.0,20220928,20220928,EXP,,"SG-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194429",BOEHRINGER INGELHEIM,,42.0,YR,A,F,Y,75.6,KG,20220928,,HP,SG,SG,2022,Q3,Adult
213859251,21385925,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Vomiting,,2022,Q3,1,I,20220906.0,20220927.0,20220928,20220928,EXP,,"SG-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194429",BOEHRINGER INGELHEIM,,42.0,YR,A,F,Y,75.6,KG,20220928,,HP,SG,SG,2022,Q3,Adult
213859251,21385925,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Off label use,,2022,Q3,1,I,20220906.0,20220927.0,20220928,20220928,EXP,,"SG-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194429",BOEHRINGER INGELHEIM,,42.0,YR,A,F,Y,75.6,KG,20220928,,HP,SG,SG,2022,Q3,Adult
213859251,21385925,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20220906.0,20220927.0,20220928,20220928,EXP,,"SG-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194429",BOEHRINGER INGELHEIM,,42.0,YR,A,F,Y,75.6,KG,20220928,,HP,SG,SG,2022,Q3,Adult
214047281,21404728,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"OTHER STRENGTH : 1MG/0.75ML, 1.5ML;?",,,D,D,,,,,,,,2022,Q3,Product packaging quantity issue,,2022,Q3,1,I,,,20220930,20220930,DIR,FDA-CDER-CTU-2022-78245,,FDA-CTU,,75.0,YR,,M,N,76.0,KG,20220930,N,PH,US,,2022,Q3,Elderly
214047281,21404728,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"OTHER STRENGTH : 1MG/0.75ML, 1.5ML;?",,,D,D,,,,,,,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,,,20220930,20220930,DIR,FDA-CDER-CTU-2022-78245,,FDA-CTU,,75.0,YR,,M,N,76.0,KG,20220930,N,PH,US,,2022,Q3,Elderly
214047341,21404734,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,D,,,,,,,,2022,Q3,Product packaging quantity issue,,2022,Q3,1,I,,,20220930,20220930,DIR,FDA-CDER-CTU-2022-78248,,FDA-CTU,,77.0,YR,,M,N,111.13,KG,20220930,N,PH,US,,2022,Q3,Elderly
214047341,21404734,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,D,,,,,,,,2022,Q3,Manufacturing production issue,,2022,Q3,1,I,,,20220930,20220930,DIR,FDA-CDER-CTU-2022-78248,,FDA-CTU,,77.0,YR,,M,N,111.13,KG,20220930,N,PH,US,,2022,Q3,Elderly
129565822,12956582,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,,,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221128.0,20161118,20221202,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2016-BI-077034",BOEHRINGER INGELHEIM,,40.0,YR,A,F,Y,94.0,KG,20221202,,PH,CA,CA,2022,Q4,Adult
129565822,12956582,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,,,,,2022,Q4,Nausea,,2022,Q4,2,F,,20221128.0,20161118,20221202,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2016-BI-077034",BOEHRINGER INGELHEIM,,40.0,YR,A,F,Y,94.0,KG,20221202,,PH,CA,CA,2022,Q4,Adult
129565822,12956582,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221128.0,20161118,20221202,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2016-BI-077034",BOEHRINGER INGELHEIM,,40.0,YR,A,F,Y,94.0,KG,20221202,,PH,CA,CA,2022,Q4,Adult
129565822,12956582,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,Unknown,,,,,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221128.0,20161118,20221202,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2016-BI-077034",BOEHRINGER INGELHEIM,,40.0,YR,A,F,Y,94.0,KG,20221202,,PH,CA,CA,2022,Q4,Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Laryngitis bacterial,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Blood pressure increased,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Movement disorder,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Intervertebral disc protrusion,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Heart rate decreased,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Muscle spasms,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Nasal congestion,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Abdominal pain,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Infectious mononucleosis,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Cortisol decreased,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Anxiety,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Headache,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Cough,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Illness,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Drug resistance,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,COVID-19,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Ligament sprain,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Blood cholesterol abnormal,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Oropharyngeal pain,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Groin abscess,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Stress,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Facial pain,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Subcutaneous abscess,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Blood growth hormone increased,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Insulin-like growth factor increased,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Sciatic nerve injury,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Drug ineffective,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Sinusitis,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Back pain,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Heart rate increased,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Back injury,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Body temperature decreased,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
1436788037,14367880,33,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 DF, QW",,,U,,,,,,,,/WK,2022,Q4,Blood pressure diastolic decreased,,2022,Q4,37,F,20151225.0,20221011.0,20180109,20221017,EXP,,PHHY2015CA111727,NOVARTIS,,27.0,YR,,F,Y,,,20221017,,CN,CA,CA,2022,Q4,Young Adult
166163476,16616347,62,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, qw",,,,,,,,3.0,ML,,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,6,F,20180704.0,20221223.0,20190723,20221227,EXP,,GB-MYLANLABS-2019M1068313,MYLAN,,57.0,YR,,F,Y,,,20221227,,MD,GB,GB,2022,Q4,Adult
166163476,16616347,62,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, qw",,,,,,,,3.0,ML,,/WK,2022,Q4,Pneumonia,,2022,Q4,6,F,20180704.0,20221223.0,20190723,20221227,EXP,,GB-MYLANLABS-2019M1068313,MYLAN,,57.0,YR,,F,Y,,,20221227,,MD,GB,GB,2022,Q4,Adult
166163476,16616347,62,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, qw",,,,,,,,3.0,ML,,/WK,2022,Q4,Diabetic ketoacidosis,,2022,Q4,6,F,20180704.0,20221223.0,20190723,20221227,EXP,,GB-MYLANLABS-2019M1068313,MYLAN,,57.0,YR,,F,Y,,,20221227,,MD,GB,GB,2022,Q4,Adult
166163476,16616347,62,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"3 milliliter, qw",,,,,,,,3.0,ML,,/WK,2022,Q4,Sepsis,,2022,Q4,6,F,20180704.0,20221223.0,20190723,20221227,EXP,,GB-MYLANLABS-2019M1068313,MYLAN,,57.0,YR,,F,Y,,,20221227,,MD,GB,GB,2022,Q4,Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Haemoptysis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Injury,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Anxiety,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Malaise,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Paranasal sinus discomfort,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Arthropod sting,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Throat irritation,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Dyspnoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Chest discomfort,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Claustrophobia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Blood pressure increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Product dose omission issue,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Bronchitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Anaphylactic shock,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Abdominal pain upper,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Ulcer,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Injection site pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Fatigue,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Muscle spasms,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Myalgia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Asthma,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Nausea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Hypersensitivity,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Psoriasis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pruritus,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Oropharyngeal pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Oedema peripheral,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Chills,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Optic neuritis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Alopecia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Body temperature decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Chest pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Laryngitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lymphadenopathy,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lethargy,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Illness,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Insomnia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lower respiratory tract congestion,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Infection,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Balance disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Mean cell haemoglobin decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Gastrointestinal motility disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pyrexia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Swelling,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Rash,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Dizziness,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Loss of consciousness,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Electrocardiogram T wave abnormal,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Choking,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Weight decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Heart rate increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Diarrhoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Oxygen saturation decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,C-reactive protein increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Type 2 diabetes mellitus,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Drug ineffective,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Injection site discomfort,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Diarrhoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Expired product administered,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Wheezing,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Acne cystic,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Productive cough,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Sinusitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Vision blurred,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pain in extremity,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lung disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Arthropod bite,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Back pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Red cell distribution width increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Food allergy,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Cough,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Autoimmune disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Stress,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Vomiting,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Headache,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Haemorrhage,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Fibromyalgia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Tachycardia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Eye pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Influenza,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Migraine,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Nasal congestion,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Diplopia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Allergy to chemicals,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Platelet count increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,64,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,(0.25mg/0.5mg weekly x 4 weeks),,,,,UNKNOWN,,,,,,/WK,2022,Q4,Respiratory tract congestion,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Haemoptysis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Injury,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Anxiety,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Malaise,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Paranasal sinus discomfort,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Arthropod sting,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Throat irritation,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Dyspnoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Chest discomfort,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Claustrophobia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Blood pressure increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Product dose omission issue,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Bronchitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Anaphylactic shock,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Abdominal pain upper,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Ulcer,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Injection site pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Fatigue,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Muscle spasms,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Myalgia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Asthma,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Nausea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Hypersensitivity,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Psoriasis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pruritus,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Oropharyngeal pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Oedema peripheral,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Chills,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Optic neuritis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Alopecia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Body temperature decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Chest pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Laryngitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lymphadenopathy,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lethargy,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Illness,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Insomnia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lower respiratory tract congestion,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Infection,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Balance disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Mean cell haemoglobin decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Gastrointestinal motility disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pyrexia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Swelling,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Rash,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Dizziness,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Loss of consciousness,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Electrocardiogram T wave abnormal,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Choking,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Weight decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Heart rate increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Diarrhoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Oxygen saturation decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,C-reactive protein increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Type 2 diabetes mellitus,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Drug ineffective,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Injection site discomfort,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Diarrhoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Expired product administered,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Wheezing,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Acne cystic,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Productive cough,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Sinusitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Vision blurred,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pain in extremity,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lung disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Arthropod bite,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Back pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Red cell distribution width increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Food allergy,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Cough,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Autoimmune disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Stress,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Vomiting,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Headache,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Haemorrhage,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Fibromyalgia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Tachycardia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Eye pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Influenza,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Migraine,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Nasal congestion,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Diplopia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Allergy to chemicals,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Platelet count increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,65,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (0.5mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Respiratory tract congestion,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Haemoptysis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Injury,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Anxiety,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Malaise,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Paranasal sinus discomfort,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Arthropod sting,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Throat irritation,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Dyspnoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Chest discomfort,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Claustrophobia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Blood pressure increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Product dose omission issue,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Bronchitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Anaphylactic shock,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Abdominal pain upper,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Ulcer,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Injection site pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Fatigue,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Muscle spasms,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Myalgia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Asthma,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Nausea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Hypersensitivity,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Psoriasis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pruritus,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Oropharyngeal pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Oedema peripheral,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Chills,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Optic neuritis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Alopecia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Body temperature decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Chest pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Laryngitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lymphadenopathy,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lethargy,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Illness,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Insomnia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lower respiratory tract congestion,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Infection,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Balance disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Mean cell haemoglobin decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Gastrointestinal motility disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pyrexia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Swelling,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Rash,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Dizziness,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Loss of consciousness,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Electrocardiogram T wave abnormal,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Choking,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Weight decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Heart rate increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Diarrhoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Oxygen saturation decreased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,C-reactive protein increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Type 2 diabetes mellitus,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Drug ineffective,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Injection site discomfort,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Diarrhoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Expired product administered,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Wheezing,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Acne cystic,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Productive cough,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Sinusitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Vision blurred,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Pain in extremity,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lung disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Arthropod bite,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Back pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Red cell distribution width increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Food allergy,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Cough,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Autoimmune disorder,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Stress,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Vomiting,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Headache,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Haemorrhage,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Fibromyalgia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Tachycardia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Eye pain,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Influenza,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Migraine,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Nasal congestion,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Diplopia,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Allergy to chemicals,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Platelet count increased,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
1670401335,16704013,66,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"1 DF, QW (1mg/0.5mg x 4-6 weeks)",,,,,UNKNOWN,,,,,,/WK,2022,Q4,Respiratory tract congestion,,2022,Q4,35,F,20170215.0,20221017.0,20190814,20221028,EXP,,CA-ROCHE-2374570,ROCHE,,32.0,YR,,F,Y,,,20221029,,CN,CA,CA,2022,Q4,Young Adult
170262559,17026255,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",16.0,MG,Y,U,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q4,Gastrointestinal disorder,,2022,Q4,9,F,20190729.0,20221212.0,20191113,20221221,EXP,,FR-NOVOPROD-694841,NOVO NORDISK,,67.0,YR,,F,Y,90.0,KG,20221221,,MD,FR,FR,2022,Q4,Elderly
170262559,17026255,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",16.0,MG,Y,U,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q4,Acute kidney injury,,2022,Q4,9,F,20190729.0,20221212.0,20191113,20221221,EXP,,FR-NOVOPROD-694841,NOVO NORDISK,,67.0,YR,,F,Y,90.0,KG,20221221,,MD,FR,FR,2022,Q4,Elderly
170262559,17026255,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.24 mg, qw",16.0,MG,Y,U,,,209637.0,,,Solution for injection,,2022,Q4,Gastrointestinal disorder,,2022,Q4,9,F,20190729.0,20221212.0,20191113,20221221,EXP,,FR-NOVOPROD-694841,NOVO NORDISK,,67.0,YR,,F,Y,90.0,KG,20221221,,MD,FR,FR,2022,Q4,Elderly
170262559,17026255,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"0.24 mg, qw",16.0,MG,Y,U,,,209637.0,,,Solution for injection,,2022,Q4,Acute kidney injury,,2022,Q4,9,F,20190729.0,20221212.0,20191113,20221221,EXP,,FR-NOVOPROD-694841,NOVO NORDISK,,67.0,YR,,F,Y,90.0,KG,20221221,,MD,FR,FR,2022,Q4,Elderly
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Constipation,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Migraine,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Cough,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Pyrexia,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Depression,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Rib fracture,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Malaise,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,SARS-CoV-2 antibody test positive,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Restless legs syndrome,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Heart valve incompetence,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Neoplasm malignant,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Hypertonic bladder,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Headache,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Oropharyngeal pain,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Musculoskeletal chest pain,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Fall,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Second primary malignancy,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Hypersensitivity,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Insomnia,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Limb injury,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Pain,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Weight increased,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Vomiting,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Gastrooesophageal reflux disease,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Hepatic cancer,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
1792066919,17920669,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intramuscular,"UNK, QW",,,U,,,,,,,Injection,/WK,2022,Q4,Blood pressure increased,,2022,Q4,19,F,20200201.0,20221213.0,20200621,20221219,EXP,,NVSC2020CA102122,NOVARTIS,,44.0,YR,,F,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Product use issue,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Constipation,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Blood magnesium decreased,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Sleep disorder,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Acute kidney injury,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Off label use,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Malaise,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Diarrhoea,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Chronic kidney disease,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Hypertension,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Urinary tract infection,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Depression,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181464927,18146492,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.25,MG,Solution,/WK,2022,Q4,Hypotension,,2022,Q4,7,F,,20221020.0,20200813,20221025,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-063768,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,131.0,KG,20221025,,CN,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Urinary tract infection,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Malaise,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Hypertension,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Sleep disorder,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Product use issue,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Chronic kidney disease,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Diarrhoea,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Off label use,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Blood magnesium decreased,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Hypotension,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Depression,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Acute kidney injury,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181468778,18146877,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 mg, weekly",,,,,,,,0.25,MG,Solution for injection,/WK,2022,Q4,Constipation,,2022,Q4,8,F,,20221020.0,20200813,20221027,EXP,,CA-PFIZER INC-2020312983,PFIZER,,72.0,YR,,M,Y,131.0,KG,20221027,,HP,CA,CA,2022,Q4,Elderly
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Influenza,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Upper respiratory tract infection,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Flank pain,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Angina pectoris,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Dyspnoea exertional,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Nasopharyngitis,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Rales,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Cough,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Insomnia,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Lower respiratory tract infection,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Productive cough,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Pyrexia,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Chest discomfort,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Injury,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Heart sounds,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Malaise,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Appetite disorder,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Depressive symptom,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Prolonged expiration,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Stress,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Wheezing,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Chest pain,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Depressed mood,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Respiration abnormal,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Nasal congestion,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Dyspnoea,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Weight decreased,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Fall,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Asthma,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,74,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),1.25 mg (once every 1 weeks),,,U,,,,,1.25,MG,Solution for injection,,2022,Q4,Rhinorrhoea,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Influenza,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Upper respiratory tract infection,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Flank pain,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Angina pectoris,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Dyspnoea exertional,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Rales,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Cough,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Insomnia,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Productive cough,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Pyrexia,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Chest discomfort,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Injury,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Heart sounds,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Malaise,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Appetite disorder,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Depressive symptom,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Prolonged expiration,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Stress,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Wheezing,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Chest pain,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Depressed mood,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Respiration abnormal,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Nasal congestion,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Dyspnoea,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Weight decreased,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Fall,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Asthma,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,75,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks)",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Influenza,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Upper respiratory tract infection,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Flank pain,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Angina pectoris,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Dyspnoea exertional,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Rales,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Cough,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Insomnia,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Productive cough,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Pyrexia,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Chest discomfort,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Injury,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Heart sounds,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Malaise,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Appetite disorder,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Depressive symptom,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Prolonged expiration,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Stress,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Wheezing,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Chest pain,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Depressed mood,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Respiration abnormal,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Nasal congestion,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Dyspnoea,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Weight decreased,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Fall,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Asthma,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,76,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (once every 1 weeks), solution subcutaneous",,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Influenza,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Upper respiratory tract infection,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Flank pain,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Angina pectoris,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Dyspnoea exertional,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Rales,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Cough,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Insomnia,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Productive cough,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Pyrexia,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Chest discomfort,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Injury,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Heart sounds,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Malaise,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Appetite disorder,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Depressive symptom,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Prolonged expiration,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Stress,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Wheezing,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Chest pain,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Depressed mood,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Respiration abnormal,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Nasal congestion,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Dyspnoea,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Weight decreased,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Fall,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Asthma,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
181801443,18180144,77,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"125 ml, QW",,,U,,,,,125.0,ML,Solution for injection,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,3,F,,20221122.0,20200821,20221129,EXP,,NVSC2020CA225240,NOVARTIS,,61.0,YR,,F,Y,,,20221129,,CN,CA,CA,2022,Q4,Adult
182591894,18259189,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,9 milligram,,,U,,,,,9.0,MG,,,2022,Q4,Myasthenia gravis,,2022,Q4,4,F,20200826.0,20221103.0,20200911,20221110,EXP,,DK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-070117,BRISTOL MYERS SQUIBB,,79.0,YR,E,M,Y,99.0,KG,20221110,,HP,DK,DK,2022,Q4,Elderly
182591894,18259189,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,9 milligram,,,U,,,,,9.0,MG,,,2022,Q4,Myocarditis,,2022,Q4,4,F,20200826.0,20221103.0,20200911,20221110,EXP,,DK-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-070117,BRISTOL MYERS SQUIBB,,79.0,YR,E,M,Y,99.0,KG,20221110,,HP,DK,DK,2022,Q4,Elderly
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Stress,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Chest pain,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Influenza,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Dyspnoea,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Flank pain,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Asthma,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Wheezing,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Productive cough,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Loss of personal independence in daily activities,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Insomnia,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Rales,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Prolonged expiration,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Fall,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Respiration abnormal,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Pyrexia,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Nasal congestion,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Angina pectoris,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Depressed mood,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Cough,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Injury,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Depressive symptom,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Heart sounds,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Appetite disorder,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Chest discomfort,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Weight decreased,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Upper respiratory tract infection,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Dyspnoea exertional,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,80,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),solution subcutaneous,,,U,,,,,1.25,MG,Solution,/WK,2022,Q4,Malaise,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Stress,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Chest pain,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Influenza,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Dyspnoea,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Flank pain,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Asthma,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Wheezing,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Productive cough,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Loss of personal independence in daily activities,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Insomnia,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Rales,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Prolonged expiration,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Fall,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Respiration abnormal,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Pyrexia,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Nasal congestion,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Angina pectoris,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Depressed mood,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Cough,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Injury,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Depressive symptom,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Heart sounds,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Appetite disorder,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Chest discomfort,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Weight decreased,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Upper respiratory tract infection,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Dyspnoea exertional,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,81,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,,/WK,2022,Q4,Malaise,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Stress,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Chest pain,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Influenza,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Dyspnoea,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Flank pain,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Asthma,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Wheezing,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Productive cough,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Loss of personal independence in daily activities,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Insomnia,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Rales,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Prolonged expiration,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Fall,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Respiration abnormal,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Pyrexia,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Nasal congestion,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Angina pectoris,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Depressed mood,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Cough,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Injury,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Depressive symptom,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Heart sounds,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Appetite disorder,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Chest discomfort,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Weight decreased,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Upper respiratory tract infection,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Dyspnoea exertional,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,82,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,125.0,ML,,/WK,2022,Q4,Malaise,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Stress,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Chest pain,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Influenza,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Dyspnoea,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Flank pain,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Asthma,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Wheezing,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Productive cough,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Loss of personal independence in daily activities,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Insomnia,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Rales,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Prolonged expiration,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Fall,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Respiration abnormal,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Pyrexia,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Nasal congestion,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Angina pectoris,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Depressed mood,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Cough,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Injury,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Depressive symptom,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Heart sounds,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Appetite disorder,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Chest discomfort,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Weight decreased,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Upper respiratory tract infection,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Dyspnoea exertional,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,83,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),,,,U,,,,,1.25,MG,Solution for injection,/WK,2022,Q4,Malaise,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Stress,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Chest pain,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Influenza,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Dyspnoea,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Flank pain,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Asthma,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Wheezing,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Productive cough,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Loss of personal independence in daily activities,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Insomnia,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Rales,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Prolonged expiration,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Fall,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Respiration abnormal,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Pyrexia,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Nasal congestion,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Angina pectoris,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Depressed mood,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Cough,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Injury,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Depressive symptom,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Heart sounds,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Appetite disorder,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Chest discomfort,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Weight decreased,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Upper respiratory tract infection,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Dyspnoea exertional,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
182657236,18265723,84,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,solution subcutaneous,,,U,,,,,,,Solution,/WK,2022,Q4,Malaise,,2022,Q4,6,F,,20221226.0,20200915,20221230,EXP,,CA-BAUSCH-BL-2020-025875,BAUSCH AND LOMB,,61.0,YR,,F,Y,,,20221230,,CN,CA,CA,2022,Q4,Adult
183624103,18362410,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Skin neoplasm excision,,2022,Q4,3,F,20200629.0,20221213.0,20201009,20221223,PER,,GB-AMGEN-GBRSP2020161041,AMGEN,,79.0,YR,E,M,Y,91.0,KG,20221223,,HP,GB,GB,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Paranoia,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Rash,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Ocular discomfort,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Blood pressure systolic increased,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Treatment failure,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Vascular cognitive impairment,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Arthralgia,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Bronchitis,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Muscular weakness,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Ocular hyperaemia,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Pyrexia,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Delirium,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Gene mutation,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Drug intolerance,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Serum amyloid A protein increased,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Dementia,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Glaucoma,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Conjunctivitis,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Illness,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Fatigue,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Ill-defined disorder,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Drug ineffective,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Arthralgia,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Asthenia,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Decreased appetite,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Chills,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Pneumonia,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Myalgia,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Skin disorder,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Fatigue,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Joint swelling,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Autoinflammatory disease,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Upper respiratory tract infection,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Hypertension,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Weight decreased,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Eye pain,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Dyspnoea,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Amnesia,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Agitation,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Lethargy,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Cryopyrin associated periodic syndrome,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Deafness neurosensory,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Urticaria,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Mood swings,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
183655333,18365533,28,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,/WK,2022,Q4,Eye inflammation,,2022,Q4,3,F,,20220928.0,20201009,20221003,EXP,,CA-BAUSCH-BL-2020-028269,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221003,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Feeling hot,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Peripheral swelling,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Weight decreased,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Psoriatic arthropathy,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Psoriasis,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Skin depigmentation,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Carpal tunnel syndrome,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Arthritis,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Atrioventricular block,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Cellulitis,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Pain in extremity,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Off label use,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
196851986,19685198,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Diabetes mellitus,,2022,Q4,6,F,20200927.0,20221212.0,20210811,20221217,EXP,,NVSC2021CA028543,NOVARTIS,,78.0,YR,,F,Y,,,20221217,,CN,CA,CA,2022,Q4,Elderly
198084622,19808462,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, pre-filled syringes",,,,,,,,,,Injection,,2022,Q4,Pain,,2022,Q4,2,F,,20221014.0,20210909,20221018,PER,DE-ADRED-06590-04,DE-Shilpa Medicare Limited-SML-DE-2021-01057,SHILPA MEDICARE,,63.0,YR,A,M,Y,95.0,KG,20221018,,PH,DE,DE,2022,Q4,Adult
198084622,19808462,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, pre-filled syringes",,,,,,,,,,Injection,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221014.0,20210909,20221018,PER,DE-ADRED-06590-04,DE-Shilpa Medicare Limited-SML-DE-2021-01057,SHILPA MEDICARE,,63.0,YR,A,M,Y,95.0,KG,20221018,,PH,DE,DE,2022,Q4,Adult
198084622,19808462,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, pre-filled syringes",,,,,,,,,,Injection,,2022,Q4,Chills,,2022,Q4,2,F,,20221014.0,20210909,20221018,PER,DE-ADRED-06590-04,DE-Shilpa Medicare Limited-SML-DE-2021-01057,SHILPA MEDICARE,,63.0,YR,A,M,Y,95.0,KG,20221018,,PH,DE,DE,2022,Q4,Adult
198084622,19808462,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, pre-filled syringes",,,,,,,,,,Injection,,2022,Q4,Urosepsis,,2022,Q4,2,F,,20221014.0,20210909,20221018,PER,DE-ADRED-06590-04,DE-Shilpa Medicare Limited-SML-DE-2021-01057,SHILPA MEDICARE,,63.0,YR,A,M,Y,95.0,KG,20221018,,PH,DE,DE,2022,Q4,Adult
198093422,19809342,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg (nach Schema, Fertigspritzen)",,,U,,,,,2.0,MG,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221017.0,20210909,20221020,EXP,,NVSC2021DE200275,NOVARTIS,,63.0,YR,,M,Y,95.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
198093422,19809342,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg (nach Schema, Fertigspritzen)",,,U,,,,,2.0,MG,,,2022,Q4,Urosepsis,,2022,Q4,2,F,,20221017.0,20210909,20221020,EXP,,NVSC2021DE200275,NOVARTIS,,63.0,YR,,M,Y,95.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
198093422,19809342,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg (nach Schema, Fertigspritzen)",,,U,,,,,2.0,MG,,,2022,Q4,Pain,,2022,Q4,2,F,,20221017.0,20210909,20221020,EXP,,NVSC2021DE200275,NOVARTIS,,63.0,YR,,M,Y,95.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
198093422,19809342,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg (nach Schema, Fertigspritzen)",,,U,,,,,2.0,MG,,,2022,Q4,Chills,,2022,Q4,2,F,,20221017.0,20210909,20221020,EXP,,NVSC2021DE200275,NOVARTIS,,63.0,YR,,M,Y,95.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
198172852,19817285,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, unknown",,,,,,,,2.0,MG,Injection,,2022,Q4,Chills,,2022,Q4,2,F,,20221014.0,20210910,20221025,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108013236,ELI LILLY AND CO,,63.0,YR,,M,Y,95.0,KG,20221025,,CN,DE,DE,2022,Q4,Adult
198172852,19817285,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, unknown",,,,,,,,2.0,MG,Injection,,2022,Q4,Urosepsis,,2022,Q4,2,F,,20221014.0,20210910,20221025,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108013236,ELI LILLY AND CO,,63.0,YR,,M,Y,95.0,KG,20221025,,CN,DE,DE,2022,Q4,Adult
198172852,19817285,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, unknown",,,,,,,,2.0,MG,Injection,,2022,Q4,Pain,,2022,Q4,2,F,,20221014.0,20210910,20221025,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108013236,ELI LILLY AND CO,,63.0,YR,,M,Y,95.0,KG,20221025,,CN,DE,DE,2022,Q4,Adult
198172852,19817285,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, unknown",,,,,,,,2.0,MG,Injection,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221014.0,20210910,20221025,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108013236,ELI LILLY AND CO,,63.0,YR,,M,Y,95.0,KG,20221025,,CN,DE,DE,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Weight decreased,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Appetite disorder,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Cough,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Upper respiratory tract infection,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Fall,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Stress,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Influenza,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Wheezing,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Injury,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Dyspnoea exertional,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Depressed mood,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Insomnia,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Chest discomfort,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Prolonged expiration,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Productive cough,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Rhinorrhoea,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Heart sounds,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Chest pain,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Rales,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Angina pectoris,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Nasal congestion,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Asthma,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Malaise,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Respiration abnormal,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Depressive symptom,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
198816072,19881607,41,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, QW (1 every 1 weeks)",,,U,,,,,1.25,MG,,/WK,2022,Q4,Flank pain,,2022,Q4,2,F,,20221122.0,20210925,20221128,EXP,,NVSC2021CA213425,NOVARTIS,,61.0,YR,,F,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
200818483,20081848,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, as per regimen, pre-filled syr",,,,,,,,2.0,MG,Injection,,2022,Q4,Chills,,2022,Q4,3,F,,20221206.0,20211117,20221212,EXP,,DE-MYLANLABS-2021M1083653,MYLAN,,63.0,YR,,M,Y,95.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
200818483,20081848,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, as per regimen, pre-filled syr",,,,,,,,2.0,MG,Injection,,2022,Q4,Pain,,2022,Q4,3,F,,20221206.0,20211117,20221212,EXP,,DE-MYLANLABS-2021M1083653,MYLAN,,63.0,YR,,M,Y,95.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
200818483,20081848,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, as per regimen, pre-filled syr",,,,,,,,2.0,MG,Injection,,2022,Q4,Pyrexia,,2022,Q4,3,F,,20221206.0,20211117,20221212,EXP,,DE-MYLANLABS-2021M1083653,MYLAN,,63.0,YR,,M,Y,95.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
200818483,20081848,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, as per regimen, pre-filled syr",,,,,,,,2.0,MG,Injection,,2022,Q4,Urosepsis,,2022,Q4,3,F,,20221206.0,20211117,20221212,EXP,,DE-MYLANLABS-2021M1083653,MYLAN,,63.0,YR,,M,Y,95.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
201646642,20164664,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"Strength: 1 mg, solution for injection in pre-filled pen",,,,,,,,1.0,MG,,,2022,Q4,Mesenteric panniculitis,,2022,Q4,2,F,20211001.0,20221011.0,20211209,20221020,EXP,FR-AFSSAPS-AM20212865,FR-Accord-246973,ACCORD,,57.0,YR,A,F,Y,74.0,KG,20221020,,MD,FR,FR,2022,Q4,Adult
201792875,20179287,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw(1 mg, QW(1 milligram every 1 day)  )",,,U,U,,,,1.0,MG,Injection,/WK,2022,Q4,Mesenteric panniculitis,,2022,Q4,5,F,20211001.0,20221021.0,20211214,20221028,EXP,FR-AFSSAPS-AM20212865,FR-MYLANLABS-2021M1091784,MYLAN,,57.0,YR,,F,Y,74.0,KG,20221028,,MD,FR,FR,2022,Q4,Adult
202356046,20235604,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1.7 mg, qw",,,,,,,215256.0,1.7,MG,Solution for injection,/WK,2022,Q4,Bile duct stone,,2022,Q4,6,F,20211218.0,20221017.0,20211228,20221027,EXP,,GR-NOVOPROD-877957,NOVO NORDISK,,69.0,YR,,M,Y,99.0,KG,20221027,,MD,GR,GR,2022,Q4,Elderly
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Myoglobinuria,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Contraindicated product administered,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Muscle spasms,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Urinary retention,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Contraindicated product prescribed,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Drug titration error,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Hyperhidrosis,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Rhabdomyolysis,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Myopathy,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Product use in unapproved indication,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Product prescribing error,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Headache,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Urine flow decreased,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Drug interaction,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Urine output decreased,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Renal failure,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Body temperature increased,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Off label use,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Chills,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Myalgia,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,11,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Serotonin syndrome,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Myoglobinuria,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Contraindicated product administered,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Muscle spasms,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Urinary retention,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Contraindicated product prescribed,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Drug titration error,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Hyperhidrosis,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Rhabdomyolysis,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Myopathy,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Product use in unapproved indication,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Product prescribing error,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Headache,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Urine flow decreased,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Drug interaction,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Urine output decreased,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Renal failure,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Body temperature increased,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Off label use,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Chills,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Myalgia,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,12,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Serotonin syndrome,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Myoglobinuria,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Contraindicated product administered,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Muscle spasms,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Urinary retention,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Contraindicated product prescribed,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Drug titration error,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Hyperhidrosis,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Rhabdomyolysis,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Myopathy,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Product use in unapproved indication,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Product prescribing error,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Headache,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Urine flow decreased,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Drug interaction,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Urine output decreased,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Renal failure,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Body temperature increased,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Off label use,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Chills,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Myalgia,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2031300112,20313001,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, Every Week",,,D,,,,,0.5,MG,,/WK,2022,Q4,Serotonin syndrome,,2022,Q4,12,F,,20221029.0,20220109,20221112,EXP,,PL-AUROBINDO-AUR-APL-2022-000371,AUROBINDO,"Woron J, Siwek M et al.. Pharmacological treatment of obesity and health and life threatening drug interactions (Pharmacological treatment of obesity and drug interactions dangerous to health and life). PSYCHOPHARMACOLOGY IN PRACTICE/PRACTICE MEDICINE ? PSYCHIATRY. 2021;83(6):49-51",29.0,YR,,F,Y,,,20221112,,MD,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Contraindicated product administered,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Off label use,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Chills,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Urine flow decreased,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Renal failure,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Serotonin syndrome,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Urinary retention,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Myalgia,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Urine output decreased,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Product use in unapproved indication,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Drug titration error,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Micturition frequency decreased,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Myopathy,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Contraindicated product prescribed,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Headache,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Myoglobinuria,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Product prescribing error,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Hyperhidrosis,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Body temperature increased,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Rhabdomyolysis,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Muscle spasms,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,6,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Drug interaction,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Contraindicated product administered,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Off label use,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Chills,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Urine flow decreased,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Renal failure,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Serotonin syndrome,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Urinary retention,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Myalgia,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Urine output decreased,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Product use in unapproved indication,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Drug titration error,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Micturition frequency decreased,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Myopathy,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Contraindicated product prescribed,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Headache,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Myoglobinuria,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Product prescribing error,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Hyperhidrosis,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Body temperature increased,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Rhabdomyolysis,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Muscle spasms,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
2034676816,20346768,7,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, qw",,,D,,,,,0.5,MG,Injection,/WK,2022,Q4,Drug interaction,,2022,Q4,16,F,,20221220.0,20220118,20221229,EXP,,PL-MYLANLABS-2022M1003692,MYLAN,Woron J;Siwek M.. Pharmacological treatment of obesity and drug interactions dangerous to health and life.. PRACTICE MEDICINE -PSYCHIATRY.. 2021;83(6):49-51,29.0,YR,,F,Y,,,20221229,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Myopathy,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Chills,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Urinary retention,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Hyperhidrosis,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Drug titration error,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Urine flow decreased,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Off label use,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Drug interaction,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Contraindicated product administered,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Myoglobinuria,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Headache,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Myalgia,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Product prescribing error,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Rhabdomyolysis,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Renal failure,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Body temperature increased,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Muscle spasms,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Urine output decreased,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Contraindicated product prescribed,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Product use in unapproved indication,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,16,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Serotonin syndrome,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Myopathy,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Chills,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Urinary retention,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Hyperhidrosis,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Drug titration error,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Urine flow decreased,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Off label use,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Drug interaction,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Contraindicated product administered,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Myoglobinuria,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Headache,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Myalgia,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Product prescribing error,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Rhabdomyolysis,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Renal failure,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Body temperature increased,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Muscle spasms,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Urine output decreased,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Contraindicated product prescribed,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Product use in unapproved indication,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,17,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Serotonin syndrome,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Myopathy,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Chills,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Urinary retention,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Hyperhidrosis,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Drug titration error,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Urine flow decreased,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Off label use,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Drug interaction,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Contraindicated product administered,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Myoglobinuria,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Headache,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Myalgia,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Product prescribing error,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Rhabdomyolysis,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Renal failure,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Body temperature increased,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Muscle spasms,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Urine output decreased,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Contraindicated product prescribed,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Product use in unapproved indication,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204119878,20411987,18,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 milligram, 1/week",,,D,,Unknown,,,0.5,MG,,/WK,2022,Q4,Serotonin syndrome,,2022,Q4,8,F,,20221101.0,20220201,20221104,EXP,,PL-TAKEDA-2022TEU000806,TAKEDA,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Psychiatria. 2021;83(6)",29.0,YR,,F,Y,,,20221104,,HP,PL,PL,2022,Q4,Young Adult
204288882,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,Solution for injection,,2022,Q4,Myopathy,,2022,Q4,2,F,,20221008.0,20220204,20221021,EXP,,PL-Accord-252187,ACCORD,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Practice Medicine-Psychiatry. 2021;83(6):49-51",29.0,YR,A,F,Y,,,20221021,,MD,PL,PL,2022,Q4,Young Adult
204288882,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,Solution for injection,,2022,Q4,Myoglobinuria,,2022,Q4,2,F,,20221008.0,20220204,20221021,EXP,,PL-Accord-252187,ACCORD,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Practice Medicine-Psychiatry. 2021;83(6):49-51",29.0,YR,A,F,Y,,,20221021,,MD,PL,PL,2022,Q4,Young Adult
204288882,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,Solution for injection,,2022,Q4,Renal failure,,2022,Q4,2,F,,20221008.0,20220204,20221021,EXP,,PL-Accord-252187,ACCORD,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Practice Medicine-Psychiatry. 2021;83(6):49-51",29.0,YR,A,F,Y,,,20221021,,MD,PL,PL,2022,Q4,Young Adult
204288882,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,Solution for injection,,2022,Q4,Drug interaction,,2022,Q4,2,F,,20221008.0,20220204,20221021,EXP,,PL-Accord-252187,ACCORD,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Practice Medicine-Psychiatry. 2021;83(6):49-51",29.0,YR,A,F,Y,,,20221021,,MD,PL,PL,2022,Q4,Young Adult
204288882,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,Solution for injection,,2022,Q4,Rhabdomyolysis,,2022,Q4,2,F,,20221008.0,20220204,20221021,EXP,,PL-Accord-252187,ACCORD,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Practice Medicine-Psychiatry. 2021;83(6):49-51",29.0,YR,A,F,Y,,,20221021,,MD,PL,PL,2022,Q4,Young Adult
204288882,20428888,3,I,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 mg subcutaneously 1 * week,,,U,,,,,0.5,MG,Solution for injection,,2022,Q4,Serotonin syndrome,,2022,Q4,2,F,,20221008.0,20220204,20221021,EXP,,PL-Accord-252187,ACCORD,"Woron J, Siwek M. Pharmacological treatment of obesity and drug interactions dangerous to health and life. Practice Medicine-Psychiatry. 2021;83(6):49-51",29.0,YR,A,F,Y,,,20221021,,MD,PL,PL,2022,Q4,Young Adult
205103165,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q4,Macular oedema,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q4,Diabetic retinopathy,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",,,,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q4,Macular oedema,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q4,Macular oedema,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q4,Diabetic retinopathy,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q4,Macular oedema,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q4,Macular oedema,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q4,Diabetic retinopathy,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q4,Macular oedema,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q4,Macular oedema,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q4,Diabetic retinopathy,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205103165,20510316,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,209637.0,,,Solution for injection,,2022,Q4,Macular oedema,,2022,Q4,5,F,20210712.0,20221019.0,20220224,20221028,EXP,,GB-NOVOPROD-887614,NOVO NORDISK,,62.0,YR,,M,Y,104.0,KG,20221028,,MD,GB,GB,2022,Q4,Adult
205870812,20587081,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",42.0,MG,Y,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q4,Cholecystitis acute,,2022,Q4,2,F,20220114.0,20221026.0,20220314,20221104,EXP,,CA-NOVOPROD-897310,NOVO NORDISK,,63.0,YR,,M,Y,71.0,KG,20221104,,MD,CA,CA,2022,Q4,Adult
205870812,20587081,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, qw",42.0,MG,Y,,,,209637.0,1.0,MG,Solution for injection,/WK,2022,Q4,Cholecystitis acute,,2022,Q4,2,F,20220114.0,20221026.0,20220314,20221104,EXP,,CA-NOVOPROD-897310,NOVO NORDISK,,63.0,YR,,M,Y,71.0,KG,20221104,,MD,CA,CA,2022,Q4,Adult
207106064,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Diabetes mellitus,,2022,Q4,4,F,,20221012.0,20220414,20221020,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20221020,,CN,CA,CA,2022,Q4,Adult
207106064,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,4,F,,20221012.0,20220414,20221020,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20221020,,CN,CA,CA,2022,Q4,Adult
207106064,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,4,F,,20221012.0,20220414,20221020,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20221020,,CN,CA,CA,2022,Q4,Adult
207106064,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Loss of personal independence in daily activities,,2022,Q4,4,F,,20221012.0,20220414,20221020,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20221020,,CN,CA,CA,2022,Q4,Adult
207106064,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Wheezing,,2022,Q4,4,F,,20221012.0,20220414,20221020,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20221020,,CN,CA,CA,2022,Q4,Adult
207106064,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Depression,,2022,Q4,4,F,,20221012.0,20220414,20221020,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20221020,,CN,CA,CA,2022,Q4,Adult
207106064,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Asthma,,2022,Q4,4,F,,20221012.0,20220414,20221020,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20221020,,CN,CA,CA,2022,Q4,Adult
207106064,20710606,10,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Hypoacusis,,2022,Q4,4,F,,20221012.0,20220414,20221020,EXP,,CA-PFIZER INC-202200545955,PFIZER,,51.0,YR,,F,Y,,,20221020,,CN,CA,CA,2022,Q4,Adult
207128672,20712867,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,U,,Unknown,,,14.0,MG,,QD,2022,Q4,Femoral neck fracture,,2022,Q4,2,F,,20221018.0,20220415,20221020,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-165585",BOEHRINGER INGELHEIM,"Nagumo K, Iso N, Takeuchi H. A Case of Diabetes Mellitus in Which Ketoacidosis Occurred After Resumption of an SGLT2 Inhibitor Following Surgery for Femoral Neck Fracture. The 23rd Annual Meeting of the Japanese Society of Endocrine Society Kanto-Koshinetsu branch academic meeting. 2022 Sep; 120-",67.0,YR,E,F,Y,,,20221020,,MD,JP,JP,2022,Q4,Elderly
207128672,20712867,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,,,,U,,Unknown,,,14.0,MG,,QD,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221018.0,20220415,20221020,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-165585",BOEHRINGER INGELHEIM,"Nagumo K, Iso N, Takeuchi H. A Case of Diabetes Mellitus in Which Ketoacidosis Occurred After Resumption of an SGLT2 Inhibitor Following Surgery for Femoral Neck Fracture. The 23rd Annual Meeting of the Japanese Society of Endocrine Society Kanto-Koshinetsu branch academic meeting. 2022 Sep; 120-",67.0,YR,E,F,Y,,,20221020,,MD,JP,JP,2022,Q4,Elderly
207140742,20714074,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.4 milligram,907.2,MG,Y,,,,209637.0,2.4,MG,,QD,2022,Q4,Muscular weakness,,2022,Q4,2,F,20191128.0,20221019.0,20220415,20221031,EXP,GB-MHRA-ADR 26724191,GB-NOVOPROD-907910,NOVO NORDISK,,78.0,YR,,M,Y,76.0,KG,20221031,,MD,GB,CA,2022,Q4,Elderly
207140742,20714074,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.4 milligram,907.2,MG,Y,,,,209637.0,2.4,MG,,QD,2022,Q4,Diplopia,,2022,Q4,2,F,20191128.0,20221019.0,20220415,20221031,EXP,GB-MHRA-ADR 26724191,GB-NOVOPROD-907910,NOVO NORDISK,,78.0,YR,,M,Y,76.0,KG,20221031,,MD,GB,CA,2022,Q4,Elderly
207140742,20714074,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.4 milligram,907.2,MG,Y,,,,209637.0,2.4,MG,,QD,2022,Q4,Myasthenia gravis,,2022,Q4,2,F,20191128.0,20221019.0,20220415,20221031,EXP,GB-MHRA-ADR 26724191,GB-NOVOPROD-907910,NOVO NORDISK,,78.0,YR,,M,Y,76.0,KG,20221031,,MD,GB,CA,2022,Q4,Elderly
207140742,20714074,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.4 milligram,907.2,MG,Y,,,,209637.0,2.4,MG,,QD,2022,Q4,Dysphagia,,2022,Q4,2,F,20191128.0,20221019.0,20220415,20221031,EXP,GB-MHRA-ADR 26724191,GB-NOVOPROD-907910,NOVO NORDISK,,78.0,YR,,M,Y,76.0,KG,20221031,,MD,GB,CA,2022,Q4,Elderly
207140742,20714074,2,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,2.4 milligram,907.2,MG,Y,,,,209637.0,2.4,MG,,QD,2022,Q4,Product use in unapproved indication,,2022,Q4,2,F,20191128.0,20221019.0,20220415,20221031,EXP,GB-MHRA-ADR 26724191,GB-NOVOPROD-907910,NOVO NORDISK,,78.0,YR,,M,Y,76.0,KG,20221031,,MD,GB,CA,2022,Q4,Elderly
208029475,20802947,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Knee arthroplasty,,2022,Q4,5,F,20220822.0,20221108.0,20220509,20221116,EXP,,US-UCBSA-2022025287,UCB,,79.0,YR,,F,Y,,,20221116,,CN,US,US,2022,Q4,Elderly
208029475,20802947,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Hearing aid user,,2022,Q4,5,F,20220822.0,20221108.0,20220509,20221116,EXP,,US-UCBSA-2022025287,UCB,,79.0,YR,,F,Y,,,20221116,,CN,US,US,2022,Q4,Elderly
208029475,20802947,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,5,F,20220822.0,20221108.0,20220509,20221116,EXP,,US-UCBSA-2022025287,UCB,,79.0,YR,,F,Y,,,20221116,,CN,US,US,2022,Q4,Elderly
208029475,20802947,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Hypoacusis,,2022,Q4,5,F,20220822.0,20221108.0,20220509,20221116,EXP,,US-UCBSA-2022025287,UCB,,79.0,YR,,F,Y,,,20221116,,CN,US,US,2022,Q4,Elderly
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Incorrect dose administered,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Asthma,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Cough,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Nasopharyngitis,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Headache,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Nasal congestion,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Malaise,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Lower respiratory tract infection,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Ocular hyperaemia,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Infection,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Weight decreased,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Infusion site swelling,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Exposure to SARS-CoV-2,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,COVID-19,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208137083,20813708,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,Solution subcutaneous,,,,,,,,1.0,MG,,/WK,2022,Q4,Tooth infection,,2022,Q4,3,F,,20221101.0,20220511,20221109,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-10945,SAMSUNG BIOEPIS,,50.0,YR,A,F,Y,104.0,KG,20221109,,HP,CA,CA,2022,Q4,Adult
208543145,20854314,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Visual impairment,,2022,Q4,5,F,20220513.0,20221015.0,20220520,20221020,EXP,,NVSC2022US114416,NOVARTIS,,74.0,YR,,M,Y,118.5,KG,20221020,,MD,US,US,2022,Q4,Elderly
210435342,21043534,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Serotonin syndrome,,2022,Q4,2,F,20210424.0,20221026.0,20220705,20221108,EXP,,BR-ROCHE-3132261,ROCHE,,24.0,YR,,F,Y,,,20221107,,CN,BR,,2022,Q4,Young Adult
210435342,21043534,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Prescription drug used without a prescription,,2022,Q4,2,F,20210424.0,20221026.0,20220705,20221108,EXP,,BR-ROCHE-3132261,ROCHE,,24.0,YR,,F,Y,,,20221107,,CN,BR,,2022,Q4,Young Adult
210535992,21053599,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, (for about 3 years)",,,D,,,,,,,,,2022,Q4,Prescription drug used without a prescription,,2022,Q4,2,F,20210424.0,20221026.0,20220707,20221105,EXP,,NVSC2022BR154648,NOVARTIS,,24.0,YR,,F,Y,,,20221105,,CN,BR,BR,2022,Q4,Young Adult
210535992,21053599,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"UNK, (for about 3 years)",,,D,,,,,,,,,2022,Q4,Serotonin syndrome,,2022,Q4,2,F,20210424.0,20221026.0,20220707,20221105,EXP,,NVSC2022BR154648,NOVARTIS,,24.0,YR,,F,Y,,,20221105,,CN,BR,BR,2022,Q4,Young Adult
210535992,21053599,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q4,Prescription drug used without a prescription,,2022,Q4,2,F,20210424.0,20221026.0,20220707,20221105,EXP,,NVSC2022BR154648,NOVARTIS,,24.0,YR,,F,Y,,,20221105,,CN,BR,BR,2022,Q4,Young Adult
210535992,21053599,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,,,,,,,,,2022,Q4,Serotonin syndrome,,2022,Q4,2,F,20210424.0,20221026.0,20220707,20221105,EXP,,NVSC2022BR154648,NOVARTIS,,24.0,YR,,F,Y,,,20221105,,CN,BR,BR,2022,Q4,Young Adult
211224762,21122476,18,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Injection,,2022,Q4,Febrile neutropenia,,2022,Q4,2,F,20210827.0,20221031.0,20220723,20221108,EXP,,CA-AstraZeneca-2022A259061,ASTRAZENECA,,59.0,YR,,F,Y,86.5,KG,20221108,,MD,CA,,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Tooth infection,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Pallor,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Chest pain,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Immunisation reaction,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Feeling cold,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Menstrual disorder,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Product preparation issue,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Disturbance in attention,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,COVID-19 immunisation,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Mental impairment,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Drug hypersensitivity,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Vaccination complication,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Dizziness,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Toothache,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Nervousness,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Memory impairment,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211781872,21178187,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,2,F,20210101.0,20221012.0,20220805,20221018,EXP,,CA-TAKEDA-2022TUS051106,TAKEDA,,50.0,YR,,F,Y,,,20221018,,HP,CA,CA,2022,Q4,Adult
211875662,21187566,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Cytokine release syndrome,,2022,Q4,2,F,20220720.0,20220930.0,20220808,20221004,PER,,US-GILEAD-2022-0592818,GILEAD,,56.0,YR,A,M,Y,,,20221004,,PH,US,US,2022,Q4,Adult
211875662,21187566,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Neurotoxicity,,2022,Q4,2,F,20220720.0,20220930.0,20220808,20221004,PER,,US-GILEAD-2022-0592818,GILEAD,,56.0,YR,A,M,Y,,,20221004,,PH,US,US,2022,Q4,Adult
211875662,21187566,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Encephalopathy,,2022,Q4,2,F,20220720.0,20220930.0,20220808,20221004,PER,,US-GILEAD-2022-0592818,GILEAD,,56.0,YR,A,M,Y,,,20221004,,PH,US,US,2022,Q4,Adult
211875662,21187566,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Aphasia,,2022,Q4,2,F,20220720.0,20220930.0,20220808,20221004,PER,,US-GILEAD-2022-0592818,GILEAD,,56.0,YR,A,M,Y,,,20221004,,PH,US,US,2022,Q4,Adult
212343042,21234304,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2022,Q4,Flatulence,,2022,Q4,2,F,,20220928.0,20220819,20221003,EXP,,CA-BAUSCH-BL-2022-020403,BAUSCH AND LOMB,,61.0,YR,,M,Y,59.0,KG,20221003,,CN,CA,CA,2022,Q4,Adult
212343042,21234304,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2022,Q4,Decreased appetite,,2022,Q4,2,F,,20220928.0,20220819,20221003,EXP,,CA-BAUSCH-BL-2022-020403,BAUSCH AND LOMB,,61.0,YR,,M,Y,59.0,KG,20221003,,CN,CA,CA,2022,Q4,Adult
212343042,21234304,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2022,Q4,Diarrhoea,,2022,Q4,2,F,,20220928.0,20220819,20221003,EXP,,CA-BAUSCH-BL-2022-020403,BAUSCH AND LOMB,,61.0,YR,,M,Y,59.0,KG,20221003,,CN,CA,CA,2022,Q4,Adult
212343042,21234304,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2022,Q4,Weight decreased,,2022,Q4,2,F,,20220928.0,20220819,20221003,EXP,,CA-BAUSCH-BL-2022-020403,BAUSCH AND LOMB,,61.0,YR,,M,Y,59.0,KG,20221003,,CN,CA,CA,2022,Q4,Adult
212343042,21234304,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2022,Q4,Blood glucose increased,,2022,Q4,2,F,,20220928.0,20220819,20221003,EXP,,CA-BAUSCH-BL-2022-020403,BAUSCH AND LOMB,,61.0,YR,,M,Y,59.0,KG,20221003,,CN,CA,CA,2022,Q4,Adult
212343042,21234304,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2022,Q4,Gastroenteritis,,2022,Q4,2,F,,20220928.0,20220819,20221003,EXP,,CA-BAUSCH-BL-2022-020403,BAUSCH AND LOMB,,61.0,YR,,M,Y,59.0,KG,20221003,,CN,CA,CA,2022,Q4,Adult
212343042,21234304,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,1.0,MG,,/WK,2022,Q4,Flatulence,,2022,Q4,2,F,,20220928.0,20220819,20221003,EXP,,CA-BAUSCH-BL-2022-020403,BAUSCH AND LOMB,,61.0,YR,,M,Y,59.0,KG,20221003,,CN,CA,CA,2022,Q4,Adult
212968092,21296809,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Balanoposthitis,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Angina pectoris,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
213007713,21300771,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,419.319,MG,Y,,,,215256.0,,,Solution for injection,,2022,Q4,Bile duct stone,,2022,Q4,3,F,20220726.0,20221025.0,20220907,20221104,EXP,,US-NOVOPROD-953437,NOVO NORDISK,,75.0,YR,,M,Y,118.0,KG,20221104,,MD,US,US,2022,Q4,Elderly
213007713,21300771,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,419.319,MG,Y,,,,215256.0,,,Solution for injection,,2022,Q4,Bile duct stone,,2022,Q4,3,F,20220726.0,20221025.0,20220907,20221104,EXP,,US-NOVOPROD-953437,NOVO NORDISK,,75.0,YR,,M,Y,118.0,KG,20221104,,MD,US,US,2022,Q4,Elderly
213007713,21300771,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,419.319,MG,Y,,,,215256.0,,,Solution for injection,,2022,Q4,Bile duct stone,,2022,Q4,3,F,20220726.0,20221025.0,20220907,20221104,EXP,,US-NOVOPROD-953437,NOVO NORDISK,,75.0,YR,,M,Y,118.0,KG,20221104,,MD,US,US,2022,Q4,Elderly
213007713,21300771,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,419.319,MG,Y,,,,215256.0,,,Solution for injection,,2022,Q4,Bile duct stone,,2022,Q4,3,F,20220726.0,20221025.0,20220907,20221104,EXP,,US-NOVOPROD-953437,NOVO NORDISK,,75.0,YR,,M,Y,118.0,KG,20221104,,MD,US,US,2022,Q4,Elderly
213007713,21300771,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",419.319,MG,Y,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q4,Bile duct stone,,2022,Q4,3,F,20220726.0,20221025.0,20220907,20221104,EXP,,US-NOVOPROD-953437,NOVO NORDISK,,75.0,YR,,M,Y,118.0,KG,20221104,,MD,US,US,2022,Q4,Elderly
213475222,21347522,5,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"7 mg, qd",1309.0,MG,,,,,209637.0,7.0,MG,,QD,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,20211214.0,20221004.0,20220919,20221017,EXP,,JP-NOVOPROD-957632,NOVO NORDISK,,62.0,YR,,F,Y,,,20221017,,MD,JP,JP,2022,Q4,Adult
213475222,21347522,5,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"7 mg, qd",1309.0,MG,,,,,209637.0,7.0,MG,,QD,2022,Q4,Cerebral haemorrhage,,2022,Q4,2,F,20211214.0,20221004.0,20220919,20221017,EXP,,JP-NOVOPROD-957632,NOVO NORDISK,,62.0,YR,,F,Y,,,20221017,,MD,JP,JP,2022,Q4,Adult
213475222,21347522,5,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"7 mg, qd",1309.0,MG,,,,,209637.0,7.0,MG,,QD,2022,Q4,Liver disorder,,2022,Q4,2,F,20211214.0,20221004.0,20220919,20221017,EXP,,JP-NOVOPROD-957632,NOVO NORDISK,,62.0,YR,,F,Y,,,20221017,,MD,JP,JP,2022,Q4,Adult
213475222,21347522,5,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"7 mg, qd",1309.0,MG,,,,,209637.0,7.0,MG,,QD,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,20211214.0,20221004.0,20220919,20221017,EXP,,JP-NOVOPROD-957632,NOVO NORDISK,,62.0,YR,,F,Y,,,20221017,,MD,JP,JP,2022,Q4,Adult
213475222,21347522,5,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,"7 mg, qd",1309.0,MG,,,,,209637.0,7.0,MG,,QD,2022,Q4,Blood glucose decreased,,2022,Q4,2,F,20211214.0,20221004.0,20220919,20221017,EXP,,JP-NOVOPROD-957632,NOVO NORDISK,,62.0,YR,,F,Y,,,20221017,,MD,JP,JP,2022,Q4,Adult
213621372,21362137,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Pulmonary embolism,,2022,Q4,2,F,20220912.0,20221024.0,20220922,20221031,EXP,,NVSC2022ES212570,NOVARTIS,,66.0,YR,,M,Y,89.0,KG,20221031,,MD,ES,ES,2022,Q4,Elderly
213653422,21365342,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,0.14,MG,Unknown,,2022,Q4,Death,,2022,Q4,2,F,20220918.0,20221128.0,20220922,20221128,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-109812,BRISTOL MYERS SQUIBB,,73.0,YR,E,F,Y,100.0,KG,20221129,,HP,CA,CA,2022,Q4,Elderly
213678332,21367833,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Febrile neutropenia,,2022,Q4,2,F,20220825.0,20221012.0,20220923,20221027,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-101586,BRISTOL MYERS SQUIBB,,70.0,YR,E,F,Y,,,20221027,,HP,US,US,2022,Q4,Elderly
213678332,21367833,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,20220825.0,20221012.0,20220923,20221027,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-101586,BRISTOL MYERS SQUIBB,,70.0,YR,E,F,Y,,,20221027,,HP,US,US,2022,Q4,Elderly
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Dyspnoea,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,"Hallucination, auditory",,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Body temperature increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Electrocardiogram ST segment elevation,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Blood triglycerides increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Ejection fraction decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Blood glucose increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Mean cell volume decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Dizziness,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Anion gap increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Electrocardiogram ST-T segment abnormal,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Blood pressure systolic decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,QRS axis abnormal,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Ventricular internal diameter abnormal,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Mean cell haemoglobin decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Drug hypersensitivity,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Sinus tachycardia,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Glomerular filtration rate decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Blood lactic acid increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Electrocardiogram T wave inversion,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Cardiomyopathy,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Hyperhidrosis,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Myocardial infarction,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Blood sodium decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Haematocrit decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Electrocardiogram QRS complex prolonged,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Electrocardiogram QT prolonged,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Haemoglobin decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Left atrial dilatation,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Left ventricular dysfunction,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Hypotension,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 mg, weekly (on wednesdays), 1 dose",,,,,,,,1.0,MG,,/WK,2022,Q4,Left ventricular hypertrophy,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Dyspnoea,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,"Hallucination, auditory",,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Body temperature increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Electrocardiogram ST segment elevation,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Blood triglycerides increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Ejection fraction decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Blood glucose increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Mean cell volume decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Dizziness,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Anion gap increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Electrocardiogram ST-T segment abnormal,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Blood pressure systolic decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,QRS axis abnormal,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Ventricular internal diameter abnormal,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Mean cell haemoglobin decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Drug hypersensitivity,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Sinus tachycardia,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Glomerular filtration rate decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Blood lactic acid increased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Electrocardiogram T wave inversion,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Cardiomyopathy,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Hyperhidrosis,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Myocardial infarction,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Blood sodium decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Haematocrit decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Electrocardiogram QRS complex prolonged,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Electrocardiogram QT prolonged,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Haemoglobin decreased,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Left atrial dilatation,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Left ventricular dysfunction,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Hypotension,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
213876303,21387630,21,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 mg(4 doses),,,,,,,,1.0,MG,,,2022,Q4,Left ventricular hypertrophy,,2022,Q4,3,F,20010101.0,20220916.0,20220928,20221014,EXP,,AU-PFIZER INC-PV202200065774,PFIZER,,27.0,YR,,M,Y,90.0,KG,20221014,,MD,AU,AU,2022,Q4,Young Adult
214007652,21400765,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25,mg,Once per week",1.0,MG,Y,,,,215256.0,0.25,MG,Solution for injection,/WK,2022,Q4,Gastritis,,2022,Q4,2,F,20220921.0,20221108.0,20221003,20221118,EXP,,GB-NOVOPROD-962434,NOVO NORDISK,,58.0,YR,,M,Y,140.0,KG,20221118,,MD,GB,GB,2022,Q4,Adult
214061761,21406176,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Urinary tract infection bacterial,,2022,Q4,1,I,,20220926.0,20221004,20221004,EXP,CA-MHPD-000994707,CA-Accord-279807,ACCORD,,76.0,YR,E,F,Y,95.0,KG,20221004,,HP,CA,CA,2022,Q4,Elderly
214061761,21406176,22,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Febrile neutropenia,,2022,Q4,1,I,,20220926.0,20221004,20221004,EXP,CA-MHPD-000994707,CA-Accord-279807,ACCORD,,76.0,YR,E,F,Y,95.0,KG,20221004,,HP,CA,CA,2022,Q4,Elderly
214073834,21407383,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Immunosuppressant drug level increased,,2022,Q4,4,F,,20221216.0,20221004,20221227,EXP,,US-PFIZER INC-202201182533,PFIZER,"Stawiarski, K.. Risks of Paxlovid in a Heart Transplant Recipient. Journal of Heart and Lung Transplantation. 2022;10.1016/j.healun.2022.08.029",76.0,YR,,M,Y,,,20221227,,MD,US,US,2022,Q4,Elderly
214073834,21407383,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,4,F,,20221216.0,20221004,20221227,EXP,,US-PFIZER INC-202201182533,PFIZER,"Stawiarski, K.. Risks of Paxlovid in a Heart Transplant Recipient. Journal of Heart and Lung Transplantation. 2022;10.1016/j.healun.2022.08.029",76.0,YR,,M,Y,,,20221227,,MD,US,US,2022,Q4,Elderly
214073834,21407383,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,4,F,,20221216.0,20221004,20221227,EXP,,US-PFIZER INC-202201182533,PFIZER,"Stawiarski, K.. Risks of Paxlovid in a Heart Transplant Recipient. Journal of Heart and Lung Transplantation. 2022;10.1016/j.healun.2022.08.029",76.0,YR,,M,Y,,,20221227,,MD,US,US,2022,Q4,Elderly
214073834,21407383,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Blood creatinine increased,,2022,Q4,4,F,,20221216.0,20221004,20221227,EXP,,US-PFIZER INC-202201182533,PFIZER,"Stawiarski, K.. Risks of Paxlovid in a Heart Transplant Recipient. Journal of Heart and Lung Transplantation. 2022;10.1016/j.healun.2022.08.029",76.0,YR,,M,Y,,,20221227,,MD,US,US,2022,Q4,Elderly
214073834,21407383,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,4,F,,20221216.0,20221004,20221227,EXP,,US-PFIZER INC-202201182533,PFIZER,"Stawiarski, K.. Risks of Paxlovid in a Heart Transplant Recipient. Journal of Heart and Lung Transplantation. 2022;10.1016/j.healun.2022.08.029",76.0,YR,,M,Y,,,20221227,,MD,US,US,2022,Q4,Elderly
214074021,21407402,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,,,,,2022,Q4,Confusional state,,2022,Q4,1,I,,20220927.0,20221004,20221004,EXP,,CA-SA-2022SA400812,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20221004,,CN,CA,CA,2022,Q4,Elderly
214119741,21411974,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringe",,,U,,Unknown,,,0.5,MG,Solution for injection in pre-filled syringe,/WK,2022,Q4,Limb injury,,2022,Q4,1,I,,20221005.0,20221005,20221005,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-195676",BOEHRINGER INGELHEIM,,59.0,YR,A,M,Y,125.0,KG,20221005,,PH,DE,DE,2022,Q4,Adult
214119741,21411974,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringe",,,U,,Unknown,,,0.5,MG,Solution for injection in pre-filled syringe,/WK,2022,Q4,Wound secretion,,2022,Q4,1,I,,20221005.0,20221005,20221005,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-195676",BOEHRINGER INGELHEIM,,59.0,YR,A,M,Y,125.0,KG,20221005,,PH,DE,DE,2022,Q4,Adult
214119741,21411974,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringe",,,U,,Unknown,,,0.5,MG,Solution for injection in pre-filled syringe,/WK,2022,Q4,Foot amputation,,2022,Q4,1,I,,20221005.0,20221005,20221005,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-195676",BOEHRINGER INGELHEIM,,59.0,YR,A,M,Y,125.0,KG,20221005,,PH,DE,DE,2022,Q4,Adult
214119741,21411974,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringe",,,U,,Unknown,,,0.5,MG,Solution for injection in pre-filled syringe,/WK,2022,Q4,Impaired healing,,2022,Q4,1,I,,20221005.0,20221005,20221005,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-195676",BOEHRINGER INGELHEIM,,59.0,YR,A,M,Y,125.0,KG,20221005,,PH,DE,DE,2022,Q4,Adult
214119741,21411974,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringe",,,U,,Unknown,,,0.5,MG,Solution for injection in pre-filled syringe,/WK,2022,Q4,Erythema,,2022,Q4,1,I,,20221005.0,20221005,20221005,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-195676",BOEHRINGER INGELHEIM,,59.0,YR,A,M,Y,125.0,KG,20221005,,PH,DE,DE,2022,Q4,Adult
214119741,21411974,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringe",,,U,,Unknown,,,0.5,MG,Solution for injection in pre-filled syringe,/WK,2022,Q4,Therapeutic drug monitoring analysis incorrectly performed,,2022,Q4,1,I,,20221005.0,20221005,20221005,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-195676",BOEHRINGER INGELHEIM,,59.0,YR,A,M,Y,125.0,KG,20221005,,PH,DE,DE,2022,Q4,Adult
214163541,21416354,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0 Milligram/Milliliter,,,U,,UNKNOWN,,,,,,,2022,Q4,Drug hypersensitivity,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,CA-TEVA-2022-CA-2078411,TEVA,,72.0,YR,E,M,Y,,,20221006,,HP,CA,CA,2022,Q4,Elderly
214163541,21416354,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0 Milligram/Milliliter,,,U,,UNKNOWN,,,,,,,2022,Q4,Syncope,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,CA-TEVA-2022-CA-2078411,TEVA,,72.0,YR,E,M,Y,,,20221006,,HP,CA,CA,2022,Q4,Elderly
214163541,21416354,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0 Milligram/Milliliter,,,U,,UNKNOWN,,,,,,,2022,Q4,Presyncope,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,CA-TEVA-2022-CA-2078411,TEVA,,72.0,YR,E,M,Y,,,20221006,,HP,CA,CA,2022,Q4,Elderly
214163541,21416354,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,3.0 Milligram/Milliliter,,,U,,UNKNOWN,,,,,,,2022,Q4,Angioedema,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,CA-TEVA-2022-CA-2078411,TEVA,,72.0,YR,E,M,Y,,,20221006,,HP,CA,CA,2022,Q4,Elderly
214338661,21433866,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 DF qd Same Time Each Day,,,U,,,,209637.0,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20220806.0,20220929.0,20221010,20221010,EXP,GB-MHRA-EMIS-4685-d921f78c-a695-41ae-95cb-8e2e04572c4c,GB-NOVOPROD-964617,NOVO NORDISK,,68.0,YR,,F,Y,107.5,KG,20221010,,HP,GB,GB,2022,Q4,Elderly
214338661,21433866,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 DF qd Same Time Each Day,,,U,,,,209637.0,,,,,2022,Q4,Nausea,,2022,Q4,1,I,20220806.0,20220929.0,20221010,20221010,EXP,GB-MHRA-EMIS-4685-d921f78c-a695-41ae-95cb-8e2e04572c4c,GB-NOVOPROD-964617,NOVO NORDISK,,68.0,YR,,F,Y,107.5,KG,20221010,,HP,GB,GB,2022,Q4,Elderly
214338661,21433866,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 DF qd Same Time Each Day,,,U,,,,209637.0,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20220806.0,20220929.0,20221010,20221010,EXP,GB-MHRA-EMIS-4685-d921f78c-a695-41ae-95cb-8e2e04572c4c,GB-NOVOPROD-964617,NOVO NORDISK,,68.0,YR,,F,Y,107.5,KG,20221010,,HP,GB,GB,2022,Q4,Elderly
214338661,21433866,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 DF qd Same Time Each Day,,,U,,,,209637.0,,,,,2022,Q4,Visual impairment,,2022,Q4,1,I,20220806.0,20220929.0,20221010,20221010,EXP,GB-MHRA-EMIS-4685-d921f78c-a695-41ae-95cb-8e2e04572c4c,GB-NOVOPROD-964617,NOVO NORDISK,,68.0,YR,,F,Y,107.5,KG,20221010,,HP,GB,GB,2022,Q4,Elderly
214338661,21433866,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 DF qd Same Time Each Day,,,U,,,,209637.0,,,,,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220806.0,20220929.0,20221010,20221010,EXP,GB-MHRA-EMIS-4685-d921f78c-a695-41ae-95cb-8e2e04572c4c,GB-NOVOPROD-964617,NOVO NORDISK,,68.0,YR,,F,Y,107.5,KG,20221010,,HP,GB,GB,2022,Q4,Elderly
214356741,21435674,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg (mittwochs, Fertigspritzen)",,,U,,,,,0.5,MG,,,2022,Q4,Erythema,,2022,Q4,1,I,,20221006.0,20221010,20221010,EXP,DE-ADRED-07864-01,NVSC2022DE226247,NOVARTIS,,59.0,YR,,M,Y,125.0,KG,20221010,,PH,DE,DE,2022,Q4,Adult
214356741,21435674,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg (mittwochs, Fertigspritzen)",,,U,,,,,0.5,MG,,,2022,Q4,Wound secretion,,2022,Q4,1,I,,20221006.0,20221010,20221010,EXP,DE-ADRED-07864-01,NVSC2022DE226247,NOVARTIS,,59.0,YR,,M,Y,125.0,KG,20221010,,PH,DE,DE,2022,Q4,Adult
214356741,21435674,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg (mittwochs, Fertigspritzen)",,,U,,,,,0.5,MG,,,2022,Q4,Limb injury,,2022,Q4,1,I,,20221006.0,20221010,20221010,EXP,DE-ADRED-07864-01,NVSC2022DE226247,NOVARTIS,,59.0,YR,,M,Y,125.0,KG,20221010,,PH,DE,DE,2022,Q4,Adult
214356741,21435674,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg (mittwochs, Fertigspritzen)",,,U,,,,,0.5,MG,,,2022,Q4,Impaired healing,,2022,Q4,1,I,,20221006.0,20221010,20221010,EXP,DE-ADRED-07864-01,NVSC2022DE226247,NOVARTIS,,59.0,YR,,M,Y,125.0,KG,20221010,,PH,DE,DE,2022,Q4,Adult
214356741,21435674,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg (mittwochs, Fertigspritzen)",,,U,,,,,0.5,MG,,,2022,Q4,Therapeutic drug monitoring analysis incorrectly performed,,2022,Q4,1,I,,20221006.0,20221010,20221010,EXP,DE-ADRED-07864-01,NVSC2022DE226247,NOVARTIS,,59.0,YR,,M,Y,125.0,KG,20221010,,PH,DE,DE,2022,Q4,Adult
214419211,21441921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,0.5,MG,,,2022,Q4,Erythema,,2022,Q4,1,I,,20221005.0,20221011,20221011,EXP,,DE-BAUSCH-BL-2022-023204,BAUSCH AND LOMB,,59.0,YR,,M,Y,125.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214419211,21441921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,0.5,MG,,,2022,Q4,Impaired healing,,2022,Q4,1,I,,20221005.0,20221011,20221011,EXP,,DE-BAUSCH-BL-2022-023204,BAUSCH AND LOMB,,59.0,YR,,M,Y,125.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214419211,21441921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,0.5,MG,,,2022,Q4,Limb injury,,2022,Q4,1,I,,20221005.0,20221011,20221011,EXP,,DE-BAUSCH-BL-2022-023204,BAUSCH AND LOMB,,59.0,YR,,M,Y,125.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214419211,21441921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,0.5,MG,,,2022,Q4,Wound secretion,,2022,Q4,1,I,,20221005.0,20221011,20221011,EXP,,DE-BAUSCH-BL-2022-023204,BAUSCH AND LOMB,,59.0,YR,,M,Y,125.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214419211,21441921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,0.5,MG,,,2022,Q4,Foot amputation,,2022,Q4,1,I,,20221005.0,20221011,20221011,EXP,,DE-BAUSCH-BL-2022-023204,BAUSCH AND LOMB,,59.0,YR,,M,Y,125.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214419211,21441921,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,0.5,MG,,,2022,Q4,Therapeutic drug monitoring analysis incorrectly performed,,2022,Q4,1,I,,20221005.0,20221011,20221011,EXP,,DE-BAUSCH-BL-2022-023204,BAUSCH AND LOMB,,59.0,YR,,M,Y,125.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214563171,21456317,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,,,,,,0.5,MG,Solution for injection,,2022,Q4,Product use issue,,2022,Q4,1,I,,20221005.0,20221014,20221014,EXP,,CA-PFIZER INC-202201208975,PFIZER,,32.0,YR,,F,Y,,,20221014,,HP,CA,CA,2022,Q4,Young Adult
214563171,21456317,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,0.5 mg,,,,,,,,0.5,MG,Solution for injection,,2022,Q4,Bronchiolitis,,2022,Q4,1,I,,20221005.0,20221014,20221014,EXP,,CA-PFIZER INC-202201208975,PFIZER,,32.0,YR,,F,Y,,,20221014,,HP,CA,CA,2022,Q4,Young Adult
214608881,21460888,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Limb injury,,2022,Q4,1,I,,20221003.0,20221015,20221015,EXP,,DE-AUROBINDO-AUR-APL-2022-041932,AUROBINDO,,59.0,YR,,M,Y,125.0,KG,20221015,,PH,DE,DE,2022,Q4,Adult
214608881,21460888,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Impaired healing,,2022,Q4,1,I,,20221003.0,20221015,20221015,EXP,,DE-AUROBINDO-AUR-APL-2022-041932,AUROBINDO,,59.0,YR,,M,Y,125.0,KG,20221015,,PH,DE,DE,2022,Q4,Adult
214608881,21460888,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Erythema,,2022,Q4,1,I,,20221003.0,20221015,20221015,EXP,,DE-AUROBINDO-AUR-APL-2022-041932,AUROBINDO,,59.0,YR,,M,Y,125.0,KG,20221015,,PH,DE,DE,2022,Q4,Adult
214608881,21460888,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Wound secretion,,2022,Q4,1,I,,20221003.0,20221015,20221015,EXP,,DE-AUROBINDO-AUR-APL-2022-041932,AUROBINDO,,59.0,YR,,M,Y,125.0,KG,20221015,,PH,DE,DE,2022,Q4,Adult
214608881,21460888,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Foot amputation,,2022,Q4,1,I,,20221003.0,20221015,20221015,EXP,,DE-AUROBINDO-AUR-APL-2022-041932,AUROBINDO,,59.0,YR,,M,Y,125.0,KG,20221015,,PH,DE,DE,2022,Q4,Adult
214608881,21460888,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Therapeutic drug monitoring analysis incorrectly performed,,2022,Q4,1,I,,20221003.0,20221015,20221015,EXP,,DE-AUROBINDO-AUR-APL-2022-041932,AUROBINDO,,59.0,YR,,M,Y,125.0,KG,20221015,,PH,DE,DE,2022,Q4,Adult
214624241,21462424,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,D,,,,,,,,2022,Q4,Cholecystectomy,,2022,Q4,1,I,20220922.0,,20221014,20221014,DIR,FDA-CDER-CTU-2022-82253,,FDA-CTU,,72.0,YR,,M,N,,,20221007,N,PH,US,,2022,Q4,Elderly
214692401,21469240,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,UNK,,,U,,,,209637.0,,,,,2022,Q4,Confusional state,,2022,Q4,1,I,,20221006.0,20221018,20221018,EXP,CA- HEALTHCANVIG-E2B_05585655,CA-NOVOPROD-967956,NOVO NORDISK,,75.0,YR,,M,Y,,,20221018,,CN,CA,CA,2022,Q4,Elderly
214827421,21482742,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Product dose omission issue,,2022,Q4,1,I,,20221013.0,20221020,20221020,EXP,,CA-APOTEX-2022AP014308,APOTEX,,62.0,YR,,F,Y,,,20221020,,HP,CA,CA,2022,Q4,Adult
214827421,21482742,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,,20221013.0,20221020,20221020,EXP,,CA-APOTEX-2022AP014308,APOTEX,,62.0,YR,,F,Y,,,20221020,,HP,CA,CA,2022,Q4,Adult
214827421,21482742,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Malaise,,2022,Q4,1,I,,20221013.0,20221020,20221020,EXP,,CA-APOTEX-2022AP014308,APOTEX,,62.0,YR,,F,Y,,,20221020,,HP,CA,CA,2022,Q4,Adult
214827421,21482742,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Pruritus,,2022,Q4,1,I,,20221013.0,20221020,20221020,EXP,,CA-APOTEX-2022AP014308,APOTEX,,62.0,YR,,F,Y,,,20221020,,HP,CA,CA,2022,Q4,Adult
214827421,21482742,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Clostridium difficile colitis,,2022,Q4,1,I,,20221013.0,20221020,20221020,EXP,,CA-APOTEX-2022AP014308,APOTEX,,62.0,YR,,F,Y,,,20221020,,HP,CA,CA,2022,Q4,Adult
214827421,21482742,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,,20221013.0,20221020,20221020,EXP,,CA-APOTEX-2022AP014308,APOTEX,,62.0,YR,,F,Y,,,20221020,,HP,CA,CA,2022,Q4,Adult
214827421,21482742,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221013.0,20221020,20221020,EXP,,CA-APOTEX-2022AP014308,APOTEX,,62.0,YR,,F,Y,,,20221020,,HP,CA,CA,2022,Q4,Adult
214827421,21482742,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,,20221013.0,20221020,20221020,EXP,,CA-APOTEX-2022AP014308,APOTEX,,62.0,YR,,F,Y,,,20221020,,HP,CA,CA,2022,Q4,Adult
214854191,21485419,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Angioedema,,2022,Q4,1,I,20221017.0,,20221019,20221019,DIR,FDA-CDER-CTU-2022-83744,,FDA-CTU,,51.0,YR,,M,N,98.0,KG,20221019,Y,MD,MX,,2022,Q4,Adult
214854191,21485419,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Oxygen saturation decreased,,2022,Q4,1,I,20221017.0,,20221019,20221019,DIR,FDA-CDER-CTU-2022-83744,,FDA-CTU,,51.0,YR,,M,N,98.0,KG,20221019,Y,MD,MX,,2022,Q4,Adult
214854191,21485419,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Anaphylactic shock,,2022,Q4,1,I,20221017.0,,20221019,20221019,DIR,FDA-CDER-CTU-2022-83744,,FDA-CTU,,51.0,YR,,M,N,98.0,KG,20221019,Y,MD,MX,,2022,Q4,Adult
214854191,21485419,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Syncope,,2022,Q4,1,I,20221017.0,,20221019,20221019,DIR,FDA-CDER-CTU-2022-83744,,FDA-CTU,,51.0,YR,,M,N,98.0,KG,20221019,Y,MD,MX,,2022,Q4,Adult
214854191,21485419,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Vision blurred,,2022,Q4,1,I,20221017.0,,20221019,20221019,DIR,FDA-CDER-CTU-2022-83744,,FDA-CTU,,51.0,YR,,M,N,98.0,KG,20221019,Y,MD,MX,,2022,Q4,Adult
214854191,21485419,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20221017.0,,20221019,20221019,DIR,FDA-CDER-CTU-2022-83744,,FDA-CTU,,51.0,YR,,M,N,98.0,KG,20221019,Y,MD,MX,,2022,Q4,Adult
214854191,21485419,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Disorientation,,2022,Q4,1,I,20221017.0,,20221019,20221019,DIR,FDA-CDER-CTU-2022-83744,,FDA-CTU,,51.0,YR,,M,N,98.0,KG,20221019,Y,MD,MX,,2022,Q4,Adult
214922381,21492238,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Product reconstitution quality issue,,2022,Q4,1,I,,20221011.0,20221021,20221021,PER,,US-BEH-2022150819,CSL BEHRING,,68.0,YR,E,M,Y,,,20221021,,CN,US,US,2022,Q4,Elderly
214922381,21492238,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Product reconstitution quality issue,,2022,Q4,1,I,,20221011.0,20221021,20221021,PER,,US-BEH-2022150819,CSL BEHRING,,68.0,YR,E,M,Y,,,20221021,,CN,US,US,2022,Q4,Elderly
214922381,21492238,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Pruritus,,2022,Q4,1,I,,20221011.0,20221021,20221021,PER,,US-BEH-2022150819,CSL BEHRING,,68.0,YR,E,M,Y,,,20221021,,CN,US,US,2022,Q4,Elderly
214922381,21492238,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Rhinorrhoea,,2022,Q4,1,I,,20221011.0,20221021,20221021,PER,,US-BEH-2022150819,CSL BEHRING,,68.0,YR,E,M,Y,,,20221021,,CN,US,US,2022,Q4,Elderly
214942351,21494235,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, according to plan, prefilled syringes",,,,,UNKNOWN,,,,,Unknown,,2022,Q4,Chills,,2022,Q4,1,I,,20221017.0,20221021,20221021,EXP,,DE-FreseniusKabi-FK202109616,FRESENIUS KABI,,63.0,YR,A,M,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214942351,21494235,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, according to plan, prefilled syringes",,,,,UNKNOWN,,,,,Unknown,,2022,Q4,Urosepsis,,2022,Q4,1,I,,20221017.0,20221021,20221021,EXP,,DE-FreseniusKabi-FK202109616,FRESENIUS KABI,,63.0,YR,A,M,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214942351,21494235,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, according to plan, prefilled syringes",,,,,UNKNOWN,,,,,Unknown,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20221017.0,20221021,20221021,EXP,,DE-FreseniusKabi-FK202109616,FRESENIUS KABI,,63.0,YR,A,M,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214942351,21494235,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2 mg, according to plan, prefilled syringes",,,,,UNKNOWN,,,,,Unknown,,2022,Q4,Pain,,2022,Q4,1,I,,20221017.0,20221021,20221021,EXP,,DE-FreseniusKabi-FK202109616,FRESENIUS KABI,,63.0,YR,A,M,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214967691,21496769,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,UNKNOWN,,,,,,,2022,Q4,Wound secretion,,2022,Q4,1,I,,20221013.0,20221022,20221022,EXP,,DE-TEVA-2022-DE-2817883,TEVA,,59.0,YR,A,M,Y,125.0,KG,20221022,,PH,DE,DE,2022,Q4,Adult
214967691,21496769,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,UNKNOWN,,,,,,,2022,Q4,Limb injury,,2022,Q4,1,I,,20221013.0,20221022,20221022,EXP,,DE-TEVA-2022-DE-2817883,TEVA,,59.0,YR,A,M,Y,125.0,KG,20221022,,PH,DE,DE,2022,Q4,Adult
214967691,21496769,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,UNKNOWN,,,,,,,2022,Q4,Foot amputation,,2022,Q4,1,I,,20221013.0,20221022,20221022,EXP,,DE-TEVA-2022-DE-2817883,TEVA,,59.0,YR,A,M,Y,125.0,KG,20221022,,PH,DE,DE,2022,Q4,Adult
214967691,21496769,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,UNKNOWN,,,,,,,2022,Q4,Erythema,,2022,Q4,1,I,,20221013.0,20221022,20221022,EXP,,DE-TEVA-2022-DE-2817883,TEVA,,59.0,YR,A,M,Y,125.0,KG,20221022,,PH,DE,DE,2022,Q4,Adult
214967691,21496769,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,UNKNOWN,,,,,,,2022,Q4,Therapeutic drug monitoring analysis incorrectly performed,,2022,Q4,1,I,,20221013.0,20221022,20221022,EXP,,DE-TEVA-2022-DE-2817883,TEVA,,59.0,YR,A,M,Y,125.0,KG,20221022,,PH,DE,DE,2022,Q4,Adult
214967691,21496769,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,"0.5 mg, Wednesdays, pre-filled syringes",,,U,,UNKNOWN,,,,,,,2022,Q4,Impaired healing,,2022,Q4,1,I,,20221013.0,20221022,20221022,EXP,,DE-TEVA-2022-DE-2817883,TEVA,,59.0,YR,A,M,Y,125.0,KG,20221022,,PH,DE,DE,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Malaise,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Dizziness,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Pain,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Fall,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Therapy change,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Cold sweat,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Tinnitus,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Multiple injuries,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Skin discolouration,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Nausea,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Hyperhidrosis,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Asthenia,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Loss of consciousness,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Feeling hot,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Gait disturbance,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
214992561,21499256,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : Once per week;?,,,,,,,99.0,,,,999,2022,Q4,Nervousness,,2022,Q4,1,I,20221022.0,,20221023,20221023,DIR,635648,,FDA-CTU,,40.0,YR,,F,N,105.75,KG,20221023,N,CN,US,,2022,Q4,Adult
215218871,21521887,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,0.25,MG,Solution,/WK,2022,Q4,Breast cancer,,2022,Q4,1,I,,20221027.0,20221028,20221028,EXP,,CA-BAUSCH-BL-2022-024407,BAUSCH AND LOMB,,71.0,YR,,F,Y,,,20221028,,CN,CA,CA,2022,Q4,Elderly
215218871,21521887,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,0.25,MG,Solution,/WK,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221027.0,20221028,20221028,EXP,,CA-BAUSCH-BL-2022-024407,BAUSCH AND LOMB,,71.0,YR,,F,Y,,,20221028,,CN,CA,CA,2022,Q4,Elderly
215218871,21521887,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,0.25,MG,Solution,/WK,2022,Q4,Breast cancer recurrent,,2022,Q4,1,I,,20221027.0,20221028,20221028,EXP,,CA-BAUSCH-BL-2022-024407,BAUSCH AND LOMB,,71.0,YR,,F,Y,,,20221028,,CN,CA,CA,2022,Q4,Elderly
215221051,21522105,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,D,D,,,,0.25,MG,,QW,2022,Q4,Illness,,2022,Q4,1,I,20220821.0,,20221027,20221027,DIR,FDA-CDER-CTU-2022-86216,,FDA-CTU,,53.0,YR,,F,N,65.0,KG,20220825,N,HP,US,,2022,Q4,Adult
215221051,21522105,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,D,D,,,,0.25,MG,,QW,2022,Q4,Vomiting,,2022,Q4,1,I,20220821.0,,20221027,20221027,DIR,FDA-CDER-CTU-2022-86216,,FDA-CTU,,53.0,YR,,F,N,65.0,KG,20220825,N,HP,US,,2022,Q4,Adult
215221051,21522105,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,D,D,,,,0.25,MG,,QW,2022,Q4,Pancreatitis,,2022,Q4,1,I,20220821.0,,20221027,20221027,DIR,FDA-CDER-CTU-2022-86216,,FDA-CTU,,53.0,YR,,F,N,65.0,KG,20220825,N,HP,US,,2022,Q4,Adult
215221051,21522105,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,D,D,,,,0.25,MG,,QW,2022,Q4,Pain,,2022,Q4,1,I,20220821.0,,20221027,20221027,DIR,FDA-CDER-CTU-2022-86216,,FDA-CTU,,53.0,YR,,F,N,65.0,KG,20220825,N,HP,US,,2022,Q4,Adult
215221051,21522105,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,D,D,,,,0.25,MG,,QW,2022,Q4,Nausea,,2022,Q4,1,I,20220821.0,,20221027,20221027,DIR,FDA-CDER-CTU-2022-86216,,FDA-CTU,,53.0,YR,,F,N,65.0,KG,20220825,N,HP,US,,2022,Q4,Adult
215246291,21524629,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Hydroureter,,2022,Q4,1,I,,20221024.0,20221030,20221030,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-199878",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,87.0,KG,20221030,,PH,CA,CA,2022,Q4,Elderly
215246291,21524629,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Fungal infection,,2022,Q4,1,I,,20221024.0,20221030,20221030,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-199878",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,87.0,KG,20221030,,PH,CA,CA,2022,Q4,Elderly
215246291,21524629,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Ureterolithiasis,,2022,Q4,1,I,,20221024.0,20221030,20221030,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-199878",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,87.0,KG,20221030,,PH,CA,CA,2022,Q4,Elderly
215246291,21524629,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Urinary tract candidiasis,,2022,Q4,1,I,,20221024.0,20221030,20221030,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-199878",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,87.0,KG,20221030,,PH,CA,CA,2022,Q4,Elderly
215246291,21524629,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20221024.0,20221030,20221030,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-199878",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,87.0,KG,20221030,,PH,CA,CA,2022,Q4,Elderly
215246291,21524629,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,White blood cell count increased,,2022,Q4,1,I,,20221024.0,20221030,20221030,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-199878",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,87.0,KG,20221030,,PH,CA,CA,2022,Q4,Elderly
215259131,21525913,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14 mg, qd",,,,,,,213051.0,14.0,MG,Tablet,QD,2022,Q4,Cholecystitis chronic,,2022,Q4,1,I,20221014.0,20221020.0,20221031,20221031,EXP,,RU-NOVOPROD-972282,NOVO NORDISK,,61.0,YR,,F,Y,93.0,KG,20221031,,MD,RU,RU,2022,Q4,Adult
215274241,21527424,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,1 every 1 Days,,,U,,,,,14.0,MG,,,2022,Q4,Fall,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05371505,CA-Accord-284340,ACCORD,,68.0,YR,E,M,Y,87.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274241,21527424,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,1 every 1 Days,,,U,,,,,14.0,MG,,,2022,Q4,Hypotension,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05371505,CA-Accord-284340,ACCORD,,68.0,YR,E,M,Y,87.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274241,21527424,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,1 every 1 Days,,,U,,,,,3.0,MG,,,2022,Q4,Fall,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05371505,CA-Accord-284340,ACCORD,,68.0,YR,E,M,Y,87.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274241,21527424,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,1 every 1 Days,,,U,,,,,3.0,MG,,,2022,Q4,Hypotension,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05371505,CA-Accord-284340,ACCORD,,68.0,YR,E,M,Y,87.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274241,21527424,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,1 every 1 Days,,,U,,,,,7.0,MG,,,2022,Q4,Fall,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05371505,CA-Accord-284340,ACCORD,,68.0,YR,E,M,Y,87.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274241,21527424,5,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,1 every 1 Days,,,U,,,,,7.0,MG,,,2022,Q4,Hypotension,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05371505,CA-Accord-284340,ACCORD,,68.0,YR,E,M,Y,87.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274851,21527485,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,2.4,MG,,,2022,Q4,Asthenia,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05379084,CA-Accord-284106,ACCORD,,67.0,YR,E,M,Y,122.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274851,21527485,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,2.4,MG,,,2022,Q4,Angina unstable,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05379084,CA-Accord-284106,ACCORD,,67.0,YR,E,M,Y,122.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274851,21527485,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,2.4,MG,,,2022,Q4,Vomiting,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05379084,CA-Accord-284106,ACCORD,,67.0,YR,E,M,Y,122.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274851,21527485,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,2.4,MG,,,2022,Q4,Hypotension,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05379084,CA-Accord-284106,ACCORD,,67.0,YR,E,M,Y,122.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274851,21527485,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,2.4,MG,,,2022,Q4,Acute myocardial infarction,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05379084,CA-Accord-284106,ACCORD,,67.0,YR,E,M,Y,122.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215274851,21527485,3,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,U,,,,,2.4,MG,,,2022,Q4,Dizziness,,2022,Q4,1,I,,20221022.0,20221031,20221031,EXP,CA-MHPD-E2B_05379084,CA-Accord-284106,ACCORD,,67.0,YR,E,M,Y,122.0,KG,20221031,,HP,CA,CA,2022,Q4,Elderly
215308561,21530856,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,D,D,,,,,,,,2022,Q4,Pancreatitis,,2022,Q4,1,I,20221023.0,,20221028,20221028,DIR,FDA-CDER-CTU-2022-86630,,FDA-CTU,,45.0,YR,,M,N,,,20221025,N,,US,,2022,Q4,Adult
215435402,21543540,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, 1/week",,,,,,,,0.25,MG,,/WK,2022,Q4,COVID-19,,2022,Q4,2,F,,20221108.0,20221102,20221118,EXP,,JP-JNJFOC-20221102935,JOHNSON AND JOHNSON,"Numura T, [W27-3 A case of hospital admission with COVID-19 (C19) and DKA while on oral SGLT2 inhibitors/Re-start of SGLT2 inhibitors after treatment/Re-admission with C19 and DKA 2 days after discharge] Diabetic Complications. The 37 Meeting of the Japan Society of Diabetic Complications/The 28th Meeting of the Japanese Society of Ophthalmic Diabetology. 2022.9.20;2022.10.21,22;36:S-1:228",6.0,DEC,A,F,Y,,,20221118,,MD,JP,JP,2022,Q4,Child
215435402,21543540,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, 1/week",,,,,,,,0.25,MG,,/WK,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221108.0,20221102,20221118,EXP,,JP-JNJFOC-20221102935,JOHNSON AND JOHNSON,"Numura T, [W27-3 A case of hospital admission with COVID-19 (C19) and DKA while on oral SGLT2 inhibitors/Re-start of SGLT2 inhibitors after treatment/Re-admission with C19 and DKA 2 days after discharge] Diabetic Complications. The 37 Meeting of the Japan Society of Diabetic Complications/The 28th Meeting of the Japanese Society of Ophthalmic Diabetology. 2022.9.20;2022.10.21,22;36:S-1:228",6.0,DEC,A,F,Y,,,20221118,,MD,JP,JP,2022,Q4,Child
215435402,21543540,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, 1/week",,,,,,,,0.25,MG,,/WK,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221108.0,20221102,20221118,EXP,,JP-JNJFOC-20221102935,JOHNSON AND JOHNSON,"Numura T, [W27-3 A case of hospital admission with COVID-19 (C19) and DKA while on oral SGLT2 inhibitors/Re-start of SGLT2 inhibitors after treatment/Re-admission with C19 and DKA 2 days after discharge] Diabetic Complications. The 37 Meeting of the Japan Society of Diabetic Complications/The 28th Meeting of the Japanese Society of Ophthalmic Diabetology. 2022.9.20;2022.10.21,22;36:S-1:228",6.0,DEC,A,F,Y,,,20221118,,MD,JP,JP,2022,Q4,Child
215435402,21543540,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.25 milligram, 1/week",,,,,,,,0.25,MG,,/WK,2022,Q4,COVID-19,,2022,Q4,2,F,,20221108.0,20221102,20221118,EXP,,JP-JNJFOC-20221102935,JOHNSON AND JOHNSON,"Numura T, [W27-3 A case of hospital admission with COVID-19 (C19) and DKA while on oral SGLT2 inhibitors/Re-start of SGLT2 inhibitors after treatment/Re-admission with C19 and DKA 2 days after discharge] Diabetic Complications. The 37 Meeting of the Japan Society of Diabetic Complications/The 28th Meeting of the Japanese Society of Ophthalmic Diabetology. 2022.9.20;2022.10.21,22;36:S-1:228",6.0,DEC,A,F,Y,,,20221118,,MD,JP,JP,2022,Q4,Child
215435402,21543540,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,,,,,,0.5,MG,,/WK,2022,Q4,COVID-19,,2022,Q4,2,F,,20221108.0,20221102,20221118,EXP,,JP-JNJFOC-20221102935,JOHNSON AND JOHNSON,"Numura T, [W27-3 A case of hospital admission with COVID-19 (C19) and DKA while on oral SGLT2 inhibitors/Re-start of SGLT2 inhibitors after treatment/Re-admission with C19 and DKA 2 days after discharge] Diabetic Complications. The 37 Meeting of the Japan Society of Diabetic Complications/The 28th Meeting of the Japanese Society of Ophthalmic Diabetology. 2022.9.20;2022.10.21,22;36:S-1:228",6.0,DEC,A,F,Y,,,20221118,,MD,JP,JP,2022,Q4,Child
215435402,21543540,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,,,,,,0.5,MG,,/WK,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221108.0,20221102,20221118,EXP,,JP-JNJFOC-20221102935,JOHNSON AND JOHNSON,"Numura T, [W27-3 A case of hospital admission with COVID-19 (C19) and DKA while on oral SGLT2 inhibitors/Re-start of SGLT2 inhibitors after treatment/Re-admission with C19 and DKA 2 days after discharge] Diabetic Complications. The 37 Meeting of the Japan Society of Diabetic Complications/The 28th Meeting of the Japanese Society of Ophthalmic Diabetology. 2022.9.20;2022.10.21,22;36:S-1:228",6.0,DEC,A,F,Y,,,20221118,,MD,JP,JP,2022,Q4,Child
215435402,21543540,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,,,,,,0.5,MG,,/WK,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221108.0,20221102,20221118,EXP,,JP-JNJFOC-20221102935,JOHNSON AND JOHNSON,"Numura T, [W27-3 A case of hospital admission with COVID-19 (C19) and DKA while on oral SGLT2 inhibitors/Re-start of SGLT2 inhibitors after treatment/Re-admission with C19 and DKA 2 days after discharge] Diabetic Complications. The 37 Meeting of the Japan Society of Diabetic Complications/The 28th Meeting of the Japanese Society of Ophthalmic Diabetology. 2022.9.20;2022.10.21,22;36:S-1:228",6.0,DEC,A,F,Y,,,20221118,,MD,JP,JP,2022,Q4,Child
215435402,21543540,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram, 1/week",,,,,,,,0.5,MG,,/WK,2022,Q4,COVID-19,,2022,Q4,2,F,,20221108.0,20221102,20221118,EXP,,JP-JNJFOC-20221102935,JOHNSON AND JOHNSON,"Numura T, [W27-3 A case of hospital admission with COVID-19 (C19) and DKA while on oral SGLT2 inhibitors/Re-start of SGLT2 inhibitors after treatment/Re-admission with C19 and DKA 2 days after discharge] Diabetic Complications. The 37 Meeting of the Japan Society of Diabetic Complications/The 28th Meeting of the Japanese Society of Ophthalmic Diabetology. 2022.9.20;2022.10.21,22;36:S-1:228",6.0,DEC,A,F,Y,,,20221118,,MD,JP,JP,2022,Q4,Child
215439291,21543929,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Therapy interrupted,,2022,Q4,1,I,20220714.0,20220912.0,20221102,20221102,PER,,US-MYOVANT SCIENCES GMBH-2022MYSCI0700300,MYOVANT SCIENCES,,66.0,YR,,M,Y,,,20221102,,CN,US,US,2022,Q4,Elderly
215439291,21543929,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Product dose omission issue,,2022,Q4,1,I,20220714.0,20220912.0,20221102,20221102,PER,,US-MYOVANT SCIENCES GMBH-2022MYSCI0700300,MYOVANT SCIENCES,,66.0,YR,,M,Y,,,20221102,,CN,US,US,2022,Q4,Elderly
215439291,21543929,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Product distribution issue,,2022,Q4,1,I,20220714.0,20220912.0,20221102,20221102,PER,,US-MYOVANT SCIENCES GMBH-2022MYSCI0700300,MYOVANT SCIENCES,,66.0,YR,,M,Y,,,20221102,,CN,US,US,2022,Q4,Elderly
215449833,21544983,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.25,MG,Unknown,/WK,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,3,F,,20221208.0,20221102,20221219,EXP,,JP-JNJFOC-20221057758,JOHNSON AND JOHNSON,,6.0,DEC,,F,Y,,,20221219,,MD,JP,JP,2022,Q4,Child
215449833,21544983,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.25,MG,Unknown,/WK,2022,Q4,Increased appetite,,2022,Q4,3,F,,20221208.0,20221102,20221219,EXP,,JP-JNJFOC-20221057758,JOHNSON AND JOHNSON,,6.0,DEC,,F,Y,,,20221219,,MD,JP,JP,2022,Q4,Child
215449833,21544983,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,Unknown,/WK,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,3,F,,20221208.0,20221102,20221219,EXP,,JP-JNJFOC-20221057758,JOHNSON AND JOHNSON,,6.0,DEC,,F,Y,,,20221219,,MD,JP,JP,2022,Q4,Child
215449833,21544983,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,0.5,MG,Unknown,/WK,2022,Q4,Increased appetite,,2022,Q4,3,F,,20221208.0,20221102,20221219,EXP,,JP-JNJFOC-20221057758,JOHNSON AND JOHNSON,,6.0,DEC,,F,Y,,,20221219,,MD,JP,JP,2022,Q4,Child
215539331,21553933,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Somnolence,,2022,Q4,1,I,20220404.0,20220603.0,20221104,20221104,PER,,US-Accord-265889,ACCORD,,58.0,YR,,M,Y,115.67,KG,20221104,,CN,US,US,2022,Q4,Adult
215539331,21553933,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Constipation,,2022,Q4,1,I,20220404.0,20220603.0,20221104,20221104,PER,,US-Accord-265889,ACCORD,,58.0,YR,,M,Y,115.67,KG,20221104,,CN,US,US,2022,Q4,Adult
215539331,21553933,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,1,I,20220404.0,20220603.0,20221104,20221104,PER,,US-Accord-265889,ACCORD,,58.0,YR,,M,Y,115.67,KG,20221104,,CN,US,US,2022,Q4,Adult
215539331,21553933,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Feeling jittery,,2022,Q4,1,I,20220404.0,20220603.0,20221104,20221104,PER,,US-Accord-265889,ACCORD,,58.0,YR,,M,Y,115.67,KG,20221104,,CN,US,US,2022,Q4,Adult
215539331,21553933,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Headache,,2022,Q4,1,I,20220404.0,20220603.0,20221104,20221104,PER,,US-Accord-265889,ACCORD,,58.0,YR,,M,Y,115.67,KG,20221104,,CN,US,US,2022,Q4,Adult
215539331,21553933,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,20220404.0,20220603.0,20221104,20221104,PER,,US-Accord-265889,ACCORD,,58.0,YR,,M,Y,115.67,KG,20221104,,CN,US,US,2022,Q4,Adult
215539331,21553933,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Dizziness,,2022,Q4,1,I,20220404.0,20220603.0,20221104,20221104,PER,,US-Accord-265889,ACCORD,,58.0,YR,,M,Y,115.67,KG,20221104,,CN,US,US,2022,Q4,Adult
215539331,21553933,13,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Peripheral swelling,,2022,Q4,1,I,20220404.0,20220603.0,20221104,20221104,PER,,US-Accord-265889,ACCORD,,58.0,YR,,M,Y,115.67,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Peripheral swelling,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Somnolence,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Insomnia,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Constipation,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Dizziness,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Headache,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Blood pressure increased,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Feeling jittery,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Palpitations,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539401,21553940,15,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Muscle spasms,,2022,Q4,1,I,20220404.0,20220621.0,20221104,20221104,PER,,US-Accord-267604,ACCORD,,58.0,YR,,M,Y,115.6,KG,20221104,,CN,US,US,2022,Q4,Adult
215539741,21553974,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Bladder discomfort,,2022,Q4,1,I,20220301.0,20220422.0,20221104,20221104,PER,,US-Accord-262436,ACCORD,,57.0,YR,,F,Y,104.33,KG,20221104,,CN,US,US,2022,Q4,Adult
215539741,21553974,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20220301.0,20220422.0,20221104,20221104,PER,,US-Accord-262436,ACCORD,,57.0,YR,,F,Y,104.33,KG,20221104,,CN,US,US,2022,Q4,Adult
215539741,21553974,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20220301.0,20220422.0,20221104,20221104,PER,,US-Accord-262436,ACCORD,,57.0,YR,,F,Y,104.33,KG,20221104,,CN,US,US,2022,Q4,Adult
215539741,21553974,23,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Blood pressure increased,,2022,Q4,1,I,20220301.0,20220422.0,20221104,20221104,PER,,US-Accord-262436,ACCORD,,57.0,YR,,F,Y,104.33,KG,20221104,,CN,US,US,2022,Q4,Adult
215634041,21563404,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2022,Q4,Peripheral swelling,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,CA-JNJFOC-20221109215,JOHNSON AND JOHNSON,,46.0,YR,A,M,Y,75.0,KG,20221108,,HP,CA,CA,2022,Q4,Adult
215634041,21563404,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2022,Q4,Weight increased,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,CA-JNJFOC-20221109215,JOHNSON AND JOHNSON,,46.0,YR,A,M,Y,75.0,KG,20221108,,HP,CA,CA,2022,Q4,Adult
215634041,21563404,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2022,Q4,Discomfort,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,CA-JNJFOC-20221109215,JOHNSON AND JOHNSON,,46.0,YR,A,M,Y,75.0,KG,20221108,,HP,CA,CA,2022,Q4,Adult
215634041,21563404,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2022,Q4,Poor venous access,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,CA-JNJFOC-20221109215,JOHNSON AND JOHNSON,,46.0,YR,A,M,Y,75.0,KG,20221108,,HP,CA,CA,2022,Q4,Adult
215634041,21563404,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2022,Q4,Intentional product use issue,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,CA-JNJFOC-20221109215,JOHNSON AND JOHNSON,,46.0,YR,A,M,Y,75.0,KG,20221108,,HP,CA,CA,2022,Q4,Adult
215634041,21563404,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,1.0,MG,Solution,,2022,Q4,Off label use,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,CA-JNJFOC-20221109215,JOHNSON AND JOHNSON,,46.0,YR,A,M,Y,75.0,KG,20221108,,HP,CA,CA,2022,Q4,Adult
215648351,21564835,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Rash pruritic,,2022,Q4,1,I,20220318.0,20221029.0,20221108,20221108,EXP,,PT-AUROBINDO-AUR-APL-2022-047226,AUROBINDO,,67.0,YR,,F,Y,134.0,KG,20221108,,MD,PT,PT,2022,Q4,Elderly
215648351,21564835,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Tongue oedema,,2022,Q4,1,I,20220318.0,20221029.0,20221108,20221108,EXP,,PT-AUROBINDO-AUR-APL-2022-047226,AUROBINDO,,67.0,YR,,F,Y,134.0,KG,20221108,,MD,PT,PT,2022,Q4,Elderly
215687171,21568717,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,Frequency : Weekly;?,,,,,,,,1.0,MG,,QW,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,20221027.0,,20221107,20221107,DIR,FDA-CDER-CTU-2022-89058,,FDA-CTU,,64.0,YR,,F,N,,,20221103,N,PH,US,,2022,Q4,Adult
215750711,21575071,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"2.4 mg, qw",,,,,,,215256.0,2.4,MG,Solution for injection,/WK,2022,Q4,Cholecystitis chronic,,2022,Q4,1,I,20221010.0,20221031.0,20221110,20221110,EXP,,BG-NOVOPROD-971231,NOVO NORDISK,,62.0,YR,,M,Y,122.0,KG,20221110,,MD,BG,BG,2022,Q4,Adult
215777261,21577726,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Chest pain,,2022,Q4,1,I,20221103.0,,20221109,20221109,DIR,637771,,FDA-CTU,,45.0,YR,,M,N,83.0,KG,20221109,N,PH,US,,2022,Q4,Adult
215777261,21577726,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,1,I,20221103.0,,20221109,20221109,DIR,637771,,FDA-CTU,,45.0,YR,,M,N,83.0,KG,20221109,N,PH,US,,2022,Q4,Adult
215777261,21577726,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,20221103.0,,20221109,20221109,DIR,637771,,FDA-CTU,,45.0,YR,,M,N,83.0,KG,20221109,N,PH,US,,2022,Q4,Adult
215777261,21577726,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221103.0,,20221109,20221109,DIR,637771,,FDA-CTU,,45.0,YR,,M,N,83.0,KG,20221109,N,PH,US,,2022,Q4,Adult
215777261,21577726,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,20221103.0,,20221109,20221109,DIR,637771,,FDA-CTU,,45.0,YR,,M,N,83.0,KG,20221109,N,PH,US,,2022,Q4,Adult
215777261,21577726,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20221103.0,,20221109,20221109,DIR,637771,,FDA-CTU,,45.0,YR,,M,N,83.0,KG,20221109,N,PH,US,,2022,Q4,Adult
215777261,21577726,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Ketoacidosis,,2022,Q4,1,I,20221103.0,,20221109,20221109,DIR,637771,,FDA-CTU,,45.0,YR,,M,N,83.0,KG,20221109,N,PH,US,,2022,Q4,Adult
215797211,21579721,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw",,,,,,,,1.0,MG,,/WK,2022,Q4,Administration site extravasation,,2022,Q4,1,I,20220902.0,20221105.0,20221110,20221110,EXP,,US-JAZZ-2022-US-034668,JAZZ,,52.0,YR,,F,Y,133.0,KG,20221110,,MD,US,US,2022,Q4,Adult
215797211,21579721,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 milligram, qw",,,,,,,,1.0,MG,,/WK,2022,Q4,Cellulitis,,2022,Q4,1,I,20220902.0,20221105.0,20221110,20221110,EXP,,US-JAZZ-2022-US-034668,JAZZ,,52.0,YR,,F,Y,133.0,KG,20221110,,MD,US,US,2022,Q4,Adult
215845261,21584526,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Drug level above therapeutic,,2022,Q4,1,I,,20221106.0,20221111,20221111,EXP,,NVSC2022US250142,NOVARTIS,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2022;1-3",76.0,YR,,M,Y,,,20221111,,HP,US,US,2022,Q4,Elderly
215845261,21584526,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221106.0,20221111,20221111,EXP,,NVSC2022US250142,NOVARTIS,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2022;1-3",76.0,YR,,M,Y,,,20221111,,HP,US,US,2022,Q4,Elderly
215845261,21584526,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221106.0,20221111,20221111,EXP,,NVSC2022US250142,NOVARTIS,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2022;1-3",76.0,YR,,M,Y,,,20221111,,HP,US,US,2022,Q4,Elderly
215852791,21585279,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Tongue oedema,,2022,Q4,1,I,20220318.0,20221106.0,20221111,20221111,EXP,PT-INFARMED-V202210-953,PT-TEVA-2022-PT-2825542,TEVA,,67.0,YR,E,F,Y,134.0,KG,20221111,,MD,PT,PT,2022,Q4,Elderly
215852791,21585279,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Rash pruritic,,2022,Q4,1,I,20220318.0,20221106.0,20221111,20221111,EXP,PT-INFARMED-V202210-953,PT-TEVA-2022-PT-2825542,TEVA,,67.0,YR,E,F,Y,134.0,KG,20221111,,MD,PT,PT,2022,Q4,Elderly
215887491,21588749,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram weekly,,,U,,,,,1.0,MG,,,2022,Q4,Mental disorder,,2022,Q4,1,I,,20221030.0,20221114,20221114,EXP,,AU-HETERO-HET2022AU02711,HETERO,,48.0,YR,,M,Y,90.0,KG,20221114,,MD,AU,AU,2022,Q4,Adult
215887491,21588749,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram weekly,,,U,,,,,1.0,MG,,,2022,Q4,Schizophrenia,,2022,Q4,1,I,,20221030.0,20221114,20221114,EXP,,AU-HETERO-HET2022AU02711,HETERO,,48.0,YR,,M,Y,90.0,KG,20221114,,MD,AU,AU,2022,Q4,Adult
215887491,21588749,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram weekly,,,U,,,,,1.0,MG,,,2022,Q4,Blood pressure decreased,,2022,Q4,1,I,,20221030.0,20221114,20221114,EXP,,AU-HETERO-HET2022AU02711,HETERO,,48.0,YR,,M,Y,90.0,KG,20221114,,MD,AU,AU,2022,Q4,Adult
215887491,21588749,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram weekly,,,U,,,,,1.0,MG,,,2022,Q4,Dizziness,,2022,Q4,1,I,,20221030.0,20221114,20221114,EXP,,AU-HETERO-HET2022AU02711,HETERO,,48.0,YR,,M,Y,90.0,KG,20221114,,MD,AU,AU,2022,Q4,Adult
215887491,21588749,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,1 milligram weekly,,,U,,,,,1.0,MG,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221030.0,20221114,20221114,EXP,,AU-HETERO-HET2022AU02711,HETERO,,48.0,YR,,M,Y,90.0,KG,20221114,,MD,AU,AU,2022,Q4,Adult
216109171,21610917,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,,,,0.5,MG,,999,2022,Q4,Pancreatitis necrotising,,2022,Q4,1,I,20221027.0,,20221117,20221117,DIR,638703,,FDA-CTU,,57.0,YR,,F,N,83.2,KG,20221117,N,PH,US,,2022,Q4,Adult
216109171,21610917,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,,,,0.5,MG,,999,2022,Q4,Alcohol use,,2022,Q4,1,I,20221027.0,,20221117,20221117,DIR,638703,,FDA-CTU,,57.0,YR,,F,N,83.2,KG,20221117,N,PH,US,,2022,Q4,Adult
216109171,21610917,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,,,,0.5,MG,,999,2022,Q4,Mesenteric vein thrombosis,,2022,Q4,1,I,20221027.0,,20221117,20221117,DIR,638703,,FDA-CTU,,57.0,YR,,F,N,83.2,KG,20221117,N,PH,US,,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Blood glucose decreased,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Nasal congestion,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Dry mouth,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Blood calcium increased,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Headache,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Hepatic enzyme increased,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Decreased appetite,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Blood pressure increased,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Cortisol increased,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Back pain,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Blood thyroid stimulating hormone decreased,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216125801,21612580,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Palpitations,,2022,Q4,1,I,20220107.0,20220301.0,20221118,20221118,PER,,US-BION-010344,BIONPHARMA,,59.0,YR,A,M,Y,88.4,KG,20221118,,CN,US,US,2022,Q4,Adult
216135241,21613524,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Appendicectomy,,2022,Q4,1,I,20220928.0,,20221117,20221117,DIR,FDA-CDER-CTU-2022-92134,,FDA-CTU,,12.0,YR,,M,N,65.2,KG,20221117,N,CN,US,,2022,Q4,Child
216135241,21613524,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220928.0,,20221117,20221117,DIR,FDA-CDER-CTU-2022-92134,,FDA-CTU,,12.0,YR,,M,N,65.2,KG,20221117,N,CN,US,,2022,Q4,Child
216225881,21622588,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Nasal congestion,,2022,Q4,1,I,20221116.0,20221118.0,20221121,20221121,PER,,US-PFIZER INC-202201313230,PFIZER,,42.0,YR,,F,Y,,,20221121,,CN,US,US,2022,Q4,Adult
216225881,21622588,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,20221116.0,20221118.0,20221121,20221121,PER,,US-PFIZER INC-202201313230,PFIZER,,42.0,YR,,F,Y,,,20221121,,CN,US,US,2022,Q4,Adult
216284161,21628416,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,PCO2 decreased,,2022,Q4,1,I,20221115.0,,20221121,20221121,DIR,639055,,FDA-CTU,,28.0,YR,,F,N,106.3,KG,20221121,N,PH,US,,2022,Q4,Young Adult
216284161,21628416,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Anion gap increased,,2022,Q4,1,I,20221115.0,,20221121,20221121,DIR,639055,,FDA-CTU,,28.0,YR,,F,N,106.3,KG,20221121,N,PH,US,,2022,Q4,Young Adult
216284161,21628416,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Euglycaemic diabetic ketoacidosis,,2022,Q4,1,I,20221115.0,,20221121,20221121,DIR,639055,,FDA-CTU,,28.0,YR,,F,N,106.3,KG,20221121,N,PH,US,,2022,Q4,Young Adult
216316892,21631689,3,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,3,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2022,Q4,Acute kidney injury,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,3,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2022,Q4,Diarrhoea,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,3,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2022,Q4,Lactic acidosis,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,3,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2022,Q4,Dehydration,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,3,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2022,Q4,Decreased appetite,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,3,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,3.0mg UNKNOWN,,,,,,,,3.0,MG,,,2022,Q4,Cardiac arrest,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,4,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,7.0mg UNKNOWN,,,,,,,,7.0,MG,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,4,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,7.0mg UNKNOWN,,,,,,,,7.0,MG,,,2022,Q4,Acute kidney injury,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,4,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,7.0mg UNKNOWN,,,,,,,,7.0,MG,,,2022,Q4,Diarrhoea,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,4,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,7.0mg UNKNOWN,,,,,,,,7.0,MG,,,2022,Q4,Lactic acidosis,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,4,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,7.0mg UNKNOWN,,,,,,,,7.0,MG,,,2022,Q4,Dehydration,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,4,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,7.0mg UNKNOWN,,,,,,,,7.0,MG,,,2022,Q4,Decreased appetite,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,4,C,SEMAGLUTIDE(GENETICAL RECOMBINATION),,2,Oral,7.0mg UNKNOWN,,,,,,,,7.0,MG,,,2022,Q4,Cardiac arrest,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216418792,21641879,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, qd",1365.0,MG,D,,,,213051.0,3.0,MG,Tablet,QD,2022,Q4,Cholecystitis acute,,2022,Q4,2,F,20221003.0,20221115.0,20221125,20221125,EXP,,TH-NOVOPROD-966900,NOVO NORDISK,,78.0,YR,,F,Y,65.0,KG,20221125,,MD,TH,TH,2022,Q4,Elderly
216418792,21641879,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"3 mg, qd",1365.0,MG,D,,,,213051.0,3.0,MG,Tablet,QD,2022,Q4,Bile duct stone,,2022,Q4,2,F,20221003.0,20221115.0,20221125,20221125,EXP,,TH-NOVOPROD-966900,NOVO NORDISK,,78.0,YR,,F,Y,65.0,KG,20221125,,MD,TH,TH,2022,Q4,Elderly
216491211,21649121,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Wheezing,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Hypoacusis,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Sleep disorder,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Asthma,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Depression,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,13,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Diabetes mellitus,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2022,Q4,Wheezing,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2022,Q4,Hypoacusis,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2022,Q4,Sleep disorder,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2022,Q4,Asthma,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2022,Q4,Depression,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216491211,21649121,14,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"UNK, solution subceutaneous",,,U,,,,,,,,,2022,Q4,Diabetes mellitus,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,NVSC2022CA263463,NOVARTIS,,51.0,YR,,F,Y,,,20221128,,CN,CA,CA,2022,Q4,Adult
216579291,21657929,3,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"1 dosage form, QW",,,,,,,,,,,/WK,2022,Q4,Folliculitis,,2022,Q4,1,I,20220824.0,20221123.0,20221129,20221129,EXP,CH-SM-2022-20431,NVSC2022CH263885,NOVARTIS,,41.0,YR,,M,Y,,,20221129,,MD,CH,CH,2022,Q4,Adult
216580071,21658007,24,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Pruritus,,2022,Q4,1,I,20221101.0,20221118.0,20221129,20221129,PER,,US-BEH-2022152345,CSL BEHRING,,62.0,YR,A,F,Y,,,20221129,,CN,US,US,2022,Q4,Adult
216637241,21663724,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,20202atwl,,,0.5,MG,Injection,/WK,2022,Q4,Mental fatigue,,2022,Q4,1,I,20221109.0,20221122.0,20221130,20221130,EXP,,CN-AstraZeneca-2022A389333,ASTRAZENECA,,43.0,YR,,F,Y,75.0,KG,20221130,,MD,CN,,2022,Q4,Adult
216637241,21663724,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,20202atwl,,,0.5,MG,Injection,/WK,2022,Q4,Urine ketone body present,,2022,Q4,1,I,20221109.0,20221122.0,20221130,20221130,EXP,,CN-AstraZeneca-2022A389333,ASTRAZENECA,,43.0,YR,,F,Y,75.0,KG,20221130,,MD,CN,,2022,Q4,Adult
216637241,21663724,2,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,20202atwl,,,0.5,MG,Injection,/WK,2022,Q4,Blood ketone body present,,2022,Q4,1,I,20221109.0,20221122.0,20221130,20221130,EXP,,CN-AstraZeneca-2022A389333,ASTRAZENECA,,43.0,YR,,F,Y,75.0,KG,20221130,,MD,CN,,2022,Q4,Adult
216643281,21664328,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,,,2022,Q4,Anuria,,2022,Q4,1,I,20220613.0,20221123.0,20221130,20221130,EXP,,LV-AstraZeneca-2022A389727,ASTRAZENECA,,21337.0,DY,,F,Y,136.0,KG,20221130,,MD,LV,,2022,Q4,Elderly
216643391,21664339,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram (Wednesdays, prefilled injections)",,,U,U,,,,0.5,MG,Injection,,2022,Q4,Therapeutic drug monitoring analysis incorrectly performed,,2022,Q4,1,I,,20221128.0,20221130,20221130,EXP,,DE-MYLANLABS-2022M1134110,MYLAN,,59.0,YR,,M,Y,125.0,KG,20221130,,PH,DE,DE,2022,Q4,Adult
216643391,21664339,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram (Wednesdays, prefilled injections)",,,U,U,,,,0.5,MG,Injection,,2022,Q4,Erythema,,2022,Q4,1,I,,20221128.0,20221130,20221130,EXP,,DE-MYLANLABS-2022M1134110,MYLAN,,59.0,YR,,M,Y,125.0,KG,20221130,,PH,DE,DE,2022,Q4,Adult
216643391,21664339,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram (Wednesdays, prefilled injections)",,,U,U,,,,0.5,MG,Injection,,2022,Q4,Wound secretion,,2022,Q4,1,I,,20221128.0,20221130,20221130,EXP,,DE-MYLANLABS-2022M1134110,MYLAN,,59.0,YR,,M,Y,125.0,KG,20221130,,PH,DE,DE,2022,Q4,Adult
216643391,21664339,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram (Wednesdays, prefilled injections)",,,U,U,,,,0.5,MG,Injection,,2022,Q4,Limb injury,,2022,Q4,1,I,,20221128.0,20221130,20221130,EXP,,DE-MYLANLABS-2022M1134110,MYLAN,,59.0,YR,,M,Y,125.0,KG,20221130,,PH,DE,DE,2022,Q4,Adult
216643391,21664339,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram (Wednesdays, prefilled injections)",,,U,U,,,,0.5,MG,Injection,,2022,Q4,Impaired healing,,2022,Q4,1,I,,20221128.0,20221130,20221130,EXP,,DE-MYLANLABS-2022M1134110,MYLAN,,59.0,YR,,M,Y,125.0,KG,20221130,,PH,DE,DE,2022,Q4,Adult
216643391,21664339,2,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"0.5 milligram (Wednesdays, prefilled injections)",,,U,U,,,,0.5,MG,Injection,,2022,Q4,Foot amputation,,2022,Q4,1,I,,20221128.0,20221130,20221130,EXP,,DE-MYLANLABS-2022M1134110,MYLAN,,59.0,YR,,M,Y,125.0,KG,20221130,,PH,DE,DE,2022,Q4,Adult
216645901,21664590,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,0.25mg/0.19ml solution for injection 1.5ml pre-filled disposable device,,,,,,,,,,Solution for injection,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,,20220406.0,20221130,20221130,EXP,GB-MHRA-MIDB-ad25aecb-8b1a-412a-9572-790cfda81cf0,GB-JNJFOC-20220953764,JOHNSON AND JOHNSON,,59.0,YR,A,F,Y,,,20221130,,PH,GB,GB,2022,Q4,Adult
216729021,21672902,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,US-MICRO LABS LIMITED-ML2022-05974,MICRO LABS,,76.0,YR,E,M,Y,,,20221202,,MD,US,,2022,Q4,Elderly
216729021,21672902,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Immunosuppressant drug level increased,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,US-MICRO LABS LIMITED-ML2022-05974,MICRO LABS,,76.0,YR,E,M,Y,,,20221202,,MD,US,,2022,Q4,Elderly
216729021,21672902,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,US-MICRO LABS LIMITED-ML2022-05974,MICRO LABS,,76.0,YR,E,M,Y,,,20221202,,MD,US,,2022,Q4,Elderly
216840811,21684081,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2022,Q4,Stress,,2022,Q4,1,I,,20221128.0,20221205,20221205,EXP,,CA-JNJFOC-20221201969,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,74.0,KG,20221205,,HP,CA,CA,2022,Q4,Adult
216840811,21684081,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2022,Q4,Blood pressure fluctuation,,2022,Q4,1,I,,20221128.0,20221205,20221205,EXP,,CA-JNJFOC-20221201969,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,74.0,KG,20221205,,HP,CA,CA,2022,Q4,Adult
216840811,21684081,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2022,Q4,Hypertension,,2022,Q4,1,I,,20221128.0,20221205,20221205,EXP,,CA-JNJFOC-20221201969,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,74.0,KG,20221205,,HP,CA,CA,2022,Q4,Adult
216840811,21684081,16,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,,,,,,,,Solution,/WK,2022,Q4,Gait disturbance,,2022,Q4,1,I,,20221128.0,20221205,20221205,EXP,,CA-JNJFOC-20221201969,JOHNSON AND JOHNSON,,58.0,YR,A,M,Y,74.0,KG,20221205,,HP,CA,CA,2022,Q4,Adult
216852551,21685255,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221124.0,20221206,20221206,EXP,,US-CIPLA LTD.-2022US07009,CIPLA,"Stawiarski K, Umapathi P, Avery R, Strout S. Risks of paxlovid in a heart transplant recipient. The Journal of heart and lung transplantation. 2022",76.0,YR,,M,Y,,,20221206,,HP,US,US,2022,Q4,Elderly
216852551,21685255,7,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221124.0,20221206,20221206,EXP,,US-CIPLA LTD.-2022US07009,CIPLA,"Stawiarski K, Umapathi P, Avery R, Strout S. Risks of paxlovid in a heart transplant recipient. The Journal of heart and lung transplantation. 2022",76.0,YR,,M,Y,,,20221206,,HP,US,US,2022,Q4,Elderly
216906011,21690601,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,UNKNOWN,,,,,,,2022,Q4,Immunosuppressant drug level increased,,2022,Q4,1,I,,20221124.0,20221206,20221206,EXP,,US-drreddys-SPO/USA/22/0157791,DR REDDYS,"Umapathi P, Stawiarski K, Avery R, Strout S. Risks of paxlovid in a heart transplant recipient. J Heart Lung Transplant. 2022;UNK:UNK-UNK. doi:10.1016/j.healun.2022.08.029",76.0,YR,E,M,Y,,,20221207,,MD,US,US,2022,Q4,Elderly
216906011,21690601,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,UNKNOWN,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221124.0,20221206,20221206,EXP,,US-drreddys-SPO/USA/22/0157791,DR REDDYS,"Umapathi P, Stawiarski K, Avery R, Strout S. Risks of paxlovid in a heart transplant recipient. J Heart Lung Transplant. 2022;UNK:UNK-UNK. doi:10.1016/j.healun.2022.08.029",76.0,YR,E,M,Y,,,20221207,,MD,US,US,2022,Q4,Elderly
216906011,21690601,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,UNKNOWN,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221124.0,20221206,20221206,EXP,,US-drreddys-SPO/USA/22/0157791,DR REDDYS,"Umapathi P, Stawiarski K, Avery R, Strout S. Risks of paxlovid in a heart transplant recipient. J Heart Lung Transplant. 2022;UNK:UNK-UNK. doi:10.1016/j.healun.2022.08.029",76.0,YR,E,M,Y,,,20221207,,MD,US,US,2022,Q4,Elderly
216922671,21692267,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221124.0,20221207,20221207,EXP,,US-Accord-289978,ACCORD,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2022",76.0,YR,E,M,Y,,,20221207,,MD,US,US,2022,Q4,Elderly
216922671,21692267,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221124.0,20221207,20221207,EXP,,US-Accord-289978,ACCORD,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2022",76.0,YR,E,M,Y,,,20221207,,MD,US,US,2022,Q4,Elderly
216922671,21692267,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Immunosuppressant drug level increased,,2022,Q4,1,I,,20221124.0,20221207,20221207,EXP,,US-Accord-289978,ACCORD,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2022",76.0,YR,E,M,Y,,,20221207,,MD,US,US,2022,Q4,Elderly
216935731,21693573,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221130.0,20221207,20221207,EXP,,US-MYLANLABS-2022M1136506,MYLAN,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. J-Heart-Lung-Transplant 2022;null:null.",76.0,YR,,M,Y,,,20221207,,MD,US,US,2022,Q4,Elderly
216935731,21693573,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Immunosuppressant drug level increased,,2022,Q4,1,I,,20221130.0,20221207,20221207,EXP,,US-MYLANLABS-2022M1136506,MYLAN,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. J-Heart-Lung-Transplant 2022;null:null.",76.0,YR,,M,Y,,,20221207,,MD,US,US,2022,Q4,Elderly
216935731,21693573,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221130.0,20221207,20221207,EXP,,US-MYLANLABS-2022M1136506,MYLAN,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. J-Heart-Lung-Transplant 2022;null:null.",76.0,YR,,M,Y,,,20221207,,MD,US,US,2022,Q4,Elderly
216935731,21693573,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221130.0,20221207,20221207,EXP,,US-MYLANLABS-2022M1136506,MYLAN,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. J-Heart-Lung-Transplant 2022;null:null.",76.0,YR,,M,Y,,,20221207,,MD,US,US,2022,Q4,Elderly
216947601,21694760,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Balanoposthitis,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Coronary artery disease,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Albuminuria,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,U,,,,,,,,,2022,Q4,Angina pectoris,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216961911,21696191,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous, 0.5 MG QWEEK SQ,,,Y,D,,,,0.5,MG,,QW,2022,Q4,Cholecystitis,,2022,Q4,1,I,20220809.0,,20221207,20221207,DIR,FDA-CDER-CTU-2022-97099,,FDA-CTU,,67.0,YR,,M,N,,,20221202,N,HP,US,,2022,Q4,Elderly
216988691,21698869,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Immunosuppressant drug level increased,,2022,Q4,1,I,,20221124.0,20221208,20221208,EXP,,US-AUROBINDO-AUR-APL-2022-050618,AUROBINDO,"Umapathi P, Stawiarski K, Avery R, Strout S.. Risks of paxlovid in a heart transplant recipient. The Journal of heart and lung transplantation. 2022",76.0,YR,,M,Y,,,20221208,,MD,US,US,2022,Q4,Elderly
216988691,21698869,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221124.0,20221208,20221208,EXP,,US-AUROBINDO-AUR-APL-2022-050618,AUROBINDO,"Umapathi P, Stawiarski K, Avery R, Strout S.. Risks of paxlovid in a heart transplant recipient. The Journal of heart and lung transplantation. 2022",76.0,YR,,M,Y,,,20221208,,MD,US,US,2022,Q4,Elderly
216988691,21698869,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221124.0,20221208,20221208,EXP,,US-AUROBINDO-AUR-APL-2022-050618,AUROBINDO,"Umapathi P, Stawiarski K, Avery R, Strout S.. Risks of paxlovid in a heart transplant recipient. The Journal of heart and lung transplantation. 2022",76.0,YR,,M,Y,,,20221208,,MD,US,US,2022,Q4,Elderly
217003321,21700332,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,Y,D,,,,0.25,MG,,QW,2022,Q4,Dermatitis allergic,,2022,Q4,1,I,20220915.0,,20221207,20221207,DIR,FDA-CDER-CTU-2022-97246,,FDA-CTU,,73.0,YR,,M,N,138.8,KG,20221123,N,PH,US,,2022,Q4,Elderly
217003321,21700332,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,Y,D,,,,0.25,MG,,QW,2022,Q4,Rash pruritic,,2022,Q4,1,I,20220915.0,,20221207,20221207,DIR,FDA-CDER-CTU-2022-97246,,FDA-CTU,,73.0,YR,,M,N,138.8,KG,20221123,N,PH,US,,2022,Q4,Elderly
217003321,21700332,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,Y,D,,,,0.25,MG,,QW,2022,Q4,Pemphigoid,,2022,Q4,1,I,20220915.0,,20221207,20221207,DIR,FDA-CDER-CTU-2022-97246,,FDA-CTU,,73.0,YR,,M,N,138.8,KG,20221123,N,PH,US,,2022,Q4,Elderly
217003321,21700332,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,Y,D,,,,0.25,MG,,QW,2022,Q4,Blister,,2022,Q4,1,I,20220915.0,,20221207,20221207,DIR,FDA-CDER-CTU-2022-97246,,FDA-CTU,,73.0,YR,,M,N,138.8,KG,20221123,N,PH,US,,2022,Q4,Elderly
217003321,21700332,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.25 MG QWEEK SQ,,,Y,D,,,,0.25,MG,,QW,2022,Q4,Papule,,2022,Q4,1,I,20220915.0,,20221207,20221207,DIR,FDA-CDER-CTU-2022-97246,,FDA-CTU,,73.0,YR,,M,N,138.8,KG,20221123,N,PH,US,,2022,Q4,Elderly
217004911,21700491,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,"OTHER STRENGTH : 1MG/0.75ML, 3ML;?Frequency : Weekly;?",,,Y,D,,,,1.0,MG,,QW,2022,Q4,Cholecystitis,,2022,Q4,1,I,20221010.0,,20221207,20221207,DIR,FDA-CDER-CTU-2022-97258,,FDA-CTU,,74.0,YR,,M,N,,,20221122,N,PH,US,,2022,Q4,Elderly
217030251,21703025,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram per week,,,D,,,,,1.0,MG,Injection,,2022,Q4,Hyperphagia,,2022,Q4,1,I,,20220428.0,20221209,20221209,PER,,US-STRIDES ARCOLAB LIMITED-2022SP005035,STRIDES,"Goldman VE, Naguib MN, Vidmar AP.. Anti-obesity medication use in children and adolescents with prader-willi syndrome: Case review and literature search.. J-Clin-Med. 2021;10:19",12.0,YR,,M,Y,,,20221209,,HP,US,US,2022,Q4,Child
217030251,21703025,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram per week,,,D,,,,,1.0,MG,Injection,,2022,Q4,Off label use,,2022,Q4,1,I,,20220428.0,20221209,20221209,PER,,US-STRIDES ARCOLAB LIMITED-2022SP005035,STRIDES,"Goldman VE, Naguib MN, Vidmar AP.. Anti-obesity medication use in children and adolescents with prader-willi syndrome: Case review and literature search.. J-Clin-Med. 2021;10:19",12.0,YR,,M,Y,,,20221209,,HP,US,US,2022,Q4,Child
217030251,21703025,5,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,1 milligram per week,,,D,,,,,1.0,MG,Injection,,2022,Q4,Condition aggravated,,2022,Q4,1,I,,20220428.0,20221209,20221209,PER,,US-STRIDES ARCOLAB LIMITED-2022SP005035,STRIDES,"Goldman VE, Naguib MN, Vidmar AP.. Anti-obesity medication use in children and adolescents with prader-willi syndrome: Case review and literature search.. J-Clin-Med. 2021;10:19",12.0,YR,,M,Y,,,20221209,,HP,US,US,2022,Q4,Child
217044201,21704420,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,CA-TEVA-2022-CA-2832785,TEVA,,56.0,YR,A,F,Y,,,20221209,,HP,CA,CA,2022,Q4,Adult
217044201,21704420,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Malaise,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,CA-TEVA-2022-CA-2832785,TEVA,,56.0,YR,A,F,Y,,,20221209,,HP,CA,CA,2022,Q4,Adult
217044201,21704420,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Nasopharyngitis,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,CA-TEVA-2022-CA-2832785,TEVA,,56.0,YR,A,F,Y,,,20221209,,HP,CA,CA,2022,Q4,Adult
217044201,21704420,25,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Vascular device infection,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,CA-TEVA-2022-CA-2832785,TEVA,,56.0,YR,A,F,Y,,,20221209,,HP,CA,CA,2022,Q4,Adult
217044831,21704483,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP016374,STRIDES,"Stawiarski K, Avery R, Strout S, Umapathi P.. Risks of paxlovid in a heart transplant recipient.. J-Heart-Lung-Transplant.. 2022",76.0,YR,,M,Y,,,20221209,,MD,US,US,2022,Q4,Elderly
217044831,21704483,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Immunosuppressant drug level increased,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP016374,STRIDES,"Stawiarski K, Avery R, Strout S, Umapathi P.. Risks of paxlovid in a heart transplant recipient.. J-Heart-Lung-Transplant.. 2022",76.0,YR,,M,Y,,,20221209,,MD,US,US,2022,Q4,Elderly
217044831,21704483,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP016374,STRIDES,"Stawiarski K, Avery R, Strout S, Umapathi P.. Risks of paxlovid in a heart transplant recipient.. J-Heart-Lung-Transplant.. 2022",76.0,YR,,M,Y,,,20221209,,MD,US,US,2022,Q4,Elderly
217044831,21704483,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP016374,STRIDES,"Stawiarski K, Avery R, Strout S, Umapathi P.. Risks of paxlovid in a heart transplant recipient.. J-Heart-Lung-Transplant.. 2022",76.0,YR,,M,Y,,,20221209,,MD,US,US,2022,Q4,Elderly
217124461,21712446,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221130.0,20221212,20221212,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-14235,LUPIN,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. The Journal of Heart and Lung Transplantation. 2022;1-3",76.0,YR,,M,Y,,,20221212,,MD,US,US,2022,Q4,Elderly
217124461,21712446,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221130.0,20221212,20221212,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-14235,LUPIN,"Stawiarski K, Avery R, Strout S, Umapathi P. Risks of paxlovid in a heart transplant recipient. The Journal of Heart and Lung Transplantation. 2022;1-3",76.0,YR,,M,Y,,,20221212,,MD,US,US,2022,Q4,Elderly
217129611,21712961,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2 MG QWEEK SQ,,,D,D,,,,2.0,MG,,QW,2022,Q4,Pancreatitis acute,,2022,Q4,1,I,20221116.0,,20221208,20221208,DIR,FDA-CDER-CTU-2022-97913,,FDA-CTU,,75.0,YR,,M,N,103.0,KG,20221116,N,HP,US,,2022,Q4,Elderly
217129611,21712961,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,2 MG QWEEK SQ,,,D,D,,,,2.0,MG,,QW,2022,Q4,Escherichia infection,,2022,Q4,1,I,20221116.0,,20221208,20221208,DIR,FDA-CDER-CTU-2022-97913,,FDA-CTU,,75.0,YR,,M,N,103.0,KG,20221116,N,HP,US,,2022,Q4,Elderly
217141731,21714173,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,Y,,,,,,,,,2022,Q4,Pancreatitis,,2022,Q4,1,I,20220723.0,,20221209,20221209,DIR,FDA-CDER-CTU-2022-98114,,FDA-CTU,,73.0,YR,,M,N,,,20220901,N,HP,US,,2022,Q4,Elderly
217142301,21714230,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,Y,D,,,,0.5,MG,,QW,2022,Q4,Vomiting,,2022,Q4,1,I,20220317.0,,20221209,20221209,DIR,FDA-CDER-CTU-2022-98153,,FDA-CTU,,65.0,YR,,M,N,105.23,KG,20220318,N,HP,US,,2022,Q4,Elderly
217142301,21714230,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,Y,D,,,,0.5,MG,,QW,2022,Q4,Pancreatitis,,2022,Q4,1,I,20220317.0,,20221209,20221209,DIR,FDA-CDER-CTU-2022-98153,,FDA-CTU,,65.0,YR,,M,N,105.23,KG,20220318,N,HP,US,,2022,Q4,Elderly
217142301,21714230,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ,,,Y,D,,,,0.5,MG,,QW,2022,Q4,Nausea,,2022,Q4,1,I,20220317.0,,20221209,20221209,DIR,FDA-CDER-CTU-2022-98153,,FDA-CTU,,65.0,YR,,M,N,105.23,KG,20220318,N,HP,US,,2022,Q4,Elderly
217142581,21714258,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,20190806.0,,20221209,20221209,DIR,FDA-CDER-CTU-2022-98157,,FDA-CTU,,55.0,YR,,M,N,,,20200530,N,HP,US,,2022,Q4,Adult
217142581,21714258,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20190806.0,,20221209,20221209,DIR,FDA-CDER-CTU-2022-98157,,FDA-CTU,,55.0,YR,,M,N,,,20200530,N,HP,US,,2022,Q4,Adult
217142731,21714273,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,20200124.0,,20221209,20221209,DIR,FDA-CDER-CTU-2022-98161,,FDA-CTU,,68.0,YR,,M,N,,,20200529,N,HP,US,,2022,Q4,Elderly
217142731,21714273,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20200124.0,,20221209,20221209,DIR,FDA-CDER-CTU-2022-98161,,FDA-CTU,,68.0,YR,,M,N,,,20200529,N,HP,US,,2022,Q4,Elderly
217142731,21714273,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20200124.0,,20221209,20221209,DIR,FDA-CDER-CTU-2022-98161,,FDA-CTU,,68.0,YR,,M,N,,,20200529,N,HP,US,,2022,Q4,Elderly
217177261,21717726,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Retinopathy,,2022,Q4,1,I,20200212.0,,20221212,20221212,DIR,FDA-CDER-CTU-2022-98574,,FDA-CTU,,61.0,YR,,F,N,,,20200529,N,PH,US,,2022,Q4,Adult
217178101,21717810,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,20190708.0,,20221212,20221212,DIR,FDA-CDER-CTU-2022-98580,,FDA-CTU,,74.0,YR,,M,N,,,20200313,N,HP,US,,2022,Q4,Elderly
217178101,21717810,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20190708.0,,20221212,20221212,DIR,FDA-CDER-CTU-2022-98580,,FDA-CTU,,74.0,YR,,M,N,,,20200313,N,HP,US,,2022,Q4,Elderly
217217271,21721727,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,,,,,2022,Q4,Illness,,2022,Q4,1,I,20221201.0,,20221212,20221212,DIR,FDA-CDER-CTU-2022-98958,,FDA-CTU,,76.0,YR,,M,N,136.7,KG,20221212,N,PH,US,,2022,Q4,Elderly
217217271,21721727,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,,,,D,D,,,,,,,,2022,Q4,Pancreatitis acute,,2022,Q4,1,I,20221201.0,,20221212,20221212,DIR,FDA-CDER-CTU-2022-98958,,FDA-CTU,,76.0,YR,,M,N,136.7,KG,20221212,N,PH,US,,2022,Q4,Elderly
217401661,21740166,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Product dose omission issue,,2022,Q4,1,I,20221206.0,20221212.0,20221216,20221216,PER,,US-PFIZER INC-202201368411,PFIZER,,73.0,YR,,F,Y,,,20221216,,CN,US,US,2022,Q4,Elderly
217401661,21740166,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Disease recurrence,,2022,Q4,1,I,20221206.0,20221212.0,20221216,20221216,PER,,US-PFIZER INC-202201368411,PFIZER,,73.0,YR,,F,Y,,,20221216,,CN,US,US,2022,Q4,Elderly
217401661,21740166,11,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,20221206.0,20221212.0,20221216,20221216,PER,,US-PFIZER INC-202201368411,PFIZER,,73.0,YR,,F,Y,,,20221216,,CN,US,US,2022,Q4,Elderly
217402151,21740215,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ?,,,Y,,MP5D364,,,0.5,MG,,QW,2022,Q4,Dizziness,,2022,Q4,1,I,20221105.0,,20221215,20221215,DIR,FDA-CDER-CTU-2022-99783,,FDA-CTU,,82.0,YR,,M,N,193.0,KG,20221206,N,HP,US,,2022,Q4,Elderly
217402151,21740215,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ?,,,Y,,MP5D364,,,0.5,MG,,QW,2022,Q4,Contusion,,2022,Q4,1,I,20221105.0,,20221215,20221215,DIR,FDA-CDER-CTU-2022-99783,,FDA-CTU,,82.0,YR,,M,N,193.0,KG,20221206,N,HP,US,,2022,Q4,Elderly
217402151,21740215,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ?,,,Y,,MP5D364,,,0.5,MG,,QW,2022,Q4,Hypotension,,2022,Q4,1,I,20221105.0,,20221215,20221215,DIR,FDA-CDER-CTU-2022-99783,,FDA-CTU,,82.0,YR,,M,N,193.0,KG,20221206,N,HP,US,,2022,Q4,Elderly
217402151,21740215,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ?,,,Y,,MP5D364,,,0.5,MG,,QW,2022,Q4,Vision blurred,,2022,Q4,1,I,20221105.0,,20221215,20221215,DIR,FDA-CDER-CTU-2022-99783,,FDA-CTU,,82.0,YR,,M,N,193.0,KG,20221206,N,HP,US,,2022,Q4,Elderly
217402151,21740215,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ?,,,Y,,MP5D364,,,0.5,MG,,QW,2022,Q4,Syncope,,2022,Q4,1,I,20221105.0,,20221215,20221215,DIR,FDA-CDER-CTU-2022-99783,,FDA-CTU,,82.0,YR,,M,N,193.0,KG,20221206,N,HP,US,,2022,Q4,Elderly
217402151,21740215,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,0.5 MG QWEEK SQ?,,,Y,,MP5D364,,,0.5,MG,,QW,2022,Q4,Limb injury,,2022,Q4,1,I,20221105.0,,20221215,20221215,DIR,FDA-CDER-CTU-2022-99783,,FDA-CTU,,82.0,YR,,M,N,193.0,KG,20221206,N,HP,US,,2022,Q4,Elderly
217444521,21744452,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, 1x/week",,,,,,,,1.0,MG,,/WK,2022,Q4,Dehydration,,2022,Q4,1,I,,20221207.0,20221218,20221218,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2022PRN00455,PRINSTON PHARMACEUTICAL,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.. J Pharm Pract. 2022,64.0,YR,,F,Y,80.0,KG,20221216,,PH,US,US,2022,Q4,Adult
217444521,21744452,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, 1x/week",,,,,,,,1.0,MG,,/WK,2022,Q4,Hypovolaemia,,2022,Q4,1,I,,20221207.0,20221218,20221218,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2022PRN00455,PRINSTON PHARMACEUTICAL,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.. J Pharm Pract. 2022,64.0,YR,,F,Y,80.0,KG,20221216,,PH,US,US,2022,Q4,Adult
217444521,21744452,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, 1x/week",,,,,,,,1.0,MG,,/WK,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221207.0,20221218,20221218,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2022PRN00455,PRINSTON PHARMACEUTICAL,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.. J Pharm Pract. 2022,64.0,YR,,F,Y,80.0,KG,20221216,,PH,US,US,2022,Q4,Adult
217444521,21744452,9,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, 1x/week",,,,,,,,1.0,MG,,/WK,2022,Q4,Hypotension,,2022,Q4,1,I,,20221207.0,20221218,20221218,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2022PRN00455,PRINSTON PHARMACEUTICAL,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.. J Pharm Pract. 2022,64.0,YR,,F,Y,80.0,KG,20221216,,PH,US,US,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Rales,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Injury,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Flank pain,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Depressive symptom,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Fall,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Lower respiratory tract infection,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Upper respiratory tract infection,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Appetite disorder,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Dyspnoea exertional,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Rhinorrhoea,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Malaise,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Chest pain,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Insomnia,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Depressed mood,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Cough,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Heart sounds,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Stress,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Wheezing,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Respiration abnormal,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Nasopharyngitis,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Sleep disorder due to a general medical condition,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Productive cough,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Prolonged expiration,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Angina pectoris,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Loss of personal independence in daily activities,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Asthma,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Chest discomfort,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Influenza,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217472591,21747259,49,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Intravenous (not otherwise specified),"1.25 mg, 1 every 1 week",,,U,,,,,1.25,MG,,,2022,Q4,Nasal congestion,,2022,Q4,1,I,,20221214.0,20221219,20221219,EXP,,CA-GLAXOSMITHKLINE-CACH2019GSK000302,GLAXOSMITHKLINE,,61.0,YR,,F,Y,,,20221219,,MD,CA,CA,2022,Q4,Adult
217513201,21751320,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Stevens-Johnson syndrome,,2022,Q4,1,I,,20221212.0,20221220,20221220,EXP,,CA-APOTEX-2022AP016807,APOTEX,,51.0,YR,,M,Y,103.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
217513201,21751320,4,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Pulmonary alveolar haemorrhage,,2022,Q4,1,I,,20221212.0,20221220,20221220,EXP,,CA-APOTEX-2022AP016807,APOTEX,,51.0,YR,,M,Y,103.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
217556021,21755602,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221212.0,20221220,20221220,EXP,,US-TEVA-2022-US-2837333,TEVA,,76.0,YR,E,M,Y,,,20221220,,MD,US,US,2022,Q4,Elderly
217556021,21755602,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q4,Immunosuppressant drug level increased,,2022,Q4,1,I,,20221212.0,20221220,20221220,EXP,,US-TEVA-2022-US-2837333,TEVA,,76.0,YR,E,M,Y,,,20221220,,MD,US,US,2022,Q4,Elderly
217556021,21755602,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,,20221212.0,20221220,20221220,EXP,,US-TEVA-2022-US-2837333,TEVA,,76.0,YR,E,M,Y,,,20221220,,MD,US,US,2022,Q4,Elderly
217556021,21755602,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221212.0,20221220,20221220,EXP,,US-TEVA-2022-US-2837333,TEVA,,76.0,YR,E,M,Y,,,20221220,,MD,US,US,2022,Q4,Elderly
217556021,21755602,12,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221212.0,20221220,20221220,EXP,,US-TEVA-2022-US-2837333,TEVA,,76.0,YR,E,M,Y,,,20221220,,MD,US,US,2022,Q4,Elderly
217578861,21757886,6,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Intradermal,,,,,,,,,1.0,MG,Injection,/WK,2022,Q4,Angioedema,,2022,Q4,1,I,20210504.0,20210713.0,20221221,20221221,EXP,,US-ROCHE-2871027,ROCHE,,48.0,YR,,F,Y,110.3,KG,20221221,,HP,US,,2022,Q4,Adult
217607211,21760721,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 MG QWEEK ,,,D,D,,,,1.0,MG,,QW,2022,Q4,Dermatitis,,2022,Q4,1,I,20221123.0,,20221220,20221220,DIR,FDA-CDER-CTU-2022-101177,,FDA-CTU,,76.0,YR,,M,N,,,20221216,N,HP,US,,2022,Q4,Elderly
217607211,21760721,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 MG QWEEK ,,,D,D,,,,1.0,MG,,QW,2022,Q4,Pemphigoid,,2022,Q4,1,I,20221123.0,,20221220,20221220,DIR,FDA-CDER-CTU-2022-101177,,FDA-CTU,,76.0,YR,,M,N,,,20221216,N,HP,US,,2022,Q4,Elderly
217607211,21760721,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,,1 MG QWEEK ,,,D,D,,,,1.0,MG,,QW,2022,Q4,Rash pruritic,,2022,Q4,1,I,20221123.0,,20221220,20221220,DIR,FDA-CDER-CTU-2022-101177,,FDA-CTU,,76.0,YR,,M,N,,,20221216,N,HP,US,,2022,Q4,Elderly
217700801,21770080,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14.0,mg,Once per day",,,,,,,213051.0,14.0,MG,Tablet,QD,2022,Q4,Cholecystitis acute,,2022,Q4,1,I,20221025.0,20221214.0,20221223,20221223,EXP,,CA-NOVOPROD-1002192,NOVO NORDISK,,79.0,YR,,M,Y,96.0,KG,20221223,,MD,CA,CA,2022,Q4,Elderly
217700801,21770080,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Oral,"14.0,mg,Once per day",,,,,,,213051.0,14.0,MG,Tablet,QD,2022,Q4,Obstructive pancreatitis,,2022,Q4,1,I,20221025.0,20221214.0,20221223,20221223,EXP,,CA-NOVOPROD-1002192,NOVO NORDISK,,79.0,YR,,M,Y,96.0,KG,20221223,,MD,CA,CA,2022,Q4,Elderly
217785421,21778542,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Upper gastrointestinal haemorrhage,,2022,Q4,1,I,,20221215.0,20221226,20221226,EXP,,CA-APOTEX-2022AP017016,APOTEX,,76.0,YR,,M,Y,,,20221226,,PH,CA,CA,2022,Q4,Elderly
217785421,21778542,20,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Angiodysplasia,,2022,Q4,1,I,,20221215.0,20221226,20221226,EXP,,CA-APOTEX-2022AP017016,APOTEX,,76.0,YR,,M,Y,,,20221226,,PH,CA,CA,2022,Q4,Elderly
217823001,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2022,Q4,Blood pressure diastolic decreased,,2022,Q4,1,I,,20221224.0,20221227,20221227,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20221227,,HP,CA,,2022,Q4,Elderly
217823001,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2022,Q4,Type 2 diabetes mellitus,,2022,Q4,1,I,,20221224.0,20221227,20221227,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20221227,,HP,CA,,2022,Q4,Elderly
217823001,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2022,Q4,Blood pressure diastolic abnormal,,2022,Q4,1,I,,20221224.0,20221227,20221227,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20221227,,HP,CA,,2022,Q4,Elderly
217823001,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2022,Q4,Blood pressure systolic increased,,2022,Q4,1,I,,20221224.0,20221227,20221227,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20221227,,HP,CA,,2022,Q4,Elderly
217823001,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221224.0,20221227,20221227,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20221227,,HP,CA,,2022,Q4,Elderly
217823001,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,,20221224.0,20221227,20221227,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20221227,,HP,CA,,2022,Q4,Elderly
217823001,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2022,Q4,Blood pressure fluctuation,,2022,Q4,1,I,,20221224.0,20221227,20221227,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20221227,,HP,CA,,2022,Q4,Elderly
217823001,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2022,Q4,Weight increased,,2022,Q4,1,I,,20221224.0,20221227,20221227,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20221227,,HP,CA,,2022,Q4,Elderly
217823001,21782300,4,SS,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,U,,UNKNOWN,,,,,NOT SPECIFIED,,2022,Q4,Blood pressure increased,,2022,Q4,1,I,,20221224.0,20221227,20221227,EXP,,CA-ROCHE-3250633,ROCHE,,66.0,YR,,F,Y,89.0,KG,20221227,,HP,CA,,2022,Q4,Elderly
217898741,21789874,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, weekly",,,,,,,,1.0,MG,,/WK,2022,Q4,Stevens-Johnson syndrome,,2022,Q4,1,I,,20221223.0,20221228,20221228,EXP,GB-MHRA-MIDB-4e4d9248-8fd2-4039-8064-49e1fe8e6717,GB-PFIZER INC-202201392983,PFIZER,,47.0,YR,,F,Y,,,20221228,,PH,GB,GB,2022,Q4,Adult
217898741,21789874,14,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, weekly",,,,,,,,1.0,MG,,/WK,2022,Q4,Rash,,2022,Q4,1,I,,20221223.0,20221228,20221228,EXP,GB-MHRA-MIDB-4e4d9248-8fd2-4039-8064-49e1fe8e6717,GB-PFIZER INC-202201392983,PFIZER,,47.0,YR,,F,Y,,,20221228,,PH,GB,GB,2022,Q4,Adult
217940711,21794071,1,PS,SEMAGLUTIDE,SEMAGLUTIDE,1,Subcutaneous,OTHER FREQUENCY : weekly;?,,,D,D,151427,20230315.0,99.0,0.05,ML,,999,2022,Q4,Heavy menstrual bleeding,,2022,Q4,1,I,20221227.0,,20221228,20221228,DIR,642820,,FDA-CTU,,41.0,YR,,F,N,,,20221228,N,PH,US,,2022,Q4,Adult
217955301,21795530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, 1x/week",,,,,,,,1.0,MG,,/WK,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221216.0,20221229,20221229,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2022JUB00503,JUBILANT,Schumacher C. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report. Journal of Pharmacy Practice. 2022;0:1-5,64.0,YR,,F,Y,80.0,KG,20221229,,HP,US,US,2022,Q4,Adult
217955301,21795530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, 1x/week",,,,,,,,1.0,MG,,/WK,2022,Q4,Hypotension,,2022,Q4,1,I,,20221216.0,20221229,20221229,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2022JUB00503,JUBILANT,Schumacher C. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report. Journal of Pharmacy Practice. 2022;0:1-5,64.0,YR,,F,Y,80.0,KG,20221229,,HP,US,US,2022,Q4,Adult
217955301,21795530,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,"1 mg, 1x/week",,,,,,,,1.0,MG,,/WK,2022,Q4,Dehydration,,2022,Q4,1,I,,20221216.0,20221229,20221229,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2022JUB00503,JUBILANT,Schumacher C. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report. Journal of Pharmacy Practice. 2022;0:1-5,64.0,YR,,F,Y,80.0,KG,20221229,,HP,US,US,2022,Q4,Adult
217959751,21795975,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221226.0,20221229,20221229,EXP,,CA-PFIZER INC-202201397656,PFIZER,,43.0,YR,,F,Y,,,20221229,,HP,CA,CA,2022,Q4,Adult
217959751,21795975,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2022,Q4,Drug intolerance,,2022,Q4,1,I,,20221226.0,20221229,20221229,EXP,,CA-PFIZER INC-202201397656,PFIZER,,43.0,YR,,F,Y,,,20221229,,HP,CA,CA,2022,Q4,Adult
217959751,21795975,8,C,SEMAGLUTIDE,SEMAGLUTIDE,1,Unknown,,,,,,,,,,,Solution for injection,,2022,Q4,Polyneuropathy,,2022,Q4,1,I,,20221226.0,20221229,20221229,EXP,,CA-PFIZER INC-202201397656,PFIZER,,43.0,YR,,F,Y,,,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Pain in extremity,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Hyperkeratosis,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Haematocrit decreased,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Musculoskeletal stiffness,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Weight decreased,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Mean cell haemoglobin decreased,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Keloid scar,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Tension,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Mouth ulceration,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Haemoglobin decreased,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Oedema,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Polyuria,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Lichenification,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Rheumatoid arthritis,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Musculoskeletal stiffness,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Peripheral swelling,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Inflammation,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Skin ulcer,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Loss of personal independence in daily activities,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Papilloma,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Pain in extremity,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Ulcer,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Hypoaesthesia,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
217960031,21796003,10,C,SEMAGLUTIDE,SEMAGLUTIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20220816.0,20221221.0,20221229,20221229,EXP,,CA-PFIZER INC-202201384743,PFIZER,,50.0,YR,,M,Y,145.0,KG,20221229,,HP,CA,CA,2022,Q4,Adult
